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summary
SUMMARY
Tliree genes {Imcpa, Imcph and Imcpc) that encode cysteine proteinases (CPs) in 
L  mexicana have previously been cloned and sequenced. The enzymes encoded differ 
significantly from each other and host CPs. In an attempt to elucidate the parts played by 
each CP in the parasite's life histoiy, mutant lines of the parasite which lack Imcpa, 
Imcpb and Imcpc have been examined in order to determine their phenotypes. Null 
mutants which have been further modified by transfecting the cells with genes encoding 
L. mexicana CPs and CPs of other trypanosomatids have also been studied. These lines 
have been analysed to determine how they differ from the parent line in terms of 
proteinase and protein content, growth and differentiation axenically in vitro and in 
peritoneal macrophage cells, infectivity to mice and susceptibility to CP inhibitors.
Null mutants for the Imcpa CP gene were found to have a ciyptic phenotype, 
since differences between the Imcpa null mutants and wild type L. mexicana were not 
detectable. This suggested that either the enzyme has a role which was not detected with 
the phenotypic tests used or that its activity was being compensated for by one o f the 
other CPs present in L. mexicana. In contrast to previously published conclusions, 
studies using null mutants for Imcpa revealed that LmCPa was not at highest levels in 
the amastigote stage. Triton X-114 phase separation revealed the protein encoded by 
Imcpa to be hydrophobic, suggesting it could be membrane-associated.
Stationary phase promastigotes o f mutants null for the multicopy Imcpb genes 
showed a marked phenotype with respect to virulence, as their ability to infect 
macrophages in vitro was severely impaired. The infectivity was restored by re­
expression o f an enzymatically active internal copy of the gene array ig2.S), suggesting 
that the enzymes play a role in intracellular survival. Time course experiments 
demonstrated that the null mutants invaded macrophages in large numbers but were 
unable to survive in the majority o f the cells. Despite their reduced virulence to PECs, 
the mutants were capable o f infecting mice although the time taken for lesions to form 
was significantly longer than with wild type and the lesions were 1 0 0 -fold smaller. 
Interestingly, lesion amastigotes o f the mutants were able to infect macrophages in vitro 
as successfully as wild type, but took three months longer to produce lesions in mice.
ii
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These data showed that the CPs encoded by Imcpb are important for parasite virulence, 
but are not essential for survival in the host. Double Imcpa/lmcpb null mutants were 
found to have a similar phenotype to the Imcpb null mutants in terms of their ability to 
infect macrophages in vitro^ suggesting that Imcpa was not compensating for the loss of 
Imcpb in this phenotypic test, although it was found that they did not cause lesions in 
mice.
Studies utilising null mutants re-expressing different copies o f the Imcpb array 
revealed that individual isoenzymes differ in their substrate preferences and ability to 
complement the loss o f virulence associated with the null mutant, suggesting that the 
individual isoenzymes have distinct roles in the parasite's interaction with the host. 
Immunogold labelling o f the megasome in transfectants re-expressing an Imcpb CP gene 
with a truncated C-terminal extension {gl)  demonstrated that the C-terminal extension 
is not necessary for intracellular targeting or activity.
All life-cycle stages o f the mutants null for the cathepsin B-like CP gene (Imcpc) 
could be cultured in vitro, demonstrating that this CP is not essential for the growth or 
differentiation of the parasite. However, they showed greatly reduced infectivity to 
macrophages in vitro, resulting in only a low percentage o f the cells being infected. Re­
expression o f Imcpc in the null mutant increased the parasite's infectivity to 
macrophages in vitro. However, the null mutants for Imcpc formed lesions in mice at a 
rate comparable with wild type parasites, suggesting that although the CP encoded by 
Imcpc may play a role in the parasite-macrophage interaction it alone is not crucial for 
infectivity or virulence.
Peptidyl-diazomethane CP inhibitors, which entered the pai'asites and inhibited 
LmCPb in situ, had little or no effect on parasite growth or differentiation axenically in 
vitro. However, at the same concentration, A-benzoyloxycarbonyl-phe-ala-diazomethane 
reduced the infectivity o f wild type parasites to macrophages by 80%, a similar 
percentage to that seen with the Imcpb null mutant. However, further experiments 
suggested that LmCPb may not be the prime target o f this inliibitor.
With respect to drug target validation it is essential to determine which CPs are 
necessary for parasite survival. The overall results of this study suggest that while none
iii
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of the CPs of L. mexicana are vital, some appear to have important and distinct roles in 
differentiation and intracellular survival.
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general introduction
CHAPTER ONE 
GENERAL INTRODUCTION
1.1. LEISHMANIA AND LEISHMANIASIS
Leishmaniasis is classified by the World Health Organisation (WHO) as one o f 
the six major parasitic diseases, an affliction which has been described in the Old World 
for almost two thousand yeai's (Lainson and Shaw, 1987). Over 12 million people 
worldwide are infected by the different species of the causative agent, the parasitic 
protozoan Leishmania (Ashford et al., 1992). The disease has a  wide spectrum of 
clinical manifestations, varying from self-healing cutaneous ulcers to non-resolving 
mucocutaneous lesions and hepatosplenomegaly leading to death (review: Grevelink 
and Lerner, 1996). Leishmaniasis in its various forms is present on all continents except 
Australia and Antarctica, and, at a minimum, approximately 400,000 new cases occur 
each year’ with almost 400 million people at risk from this disease (Ashford et aL, 1992).
1.1.1. Life cycle
Leishmania is a kinetoplastid protozoan of the family Trypanosomatidae.
Trypanosomatids are obligate uniflagellated parasites defined by the presence o f the
kinetoplast, a DNA-eontaining struetui’e representing a specialised component o f the
single mitochondrion (Clark and Wallace, 1960). Leishmania exist in 3 distinct forms
during the life-cyele; a flagellated multiplicative promastigote form in the gut o f the
sandfly vector, a mammal-infective metacyclic form that occurs in the insect
mouthparts, and, subsequent to inoculation into a mammalian host, as a non-motile
amastigote stage within macrophages.
Transmission o f leishmania infection occurs almost exclusively by the bite of an
infected female sandfly in the tropics and sub-tropics. In the Old World the disease is
transmitted by flies of the genus Phlehotomus, while in the Americas it is transmitted
primarily by Lutzomyia species. Transmission occurs when infective metacyclic
.promastigotes are ejected into the host tissues during regurgitation of the bloodmeal 
from the fly by repeated pump pulsation. This is thought to occur due to Leishmania
1
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infections damaging the feeding mechanism o f the sandfly vector (Schlein et aL, 1992). 
The metacyclic promastigote is phagocytosed by host macrophages, within which it 
transforms to the round, non-flagellated amastigote form. A remarkable feature o f the 
intracellular amastigotes is that they are not only resistant to, but actively thrive in, the 
apparently hostile environment o f a phagolysosome (PL). The eventual rupture of 
infected cells releases amastigotes to be phagocytosed by other mononuclear 
phagocytes, and thus the infection spreads. When a sandfly bites an infected host, 
amastigotes taken up during the blood meal transform back to the promastigote form in 
the gut of the vector, thereby completing the life cycle.
Leishmaniasis is a zoonosis, the natural mammalian hosts in addition to humans 
including the domestic dog and a vai'iety o f wild mammals such as desert or forest 
rodents, foxes and sloths. At least four major groups o f parasites, similar in morphology 
but differing in cultural characteristics, clinical manifestations, geographic distribution, 
and sandfly vectors, cause disease in humans (Grevelink and Lerner, 1996). These are :
1) A donovani, the aetiological agent o f classic visceral leishmaniasis in Asia ('kala- 
azar')
2) L  major, which causes Old World cutaneous leislunaniasis ('oriental sore')
3) the L. braziliensis complex which results in cutaneous and mucocutaneous disease in 
the Americas ('espundia')
4) the L. mexicana complex, which includes A amazonensis and A pifanoi, and is 
associated mainly with cutaneous lesions in Central and South America ('Chiclero’s 
ulcer').
1.1.2. Clinical aspects
Three major clinical manifestations are recognised. These reflect mainly the 
different species o f  Leishmania involved, although host factors also contribute. The 
most life threatening is Kala-azar, or visceral leishmaniasis, a systemic disease caused 
by the dissemination o f L. donovani tlnoughout the reticuloendothelial cells o f the 
spleen, liver, lymph nodes and bone marrow (Rees and Kager, 1987). After an
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incubation period o f two to four months, characteristic symptoms of the disease develop 
and include fever, splenomegaly, anaemia, emaciation and hyperglobulinaemia. When 
untreated, the disease usually progresses to a fatal termination within two years. A 
condition known as post Kala-azar dermal leislimaniasis occasionally affects patients 
recovering from visceral leishmaniasis in India and East Africa, generally appearing one 
to two years after the visceral disease. In this condition, hypopigmented areas appear on 
the body, which do not always respond to treatment and almost never completely 
repigment. Post Kala-azar dermal leishmaniasis is of great epidemiological significance, 
since parasites can easily be picked up by biting sandflies.
Mucocutaneous leislimaniasis is most commonly reported in the jungle areas of 
Brazil, Venezuala, Bolivia and Ecuador. L. b. braziliensis is the most common etiologic 
agent, although cases caused by other Leishmania species have been reported, 
particularly L. b. panamensis, which increases the risk to travellers in Central America. 
Fifty percent o f patients infected have mucocutaneous lesions within two years o f the 
initial cutaneous lesions; associated factors with the development o f mucocutaneous 
disease include male sex and large, persistent cutaneous lesions. The disease often 
begins in the nasal septum, which becomes inflamed and infiltrated and subsequently 
perforates. Further mutilation of the palate, pharynx, tonsils, gums and lips leads to 
invasion of the respiratory tract, and, as a result, malnutrition and acute respiratoiy 
pneumonia are the leading causes o f  death in victims (Saravia et a l ,  1985).
Cutaneous leishmaniasis, frequently caused by L. major in the Old World and L. 
mexicana in the New World, is usually a localised infection starting with a solitary 
primary lesion, although multiple primary lesions may be evident in Old World disease 
(Grevelink and Lerner, 1996). After an incubation period o f 1 week to 3 months, there is 
the appearance of a red papule, which enlarges to a plaque or nodule. This finally 
develops into an ulcer which spontaneously regresses after six to twelve months leaving 
a scar. The locations of lesions may be distinctive. For example, 'Chiclero's ulcer', 
caused by infection with L. mexicana, results in erosion of the ear o f forest workers who 
gather chicle gum. However, a more serious variant o f localised cutaneous leishmaniasis 
can occur, called diffuse cutaneous leislimaniasis, in which lesions are disseminated and
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resemble lepromatous leprosy. This disease, caused primarily by L. mexicana and L  
amazonensis in Central and South America, does not invade internal organs but 
responds only partially to treatment and often relapses, becoming clnonic.
1.1.3. Chemotherapy
Treatment o f all forms o f leishmaniasis is still largely dependent on the 
pentavalent antimonials, notably sodium stibogluconate (Pentostam), a treatment 
developed empirically more than 50 years ago (review: Croft, et al., 1997). Although the 
exact structure o f the drug is still unknown, the mechanism o f action appears to be the 
inhibition o f amastigote glycolytic activity and fatty acid oxidation. Pentostam is far 
from an ideal chemotherapeutic agent, requiring parenteral administration and 
prolonged hospitalisation, and moreover, treatment commonly results in side effects 
such as cardiac and renal toxicity. Although visceral and cutaneous leishmaniasis 
frequently respond to this drug, severe mucosal disease does not (Herwaldt and Berman,
1992).
The second line drugs cuiTently in use are the aromatic diamidine pentamidine 
and the anti-fungal agent amphotericin B (review: Olliaro and Bryceson, 1993). They 
must be administered intravenously, and are less effective and even more toxic than 
Pentostam (Croft, et aL, 1997). The antibiotic paramomycin is currently used for the 
treatment o f some leishmaniases but, like the other treatments, it is not absorbed when 
administered orally and little is known about its mechanism of action (Maarouf et aL, 
1997). New formulations o f the same drugs, such as liposomal amphotericin B, are less 
toxic and show good activity (Castagnola et al., 1996) but are veiy expensive.
WHO has established as a priority objective the ability to provide oral treatment 
for cutaneous leishmaniasis; this would provide clinical benefits and cost savings over 
present drugs for treating patients from areas where leislimaniasis is endemic. Among 
potential orally active drugs, combination therapy using sterol biosynthesis inhibitors, 
such as ketokonazole and terbinafme, offers an attractive possibility (Rangel et aL, 
1996).
Resistance o f both visceral and mucocutaneous leishmaniasis to pentavalent
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antimonials has been increasing in all areas of endemicity (review: Ouellette and 
Papadopoulou, 1993) and, coupled with the emergence of AIDS-related leishmaniasis, 
there is an increased urgency for new drugs to be developed (Olliaro and Bryceson,
1993). Among the potential drug targets, polyamine synthesis, purine salvage, sterol 
metabolism and cysteine proteinases are the foci o f much o f the present research 
activities (Traub-Cseko and Momem, 1995; Maingon et aL, 1995).
1.2. PROTEINASES
Proteinases are enzymes that are found throughout the plant and animal 
kingdoms. These enzymes cleave peptide bonds after binding to a specific amino acid 
sequence and are thus the tools o f the cell for the turnover o f proteins. They can be 
highly specific, both in the reaction catalysed and in their preferred substrates. The 
cellular functions o f proteinases are widespread and include the removal o f signal 
peptides from nascent polypeptides, cellular reorganisation and degradation of proteins 
to amino acids for nutritional purposes (Barrett and McDonald, 1980). A number of 
these enzymes are present in lysosomes for both intracellular protein breakdown and 
breakdown o f endocytosed extracellular proteins. Proteinases at the cellular membrane 
can be involved in intracellular cormnunication by proteolytic activation of bioactive 
compounds such as growth factors and cytokines. Conversion of inactive prohormones 
or proenzymes into their active counterpart is also a proteolytic process as is the 
activation o f the blood clotting system.
Synthetic inhibitors o f proteinases have proved useful in classifying proteinases 
into four major groups. These have been termed aspartic, cysteine, métallo- and serine 
proteinases, according to the residue involved in the binding and catalysis o f substrate at 
the active site (Barrett and McDonald, 1980). Peptide substrates are used to map active- 
site specificity o f proteinases and provide specific and sensitive assays. By convention, 
the amino acid residues on the amino terminal side o f the peptide bond being cleaved 
are designated P^,P2 , P 3  etcetera, whereas on the carboxy temiinal side they are termed 
P]% P 2 , P 3 ' and so on (Berger and Schecter, 1970).
The cathepsins are mammalian lysosomal proteinases which are widely
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distributed and differentially expressed among tissues. Intracellularly they serve a 
variety o f digestive and processing functions, whereas extracellularly they may be 
involved in tissue remodelling and in pathologies such as artliritis, Alzheimer's disease 
and cancer. The cathepsins are subdivided on the basis o f their active site residues as 
cysteine, serine or aspartic proteinases. O f the cathepsins, B, C, H, L and S are cysteine 
proteinases, D and E are aspartic proteinases and G and A are serine proteinases.
1.2.1. Cysteine Proteinases
The proteolytic enzymes containing a nucleophilic cysteine as a member o f the 
catalytic machineiy are collectively known as the cysteine proteinases (CPs). The 
majority o f CPs are endopeptidases, but some act additionally or exclusively as 
exopeptidases. The archetypal CP is papain, from the latex of the unripe fruit o f Carica 
papaya. Subsequently CPs have been found in nearly every kind of organism, from 
RNA and DNA viruses to eubacteria, protozoa, fungi plants and animals. As yet, no 
archaebacterial CP has been sequenced, but there is evidence that it exists (Banett and 
Rawlings, 1996).
The well characterised CPs found in mammalian cells can be divided into 2 
groups, one comprising mainly the lysosomal enzymes cathepsins B, H and L (Barrett 
and Kirschke, 1981) and the other the cytoplasmic Ca^^-dependent enzymes, the 
calpains (Murachi, 1983). Apart from their cellular location, a featui'e that distinguishes 
the ealpains from the cathepsins is their lack o f inliibition by diazomethane compounds 
(Barrett et al., 1982), although in common with the lysosomal CPs, the calpains are also 
inhibited by the class-specific inhibitor, E-64. All o f the CPs have an essential cysteine, 
histidine and asparagine, the mechanism o f action depending on the sulphonium ion of 
the cysteine providing nucleophilic attack on the carbonyl group in the peptide bond. 
CPs are generally > 3 1  kDa in size, have broad pH optima, from 5.5 to 7.5, and can 
function in a variety o f environments as long as sufficient reducing agent is present to 
prevent the active-site thiol group being oxidised (McKerrow et a l ,  1993).
Studies of many lysosomal enzymes, including CPs, have indicated that they are 
synthesised as inactive preproproteins that acquire activity only after the removal o f the
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N-terminal pro-peptides in the pre-lysosomal compartment (Fig. 1.). Metalloproteinases 
and aspartic proteinases have been reported to be involved in the processing of 
lysosomal enzymes (Hara el a l, 1988; Nishimura et a l, 1989). This cleavage, with 
mammalian cathepsin B for example (Mach et al., 1994), may be brought about in vitro 
at acid pH, suggesting that the lower pH of the lysosome may be responsible for 
triggering activation in vivo. The papain family has more Icnown members than any 
other family o f CPs. With few exceptions these endopeptidases, which include the 
majority o f parasite CPs, show a strong preference for hydrolysis o f bonds in which the 
P2  residue is a hydrophobic one. Typical members o f the family are the proteinases o f 
the food vacuoles of protozoa, and the lysosomal proteinases, cathepsins B, H, L, K, S 
and others, in higher animals. In the lysosome, enzymes of this type contribute to the 
turnover of cellular proteins and also act in phagocytic cells to digest the proteins of 
microrganisms. This activity contributes antigenic peptides to the major 
histocompatibility system, leading to the production of antibodies (Mizuochi el al.,
1994). The lysosomal enzymes can also be secreted into the extracellular matrix, where 
they contribute to tissue remodelling in cartilige and bone. Specific CPs are also thought 
to be involved in pro-hormone processing, cyclin B degradation and platelet activation 
(review: Kirsclike et al., 1995). Proteolysis by CPs outside the lysosomes is regulated by 
physiological pH values and natural inhibitors. However, as will be discussed later, an 
alteration o f this balance in favour o f the enzymes leads to uncontrolled proteolysis seen
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in several disorders such as inflammation, tumour growth and arthritis (see section 
1.2.1.3).
1.2.1.1, Cathepsin L
Cathepsin L is a lysosomal protein involved in protein degradation (Kirsclike and 
Barrett, 1987) and is synthesised as an inactive precursor that is processed to produce a 
28 kDa single chain mature enzyme (Fig 1). The pro-region is a potent inhibitor o f the 
enzyme's activity (Carmona et al., 1996) through its binding to the active site 
(Coulombe et al., 1996), thus maintaining the proteinase in an inactive form during 
trafficking to the lysosome. Cathepsin L is catalytically active at pHs 3.0 - 6.5 in the 
presence of -SFI containing compounds, while the precursor is stable at physiological 
pH. Studies on the activation of pro-cathepsin L showed that this can occur 
autocatalytically as well as by other proteinases such as cathepsin D and 
metalloproteinases (review: Kirschke et al., 1995). Cathepsin L is a strong 
endopeptidase implicated in the modification o f numerous proteins, such as degradation 
o f matrix proteins, the activation o f pro-plasminogen and the inactivation o f bradykinin, 
to name but a few (Kirschke et al., 1995). The enzyme has been found to have a 
restricted specificity in the hydrolysis of synthetic substrates, cleaving preferentially at 
pH 5.5 those with arginine in the P, position and hydrophobic residues in the ? 2  and P3  
positions. The methylcoumarylamide substrate Z-Phe-Arg-NHMec is a suitable 
substrate for determining cathepsin L activity. Cathepsin L-like enzymes have been 
characterised from a wide range o f eukaryotes, including some protists that are thought 
to form the earliest branches of the eukaryotic tree (Berti and Storer, 1995), although 
there appear to be differences in properties between enzymes from the various species.
1.2.1.2. Cathepsin B
Cathepsin B is similar to cathepsin L in being a lysosomal proteinase present in 
all mammals and nearly all organs and tissues; similar enzymes also occur in lower 
organisms, as will be discussed later (section 1.2.2.2). Synthesised as a glycosylated pre- 
pro-enzyme (Fig. 1.), it is processed to a -3 0  kDa single chain active protein on route to
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the lysosome. Secreted cathepsin B is in the pro-enzyme form, which differs from the 
mature processed form since it is stable at neutral pH. The eathepsin B pro-peptide is a 
potent inhibitor o f cathepsin B at pH 6.0. but can be removed autocatalytically, as well 
as by cathepsin D, pepsin, and other serine, métallo- and cysteine proteinasess. 
Cathepsin B has broad substrate specificity and cleaves several synthetic substrates, 
notably methylcoumarylamides containing the Ai'g-Arg sequence. The specificity o f the 
endopeptidase activity of cathepsin B is uncleai" the amino acid in P, can be varied 
greatly, and glycine and arginine as well as hydrophobic amino acids can be 
accommodated as the Pg residue. As a result, a great many proteins are degraded or 
modified by cathepsin B. For example, plasminogen is activated whereas fibronectin is 
degraded (for a review o f cathepsin B, see Kirschke et al., 1995).
1,2.1.3. Involvement in mammalian pathologies
Although lysosomal CPs play an important role in the turnover of intracellular 
proteins, the results o f recent studies suggest that cathepsins L and B are more stable in 
the extracellular enviromnent than was previously believed and evidence is increasing 
that they play a significant extracellular role in a range o f physiological disorders. For 
example, tumours o f various types have been reported to express increased levels of 
cathepsins B, H and L, and extracellularly these enzymes have been implicated in 
tumour invasion and metastasis (Liotta and Stetler-Stevenson, 1991). Furthermore, 
cathepsins S, B and L have been implicated in Alzheimer's disease, arthritis and 
inflammation (review: Mtiller-Ladner ct rzA, 1996)
Secretion o f precursor forms o f cathepsin L is known to occur not only from 
normal cells such as macrophages and fibroblasts, but also from cells treated with 
growth factors and tumour promoters and malignantly transformed cells (Kirschke el al.,
1995). Cathepsin L has been shown to be active towards extracellular matrix proteins at 
physiological pH and it is hypothesised that this enzyme might facilitate the invasive 
steps of metastasis during which tumom* cells cross through the basement membranes 
(Duffy, 1992). Other physiological processes that this enzyme has been specifically 
implicated in are bone resorption and arthritis (Trabandt, et al., 1990).
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Cathepsin B is the lysosomal CP that has been implicated most in disease 
pathogenesis, paiticulaiiy with regards to joint destruction in rheumatoid artluitis, 
muscular dystrophy and tumour metastasis (reviews: Elliot and Sloane, 1996; Müller- 
Ladner et al., 1996). Production o f cathepsin B by tumour cells has been linked to 
metastatic potential in several experimental models, and it is found in higher amounts in 
Lewis lung carcinoma, colon carcinoma cell lines and ascites fluid o f women with 
ovarian carcinoma. The ability o f tumour cells to invade into the extracellular matrix has 
been attributed to cathepsins released by tumour cells or associated with the plasma 
membrane o f  tumour cells (Sloane et al., 1994, and references therein). Cathepsin B 
secreted by invading tumour cells can degrade collagen and elastin (Kirschke et al., 
1982) thereby destroying the basal laminar region. The finding that in tumour cells 
cathepsin B is delivered to the plasma membrane rather than to the lysosome (Sloane et 
al., 1994b) and secreted into the surrounding medium (Sukoh et al., 1994) indicates that 
tumour cells are defective in their intracellular processing o f proteinases.
Bacterial proteinases have been implicated as both pathogenic and virulence 
factors, with many o f the medically important species producing enzymes involved in 
tissue invasion and desti'uction, evasion o f host defences and modulation o f the host 
immune system during infection and inflammation (review: Travis et al., 1995). An 
example is the anaerobic Gram-negative rod bacterium Porphyromonas gingivalis, 
which has been implicated in the initiation and progression o f certain forms o f 
periodontitis, including juvenile and adult periodontal disease. The combined 
proteolytic activities o f P. gingivalis have been shown to be virulence factors capable o f 
degrading and inactivating host defence proteins, structural proteins and plasma 
proteinase inhibitors (Johnson, 1991, and references therein). Multiple CPs designated 
gingipains have been identified in P. gingivalis and are unusual in not only having a 
putative role in adhesion o f the microorganism to host tissue, but also in having no 
homology to other known CP families (Pavloff et al., 1997).
1.2.2. Proteinases of Parasites
Parasite proteinases have been the subject of much research and this topic has
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been extensively reviewed (North et al., 1990; North, 1992; McKerrow, 1989, 1993; 
Robertson et a l ,  1996; Coombs and Mottram, 1997). Broadly speaking, these enzymes 
appear to have important roles in parasite transformation, parasite nutrition, host 
invasion and also evasion o f the host immune response. Many parasitic organisms 
differentially express proteinases at different stages o f tlieir life cycle, as appropriate for 
their role. In the process o f tissue infection by helminth parasites, for example, 
proteinases are thought to be important not only for tissue lysis and migration 
(McKerrow, 1989, Pritchard, 1995) but also for nutrient uptake (Chappell and Dresden,
1986) and immune evasion (Carmona et ah, 1993). The cathepsin L-like proteinases o f 
parasitic protozoa often play an important role in the destruction o f host proteins 
(Stanley et al., 1995), in the nutrition o f the parasite (Rosenthal, 1995) and in the 
neutralisation o f the host immune response (Reed et al., 1995; Leao et al., 1995). There 
is great interest in these enzymes since several appear to be promising targets for the 
development o f new anti-parasite chemotherapy.
There is an enormous amount o f literature concerning the proteinases o f 
parasites; therefore, I have concentrated on a few examples which best illustrate the 
diversity o f these enzymes, both in helminths and in protozoa.
1.2.2.L Helminths
Haemonchus contortus is a highly pathogenic blood feeding nematode which 
resides in the abomasum o f sheep, goats and other small ruminants. A number o f 
proteinases have been described from this ovine parasite including a zinc 
metalloproteinase, the secretion of which controls the ecdysis o f infective 3rd stage 
larvae (Gamble et a l ,  1989, 1996), and several CPs from the adult stage (Pratt et al., 
1990). Cathepsin B-like CPs are widely distributed in parasitic helminths, and H. 
contortus contains at least 5 genes (Cox et al., 1990), the corresponding enzymes o f 
which are thought to have a role in nutrition. The latter proteinases were cloned and 
sequenced, and were found to represent a multigene family (Pratt et a l, 1992). The 
transcribed CPs have been found in adult worm extracts but not 3rd or 4th stage larvae, 
suggesting their function is in worm feeding. Developmentally regulated secretion of gut
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associated cathepsin L-like CPs by adult H. contortus has been reported (Rhoads and 
Fetter, 1995). It has been hypothesised that the gut-associated enzymes may function as 
digestive enzymes, and the secreted proteinases may function in the degradation of 
abomasal tissue and blood vessel walls, facilitating the parasites access to tissue or 
blood components (Rhoads and Fetterer, 1996). More recently, a developmentally- 
regulated zinc metalloproteinase was characterised from secretions o f 4th stage larvae o f
H. contortus (Gamble et a l ,  1996b). It was shown that this differed from the previously 
characterised metalloproteinase involved in the ecdysis o f 3rd stage larvae, prompting 
speculation that this enzyme is involved in feeding or prevention o f blood clotting. //. 
contortus also has a putative metalloproteinase found in host protective gut-extracts o f 
the adult helminth (Redmond et al., 1997); this enzyme is thought to be involved in 
proteolytic digestion of the blood meal and has potential as a sub-unit vaccine 
component or novel target for chemotherapeutic intervention. Indeed another higlily 
protective gut membrane protein isolated from Haemonchus was found to be an 
aminopeptidase, suggesting that vaccination with helminth proteinases could prove to be 
an effective anti-parasite strategy.
The apparent intestinal source o f the CPs and their release via defecation might 
represent an adaptation enabling H. contortus to modify its host microenvironment. This 
mechanism is similar to the secretion of cathepsin L-like CPs by the liver fluke Fasciola 
hepatica from intestinal cells and release via regurgitation (Smith et al., 1993) 
suggesting that the release o f gut proteinases might represent a specific adaptation to 
parasitism. This concept is supported by the fact that Caenorhabditis elegans, a free- 
living nematode that contains a CP gene with specific expression in the gut and a 
predicted amino acid sequence with 50% homology to that o f the H. contortus CP (Ray 
and McKerrow, 1992), does not release proteinases during culture (Lackey et al., 1989). 
CPs also appear to play a nutritional role in other parasitic nematodes that digest 
haemoglobin, such as Ascaris (Maki and Yanagisawa, 1986) and the hookworm 
Ancylostoma caninum. The latter secretes both cathepsin L-like and cathepsin B-like 
CPs, apparently for their anticoagulation properties (Harrop et a l ,  1995).
An extracellular matrix model, which mimics the in vivo structure o f connective
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tissue and basement membranes, has become a useful tool in analysing host-parasite 
interactions, parasite developmental processes and, in particular, parasite proteinase 
roles (review: Rhoads and Fetterer, 1997). For example, the hypothesis that the skin 
invasive larval stages o f nematode parasites such as Strongyloides stercoralis 
(Mckerrow et al., 1990) and Onchocerca species (Lackey et al., 1989) utilise secreted 
proteinases to traverse keratin, epidermal cell layer, basement membrane, dermal 
cormective tissue and blood vessel walls was supported by the ability of these parasites 
to degrade extracellular matrix efficiently (Rhoads and Fetterer, 1997). The enzymes 
involved were characterised as either serine or metallo-elastases, a finding consistent 
with the elastin-rich extracellular matrix of skin. Proteinase release by the filarial 
nematode Dirofilaria immitis increases at the time o f moulting from the 3rd to 4th larval 
stage and corresponds to an increase in the specific degradation o f the collagen 
component o f extracellular matrix (Richer et al., 1992). A cathepsin L-like CP has 
recently been implicated in the moulting process of the related species Brugia pahangi 
(McKerrow, 1994).
The CPs o f F. hepatica have been implicated in invasion by the juvenile stages 
(Dalton and Fleffernan, 1989) as well as the haematophagic activities o f the established 
liver fluke (Rege et al., 1989, and references therein). A number o f workers have shown 
that the CPs of F. hepatica can cleave human IgG and IgM (Chapman and Mitchell, 
1982; Heffernan et al., 1991), which may allow the parasite to evade host antibody- 
mediated immune mechanisms whilst in the blood circulatoiy system during migration. 
Although several CPs are present, the major protein in the excretoiy-secretory products 
o f adult and juvenile F. hepatica is a 25-26 kDa CP with a subsite specificity similar to 
that of cathepsin B (McGinty et al., 1993; Dowd et a l,  1995). The importance o f this 
CP in parasite fecundity has been implicated, since vaccination using a CP o f Fasciola 
has been shown to decrease worm burden and egg production by the parasite (Smith el 
al., 1994).
Both cathepsin L-like and cathepsin B-like CPs have been identified in 
secretions and extracts o f the adult blood fluke Schistosoma mansoni. The cathepsin L- 
like CP has been hypothesised as the major proteinase involved in the degradation o f
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haemoglobin by schistosomes. This suggestion was based on the finding that the 
cathepsin L activity greatly predominated over the cathepsin B (Smith et a l,  1994b; 
Dalton et al., 1995, 1996). However, the recent report that the vomitus of adult 
schistosomes contains a major cathepsin B-like but only minor cathepsin L-like activity, 
biochemically variable between schistosome species (Caffrey et al., 1997), argues 
against this hypothesis. S. mansoni cercariae release both cathepsin L-like and cathepsin 
B-like CPs and it is thought that they may be involved in the process o f  skin penetration 
(Dalton et ah, 1997) together with the well documented serine proteinases (McKerrow 
et ah, 1985, 1991). Sequence comparisons have recently shown that a S. mansoni 
protein from extracts of adult worms, named Sm32, is similar to asparaginyl 
endoproteinases, a novel family of CPs o f which the legumains from legumes are the 
best characterised (Takeda et ah, 1994; Dalton et al, 1995b). It is proposed that Sm32 is 
involved in pro-enzyme activation, due to its strict substrate specificity (Dalton and 
Brindley, 1996), and may therefore represent a potential drug target.
Proteinases with parasite specific functions have also been identified in several 
cestode species. The plerocercoid stage o f the pseuodophyllidean tapeworm Spirometra 
mansonoides has been found to contain a neutral CP that is also a growth hormone 
agonist, facilitating tissue penetration while stimulating the host's growth (Phares et ah,
1996). CPs have also been identified in the related species S. eriacei and S. mansoni 
plerocercoids (Fukase et ah, 1985; Song and Chappell, 1993). These have been found to 
cleave immnuoglobulins (Kong et ah, 1994) and invoke a specific IgE response in 
infected individuals (Kong et ah, 1997). Human neurocysticercosis is caused by 
infestation o f the central nervous system with the cyst stage o f Taenia solium, the pork 
tapeworm, and the cysts produce cysteine, aspartic and metalloproteinases (White ei ah, 
1992). A CP has been found to be the predominant enzyme involved in IgG degradation 
by the cysts o f the related species T. crassiceps and is another potential target for anti- 
parasitic chemotherapy (White et ah, 1997).
1,2.2,2, Protozoa
Although the parasitie protozoa represent a very diverse group o f organisms, the
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highest activity proteinases are often the CPs (North, 1992). These have heen found in 
most o f the important parasites during at least one stage o f the life cycle, often a stage 
present in the mammalian host. Some o f their potential functions include tissue 
invasion, penetration into and survival in the host cell, and parasite remodelling during 
transition of one morphological state to another. The occuiTence o f CPs in parasitic 
protozoa has been summarised (North et al., 1990); the enzymes most studied are those 
in Leishmania mexicana, Trypanosoma brucei, T  cruzi, Trichomonas vaginalis, 
Tritrichomonas foetus, Giardia intestinalis. Entamoeba histolytica, Theileria and 
Plasmodium falciparum. Many o f the enzymes are located in lysosomes, and in 
comparison with the mammalian enzymes some are unusually large and relatively stable 
to alkali.
Giardia species cause a common water borne intestinal infection in humans. 
Lindmark (1988) first reported that proteinases were present in ly so some-like 
subcellular particles in Giardia trophozoites, and subsequent studies confirmed the 
occurrence o f CP activity (Hare et al., 1989; and references therein). More recently two 
CPs fi'om G. intestinalis have been characterised (Werries et al., 1991) and multiple 
proteinase activities due not only to CPs but also serine and aspartic proteinases have 
been detected in lysates o f trophozoites o f Giardia intestinalis (Williams and Coombs, 
1995). However, it is not yet known in which aspect o f parasite development, 
metabolism or pathogenesis they are involved in.
Trichomonas vaginalis secretes CPs which are significantly larger in size than 
the well characterised mammalian lysosomal enzymes (Lockwood et al., 1987) and 
there is evidence that these CPs can degrade host antibodies (Provezano and Alderete, 
1995). Surface-associated CPs have been reported to be involved in the cytoadherence 
and cytotoxicity o f this organism and are thus perceived to be important virulence 
factors (Arroyo and Alderete, 1989, 1995).
Severe tissue damage can result from infection by certain pathogenic amoebae 
and released CPs have been implicated in the pathogenesis o f Entamoeba histolytica 
(Keene et al., 1986), Acathamoebapolyphaga  (Mitro et al., 1994) and Naegleria fow leri 
(Aldape et al., 1994). CPs are important virulence factors o f pathogenic E. histolytica
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(Scholze and Tannich, 1994), having been shown to degrade host proteins such as 
complement factors (Reed et al., 1989) and be released by viable trophozoites, rather 
than simply leaking out upon cellular disentegration (Leippe et al., 1995). However, a 
homologue o f one o f the tliree CPs genes o f pathogenic E. histolytica has been found in 
non-pathogenic E. dispar strains (Mirelman et al., 1996), a finding which rules out the 
proposed test for pathogenic or non-pathogenic stiains based on the presence or absence 
of these genes (Reed et al., 1995).
Malaria is the most important protozoan infection worldwide, with hundreds o f 
millions of cases and approximately one million deaths reported annually (Walsh, 
1989). Trophozoites o f Plasmodium falciparum  obtain free amino acids for protein 
synthesis by degrading host eiythrocyte haemoglobin in an acidic food vacuole. 
Available evidence suggests roles for CPs, serine and aspartic proteinases in the 
invasion and rupture o f erythrocytes by malaria parasites, as well as in haemoglobin 
degradation by trophozoites. Two CPs o f apparent sizes 28 kDa and 6 8  kDa have been 
identified in P. falciparum  (Rosenthal, et al., 1988, 1989). The 6 8  kDa enzyme is 
involved in invasion of eiythrocytes by merozoites (Mayer, et al., 1991) whereas the 28 
kDa proteinase (falcipaiii) is implicated in parasite multiplication and haemoglobin 
digestion within the erythrocyte, and is located within an acidic food vacuole 
(Rosenthal, et al., 1987; Rosenthal, et al., 1988; Rocket et al., 1989). A P. falciparum  
CP gene was recently eharacterised as having 37% amino acid identity to cathepsin L 
(Rosenthal and Nelson, 1992) and appeared to be the gene encoding the 28 kDa 
trophozoite proteinase falcipain. The P. falciparum  food vacuole contains not only the 
CP falcipain but also the aspartic proteinases plasmapepsins I and II (Gluzman et al., 
1994, and references therein). All thi'ee enzymes can cleave denatured haemoglobin in 
vitro (Rosenthal, et ah, 1988; Salas et ah, 1995). It has recently been discovered that the 
falcipain gene is the only CP gene whose transcript can be detected in the early 
intraerythrocytic parasites (Francis et ah, 1996) and it has been proposed that falcipain 
works by degrading haemoglobin fragments after initial aspartic proteinase attack has 
denatured the substrate. For a detailed review of haemoglobin catabolism by malaria 
parasites see Rosenthal and Meshnick, 1996.
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CPs and metalloproteinases have been found in a wide range of trypanosomatids 
(Branquinha et ah, 1996, and references therein) although there are marked differences 
between the enzyme profiles from the monogenetic {Crithidia, Herpetomonas, 
Leptomonas) and digenetic (Trypanosoma, Leishmania, Endotrypaniim, Phytomonas) 
species. In the case o f T. brucei, the causative agent of African sleeping sickness, a CP 
gene was cloned and sequenced, and the amino acid sequence deduced from cDNA 
showed similarity with human cathepsin L (Mottram et al., 1989). The cDNA of the 28 
kDa enzyme predicted a protein with a 108 residue C-terminal extension (CTE) of 
unknown function, similar to that of T. cruzi (see below). The substrate specificities o f 
CPs o f the parasite were studied in more detail (Robertson et al., 1990) and the results 
showed that T. brucei contains a group o f four CPs similar in substrate and inhibitor 
specificities to cathepsin L, and also larger enzymes that are probably serine proteinases. 
Subcellular fractionation studies indicate that the main hydrolytic activity o f T. brucei is 
located within organelles that resemble lysosomes (Lonsdale-Eccles and Grab, 1987), 
with higher levels being reported in short stumpy bloodstream forms infective for the 
tsetse fly vector (Pamer et al., 1989, 1990). This suggests a biological role for this CP 
activity in differentiation or adaptation to the insect host. A developmentally regulated 
lysosomal CP, termed congopain, exists in T. congolense (Mbawa et al., 1991, Fish el 
al., 1995). It has high homology to CPs o f T  brucei and T. cruzi including the presence 
o f a CTE (Authie el al., 1993), which is characteristic o f the so called Type I CPs of 
trypanosomatids (see section 1.5.2.1). Host proteins such as immunoglobulins and 
complement factors are degraded by congopain in vitro (review: Authie, 1994). 
Congopain elicits a high IgG response in tiypanotolerant but not trypanosusceptible 
cattle during primaiy infections, which suggests that congopain may play a role in 
pathogenicity and that more efficient immune responses to congopain may contribute to 
tiypanotolerance (Authie, 1994). The CTE o f congopain is thought to be the most 
immunogenic part of the molecule, stimulating antibodies that do not affect the enzyme 
function.
The trypanosomatid Trypanosoma cruzi is the causative agent o f Chagas' 
Disease, estimated to affect over 16 million people in Central and South America and is
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the leading cause o f heart disease in these countries. Three CPs have been purified to 
homogeneity from epimastigotes (Bontempi et a l,  1984; Rangel et a l,  1981b; Bongertz 
and Hungerer, 1978). The major enzyme, tenned 'cruzipain', has a cathepsin L-like 
preference for dipeptide substrates containing phenylalanine and arginine (Bontempi, et 
a l ,  1984), hydrolyses casein and haemoglobin in substrate SDS-PAGE gels (Rangel, et 
ah, 1981), and has a molecular mass of ar ound 40 kDa (Martinez and Cazzulo, 1992). It 
is a high mannose-type glycoprotein (Cazzulo et al., 1989) whose expression is 
developmentally regulated, with highest levels being found in the insect vector 
(epimastigote) form o f the parasite (Campetella, et al., 1990). Cruzipain is found in 
lysosomes, perhaps indicating a role in parasite nutrition (Bontempi, et a i,  1989), but 
some is also detected on the cell surface (Souto-Padron, et al., 1990) and so the enzyme 
could be involved in host cell penetration. The multicopy (-130) cruzipain gene has 
been cloned, by sequencing a DNA fragment obtained by PCR amplification (Eakin el 
al., 1990; Campetella et al., 1992), and appears to encode a protein that includes the 
expected pre-pro-enzyme form as well as an unusual CTE o f approximately 145 amino 
acids (Aslund, et al., 1991; Eakin, et al., 1992). The pre-pro form is similar to that found 
in other members o f the papain superfamily, but the CTE is relatively rare, having been 
identified so far only in some other trypanosomatid CPs, including CPs of Trypanosoma 
(see above) and Leishmania species (see section 1.4), in the tomato (Mottram, et al., 
1989; North, 1991) and also in rice (Watanabe et al., 1991). However, the CTE is 
present in the mature enzyme of T. cruzi, whereas it appears to be largely removed 
during post-translational processing in the other trypanosomatids. Proposed functions 
for the CTE, which can be obtained by self proteolysis (Heilman et al., 1991), and 
which is not necessary for enzyme activity (Eakin et al., 1992, 1993) include targeting 
the proteinase within the parasite cell and/or anchoring it to a cell membrane, Cruzipain 
and its CTE are detected in biological fluids during experimental infection o f mice 
(Gonzalez et ah, 1996) and, interestingly, the relative amount o f CTE detected is 7-fold 
higher than that o f the catalytic domain, reinforcing the idea o f a highly 
immunodominant but enzymatically inactive CTE domain (Cazzulo et al., 1992; Authie,
1994), The presence o f cruzipain in serum means that differential serodiagnosis o f
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human infections caused by T. cruzi and Leishmania spp is now possible using purified 
cruzipain as the specific antigen (Malchiodi et al., 1994). The 3 dimensional structure o f 
the enzyme has been solved, revealing that cruzipain is isostructural with papain 
(McGrath et al., 1995) and suggests a common catalytic mechanism (Storer et al.,
1994).
1.3. PROTEINASE INHIBITORS AS DRUGS
It has become apparent that proteinases play crucial roles in numerous 
pathological processes and the development of non-toxic proteinase inhibitors for in 
vivo application is the subject of much research. The general belief is that the highly 
specific recognition by proteinases o f defined amino acid sequences should make it 
possible to inhibit enzymes involved in pathological processes while leaving other 
proteinases unaffected. Arthiitis, tumour invasion and metastasis, parasitic infection, 
HIV infection and a number o f degenerative diseases have been linked with the 
involvement o f one or more proteolytic enzymes and so proteinase inhibitors could have 
beneficial activities.
1.3.1. Synthetic inhibitors
An extremely important breakthrough in the understanding o f proteolysis was 
the development o f specific synthetic substrates (Smith et al., 1992, and references 
therein), a principle that has been extended for the development o f selective synthetic 
inhibitors. The binding o f an amino acid sequence to the active centre o f a proteinase 
can be applied to achieve selective inhibition of an enzyme, by linking to the peptide 
sequence a group that can bind covalently to, and so inactivate, the active site of the 
enzyme (Evans and Shaw, 1983). Specific and irreversible proteinase inhibitors have 
been developed against mammalian cathepsins, and have great potential for 
chemotherapy against arthritis, metastasis o f cancer cells and parasitic infections.
Selective synthetic inliibitors o f CPs typically form ineversible covalent bonds 
to the active site thiol (review: Rasnick, 1996). Peptidyl diazomethanes (Shaw, 1984, 
and references therein) and peptidyl fluoromethanes (Rasnick et al., 1985) are specific,
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irreversible inactivators of CPs that inhibit the enzymes by alkylation o f the reactive-site 
cysteine residue, the peptide sequence providing the affinity required for binding to the 
active site o f the enzymes (review: Shaw, 1990). The compounds readily permeate 
through cell membranes and do not react significantly with fiee thiols such as 2 - 
mercaptoethanol and cysteine (Green and Shaw, 1981) or other classes o f proteinases 
(Crawford et al., 1988; Shaw et al., 1990), although it has been shown that certain 
diazomethanes inactivate some serine proteinases by alkylation o f  the active site 
histidine. The principal liabilities o f the diazomethanes as chemotherapeutic agents are 
their instability at low pH (which may limit oral administration) and the fact that they 
are mutagenic. Investigation o f various peptidyl diazomethanes as inactivators o f the 
lysosomal CPs identified Z-Phe-Thr-CHN 2  as an effective inactivator of cathepsin B 
(Shaw et al., 1983) and Z-Phe-Phe-CHN 2  and Z-Phe-Ala-CHN 2  as very rapid 
inactivators of cathepsin L (BaiTett et ah, 1982; Mason et al., 1985).
1.3.2. Natural inhibitors
The action o f mammalian CPs is biologically controlled by natural and specific 
inhibitors called cystatins (review: Henskens et ah, 1996). The cystatins make up a 
super-family o f structurally related homologous proteins eonsisting of 3 groups: stefins, 
cystatins and kininogens (Turk and Bode, 1991). Increasing attention is being paid to 
their physiological significance in pathological processes, since uncontrolled proteolysis 
can lead to iiTeversible damage, for example, in cluonic inflammation or tumour 
metastasis. Cystatin-like molecules have been identified in both parasitic helminths and 
protozoa, although it is not yet clear whether they have evolved as a protective 
mechanism against their own CPs or the host's (Robertson et al., 1996).
The invariant chain (li) is an integral membrane protein which is associated with 
the major histocompatability complex (MHC) Class II heterodimer during early stages 
o f its intracellular transport, and contributes critically to a proper presentation of 
antigens to CD4+ T lymphocytes (Geimain and Margulies, 1993). Recently a novel 
propeity o f  li has been established, since a fragment distinct (in sequence) from the 
cystatins (Bevec et al., 1996) has been found to strongly inhibit cathepsin L,
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representing a new class o f natural CP inhibitors.
The pro-region o f CPs is thought to play many roles in the folding, transport and 
activity o f the zymogen. As predicted from the total or partial absence o f activity o f the 
pro-enzymes, CP pro-peptides are also inliibitors o f the mature cathepsin B and 
cathepsin L enzymes (Fox et al., 1992; Carmona et al., 1996). In addition to being 
potent inhibitors, the CP pro-peptides also contain features insuring that inhibition is 
highly selective for the proteinases they originate from. This is an important finding 
regarding future efforts in designing selective CP inhibitors. Most inhibitors available so 
far are at least in part peptide-based and it has been proposed that the use o f non- 
peptidyl compounds may bring an added flexibility in the design that could exploit 
subtle differences in structure that the constraints imposed on peptide-based inliibitors 
could not address (review: Storer and Menard. 1996).
1.3.3. Therapeutic uses and potential
1.3.3.1. In degradative and invasive disease
As was discussed in section 1.2.1.3, the destruction o f the extracellular matrix o f 
articular' cartilage and bone which occurs in arthritic joints is thought to be mediated by 
excess proteolytic activity and there is evidence that cathepsins B, H and L are involved 
(McKerrow, 1994; Müller-Ladner et al., 1996). Therapeutic advances have been made 
using proteinase inhibitors for the treatment o f arthr itis. Oral administration o f peptidyl- 
fluoroniethanes to animals not only inhibited the activity o f cathepsins B and L in vivo, 
but significantly reduced the inflammation and joint destruction in experimentally 
induced arthritis (Esser et al., 1994).
Another example is in the development o f novel anti-cancer treatments. The 
most life threatening aspect o f cancer is metastasis and CPs and metalloproteinases are 
thought to be involved in the invasion process. Cathepsin B has been found on the 
surface membrane o f some cancer cells, suggesting proteolytic activity at the cell 
surface (Sloane, et al., 1994, and references therein) and a decrease o f endogenous CP 
inhibitors has been observed in several cancer cell lines with metastatic properties 
(Liotta and Stetler-Stevenson, 1991). Detailed studies on limiting cancers using
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proteinase inhibitors have not yet been published, but some in vitro experiments have 
been promising (Navab et a l ,  1997).
Aspartyl proteinases are essential in the life cycle o f the HIV virus, where they 
convert protein precursors to mature proteins which are required for assembly of new 
infectious virus particles (Kohl et al, 1988). Synthetic inliibitors against these aspartyl 
proteinases have been developed by Kem f et al. (1994) and much attention has been 
given to this method as a therapeutic intervention of AIDS. Treatment regimens 
employing the proteinase inliibitor ritonavir, for example, significantly delayed the 
progression of HIV-related disease and prolonged survival in patients with advanced 
AIDS, while combination therapy with ritonavir and other proteinase inhibitors 
produced greater clinical benefits (Kemf et al., 1997).
1.33.2. In parasitic infection
Proteinase inhibition has long been considered a good target in the search for 
novel parasitic disease treatments. Certain proteinase inliibitors that are currently 
available have been found to have anti-parasite effects against some helminths and 
protozoa. For example, inhibitors o f schistosome CPs block parasite haemoglobin 
degradation in vitro and decrease worm burden and egg production in vivo (Wasilewski 
et ah, 1996). Specific CP inhibitors not only block the CP activities in cysts and 
trophozoites of Entamoeba, but decrease the efficiency o f encystation by trophozoites 
(Sharnia et a i,  1996). Peptidyl diazomethanes have been shown to inhibit both the CPs 
and the growth o f T. brucei (Robertson et al., 1990) and leupeptin, an inhibitor o f CPs 
and some serine proteinases, has shown both anti-trichomonal and anti-leishmanial 
activity (Bremner et al. 1986; Coombs and Baxter, 1984). However, by far the most 
promising results have been achieved by using proteinase inhibitors against Pla.smodium 
and T. cruzi.
Inhibitors of both classes o f malarial food vacuole proteinases have shown 
antimalarial effects. The aspartic proteinase inhibitor pepstatin acts on rings and 
schizonts causing the formation o f pyknotic parasites (Bailly et al., 1992; Rosenthal,
1995) and a peptidomimetic inhibitor o f plasmepsin I killed cultured parasites at low
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micromolar concentration (Francis et ah, 1994). Peptide inhibitors of the 6 8  kDa CP 
appeared to inhibit invasion of erythrocytes by merozoites (Mayer, ei al., 1991) whereas 
inhibitors o f the 28 kDa CP prevented parasite multiplication within the erythrocyte 
(Rosenthal, et al., 1987; Rosenthal, et ah, 1988; Rockett et a l,  1990). The CP inhibitor 
E-64 acts mainly on trophozoites causing undegraded haemoglobin to accumulate in the 
food vacuoles and halt intracellular development (Rosenthal, et ah, 1989; Bailly et ah, 
1992; Rosenthal, 1995). In in vitro studies using peptide-based fluoromethanes such as 
Z-Phe-Ala-CH 2 p (Rosenthal et ah, 1991) and vinyl sulfone CP inhibitors (Rosenthal et 
ah, 1996), the antimalarial effects directly correlated with the ability o f a compound to 
inhibit falcipain, block globin hydrolysis and inhibit parasite development. Interestingly, 
the antimalarial effects o f  E-64 and pepstatin are markedly synergistic (Bailly et ah,
1992), suggesting that combination therapy might be a promising approach. 
Encouraging in vivo results have been achieved using a peptidyl-fluoromethane, which 
successfully cured murine malaria infeetions (Rosenthal et ah, 1993). To identify non­
peptide proteinase inhibitors, a database o f small molecules has been screened against 
falcipain using computer modelling techniques. This approach identified a low- 
micromolar lead compound (Ring et ah, 1993) and subsequent chemical synthesis and 
screening identified a set o f chalcones effective against cultured parasites at low- 
nanomolar concentrations (Li et ah, 1995).
Cruzipain is thought to participate in host cell invasion, binding to target cells, 
intracellular replication and differentiation o f T. cruzi (Harth et ah, 1993, and references 
therein). These putative functions at important stages o f the life cycle of the parasite 
make cruzipain an excellent target for specific irreversible inliibitors that may be used to 
develop a new chemotherapy. Several successful developments have been made in this 
direction using peptidyl-diazomethanes and peptidyl-fluoromethanes, resulting in 
impairment o f host cell invasion by T. cruzi and intracellular development o f the 
parasite (Bonaldo et ah, 1991; Mereilles et ah, 1992; Harth et ah, 1993; Franke de 
Cazzulo et ah, 1994). Cruzipain is inhibited by a range o f peptide aldehyde compounds 
(Bontempi et ah, 1984; Cazzulo et ah, 1990) as well as by proteinase inhibitors 
belonging to the cystatin superfamily (Stoka et ah, 1995; Serveau et ah, 1996). The
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presence o f cruzipain in both the intracellular and extracellular developmental forms o f 
T. cruzi has stimulated efforts to develop first generation inhibitors and these have 
proved to be highly effective in vitro. Some o f these compounds have recently given 
promising results in mice infected with T. cruzi (McGrath et al., 1995).
The naturally occurring CP inhibitors known as cystatins have been found to be 
very potent inhibitors o f cruzipain (Stoka et al., 1995) and indicates that they may play a 
defence role in the host. Furthermore they may serve as promising starting points for the 
design of non-covalently bound, reversible CP inhibitors as new anti-parasite drugs. X- 
ray ciystallography and inliibitor screening against cruzipain using computer graphics 
analysis is allowing rapid identification o f new inliibitors based on either leads already 
identified or compounds selected by computer graphics screening o f chemical databases 
(review: McKerrow et al., 1995). Biotin labelled peptidyl diazomethane inhibitors o f 
CPs, based on the N-terminal substrate-like segment o f human cystatin C, have been 
synthesised (Lalmanach et al., 1996) and have been shown to target cruzipain in 
infected mammalian cells. Cruzipain has also recently been shown to be inhibited by an 
alternatively spliced li fragment (Bevec et a l,  1997), suggesting the possibility o f using 
the invariant chain (see section 1.3.2) as a model for a potential drug to combat Chagas' 
disease.
In summary, CPs represent attractive targets for the development of inhibitors as 
potential therapeutic agents, to treat not only diseases involving abnormal elevations o f 
proteolytic activity, but also parasitic infections where one or more CPs are essential to 
the parasite. However, such reagents must be specific so that they do not interfere with 
related proteinases from the host. The close structural and functional relationship 
between parasite CPs and papain-related mammalian CPs has meant that the substrates 
and inhibitors used so far to assay the activity o f parasite CPs are the same as those 
currently used for cathepsins L and B of mammalian lysosomes (North et al., 1990). It 
would thus appear that better knowledge o f the substrate specificity of parasitic CPs and 
their sensitivity to inhibitors is needed for the rational development o f new drugs that 
can discriminate between parasite and host cell proteinases.
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1.4. PROTEINASES OF LEISHMANIA
Tiypanosomatids are known to contain CPs, métallo- and serine proteinases, but 
there have been no reports yet o f aspartic proteinases, which appear to be relatively rare 
in parasitic protozoa (review: McKerrow et al., 1993). By far the most abundant and 
hence most studied proteinases in Leishmania species are the metalloproteinase gp63 
and the CPs.
1.4.1. Promastigote surface proteinase
Gp63 is a metalloproteinase expressed in large quantities on the surface of 
Leishmania promastigotes (Bouvier et al., 1985) and accounts for about 1% o f the total 
protein in promastigotes (Bordier, 1987). gp63 has been purified to homogeneity from 
several species of Leishmania (review: Chang and Chaudhuri, 1990) and was found to 
have proteinase activity that requires zinc ion (Chaudhuri et al., 1989). The natural 
substrate for this proteinase is not known and the optimum pH o f gp63 action appears to 
be dependent on the nature o f the substrate used for the in vitro assay (Chang and 
Chaudhuri, 1990).
The surface expression o f this glycosylphosphatidylinositol (GPI)-anchored 
metalloproteinase in promastigotes is well established for all Leishmania species 
investigated. Gp63 is also expressed, but at lower levels, by intracellular Leishmania 
amastigotes (Trommel et al., 1990; Schneinder et al., 1992). More recent experiments 
suggest that the amastigote protein has hydrophilic properties, an acidic pH optimum, 
and is localised in the extended lysosomes o f L. mexicana (Ilg et al., 1993) which are 
likewise known to be a rich source o f CPs. Thus amastigote gp63 may be involved in 
lysosomal enzyme processing. These observations are consistent with a differential 
expression o f niRNAs derived from the multicopy gp63 genes in different parasite 
stages (Medina-Acosta et al., 1993). Transcripts found predominantly in promastigotes 
predict a hydrophobic sequence at the COOH-terminus serving as a GPI anchor addition 
signal, while the otherwise highly homologous mRNA in amastigotes codes for a 
COOH-terminal extension lacking this signal. Therefore, the promastigote protein is 
routed to the cell surface while the amastigote protein is delivered to lysosomes.
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The active site structure of the gp63 proteinase appears to be very similar to 
those of other well known mammalian matrix metalloproteinases (Button et at., 1993; 
McMaster et al., 1994). However, antigenicity and conformational analysis o f the Zn^^”- 
binding sites o f Leishmania gp63 and mammalian endopeptidase-24.11 showed them to 
be antigenically and structurally different although their respective antibodies cross­
reacted (Soteriadou et al., 1996). The Leishmania surface proteinase has many putative 
roles, for example, in eomplement fixation, cell adhesion and resistance to complement- 
mediated lysis (Brittingham et al., 1995). In several reports the importance of gp63 in 
the initial infection o f macrophages by Leishmania has heen emphasised. It has been 
reported that gp63 mediates attachment o f promastigotes to macrophages directly or via 
the complement component C3 (Chang and Chaudhuri, 1990). Furthermore gp63 
appeal’s to play an important role in the intracellular survival o f the parasite in the 
macrophage PL probably thi'ough its non specific proteinase activity (Chaudhuri et al., 
1989). Metalloproteinases related to gp63 have however been described in the 
monogenetic trypanosomatids Crithidia fasciculata, Herpetomonas samiielpessoai and 
Leptomonas seymoiiri, which infect invertebrate hosts but do not infect mammalian 
cells (Medina-Acosta et al., 1993b), suggesting that the proteinase must also have a role 
in the insect vector stage.
gp63 has been considered a good candidate for a vaccine against leishmaniasis. 
Mice immunised with purified gp63 or orally treated with a Salmonella mutant carrying 
the L. major gp63 developed significance resistance against L. major challenge infection 
(Yang et al., 1990). In addition, synthetic peptides modelled bom  different regions o f 
the amino acid sequence o f gp63 were found to be highly immunogenic and induced 
protective immunity in mice (Button and McMaster, 1988).
1.4.2. Cysteine proteinases
Amastigotes o f the L. mexicana family, which includes L. mexicana, L. pijdnoi 
and L. amazonensis, contain high CP activity (Pupkis et al., 1986; Robertson and 
Coombs, 1990; Alfieri et al., 1991). A radioiodinated peptidyl diazomethane probe 
specific for CPs has been found to detect similar enzymes in amastigotes and
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promastigotes o f various isolates of L. mexicana and L. amazonensis (Alfieri et al.,
1995), although CP banding may differ among Z. amazonensis isolates.
Degenerate primers encoding the evolutionaiy conserved active site amino acids 
o f proteinase genes, successfully employed for PCR amplification o f  CP and serine 
proteinase genes o f protozoan pai’asites (Eakin et ah, 1990; Sakanari et a/., 1989), have 
been used to obtain sequence data for the amastigote CPs o f axenically cultured 
amastigotes o f L. pifanoi (Traub-Cseko et al., 1993). Lpcys2 was found to have multiple 
tandemly repeated copies similar to the cathepsin L-like CP genes o f T. brucei and T. 
cruzi (section 1.2.2.2) and L. mexicana (section 1.5.2). These have now been designated 
Type I CP genes (Robertson et al., 1996; Coombs and Mottram, 1997). In contrast, 
Lpcysl occurred as only one or two copies (Traub-Cseko et al., 1993) and has since 
been designated a Type II CP gene. The developmental regulation characterised by 
increases in Lpcysl and Lpcys2 mRNA levels in the amastigote forms o f L. pifanoi is 
consistent with previous reports concerning L. mexicana parasites (see section 1.5). 
Related Lpcysl and Lpcys2 CP genes appear to be present in all species of Leishmania, 
although fewer copies o f the genes for Lpcys2 appear to be present in species outside the 
L. mexicana complex (Traub-Cseko et a l ,  1993).
Although none contain the high activities characteristic o f  amastigotes o f the L. 
mexicana complex (section 1.5), activities with some o f the properties of CPs have been 
described in other Leishmania species, such as L. tarentolae (North et al., 1983) and L. 
donovani (Ghoshal, et al., 1989). There is some evidence for Ca^'^-dependent CPs 
similar to calpains in L. donovani (Battachaiya et al., 1993). The discoveiy o f Type I 
and Type III CP genes (see section 1.5) in L. major suggests that this species contains at 
least two such enzymes (Sakanari et al., 1997).
1.5. CYSTEINE PROTEINASES OF LEISHMANIA MEXICANA
1.5.1. Stage specificity of L. mexicana CPs
An interesting feature o f members of the Leishmania mexicana complex is the 
presence o f CP activity (North and Coombs, 1981). Levels are highest in the amastigote 
stage, where their abundance is associated with numerous megasomes, unique
27
general introduction
lysosome-like organelles which display cytochemically demonstrable lysosomal markers 
such as acid phosphatase and arylsulphatase activities (Pupkis ei al., 1986) and can be 
stained using monoclonal antibody against rat cathepsin B (Prina, et al., 1990). 
Although the megasomes can constitute as much as 15-20% of the total cell volume of 
L. mexicana amastigotes (Coombs et ah, 1986), these organelles are not evident in other 
members o f the genus.
Similar enzymes are apparently produced in the mammal-infective metacyclic 
forms, but are absent from the multiplicative promastigote stage (Lockwood, et al., 
1987). Although a specific role has yet to be found for L. mexicana CPs, their high 
activity and stage specificity suggests their involvement in parasite survival within the 
macrophage.
Three types o f CP have been identified in L. mexicana. In addition to the Type I 
enzymes found in other trypanosomatids, L. mexicana contains at least 2 other types o f
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CP, designated Type II and Type III (see Fig. 1.). A summary o f the gene-enzyme 
relationship of the CPs o f L. mexicana is shown in Table 1.0.
1.5.2. Characterisation of L. mexicana CPs
1.5.2,L Type I  CPs
Amastigotes o f L. mexicana contain multiple Type I CPs of apparent sizes 22-28 
kDa that are readily detectable by gelatin-SDS-PAGE (Lockwood et al., 1987b). Since 
their discoveiy (North and Coombs, 1981) 6  groups of CPs in the amastigotes o f L. 
mexicana have been identified (Robertson and Coombs, 1990) and designated groups A, 
B, C, E, F and H. Group A consists o f at least 4 isoenzymes that bind to Con A 
Sepharose CL4B, demonstrating that they are glycosylated. The CP isoenzymes o f the 
groups B and C were separated by ion-exchange chiomatography and showed different 
specificities towards a range o f fluorogenic peptide substrates. The 3 group B enzymes 
were found to prefer substrates with tyrosine in the P, position and have a lower net 
negative charge than the 2 enzymes of group C, which are more active towards 
compounds with a basic amino acid in the P , position. Although the enzymes o f the 3 
CP groups A, B and C were found to be distinct, there were some similarities including
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preferences for substrates with bulky amino acids at the P, and ? 2  positions similar to 
the mammalian enzyme cathepsin L. The enzymes were found to be susceptible to 
inhibitors such as cystatins and to be stimulated in the presence o f the reducing agent 
DTT, clearly demonstrating them to be o f the CP type (Robertson and Coombs, 1990).
Table 1. Cysteine Proteinases o i Leishmania mexicana 
Gene: enzyme relationship
Enzyme Activity 
Type
Genes
Type Name Class Number
A,B,C,E,F,H I Imcph cathepsin L-like 19
? II Imcpa cathepsin L-like 1
D III Imcpc cathepsin B-like 1
Two molecules recognised by anti-group C CP antiserum in western blots of 
amastigote lysates also appear to be Type I CP activities, which were designated group 
E CPs (Robertson and Coombs, 1994). These activities remain with the pellet fraction 
after centifugation o f a crude amastigote lysate. Their inhibitor sensitivity indicates that 
they are CPs and their activities can be released from the pellet fraction by 1% SDS, 
high ionic strength and high pH, suggesting they are peripheral membrane proteins that 
act ionically with a membrane. Their relatively large size suggests that they are a less 
processed gene product (Robertson and Coombs, 1994). Purification and N-terminal 
sequence analysis o f the E CPs may indicate whether these proteins are pro-enzymes or 
mature enzymes with the retained CTE.
Some o f these Type I enzymes are present at low activity in stationary phase 
promastigotes grown in vitro (Lockwood, et al., 1987b; Robertson, and Coombs, 1992). 
Three o f the bands apparent in gelatin-SDS-PAGE resemble the high activity CPs
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characteristic o f amastigote s. Two are similar to the amastigote group B proteinases 
whereas the highest mobility band F, o f around 21 kDa, was found only with stationary 
phase promastigote populations, suggesting this activity is a feature of metacyclic 
promastigotes (Robertson, and Coombs, 1992). Further studies have shown this faster 
moving activity comprises at least 3 distinct enzymes, which were separated by mono Q 
anion exchange chromatography. It is proposed that they may have a role in 
metacyclogenesis or be a pre-adaptation for survival in the mammalian host. An in vi/ro 
culture method has recently been developed (Bates and Tetley, 1993) which favours the 
production of metacyclic forms, and this system has been used to examine the 
expression o f CPs of L. mexicana metacyclics (Bates, et al., 1994). Two prominent 
bands were detected which distinguished metacyclics from multiplicative promastigotes, 
lacking CP activity, and amastigotes, with the distinctive banding pattern comprised o f 
multiple enzymes. A correlation between relative activity of the metacyclic specific 
bands and the prevalence o f metacyclics was found both during the growth cycle in vitro 
as metacyclogenesis occurred, and by comparison o f stationary phase populations from 
consecutive subpassages in vitro. Late log and stationaiy phase promastigotes o f L. 
mexicana were also shown to contain two acid-activable CPs, designated HI and H2, 
detected around 36 kDa in gelatin gels (Robertson and Coombs, 1992). It is thought that 
they may be pro-enzymes to two o f the activities that run together to the give the fastest 
moving band F, and that the acid treatment causes removal o f the pro-region.
For some time it has been accepted that the Type I CPs of L. mexicana are 
encoded by the tandemly arranged multicopy Imcpb genes (Souza et aL, 1992; 
Robertson and Coombs, 1994); this aspect is dealt with in more detail in the Chapter 3 
Introduction.
1,5.2.2. Type II  CPs
L  mexicana and L. pifanoi are so far the only trypanosomatids in which Type II 
enzymes have been identified, and then only using a molecular approach (Mottram et 
al., 1992; Traub-Cseko et al., 1993). These enzymes are encoded by cathepsin-L-like 
single copy genes characterised as lacking a long C-terminal extension and having a
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thi'ee amino acid insertion close to the matm*e N-terminus. The gene encoding the type II 
CP was the first CP gene o f L. mexicana to be cloned (Mottram et aL, 1992) and was 
thus designated Imcpa (see also Chapter 2 Introduction). Although the gene was shown 
to be transcribed in a stage-dependent manner and a protein was detected using a 
specific antibody, the protein has not yet been purified or shown to be a functional 
enzyme.
L5.2.3. Type III CPs
The third CP type known to be present in L. mexicana is encoded by the Imcpc 
gene (see Table 1.0 and the Chapter 4 Introduction). It is cathepsin B-like, single copy 
(Bart et aL, 1995) and has a homologue in L. major (Sakanari el aL, 1997). Imcpc 
encodes 2 major ampiphilic proteins of 31 and 33 kDa which have type D enzyme 
activity i.e. lack activity towards gelatin but have been shown to hydrolyse various 
peptidyl substrates used by mammalian cathepsin B such as Bz-Phe-Val-Arg-AMC 
(Robertson and Coombs, 1993). Members o f this class o f CP have not been discovered 
in many parasitic protozoa, possibly because they occur at low activity compared with 
the abundant cathepsin L-like enzymes.
1.6. LEISHMANIA  VIRULENCE AND INTRACELLULAR SURVIVAL
1.6.1. Importance of surface and secreted molecules
Leishmania virulence is thought to require the development o f infective forms 
called metacyclic promastigotes either in culture or in the sandfly (Sacks, 1989). The 
metacyclic markers that have been identified are changes in mobility and promastigote 
body shape (Mallinson and Coombs, 1989; Schlein, 1993, and references therein) and an 
increased resistance to the lysis mediated by human complement (Puentes el al., 1990; 
Bates and Tetley, 1993). In L. major this is mediated through structural modification of 
the surface lipophosphoglycan (LPG) which occurs during the transformation to 
metacyclics: there is a doubling o f the mean number o f LPG phosphorylated 
disaccharide repeat units (McConville et aL, 1992), reflected by decreased binding of 
peanut agglutinin in the case o f L. major (Sacks et al., 1985).
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Collective contributions o f several parasite surface molecules enable the parasite 
to establish infection inside macrophages (for reviews see Chang and Chaudhuri, 1990;
Mauël, 1996). The Zn-proteinase of -63  kDa, gp63 (see section 1.1.4) and the LPG 
(Descoteaux and Turco, 1993), two abundant parasite surface molecules, are those most 
implicated in this process. The importance o f gp63, however, remains a topic o f much 
debate, mainly due to species-specific differences. LPG and gp63 have been considered 
parasite ligands (Handman and Goding, 1985; Russell and Wright, 1988) with C R l,
CR3 and the mannose-fucose receptor as the corresponding macrophage receptors 
(Blackwell et a l ,  1985; Da Silva et a l ,  1989), although parasites also use host-derived 
opsonins such as complement to facilitate uptake by macrophages. Metacyclic 
promastigotes are found to use primarily the CRl receptor (tlirough which endocytosis 
is known to produce less respiratory burst) since the complement component C3b is the 
major covalently associated fragment on these cells. Multiplicative promastigotes, 
which are killed after internalisation, are found to use CR3 in addition to C R l, 
suggesting that the loss o f CR3 binding ligand during transition from procyclic to 
metacyclic might constitute an adaptive change (Da Silva, et al., 1989). The abundant t
expression of gp63, which has been shown to react directly with CR3 in the absence o f 
complement, has in some cases resulted in poor infectivity for macrophages; it was 
hypothesised that the elongated LPG of vimlent cells may mask its gp63 and thus 
metacyclics may primarily use the CRl receptor, thereby avoiding macrophage 
activation (Camai’a et al., 1995). It has, however, been shown that gp63 not only binds 
C3 (Russell, 1987) but also cleaves C3 to the haemolytically inactive iC3b (Puentes et
.al., 1989), thereby avoiding the formation o f the complement cascade.
The interaction between the macrophages and the parasites plays a central role in 
establishing Leishmania infection. Macrophages constitute one o f the primary defence 
mechanisms of the body against microbial invasion and are capable o f fulfilling a 
variety o f microbicidal functions. For example, they produce superoxide anions and 
H2 O2  (hydrogen peroxide) during the respiratory burst, nitric oxide (NO) and abundant 
lysosomal enzymes (Lewis and McGee, 1992; Zwilling and Eisenstein, 1994). It has 
been postulated that the impairment o f macrophage activation by intracellular
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Leishmania contributes to their survival in the toxic environment of the host 
(Chakiaborty et al., 1996). Virulence factors like gp63 and LPG present on the surface 
o f virulent parasites may help them to circumvent and reduce the respiratoiy burst 
activity of macrophages upon binding and phagocytosis (Hall and Joiner, 1991; Mauël,
1996). For example, gp63 strongly iiiliibited the oxidative burst response o f 
macrophages (compared with neutrophils) stimulated with opsonised zymosan 
(Sorensen et al., 1994) and could be one o f the mechanisms whereby Leishmania is 
capable o f establishing itself intracellularly in an otherwise hostile environment. 
Evidence exists that other enzymes such as acid phosphatase present on parasite surface 
membranes may block the production of oxidative burst metabolites (Remaley et al., 
1985) and that LPG scavenges oxygen free radicals and other PKC-mediated events o f 
the oxidative burst (Chan et ah, 1989; review: Descoteaux and Turco, 1993). It has also 
been shown that LPG glycoconjugates have a profound effect on the survival o f 
Leishmania parasites, through their ability to regulate the expression of inducible nitric 
oxide synthase (iNOS) by macrophages (Proudfoot et al., 1996).
The relative failure o f amastigotes to trigger a respiratory burst is thought to 
coiTelate with their intracellular survival. In contrast to promastigotes, the surface o f 
Leishmania amastigotes is dominated by species-specific glycoinositol phospholipids 
(GIPLS) (Winter et al., 1994, and references therein) which may mediate Leishmania 
binding to macrophages and shield the surface against lysosomal hydrolases. GIPLs 
have been shown to inhibit the production o f NO by macrophages and thus entrance the 
survival o f L. major in activated macrophages (Proudfoot et a l,  1995).
How Leishmania parasites not only survive but also proliferate in the potentially 
hostile environmemt o f the macrophage phagolysosome is something o f an enigma 
(reviews: Russell, 1995; Garcia-del Portillo and Finlay, 1995). Most other intracellular 
pathogens have developed strategies to escape the phagolysosomal environment. For 
example, after phagocytosis, 71 cruzi trypomastigotes escape the phagosome to multiply 
within the host cell cytoplasm, whereas Toxoplasma gondii inhibits the acidification of 
phagosomes and/or phagosome lysosome fusion (review: Mauël, 1996). However 
Leishmania amastigotes exhibit elevated metabolism under acidic conditions, reflecting
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their adaptation to intracellular growth (Mukkuda el aL, 1985). Gp63 may be involved 
in the intracellular survival o f Leishmania, since it is capable o f degrading lysosomal 
enzymes under the acidic conditions o f the PV, and incorporated into liposomes is able 
to protect protein substrates from intralysosomal degradation within macrophages 
(Chaudhuri et ah, 1989). Furthermore gp63 has been shown to be functionally 
significant in the early stages o f leishmanial infection o f macrophages in vitro using 
genetic rescue o f gp63-deficient variants (McGwire and Chang, 1994). In vitro studies 
with parasite glycosylation mutants or natural variants lacking LPG have shown LPG 
also to be critical to survival in the PL (Cappai et al., 1993, and references therein).
1.6.2. Potential roles of cysteine proteinases
There are several suggestions as to how the metacyclic and/or amastigote- 
specific CPs of L. mexicana aid survival o f the parasite in macrophages. It has been 
postulated that the proteinases may inactivate the host cell's lysosomal enzymes, or that 
they may be involved in producing amines which would raise the vacuolar pH and 
perhaps denature the host hydrolases (Coombs, 1982). However, there is currently no 
firm evidence to back up either o f these theories. It has been supposed that amastigotes 
do not take up proteins from the parasitophorous vacuole (Pupkis, et al., 1986) and there 
is little evidence that amastigote CPs are secreted (Coombs, 1982; Pupkis et al., 1986; 
Ilg et al., 1994). Indeed evidence suggests that amastigotes of the L. mexicana complex 
are in fact acidophilic and have evolved plasma membrane components compatible with 
the harsh environment o f the PV (Antoine et a l ,  1990).
Amastigote CPs effectively degrade denatured proteins like gelatin or azocasein 
and also native proteins like transferrin, serum albumin and immunoglobulins at the 
acidic pH o f the lysosomal compartment (pH 4.5-5.5) of Leishmania (Antoine et al., 
1988, 1990). This suggests that these enzymes may be required for the nutrition o f the 
parasites and/or in immune response neutralisation. It has been demonstrated that 
exogenous proteins entering L. mexicana-infQoXQà macrophages by endocytosis are 
delivered to the PV (Russell et al., 1992) by selective fusion o f the PV with other 
particle-containing vacuoles (Collins et al., 1997). These proteins may be taken up by
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amastigotes and transfeiTed to the lysosomes o f the parasites, where they are likely 
degraded by CPs and, possibly, by the amastigote metalloproteinase gp63 (Ilg et al.,
1993).
CPs released after amastigote lysis into the acidic PV could lead to host cell 
damage and, upon host cell lysis, the Leishmania proteinases entering the extracellular 
space may contribute to the disintegrated state o f the lesion tissue by proteolysis of the 
extracellular matrix (Ilg et al., 1994). This may represent an altruistic mechanism 
whereby the release o f CPs by dead parasites favours vector transmission, by increasing 
dissemination o f the parasite and, therefore, the chance o f being uptaken during a 
bloodmeal. In analogy, the homologous enzymes cathepsins B and L, which are secreted 
by metastatising mammalian tumour cells, degrade the comiective tissue and basement 
membrane components collagen, elastin, laminin and fibronectin (Bond and Butler,
1987). Thus it is possible that the killing o f intracellular parasites by activated 
macrophages, which is crucial for resolution o f the infection, could also lead to host 
tissue damage by released amastigote enzymes.
Immunological control o f cutaneous leishmaniasis depends on activated 
macrophages producing IL-12 which drives Thl cell differentiation and proliferation; 
Thl cells produce IFN-y which activates macrophages to produce NO that in turn kills 
the parasite in macrophages (Proudfoot et al., 1996). It has been postulated that 
enzymatically active CPs like papain or schistosome ova enzymes are potent allergens 
and may lead to a pronounced Th2-helper cell response (Finkelman and Urban, 1992) 
which is deleterious for the host in the case of Leishmania infections. However, 
immunisation with recombinant Leishmania CP, and T-cell stimulation experiments 
using recombinant and native antigen, showed that the enzymes are T-cell immunogens 
allowing the development o f potentially protective Thl-helper cell lines (Wolfram et al.,
1995). The suggestion that amastigotes attempt to minimise the exposure o f their 
antigens to the immune system (Russell and Chakraborty, 1992) agrees with the finding 
that intracellular proteins o f intact amastigotes are not available for presentation when 
parasites are alive (Wolfram et al., 1995). Thus it may be an imniune-evasion 
mechanism that the CPs o f amastigotes are not secretory antigens (II et al., 1994),
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although secretion o f CPs has been reported for several parasites (North et al., 1990; 
McKerrow and Doenlioff, 1988).
It was previously suggested (Antoine et al., 1991) that the presence o f high 
amounts o f MHC II li in the PV o f L. amazonensis-mltoXeà macrophages could be due 
to a Leishmania induced mechanism by means o f which this organism may evade the 
immune system. Recently amastigotes have been shown to internalise and degrade class 
II molecules using their CPs and the authors proposed that this might result in a reduced 
capacity for infected cells to process and present parasite proteins (Leao et al., 1995). L. 
major has also been implicated in interfering with the intracellular loading o f MHC 
class II molecules with antigenic peptides, although CPs are not as abundant in this 
parasite (Fruth et al., 1993).
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AIMS OF PROJECT
Cysteine proteinases are implicated in playing important roles in a number o f 
host-parasite interactions, and they are the focus o f much research in the quest to find 
and develop novel anti-parasite agents.
The main evidence for CPs as potential drug targets is two-fold. Firstly, CP 
inhibitors have been shown to have anti-parasite activity in vitro, and in some cases, in 
vivo. Secondly, some parasitic CPs have unusual structures which distinguish them from 
mammalian enzymes and thus could be exploited by drugs. My project stemmed from 
the fact that L. mexicana has stage-regulated CP activity, particularly abundant in the 
intracellular amastigote stage, suggesting these enzymes are crucial to parasite survival 
in the host macrophage and ai’e therefore good targets for chemotherapeutic attack.
Although the multiple CP activities of L. mexicana had been well characterised, 
a specific role was yet to be found and so this was one o f the overall aims o f the project. 
With regards to this, there were two main questions addressed:
1. Are the CPs involved in differentiation? It seems likely that remodelling o f a cell 
from one morphological form to another would require the breakdown o f proteins.
2. Do the enzymes have a role in intracellular survival? The amastigote form of the 
parasite lives in the hostile environment o f the phagolysosome, and it has been 
postulated that the CPs could be involved in inactivating the host cell lysosomal 
enzymes or in circumventing the host immune response.
The second overall aim o f the project was to determine whether the CPs o f L. 
mexicana were in fact good drug targets. The approach adopted to investigate the 
importance of these enzymes to the parasite was primarily an investigation o f the 
phenotypes o f mutants deficient in specific CP genes. A complementaiy approach was 
the utilisation of novel CP inhibitors to characterise the parasite CPs and determine the 
roles they play at different stages in the life cycle.
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CHAPTER TWO
STUDIES ON THE LEISHMANIA MEXICANA CATHEPSIN L LIKE 
CYSTEINE PROTEINASE LMCPA
2.1. INTRODUCTION
2.1.1. The Imcpa gene product(s)
The first CP gene to be cloned from L  mexicana was Imcpa, which was isolated 
from a L. mexicana amastigote lambda zap cDNA library using as a heterologous probe 
a T. brucei gene fragment (Mottram et at., 1992). The single copy, cathepsin L-like 
Imcpa sequence, designated Type II (see Chapter 1, Table 1), has features that 
distinguish it from mammalian cathepsins and also CPs encoded by genes that have 
been isolated from T. brucei and T. cruzi (Mottram et al., 1989; Aslund et al., 1991). 
The protein predicted from the gene sequence has the highly conserved residues found 
in all CPs, but the predicted Imcpa gene product contains a unique 3 amino acid 
insertion near the N-terminus o f the central domain and only a short C-terminal 
extension.
There is differential expression o f the protein in the life cycle, due to regulation 
o f the Imcpa gene at both RNA and protein levels (Mottram et al., 1992). Antibodies 
raised against fusion proteins expressed from Imcpa gene fragments covering the pro- 
and central domains detected the protein in cell extracts prepared from different life­
cycle stages of the parasite. This antiserum did not cross-react with the central domain 
o f all CPs as it did not recognise the 3 major classes o f LmCPb in amastigotes (types A, 
B, and C). The mature region antiserum recognised major species o f 24 kDa and 27 kDa 
as well as the 38 kDa precursor protein. In stationary phase promastigotes the 24 kDa 
protein predominated as detected by Western blotting, whereas in amastigotes there was 
about equal amounts o f the 24 kDa and 27 kDa proteins. It is thought that expression o f 
L. mexicana Imcpa may be controlled thi’ough a combination of mechanisms at the 
mRNA and protein levels.
Although Imcpa has been identified only tlirough molecular means, with an 
activity for the LmCPa proteinase not yet detected, the antiserum does recognise a
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distinct protein separated during the purification protocols designed for the major 
amastigote Type I CPs (Robertson and Coombs, 1990). Fractions containing the protein 
recognised by the anti-cential domain antiserum have what has been termed type D 
activity, that is, no activity towards gelatin but hydrolysing the peptide substrate Bz- 
Phe-Val-Arg-AMC. However, this type D activity is now thought to be distinct from the 
Imcpa gene product. Although the Imcpa gene product does not possess geiatinase 
activity, it does bind active-site-directed inhibitors (Mottram et al., 1992).
2.1.2. Aims
The development o f vectors that allow gene transfer into protozoa has enabled 
investigators to analyse proteinase function by transformation with a proteinase gene, or 
knockout of a proteinase gene (Cruz et al., 1991). To investigate the role o f the LmCPa 
proteinase in L. mexicana, Souza et al. (1994) used gene taigeting o f promastigotes with 
hygromycin- and phleomycin- resistance markers to generate null mutants, by disrupting 
sequentially both alleles of Imcpa. Preliminary observations on the morphology, 
differentiation and infectivity of the null mutants for Imcpa (Souza et al., 1994) 
concluded that they did not differ significantly from wild type cells, although these 
conclusions were based only on qualitative data. The initial aims o f this part of my work 
were to compare in more detail the lmcpa~mx\\ mutant cells with wild type cells, in order 
to define the phenotype o f the mutants with respect to their growth, differentiation and 
CPs. The Imcpa gene product (LmCPa) was to be further analysed to find out the 
relationship o f  the 24 kDa and 27 kDa proteins that appeared to be encoded by the gene.
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2.2. MATERIALS AND METHODS
2.2.1. Parasites
2 .2 J .L  Cell lines o fL .  mexicana
The mutant line studied in the work described in this chapter, which was created 
by colleagues in the Wellcome Unit o f Molecular Parasitology (WUMP), is described in 
Table 2.0. Details o f the transfection procedure used can be found elsewhere (Souza et 
al., 1994). All parasites used in this study had been passaged through BALB/c mice.
Table 2.0. Cell lines of Leishmania mexicana used
cell line gene deletion antibiotic used for 
selection
wild type 
Almcpan
/
null mutant for Imcpa
/
hyg/phleo
Abbreviations: hyg, hygromycin; phleo, phleomycin.
2.2.I.2. Promastigotes
Infections o f wild type Leishmania mexicana (MNYC/BZ/62/M379) were 
maintained in female BALB/c mice as previously described (Hart et al., 1981), and 
promastigotes were obtained by transformation of hai'vested subcutaneous lesion 
amastigotes at 25°C (see section 2.2.1.4). Promastigotes were grown axenically in vitt'o 
at 25°C in HOMEM medium (Berens et a l ,  1976), pH 7.5, supplemented with 10% 
(v/v) heat-inactivated foetal calf serum (Labtech International) and 25 pg/ml 
gentamycin (Sigma). Routinely, 10 ml volumes were cultured in 25 cm^ tissue culture 
flasks using air as the gas phase. Where appropriate, other antibiotics were included for 
selection o f transfectants: hygromycin B (Sigma) at 50 pg/ml and phleomycin (Sigma) 
at 10 pg/ml (see Table 2.0). Cultures were subpassaged by subinoculation of 
promastigotes from log phase or early stationary phase cultures into fresh growth 
medium to a final density o f 5 x 10  ^ cells/ml. On occasions, stabilates that had been 
stored in liquid nitrogen were used to initiate cultures. All culture work was done
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aseptically and all subsequent manipulations involving live parasites were perfonned 
under sterile conditions. Cell counting was performed using Improved Neubauer 
haemocytometers under phase contrast microscopy using 0.1 ml culture samples that 
had been immobilised by mixing with 0.1 ml 4% (v/v) formaldehyde in 100 inM 
phosphate-buffered saline, pH 7.4 (PBS).
2.2.1.3. Axenic amastigotes
Axenic amastigote cultures were set up at a starting density of 1 x 10^ cells/ml 
from stationary phase promastigote cultures and were subpassaged every 7 days to the 
same starting density. Growth medium consisted o f Schneider's Drosophila Medium 
(SDM, GIBCO), supplemented with 20% (v/v) heat-inactivated foetal calf serum 
(Labtech) and 25 pg/ml gentamycin, as previously described (Bates et a l,  1992, Bates,
1994). The pH was adjusted to 5.5 using IM  HCl, and generally 10 ml volumes were 
cultured at 32“C in sealed 25 cm^ tissue culture flasks, with air as the initial gas phase. 
Axenic amastigotes did not need to be immobilised for counting but tended to grow in 
clumps, which were disrupted by passing them 3 times through a 26G needle.
2.2.1.4. Harvesting cells
Promastigotes: Log phase cultines were harvested 2 or 3 days after initiation of 
the cultures when the cell density was no gieater than 5 x 10^ cells/ml. Stationaiy phase 
cells were usually harvested after 7-8 days growth, depending on when the individual 
culture's cell density started to decline (at which point the cell density was usually 1-2 x 
10  ^ cells/ml). Only promastigotes that had been subpassaged less than 10 times were 
used in this study. Cell cultures ranging from 10 ml to 50 ml were dispensed into 
centrifuge tubes and centrifliged at 2000g for 10 min at 4°C. Cells were then washed by 
sedimentation and resuspension 3 times in 0.25 M sucrose solution, which involved 
discarding the supernatant and resuspending the cell pellet gradually in 10-50 ml of 
fresh sucrose solution using a vortex, as described previously (Mallinson and Coombs, 
1986). After the final centrifugation, the pellet was resuspended in 1 ml o f sucrose 
solution, placed in an eppendorf tube and a 10 pi sample removed in order to perform a
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cell count and calculate the number o f cells per pellet. The 1 ml cell suspension was 
then centrifuged in a microfuge at 2000g for 10 min, and the supernatant from the 
resulting pellet discarded. Harvested cell pellets were stored frozen at -70°C, with there 
being no detectable loss of proteinase activity (determined using gelatin-SDS-PAGE) 
over a period o f months.
Axenic amastigotes: Harvesting o f axenic amastigotes was carried out normally 
after 6-7 days growth, using the method described above for harvesting promastigotes.
Lesion amastigotes'. Mice with medium-sized lesions (10-15 mm diameter) were 
selected as a source o f amastigotes (unmptured lesions were used in order to minimise 
the danger of contamination with micro-organisms) and were killed by terminal 
anaestliesia; they were then rinsed with 70% ethanol to sterilise the skin. The lesions 
were excised aseptically and gently homogenised in 10 ml complete growth medium 
(see sections 2.2.1.2 and 2.2.1.3) using a sterile 10 ml syringe plunger to squash the 
tissue repeatedly tlu'ough an '80 mesh' wire gauze (Sigma) in a petri dish. The resulting 
crude homogenate was collected with a 21G needle and syringe, then passed through a 
26G needle to disrupt clumps of parasites and a cell count performed. If needed, 
cultures were started by inoculation o f a sample o f this amastigote preparation into 10 
ml complete growth medium. The homogenate was then centrifuged at 1 OOOg for 5 min 
at ambient temperature to sediment any host cells. The resulting pellet was discarded 
and the supernatant containing the amastigotes was retained and further centrifuged at 
2000g for 10 min. The subsequent pellet was resuspended and centrifuged a further 3 
times in 50 ml o f either 0.25 M sucrose solution (if the cells were to be stored as frozen 
pellets) or serum-free growth medium (if the cells were for infectivity studies, section 
2.2.5).
2.2.1.5. Light microscopy
Measurement o f cells was carried out essentially as described previously (Bates 
and Tetley, 1993). Promastigotes were removed from culture and used to prepare smears 
which were air-dried, fixed in absolute methanol for 30 sec and stained for 15 min with 
10% Giemsa's stain in 10 niM phosphate buffer, pH 7.2. The slides were examined at
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1 OOOx magnification and measurements o f promastigotes were made using an eyepiece 
graticule, which had been calibrated using a test slide (each graticule unit was 
equivalent to 1.25 pm). Cell body lengths were measured to the nearest graticule unit 
and promastigotes with a bent body were excluded. At least 100 cells were measured in 
each case, and the median cell length then calculated. To determine the statistical 
significance o f any observed differences in cell lengths between different lines, the z- 
test for comparing the means of large samples was used - for which data do not have to 
be normally distributed provided that samples are quite large (at least 25 in each).
2.2.2. Proteinase assays and analyses
2.2.2.L Gelatin~SDS~PAGE
Gelatin-SDS-PAGE analyses were carried out essentially as described by 
Lockwood et al. (1987) and Robertson and Coombs (1990). L. mexicana lysates were 
usually prepared by thawing Ifozen pai'asite pellets and resuspending to the equivalent 
o f 1 X 10  ^ cells/ml in 0.25 M sucrose/0.1% Triton X-100 solution. Lysates were either 
used immediately or stored at -20°C, which had no detectable effect on the proteinase 
band patterns observed. Samples normally consisted o f a 1 ; 1 dilution o f cell lysates with 
2x reducing sodium dodecyl sulphate (SDS) sample buffer (0.1 M Tris-HCl, pH 6.8, 3%
(w/v) SDS, 7% (v/v) 2-mercaptoethanol, 14% (v/v) glycerol) and subjected to 
polyacrylamide gel electrophoresis (PAGE) using the SDS-discontinuous buffer system 
as described by Hames (1981). Generally 20 pi samples were loaded, corresponding to 
approximately 10^ cells per track. Gelatin was co-polymerised into the separating gels to 
act as a proteinase substrate, with a final concentration o f 0.2% (w/v). The aciylamide 
concentration o f the separating gel (0.75 mm thickness) was normally 12% (w/v), and 
electrophoresis was carried out for approximately one hour at a constant voltage of 
150V. All SDS-PAGE was carried out using the Bio-Rad Mini Protean electrophoresis 
apparatus.
After electrophoresis the gels were washed free o f  SDS by immersion in 2.5%
(v/v) Triton X-100 for 30 min at 37°C, in order to renature the proteinases. Gelatin 
hydrolysis was performed at 37*^0 in 0.1 M sodium acetate buffer, pH 5.5, containing 1
ÿv
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mM dithiothreitol (DTT) for between 2 and 24 h, depending on the number and sample 
of cells used, with amastigote samples generally requiring shorter incubation times than 
promastigote samples. Thereafter, Coomassie Blue stain was used to visualise the bands 
o f proteinase activity, which appeared as white areas of gelatin digestion within the 
blue-stained gel, after which gels were destained and stored in 10% (v/v) acetic acid.
2.2.2.2. Western blotting
L. mexicana extracts were prepared by lysing cells at the eqiuvalent of 5 x 10  ^
cells/ml in lysing solution (see section 2.2.2.1) containing proteinase inhibitors [1 pM 
E-64 and 10 pM PMSF], leaving on ice for 5 min, adding equal volumes of 2x SDS 
sample buffer (see section 2.2.2.1) and boiling for 2 min. Normally 20 pi samples were 
loaded into each well of a 12% polyacrylamide gel, corresponding to 5 x 10^ cells per 
track, followed by electrophoresis performed at 200V for about 40 min.
After electrophoresis, SDS-PAGE gels were blotted to 0.22 pm nitrocellulose 
(Amersham, ECL grade) in ice cold 20 mM Tris/150 mM glycine/20% (v/v) methanol 
for 60 min at lOOV using a Bio-Rad mini-transblotter. Blots were blocked overnight at 
4°C in 25 mM Tris/0.15 M NaCl/O.l % Tween 20, pH 7.6 (TBS-Tween), containing 5% 
(w/v) non-fat dried milk, 10% (v/v) horse serum and 0.001% thimerisol. Using the same 
solution, detection of antigens was achieved using a 1:500 dilution o f polyclonal 
antiserum to LmCPa CP (known as R24) for 2 h at 4°C (Mottram ei al., 1992) or 1:500 
dilution of polyclonal antiserum to LmCPb group B or group C CP (Robertson and 
Coombs, 1994). Blots were washed for 3 x 20 min in TBS-Tween at room temperature 
followed by incubation in a 1:2000 dilution o f horseradish peroxidase (HRP)-coupled 
secondaiy antibodies (goat anti-rabbit HR? conjugate from Scottish Antibody 
Production Unit) in blocker for one hour at room temperature. After a further 3 washes 
as above, the blots were developed using the Amersham Enlianced Chemiluminescence 
(ECL) system according to the manufacturer's instructions, which involved incubating 
the blots in a 1:1 mixture o f ECL reagents for 1 min then exposing them to blue-light 
sensitive autoradiography film (Fuji) in a cassette for between 10 sec and 5 min. The X- 
ray film was then developed in trays using Kodak photographic developer and fixer, and
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hung up to dry.
2.2.3. Protein estimations
Stationaiy phase promastigotes o f wild type parasites and Almcpan were lysed at 
5 X 10^ cells/ml in lysing solution containing proteinase inhibitors (as in section 
2.2.2.2). Protein concentrations of lysates diluted 1:10 in standard buffer (see below) 
were determined using the Pierce BCA protein assay kit (microtitre plate protocol), 
according to the manufacturer's instructions, with 6 standards (1200, 1000, 800, 600, 
400, 200 pg/ml) o f bovine serum albumin (Sigma) made up in 100 mM sodium 
phosphate, pH 7.5. All determinations were carried out in triplicate.
2.2.4. Infection of peritoneal exudate cells
The methods used were modified from those reported previously (Hunter and 
Coombs, 1991; Mallinson and Coombs, 1989). The medium used for all o f these studies 
was RPMI 1640 (Labtech), pH 7.2, supplemented with 10 % (v/v) heat-inactivated PCS 
(Seralab), 25 pg/ml gentamycin (Sigma) and 2 mM L-glutamine (Gibco). Resident 
peritoneal exudate cells (PECs) were obtained by peritoneal lavage using 5 ml of ice- 
cold complete RPMI per female BALB/c mouse. A typical yield consisted of 2 ml at 2 x 
10  ^ cells/ml per mouse, although younger mice gave lower yields and vice versa. The 
PECs of miee> 4 months old appeared to be somewhat resistant to L. mexicana 
infection, hence mice aged 2 - 4  months were generally used in this study to obtain 
PECs and for in vivo infectivity studies (see section 2.2.5). The cellular exudates from 
the mice were pooled and 2 x 1 0 ^  PECs were plated into each chamber o f either 4 or 8 
chamber Lab-tek tissue culture chamber slides (NUNC). The cells were allowed to 
adhere overnight at 32°C with a gas phase of 95% air/5% CO 2 , whereupon non-adherent 
cells were removed by washing. The adherent cells remaining were used in the 
experiments and were assumed to be macrophages, with the number o f macrophages 
present in each chamber taken to be 2 x 104 Parasites were resuspended in complete 
RPMI medium and 2 x 10  ^ cells were added to individual chambers such that the 
apparent ratio o f parasites to macrophages was routinely 1:1. After a 4 h incubation, any
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free parasites were removed by repeated washing with complete RPMI medium.
Cultures were incubated for seven days in the above medium at 32°C and under 
95% air/5 % COj, after which they were washed in RPMI medium, wet-fixed in 
methanol for 2 min and stained with 10% (v/v) Giemsa's stain for 15 min. For all 
preparations, not less than 200 macrophages were examined under lOOOx bright field 
microscopy to determine the % o f macrophages that were infected and the number of 
intracellular parasites per macrophage. T-tests were used to determine the statistical 
significance o f any observed differences in % infectivity between the different lines.
2.2.5. Infection of BALB/c mice
Stationary phase cultures of promastigotes were centrifuged at 2000g for 10 min 
and resuspended at 2.5 x 10^ cells/ml in serum-free HOMEM. Each mouse was 
inoculated subcutaneously in the shaven rump with 0.2 ml o f the cell suspension, 
corresponding to 5 x 10  ^cells. Where infections were initiated using lesion amastigotes, 
amastigotes were harvested as in section 2.2.1.4. and re-suspended as above but to 2.5 x 
10^ cells/ml - such that each mouse was inoculated with 5x10^  amastigotes.
Mice were monitored weekly for the appearance o f lesions, and the length, 
breadth and depth o f each lesion that appeared was measured (to the nearest mm) 
weekly, using a Mitutoyo micrometer, for up to 9 months. At this point, experiments 
were terminated in accordance with Home Office regulations. Infectivity was calculated 
as the mean lesion volume in mm^, using the following formula for a half spheroid; 
0.5236 X [length x breadth x height]. Mean values were calculated including all animals 
in a group, treating those without lesions as possessing a lesion volume o f 0 mm-f
2.2.6. Autohydrolysis of parasite lysates
The following conditions were selected to optimise the autoproteolysis of 
parasite proteins by endogenous amastigote CPs, resulting in a partial purification of 
stable proteinases, and was based on a method from a previously published protocol (Ilg 
et al., 1993). Wild type amastigotes were lysed at 2 x 10^ cells/ml in lysing solution 
(section 2.2.2.1), diluted to 5 x 10  ^ cells/ml in O.I M sodium acetate buffer, pH 5.5,
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containing 20 mM DTT, and incubated at 37°C in eppendorf tubes. After time points of 
0, 24 and 48 h, samples were removed and added to an equal volume of 2x SDS sample 
buffer. They were then frozen at -20°C until required for analysis by Western blotting.
2.2.7. Phase partitioning with Triton X-114 solution
The procedure adopted was modified from that published by Bordier (1981) and 
is based on the physical characteristics displayed by a diluted solution o f the nonionic 
detergent Triton X-114 at different temperatures. The detergent is homogenous at 0°C 
but separates into an aqueous phase and detergent phase above the 'cloud point' of 20°C, 
thus enabling the separation o f integral membrane proteins (amphiphilic) from 
hydrophilic proteins. A 4% (v/v) Triton X-114 solution was made up on ice, in PBS 
(section 2.2.1.2), and mixed with an equal volume (100 pi) o f amastigote lysate, 
resulting from suspension in distilled water at 10  ^ cells/ml. The sample was incubated 
on ice for one h, then centrifuged in a 10 ml conical tube at 4000g for one hour at 4”C to 
remove insoluble material. The soluble fraction was overlaid on a 300 pi cushion in an 
eppendorf tube, consisting of 6% (v/v) sucrose in PBS. The tube was warmed to 30"C 
for 10 min then centrifuged at room temperature for 10 min at lOOg. After 
centrifugation the detergent phase was found as an oily droplet at the bottom of the tube; 
200 pi o f the upper aqueous phase was carefully removed, although the sucrose cushion 
was now difficult to distinguish from the aqueous phase, and added to 1 pi of Triton X- 
114 to give a final concentration 0.5% (v/v) Triton X-114. After dissolution o f the 
surfactant at 0°C for 10 min, the sample was again overlaid on the sucrose 
cushion/detergent phase in the eppendorf used previously, warmed to 30°C for 10 min 
as before, and again subsequently microfuged at room temperature for 10 min at lOOg. 
The aqueous phase (approximately 200 pi) was removed into a separate tube containing 
3 pi of Triton X-114, the sucrose cushion was discarded and the remaining detergent 
phase (oily droplet) was resuspended in PBS to give a final volume o f 200 pi; these 
latter steps were taken to obtain equal volumes and approximately the same salt and 
surfactant values for o f each the two phases. The samples were frozen at -20°C until 
required for Western blotting and gelatin-SDS-PAGE analyses (section 2.2.2).
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2.3. RESULTS
2.3.1. Phenotype of mutants null for Imcpa
2.3.1.1. Growth and differentiation
Throughout the growth cycle in vitro, the Almcpan promastigotes appeared to be 
bigger in size than the wild type (Fig. 2.1). The difference in size was particularly 
noticeable in stationary phase populations, where the wild type cell population contains 
many small, putative metacyclic forms (Fig. 2.1, A). It appeared that in stationary phase 
cultures o f the null mutants, the small metacyclic forms were not produced (Fig. 2,1, B). 
Cell measurements confirmed that the null mutants were significantly bigger than wild 
type parasites; the median cell lengths (since data were skewed) were 10 and 17.5 pm, 
respectively (Fig. 2.2). On Giemsa-stained smears, the Imcpa nulls also appeared to 
contain large vacuoles and granules not seen in the wild type parasites. A protein 
estimation comparing equal cell numbers o f the two cell lines showed Almcpa stationary 
phase promastigotes to have 2.7 times as much protein as the wild type promastigotes 
(Table 2.2). Despite these differences, there was no observable difference between the 
growth rates of wild type and Almcpan promastigotes (Fig. 2.3).
As with wild type stationary phase promastigotes, it was possible to transform 
stationary phase Almcpan promastigotes to amastigote-like forms in vitro. These forms 
looked very similar to wild type axenic amastigotes, although perhaps being slightly less 
homogenous (Fig. 2.4). They reached approximately the same cell densities as wild type 
axenic amastigotes, around 2-3 x 10^ cells/ml after 7 days (Fig. 2.5), and also could be 
successfully cultured for at least 3 subpassages, as could wild type parasites.
2.3.1.2. Proteinases
Null mutant and wild type promastigotes were cultured and harvested on 
reaching stationary phase, and their proteinases analysed by gelatin-SDS-PAGE (Fig. 
2.6). High mobility proteinases in the range of 21-28 kDa were present in the null 
promastigote lysates (lane 2), but at a much lower activity than those of the wild type 
(lane 1). Low mobility proteinase activity (>60 kDa) was similar in the two lines. The 
null mutant axenic amastigote proteinase profile (lane 3) was very similar to that o f wild
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type axenic amastigotes (lane 4), both in banding pattern and intensity.
In agreement with the gelatin gel analysis, Western blot analysis (Fig 2.7, A) 
revealed that the null stationary phase promastigotes contained much less Imcpb group 
C CPs (lane 2), around 30 kDa, compared with wild type stationaiy phase promastigotes 
(lane 1) or amastigotes (lane 3). The lower mobility bands were non-specific bands also 
detected with pre-immune serum; they are more pronounced in Almcpan which may 
indicate that less autohydrolysis is occuring in this line (a further indication o f less 
proteinase activity). A control Western blot o f the three lines (Fig. 2.7, B) showed no 
detectable LmCPa in Almcpan (lane 2) in contrast to wild type stationary phase 
promastigotes (lane 1), which had the 24 kDa protein, and amastigotes (lane 3) which 
had the 24 kDa protein and the stage specific 27 kDa protein. Also in agreement with 
the gelatin gel analysis (Fig. 2.6), Western blot analysis (Fig. 2.8) of Almcpan axenic 
amastigotes showed that this form o f the null mutant (lane 3) had as much LmCPb 
group C proteinase as wild type axenic amastigotes (lane 2), whereas the null mutant 
promastigotes (lane 5) again had less proteinase than this stage o f wild type parasites 
(lane 4).
2.3.1.3. Infectivity
Resident peritoneal macrophage cultures were set up in chamber slides and 
incubated 1:1 with stationary phase promastigotes o f wild type par asites and Almcpan 
for 4 h. The results (Table 2.2) showed that after 7 days both the percentage o f infected 
PECs and the number o f amastigotes per infected cell was very similar with the two 
lines.
In order to establish whether the lack o f Imcpa had an effect on the infectivity of 
L. mexicana to animals, lesions resulting from an inoculation of either wild type or A 
Imcpan parasites were monitored weekly by measuring with a micrometer. Lesions 
initiated using wild type and Almcpan stationary phase promastigotes were similar in 
that they first appeared, respectively, 9 and 10 weeks post-inoculation (Fig 2.9, A). 
Thereafter, however, there was a difference in mean lesion volume between the two 
lines, with the wild type lesions on average being some 3-4 times bigger than the A
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Imcpan lesions tlii'oughout the duration o f the experiment.
Since the Almcpan promastigotes were able to produce lesions, this allowed the 
infectivity o f Almcpan lesion amastigotes to BALB/c mice to be investigated (Fig. 2.9, 
B). Again Almcpan lesions started to appear only one week after those resulting from 
inoculation o f wild type parasites. In contrast to the results found with Almcpan 
stationaiy phase promastigotes (Fig. 2.9, A), however, the lesion amastigotes o f this line 
produced lesions that increased in size at a rate very similar to those produced by the 
wild type line.
2.3.2. Relationship of the 24 kDa and 27 kDa proteins detected with anti-LmCPa 
antis erum
2.3.2.1. Autohydrolysis o f  wild type amastigote lysates
One working hypothesis with regai'ds to the relationship o f the two proteins was 
that the 27 kDa protein was a precursor form o f the 24 kDa protein. To thus investigate 
whether the 27 kDa protein could be converted to the 24 kDa by autoproteolytic 
digestion, wild type amastigotes were lysed in 0.1 M sodium acetate buffer, pH 5.5, 
containing 20 mM DTT, and incubated at 37°C. Samples taken from various time points 
were analysed by immunoblotting using anti-LmCPa antiserum (Fig. 2.9). However, 
two distinct bands were still present after 48 hours, suggesting that no interconversion 
o f the 27 and 24 kDa proteins had occurred.
2.3.2.2. Separation o f  LmCPa into aqueous and detergent phases
Another working hypothesis was that the heavier protein was a membrane- 
bound form of the 24 kDa protein, with a putative lipid anchor causing the increase in 
molecular weight to 27 kDa. Therefore, in order to establish if  one o f the LmCPa 
proteins was hydrophobic and the other hydrophilic, the partition of the proteins during 
phase separation in Triton X-114 solution was investigated. After separation samples 
were analysed by Western blotting and gelatin-SDS-PAGE. The doublet of 24 and 27 
kDa proteins was detected (Fig. 2.11, A, lane 1) by Western blotting using anti-LmCPa 
antiserum. After phase separation in the detergent, the lower moblity 27 kDa band was
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recovered in the aqueous phase (lane 2) while the higher mobilty 24 kDa band was 
found in the detergent phase (lane 3). A control Western blot (Fig 2.11, B) probed with 
anti-group B CP antibody, showed that the majority of the Imcpb group B CPs were 
recovered in the aqueous phase (lane 2, arrowed), a prediction based on previous studies 
(Robertson and Coombs, 1990). Higher molecular weight bands were due to non­
specific binding found in pre-immune serum. A control gelatin gel (Fig 2.12) showed 
the membrane protein gp63 had been separated into the detergent phase (lane 3, 
arrowed) and confirmed that the major Imcpb group B CPs were recovered in the 
aqueous phase (lane 2, around 24 kDa).
2.3.2.3. Detection o f  the 27 kDa band in Almcpan axenic amastigotes
An immunoblot comparing samples (identical to those used in Fig. 2.8) probed 
with anti-LmCPa antiserum (Fig. 2.13) clearly showed the 24 and 27 kDa proteins in 
lesion amastigotes (lane 1), wild type axenic amastigotes (lane 2), and the 24 kDa 
protein in wild type promastigotes (lane 4); the protein was not present in null 
promastigotes (lane 5). However, this blot also showed the surprising result that the 
lower mobility 27 kDa band was present in Imcpa null axenic amastigotes (lane 3), 
strongly arguing that the 27 kDa protein is not encoded by the Imcpa gene.
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Figure 2.1. Light micrographs of stationary phase promastigotes. Wild type (A) and 
Almcpan (B) cells were fixed in methanol and stained in 10% Giemsa's stain. 1 here was 
a clear difference in the size o f cells between the two lines, with the Almcpan 
promastigotes (B) being much bigger then the majority o f wild type cells (A). 1 he scale 
bar represents 10 pm.
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Figure 2.2. The cell lengths of stationary phase promastigotes. Giemsa-stained 
smears of stationary phase promastigotes (see Fig. 2.1) were used to compare the 
lengths of wild type parasites and Almcpan (both subpassage I ). Measurements were 
made with a graticule under lOOOx bright field microscopy. At least 100 cells were 
measured in each case, to the nearest graticule unit (1 graticule unit = 1.25 pm). The 
results indicate a highly significant difference between the lengths o f wild type (open 
bars) and Almcpan (closed bars) parasites (z=13.88, greatly exceeding the critical value 
of 2.58 at P=0.01).
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Figure 2.3. Typical m vitro grow th curves of L, m exicana  prom astigotes. Cultures of 
wild tyjje (-#-) and Mmcpan (-o )  promastigotes were initiated at 5 x 10  ^ ceUs/ml in 
complete HOMEM medium and iiicubfited at 25°C. Cell counts were peiformed on 
consecutive days. The results are the means ± SD fiom 3 independent cultures for each 
Ihie.
cell line protein content (mg/10® cells)
wild type 
Mmcpan
3.00 + 0.08 
8.10 + 0.70
Table 2.1. P rotein content of stationary  phase prom astigotes. Data are the means ± 
SD o f one determination o f  fieshly lysed stationary phase promastigotes, peiformed in 
tiiphcate.
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Figure 2.4. Light micrographs of Giemsa-stained axenic amastigotes; (A) wild type, 
(B) f^Imcpan. Tliere was uo difference between the sizes o f the cells of the 2 lines, with 
the l^lmcpan axenic amastigotes (B) appearing morphologically very similar to wild type 
cells (A). The scale bar represents 10 pm
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Figure 2.5. l ypical in vitro growth curves of axenic amastigote lines. Cultures were 
routinely initiated using stationary phase promastigotes at 1 x 10^  cells/ml in complete 
SDM, pH 5.5, and incubated at 32°. Cell counts revealed no difference between growth 
rates and final cell density o f wild type (-#-) and àlmcpan ( -0 )  axenic amastigotes.
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Figure 2.6. Gelatin SDS PAGE analysis of cell lines. Lane 1, wild type L mexicamt 
stationary phase promastigotes; lane 2, Almcpan stationary phase promastigotes; lane 3. 
Almcpan axenic amastigotes; lane 4, wild type axenic amastigotes; lane 5, wild type 
lesion amastigotes. Lanes were loaded with lysate containing 10^  cells. 1 he positions o f  
molecular weight markers in kDa are indicated.
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Figure 2.7. Western blots using anti-LmCPb antiserum (A) and anti-LmCPa 
antiserum (B). Lane 1, wild type stationary phase promastigotes; lane 2, Almcpan 
stationary phase promastigotes; lane 3, wild type lesion amastigotes. Lach lane was 
loaded with lysate from 5 x 1 0 ^  cells. The bands >42 kDa were also produced with the 
pre-immune serum (lane 4).
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Figure 2.8. Western blot probed with anti-LmCPb antiscrum. Lane 1, wild type 
lesion amastigotes; lane 2, wild type axenic amastigotes; lane 3, Almcpan axenic 
amastigotes; lane 4, wild type stationary phase promastigotes; lane 5, Almcpan stationary 
phase promastigotes. Each lane was loaded with lysate from 5x10^ cells.
cell line % Infected PECs am astigotes/infected PEC
wild type 36 ±8.3 4.6 ±1.3
Almcpan 36 ±10 4.4 ±1.2
Table 2.2. Infectivity to macrophages. PECs were obtained from peritoneal lavage of 
BALB/c mice and infected with stationary phase promastigotes o f wild type parasites 
and Almcpan at a ratio o f 1:1. After 7 days incubation at 32°C, cells were fixed, stained 
with Giemsa's stain, and parasite load determined by counting 200 PECs. The values 
presented are means + SD from 4 independent experiments.
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Figure 2.9. Infectivity to BALB/c mice. Subcutaneous lesions in the rumps o f female 
BALB/c mice resulting from an inoculum o f 5 x 10^ promastigotes (A) or 5 x 10  ^ lesion 
amastigotes (B) were measured at weekly intervals using a micrometer, and the mean 
lesion volume + SD per group o f 3 mice (A) or 5 mice (B) calculated. The lines 
inoculated were wild type (-#-) and Almcpan (-0-) parasites. The majority o f error bars 
have been omitted for clarity, while some are so small they are obscured by the data 
points.
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Figure 2.10. Autohydrolysis of wild type amastigote lysates. Samples were taken at 
time points and analysed by Western blotting, using a polyclonal antiserum to LmCPa. 
Lanes 1 , 3 and 5 are control autolysates at 0, 24 and 48 hours containing the proteinase 
inhibitors E-64 and PMSF. L anes 2, 4 and 6 are autolysate samples at 0, 24 and 48 
hours. Each lane was loaded with lysate from 5x10^ cells.
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Figure 2.11. Western blot analyses of wild type L. mexicana amastigote lysate 
having undergone phase partitioning in Triton X-114 solution. Blots were probed 
with anti-LmCPa antibody (A) and anti-LmCPb antibody (B). Lane L original 
amastigote sample, lane 2, aqueous phase sample, lane 3, detergent phase sample. The 
positions o f molecular weight markers are indicated in kDa. Lane 1 was loaded with 
lysate from 5x10^ cells; lanes 2 and 3 with approximately 1.25 x 10^ ’ cells each.
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Figure 2.12. Gelatin gel analysis of wild type L. mexicana amastigote lysate having 
undergone phase partitioning in Triton X-114 solution. Lane 1, original amastigote 
sample, lane 2, aqueous phase sample, lane 3, detergent phase sample. I he usual 
positions of molecular weight markers are indicated. Each lane contained lysate from 
approximately 1 x 10^  cells.
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Figure 2.13. Western blot of axenic amastigote samples probed with anti-LmCPa 
antiserum, l.ane 1, wild type lesion amastigotes; lane 2, wild type axenic amastigotes; 
lane 3, Almcpan axenic amastigotes; lane 4, wild type stationary phase promastigotes; 
lane 5, Almcpan stationary phase promastigotes. Each lane had an equal loading o f 5 x 
10^  cells. The low mobility bands present in each track were also detected using pre- 
immune serum.
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2.4. DISCUSSION
Stationary phase promastigote cultures of Almcpan differed from those of wild 
type parasites in that they did not seem to contain the small putative metacyclic form 
(Fig. 2.1). Measurements o f the cells (Fig. 2.2) confirmed that the Almcpan stationary 
phase promastigotes were substantially bigger than those o f wild type, although the in 
vitro promastigote growth rate was very similar to that o f wild type parasites (Fig. 2.3). 
A protein estimation of wild type stationary phase promastigotes (Table 2.2) was similar 
to previous findings, although slightly lower at 3.0 m g/10  ^ cells compared with 3.5 
m g/10^ cells for metacyclics (Bates, 1994), and verified that the null mutants (8.1 
m g/10^ cells) were bigger than wild type parasites. However it is not impossible that 
some autohydrolysis o f parasite proteins occurred with the wild type samples, even 
though they were lysed in the presence of proteinase inliibrtors, and that less 
autohydrolysis occurred with Almcpan due to less overall CP activity (as is discussed 
later). This could mean that the real difference in protein content between the two lines 
is not quite as large as calculated. It should be mentioned that promastigotes o f wild 
type parasites and Almcpan were grown with and without the antibiotics hygromycin 
and phleomycin to establish whether or not these caused the observed difference in 
morphology of the nulls, but this did not seem to be the case. Although a morphological 
difference was observed between stationary phase promastigotes o f wild type parasites 
and Almcpan, the latter cells could transform to and grow as axenic amastigotes as well 
as wild type (Fig. 2.5) and were moiphologically identical to wild type at this stage in 
the in vitro developmental cycle (Fig. 2.4).
Biochemical analyses o f Almcpan stationary phase promastigotes showed them 
to have less Imcpb protein and activity than wild type parasites (Figs. 2.6 and 2.7). This 
could indicate a role for Imcpa in the processing and/or activation o f these enzymes, 
since pro-enzyme activation is likely to require an enzyme with very specific substrate 
specificity; such a high specificity could explain why the target substrate for the 
fimctional LmCPa enzyme has not yet been detected. With respect to CP activity and 
protein, however, the null mutant axenic amastigotes were very similar to wild type 
parasites (Figs. 2.6 and 2.8). Taken together with the data on morphology, the
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observation that there was less proteinase activity in the null mutant stationary phase 
promastigotes suggests that the null mutants were not forming typical metacyclics. 
However, the suggested lack o f formation of this stage in vitro is not consistent with 
their ability to transform to, and grow as, axenic amastigotes. Unfortunately, a definite 
conclusion regarding the metacyclogenesis of Almcpan promastigotes was not reached 
from the data presented; the lack o f a purification method for possible metacyclic forms 
o f L. mexicana has resulted in the identification of several putative metacyclic markers, 
such as surface ultrastructure (Bates and Tetley, 1993, and see Chapter 3) which could 
be examined to resolve this question.
Nor does the apparent lack o f metacyclic formation appear to affect the ability of 
the Almcpan stationary phase promastigotes to infect and multiply within macrophages 
(Table 2.2). Almcpan stationary phase promastigotes had previously been shown to 
infect the J774 macrophage-like cell line (Souza et aL, 1994) but this had not been done 
quantitatively; clearly though the lack o f Imcpa does not have an effect on infectivity or 
intracellular growth o f the parasite.
In vivo experiments showed that Almcpan promastigotes produced lesions as 
quickly as wild type, but that these lesions did not increase in size at the same rate as 
those produced by wild type parasites, such that by the end o f the experiment they were 
about four fold smaller than those o f the wild type parasites (Fig. 2.9, A). This slow 
multiplication in vivo could perhaps indicate a role for Imcpca in in vivo parasite 
nutrition. However, lesion amastigotes o f the null mutants were as infective to mice as 
the wild type parasites (Fig. 2.9, B), perhaps suggesting that the Imcpa gene is more 
important in the promastigote stage o f the parasite. The fact that overall the lesion sizes 
were smaller when the mice were infected with lesion amastigotes (Fig. 2.9, B) than 
with promastigotes (Fig. 2.9, A) may be explained by the fact that ten fold fewer lesion 
amastigotes were used to initiate infections in mice that were older, and therefore more 
resistant to infection (see section 2.2.4)
Autohydrolysis o f wild type amastigote samples (which contain about equal 
amounts of the 24 kDa and 27kDa proteins) did not result in any interconversion o f one 
Imcpa product to the other (Fig. 2.10), casting some doubt on the theory that the proteins
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were different processing products o f the same 38 kDa precursor protein (Mottram et 
al., 1992), with one a further precursor form o f the other. Another hypothesis aimed at 
explaining the relationship between the 24 kDa and 27 kDa proteins that appeared to be 
encoded by Imcpa was that the heavier protein was a glycosylated or membrane-bound 
form o f the 24 kDa protein, causing the increase in molecular weight of the protein from 
24 kDa to 27 kDa. It had been hoped to investigate this using deglycosylation techniques 
and phospholipse C cleavage
Triton X-114 phase separation, in which hydrophilic proteins are found 
exclusively in the aqueous phase, and hydrophobic proteins (such as integral membrane 
proteins with a lipid anchor) are recovered in the detergent phase, successfully separated 
the two LmCPa proteins according to their hydrophobicity (Figs. 2.11 and 2.12). 
However the 24 kDa protein separated into the detergent phase, and the 27 kDa into the 
aqueous. This was a surprising result, since my working hypothesis was that the heavier 
27 kDa protein may have a lipid anchor. Western blot analysis o f different stages o f A 
Imcpan revealed that the 27 kDa band detected by the antiserum was in fact present in A 
Imcpan axenic amastigotes. This offered an explanation as to why there was no 
interconversion o f the 27 kDa band to the 24 kDa during autohydrolysis, and the rather 
puzzling result with the Triton X-114 separation in that the heavier 27 kDa protein had 
no lipid anchor. The 27 kDa protein is likely to be another stage-specific CP very similar 
to the 24 kDa one, since it reacts very strongly with the antiserum.
Previously it had been impossible to say if the 24 kDa and 27 kDa proteins were 
products o f different genes or processing products o f the same 38 kDa precursor 
(Mottram et al., 1992), but the 24 kDa protein was implicated as the mature form o f the 
38 kDa precursor and the major product o f the Imcpa gene as it had the size predicted 
for the mature protein from the gene sequence (Mottram et al., 1992), Clearly from the 
results presented in this chapter, the 24 kDa protein is indeed the major product o f 
Imcpa and the 27 kDa protein must be the product of another gene.
The ability of the nulls to transform to all the developmental stages in vitro and 
infect animals efficiently indicates Imcpa to be non-essential under the conditions tested 
and hence the biological phenotype o f Almcpan has been dubbed 'cryptic', as reported
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previously (Souza et al., 1994). Since the specific antiserum was shown not to detect the 
highest levels o f LmCPa in the amastigote stage (as was previously thought), it is 
possible that LmCPa may play a role in survival o f the parasite within the insect vector, 
a criterion not examined in this investigation. Another explanation for the lack o f a 
noticeable phenotype associated with the Imcpa null mutants could be due to the fact 
that L  mexicana also contains the biochemically distinct Type I and III CPs and the role 
o f Imcpa may be assumed by these or other CPs in the null thus making the phenotype 
ciyptic. Although the Type 1 CP gene Imcpb is more closely related to homologues in T  
brucei and in T. cruzi than to Imcpa, it is a possibility that the highly active CPs encoded 
by the Imcpb array compensate for Imcpa's inactivation, and hence LmCPa is probably 
not a suitable drug target.
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CHAPTER THREE 
AN INVESTIGATION INTO THE ROLES OF THE LMCPB 
CYSTEINE PROTEINASES OF LEISHMANIA MEXICANA
3.1. INTRODUCTION
3.1.1. The Imcpb genes and gene products
Imcpb, the gene o f L. mexicana which encodes the Type I CPs (see Chapter 1, 
Table 1), has been cloned and sequenced (Souza ei a l ,  1992). The genomic arrangement 
o f Imcpb was characterised and the results implied that Imcpb was a multi-copy gene of
2.8 kb unit size with at least 10 tandemly repeated copies per locus. In being multicopy, 
it is similar in arrangement to the Type 1 enzymes o f T. brucei and T. cruzi (Mottram et 
al., 1989; Pâmer et a l ,  1990; Campetella et a l, 1992; Eakin et a l ,  1992). Subsequent 
studies (Appendix B: Mottram et a l ,  1996, 1997) showed the Imcpb genes to be in a 
tandem array o f 19 units, with there being no other copies in the genome.
The steady state levels o f Imcpb RNA correlate veiy well with the activities of 
the types A, B and C CPs that occur in different forms o f L  mexicana (Lockwood et a i , 
1987; Robertson and Coombs, 1990, 1992) in that the gene transcript is found at much 
higher levels in amastigotes than in metacyclics, and not at all in log phase 
promastigotes (Souza et a l ,  1992). This stage regulation suggests that the enzyme plays 
an important role in the intracellular survival of the parasite. A study by Robertson and 
Coombs (1994) was undertaken to provide more information on the 6 categories o f L  
mexicana CP activities (groups A, B, C, E, F and H) detected using gelatin-SDS-PAGE. 
A direct amino acid sequence analysis o f purified CPs o f types A, B, and C yielded 
highly similar N-terminal sequences for each, the consensus sequence matching that 
predicted for the N-terminus of the mature Imcpb gene product (Souza et a l ,  1992). It 
was suggested that the observed differences among the L  mexicana CPs could be either 
due to variable post-translational processing of a single CP gene product or the 
individual isoenzymes being encoded by different genes o f the tandem array. The groups 
B and C CPs had been found to show some different preferences for peptidyl 
fluorogenic substrates after SDS-PAGE; the tluee enzymes o f Group B being more
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active towards substrates with tyrosine in the P, position (such as SucLY-NHMec) 
whereas the two group C proteinases were as active towards eompounds with a basic 
amino acid in this position (such as BzFVR-NHMec) (Robertson and Coombs, 1990). 
However, their protein sizes are the same, they react with the same anti-sera and have 
almost identical N-terminal amino acid sequences. It was proposed that limited amino 
acid substitutions in the different Imcph products could explain the isoenzymes' different 
substrate preferences. Anti-sera raised separately against the group B and C CPs both 
recognised the groups A, B, and C CP proteins in Western blots, indicating that they 
have shared epitopes, and groups B and C CP proteins produced the greatest signal, in 
keeping with their high abundance. A protein o f the same size was recognised in 
stationary phase promastigote lysates in which groups B and C CP activities have been 
found along with the metacyclic-specific group F CPs that have a faster mobility in 
gelatin-SDS-PAGE gels (Robertson and Coombs, 1992); this suggested group F CPs 
could also be Imcpb products (Robertson and Coombs, 1994). So too could the group E 
enzymes that differed from the other amastigote CPs in having lower mobilities in 
gelatin gels and apparently being membrane associated. Molecules o f around 30 kDa 
were specifically recognised by the anti-C CP anti serum in Western blots o f L  donovani 
and L  major lysates, suggesting that Imcpb homologues may be common to all 
leishmanias (Robertson and Coombs, 1994). Homologues have subsequently been 
identified in L  pifanoi (Traub-Cseko et al., 1993) and in L. major (Sakanari et a l,  
1997).
3.1.2. Aims
As introduced previously in Chapter 2, a novel way o f determining the 
importance o f parasite enzymes is by performing gene deletion experiments. 
Transfection systems have recently been developed which allow not only the disruption 
o f chr omosomal genes in Leishmania, but also the complementation o f mutant parasites 
(Ryan et a l,  1993). Null mutants for the Imcpb gene array were created by colleagues in 
the Wellcome Unit o f  Molecular Parasitology (WUMP), University o f Glasgow 
(Appendix B: Mottram et al, 1996). The procedure involved sequential replacement of
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the two alleles o f the array with antibiotic-resistance genes, and then selection by 
applying antibiotic pressure. Individual CP genes were then re-expressed in this null line 
via the episomal vector pTEX (Kelly, et a l ,  1992).
The main aims o f this part o f my work were to establish the ways in which the 
Imcpb mutant lines differed from the wild type line (that is, to ascertain the biochemical 
and biological phenotype o f the mutants), in order to gain insight into the function o f the 
Imcpb CPs and their importance to the parasite. The features compared included the 
number and activity o f proteinases present, growth and differentiation o f the parasites in 
vitro, and their infectivity to macrophages and animals. It was hoped that by using this 
approach it would be possible to pinpoint the roles o f Imcpb and the individual 
isoenzymes and hence determine the suitability o f Imcpb as a useful drug target.
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3.2. MATERIALS AND METHODS
3.2.1. Parasites
3.2,L I, Transfected cell lines o fh ,  mexicana
The lines studied in the work described in this chapter, which were created by 
colleagues in WUMP, are sunuiiarised in Table 3.0. Details o f the transfection 
procedures used can be found elsewhere (Souza et a i ,  1994) and in Appendix B 
(Mottram et al., 1996, 1997). In this study, all cell lines used were parasites derived 
from a BALB/c mouse lesion subsequent to the transfection procedure, unless 
designated otherwise by the letter (t) following the cell line name.
Table 3.0. Leishmania mexicana transfectants used
line gene deletion(s) antibiotic used for 
selection
AlmcpbBL single allele Icnockout for Imcpb phleo
Almcpbn null mutant for Imcpb hyg/phleo
AlmcpbTEX null mutant for Imcpb transfected with 
pTEX vector
hyg/phleo
Almcpbg2.8 Almcphn re-expressing a 2.8 kb Imcpb 
internal genomic fragment
neo
àlm cpbcl Almcpbn re-expressing Imcpb cDNA neo
Almcpbib Almcpbn re-expressing a T. brucei CP 
cDNA
neo
Almcpan null mutant for Imcpa hyg/phleo
Almcpbn/A
Imcpan
mutant null for both Imcpa and Imcpb 
('double null')
hyg/phleo/sat/puro
Almcpbn/A 
lmcpag2.8
double null re-expressing a 2.8 kb Imcpb 
genomic fragment
neo
Almcpbgl Almcpbn re-expressing 
gene 1 o f the Imcpb array
neo
AlmcpbglS Almcpbn re-expressing 
gene 18 o f the Imcpb array
neo
Almcpbgl 9 Almcpbn re-expressing 
gene 19 of the Imcpb array
neo
Abbreviations: hyg, hygromycin; phleo, phleomycin; SAT, nourseotliricin
hydrosulphate; neo, neomycin; puro, puromycln.
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3.2.1.2. Cell culture
The tlu’ee major developmental stages o f L. mexicana (MNYC/BZ/62/M379) 
were cultured and harvested as described in Chapter 2, section 2.2.1. Where appropriate 
other antibiotics were included for selection o f transfectants: hygromycin B (Sigma) at 
50 pg/ml, phleomycin (Sigma) at 10 pg/ml, nourseothiicin hydrosulphate (a gift from P. 
I I. Grafe, Hans-Knoll Institute, Thuringen, Germany) at 25 pg/ml, puromycin (Sigma) at 
10 pg/ml or neomycin (Geneticin, BRL) at 25 pg/ml (initially) or 500 pg/ml (to promote 
episomal re-expression o f gene product) were added, singly or in combination (see 
Table 3.O.). To standardise the cultui'es, all transfected promastigote lines (t) were 
routinely grown through one passage as axenic amastigotes (see Chapter 2, section
2.2.1.3) to 'reset' them, and then transformed back to promastigotes for experimental 
work. Approximate doubling times for promastigotes and axenic amastigotes were 
calculated from cell counts taken during exponential (log.) growth, using the equation: 
[time elapsed (new cell count/old cell count)] x 2.
3.2.2. Proteinase assays and analyses
3.2.2.1, Gelatin-SDS~PA GE
Substrate SDS-PAGE was earned out essentially as described in Chapter 2, 
section 2.2.2.1. Where macrophage samples were being analysed, resident peritoneal 
macrophages were harvested as before (Chapter 2, section 2.2.4.) and lysed at 5 x 10  ^
cells/ml in lysing solution (section 2.2.2.1). Lysates were diluted 1:1 with 2x sample 
buffer (section 2.2.2.1.). Lanes were loaded with 20 pi samples, corresponding to 5 x 
10  ^macrophages per track.
3.2.2.2. Western blotting
Western blotting was carried out as described in Chapter 2, section 2.2.2.2., 
using a 1:500 dilution o f anti-LmCPb group C CP (Robertson and Coombs, 1994) as the 
primary antibody.
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3.2.2.3. Fluorogenic substrate assay
This method was adapted from protocols published by North et a i  (1990b), and 
Robertson and Coombs (1990). Preparation o f samples and the electrophoresis itself 
were carried out as is standard for gelatin gels (Chapter 2, section 2.2.2.1) with the 
exception that 40 pi of sample was added per lane, coiTesponding to 2 x 10"^  cells. After 
washing gels in 2.5% (w/v) Triton X-100 for 30 min at 37°C, gels were incubated at the 
same temperature in 0.1 M sodium acetate buffer, pH 5.5, containing 1 mM DTT and 
0.01 niM of fluorogenic peptide substrate. Fluorescent bands corresponding to 
proteinase activity were detected using a UV transilluminator, with maximal activity 
observed after about 20 min. Results were recorded immediately on photographic film, 
using a yellow filter and with exposure times ranging from 30 sec to 60 sec. Gels could 
be left to incubate for longer and then stained with Coomassie blue to observe gelatin 
hydrolysis, if required.
The peptidyl amidomethylcoumarin substrates used were N-benzoyl-phe-val- 
arg-7“(4-methyl)-coumarylamide (BzFVR-NFIMec) and N-succinyl-leu-tyr-7-(4-
methyl)-coumarylamide (SucLY-NHMec). Approximately 5 mM stock solutions were 
made in 50% (v/v) acetonitrile, some used fresh and the remainder stored at -20°C until 
further required.
3.2.2.4. Immunoelectron microscopy
CPs were localised using immunogold electron microscopy (performed by L. 
Tetley), Parasites were fixed in 2% (v/v) formaldehyde/0.1% glutaraldehyde, low 
temperature dehydrated in ethanol and embedded in LR White resin. 80 nm sections 
were incubated in anti-LmCPb antibody diluted 1:50 in 1 % (w/v) acetylated bovine 
serum albumin/PBS for 30 min and then for 60 min in goat anti-rabbit antibody/10 nm 
gold conjugate (Aurion) at 1 in 10 in bovine serum albumin/PBS. The sections were 
then stained in uranyl acetate and lead citrate.
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3.2.3. Identification of L. mexicana metacyclic forms
3.2.3. L  Light microscopy
Measurement o f cells was carried out as described in Chapter 2, section 2.2.1.5.
3.2.3.2. Complement lysis
Guinea pig serum (GPS, from Seralab) that had been stored at -70°C was used as 
a source of complement. The lytic assay used was essentially as described (Mallinson 
and Coombs, 1989b) with the exception that incubations were performed at 25°C (Bates 
et a i ,  1993). Promastigotes were resuspended to 2 x 10^ cells/ml in complete HOMEM 
medium and then mixed 1:1 with 60% (v/v) GPS in complete HOMEM such that the 
final concentrations in the assay were 1 x 1 0 ^  cells/ml in 30% (v/v) GPS. After 30 min 
incubation, parasites were exposed to hypo-osmotic stress by diluting a sample 1:1 with 
double distilled, deionised water (dH 2 Ü) in order to burst any partially-lysed cells and so 
enable a more accurate 'intact cell' count to be made (intact cells were observed to swell 
but resumed their initial shape within seconds). Promastigotes were only considered 
intact if  they possessed the usual appearance o f viable cells under phase contrast 
microscopy and did not show any strange shape or evidence o f membrane damage or 
swelling. The percentage lysis was calculated by reference to control incubations using 
heat-inactivated serum. However, much clumping of cells was apparent in these controls 
and the clumps were disrupted as far as possible using a 26G needle before counting. T- 
tests were used to determine the statistical significance o f any observed differences in 
percentage lysis between the different lines.
3.2.3.3. Transmission electron microscopy
Parasites were sedimented from culture medium by centrifugation at lOOOg for 
15 min at 25°C and fixed at that temperature with 2.5% glutaraldehyde in 100 niM 
phosphate buffer, pH 7.4, for 40 min. Subsequent processing procedures followed 
methods described previously (Tetley et aL, 1989) except that sections of 100 nm were 
used for optimal contrast enliancement by zero-loss imaging with a Zeiss 902 
transmission electron microscope (performed by L.Tetley).
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3.2.4. Nuclease analyses
3.2.4.L Poly(A)-SDS-PAGE
This method was based on that published by Bates (1993). Cell pellets were 
lysed in 38 mM Tris/100 mM glycine, pH 8.5, 1% (w/v) SDS, 50 pg/ml leupeptin at the 
equivalent o f 1 x 10^ cells/ml. The lysates were then mixed with an equal volume of 
double strength non-reducing sample buffer (as in section 2.2.2.1, omitting the 
mercaptoethanol). All samples were incubated in a boiling waterbath for 2 min and then 
allowed to cool, prior to electrophoresis. SDS-PAGE with a 10% resolving gel and 
discontinuous buffer system was performed using standard methods (Section 2.2.2.1), 
but including poly(A) (5' poly-adenylic acid. Sigma) at 0.3 mg/ml, final concentration, 
in the resolving gel. After electrophoresis, gels were washed by gentle agitation for 30 
min in 0.1% (v/v) Triton X-100/100 mM HEPES, pH 8.5 to enable renaturation of 
enzyme activity, then incubated at 37°C in the same buffer for a further 1-2 h. Each gel 
was then fixed in 7.5% (v/v) acetic acid for 10 min, washed in 50 ml dH^O for 3 x 1 0  
min, stained with 0.2% (w/v) Toluidine Blue in 10 niM HEPES, pH 8.5, for 15 min, and 
destained with dH^O. Regions of enzyme activity were revealed by digestion o f poly(A) 
and appealed as clear bands in a dark blue-staining gel.
3.2.5. Infection of peritoneal exudate cells
The methods used were as described earlier (Chapter 2, section 2.2.4) with the 
following additions. Where lesion amastigotes were used to initiate infections, PECs 
were incubated with the amastigotes for one hour at an apparent ratio o f 1:1, after which 
free parasites were removed by repeated washing with complete RPMI medium.
In experiments where the parasite:macrophage ratio and exposure time were 
varied, parasites were diluted in RPMI medium to the appropriate cell density, added to 
the PECs and left to incubate for the required exposure time before washing off free 
promastigotes. Where time course experiments were undertaken, PECs were allowed to 
adhere overnight and then incubated in medium axenically for a further 2 days before 
initiation of infection; this then allowed intracellular parasites to be more easily 
observed at the early time points of 2, 4 and 8 h since the macrophages had spread
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sufficiently during the 2 days prior to infection.
In certain cases parasitophorous vacuole size was measured using a calibrated 
eyepiece graticule, as detailed in Chapter 2, section 2.2.1.5.
3.2.6. Infection of BALB/c mice
The inoculation o f parasites into BALB/c mice was canied out exactly as 
described in Chapter 2, section 2.2.5.
3.2.8. 'Api Zym' analyses
The 'Api Zym' enzyme screening kit was used according to the manufacturer's 
instructions. Resident peritoneal macrophages were lysed at 5 x 10^ cells/ml in lysing 
solution (0.25 M sucrose, 0.1% Triton X-100) and passed through a 26G needle 3 times 
to break up the DNA. After adding water drops to the underlying tray o f the kit to aid 
humidity, 95 pi of the cell lysate was added to each well (1-20) o f the kit, along with a 
drop each o f the reagents 'zym A' and 'zym B' supplied, and then incubated at 37°C for 
24 h. After this time, the tray was removed from the incubator and held under a bright 
lamp for 30 sec to ensure the colour change was optimum before reading. Enzyme 
activity was observed as a change in colour, the stronger the colour the greater the 
enzyme activity. The colour change was classified in the range from 1 (lowest) - 5 
(highest). Where infected macrophages were used, macrophages were harvested 7 days 
after initiation o f the in vitro infection- when the infection rate was approximately 40%.
3.2.8. Exposure of promastigotes to hydrogen peroxide and nitric oxide
3.2.8. L Pilot studies
Stock solutions consisting of 100 mM hydrogen peroxide (H 2 O 2 ) (in complete 
HOMEM medium) and 100 mM sodium nitrite (in complete SDM, pH 5.5, since 
sodium nitrite is only a good source o f nitric oxide (NO) at acidic pH) were made up 
and serial dilutions ranging from 100 mM to 0.00016 mM were made in 24 well plates 
using the appropriate media. Control wells contained complete medium only. Stationary 
phase promastigotes o f wild type parasites and Almcpbn were added to the 1 ml medium
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samples in the 24 well plates such that the final cell concentration was 5 x 1 cells/ml. 
Cells were observed after 2, 4, 8 and 24 h for motility using an inverted microscope. 
Cell motility was designated as follows: (+), if very few cells were observed to be 
moving; (++), if  approximately half the field o f cells were moving; and (+++), if  the 
majority o f cells showed movement. After 24 h, 0.1 ml was passaged from each well 
into further plates containing medium only and left for 24 h, after which the cultures 
were again observed for motility.
3.2.8.2. Effect o f  nitric oxide
Stationary phase cells o f wild type parasites and Almcpbn were resuspended in 1 
ml o f SDM containing 10, 2, 1, 0.5 and 0.25 mM sodium nitrite (final concentration) at 
5x10*^ cells/ml in 24 well plates. The cells were incubated for 24 h, after which they 
were examined under phase contrast microscopy for motility and scored as before 
(section 3.2.8.1). Parasite viability was measured, using the method based on the 
metabolism o f a tétrazolium salt, MTT, by living cells (Alfieri et a l ,  1989), as follows. 
Cells were resuspended in HOMEM medium containing 450 pg/ml MTT (Sigma) to the 
same starting density, and incubated for a further 24 h to assess the parasites' ability to 
reduce MTT. Subsequently 50 pi samples were diluted 1 in 6 with 0.04 M HCl- 
isopropanol to give 300 pi in a microtitre plate and the absorbance read at 540 nm using 
a multi skan mirotitre plate reader.
3,2.9, Effect of inhibition of nitric oxide synthase upon L. mexicana infection of 
peritoneal exudate cells
Peritoneal exudate cells were infected using stationary phase promastigotes of 
wild type parasites and Almcpbn as in Chapter 2, section 2.2.4., with the exception that 
the nitric oxide synthase inhibitor N-nitro-L-arginine methyl ester (L-NRME) was 
included at 0.4 mM throughout the experiment (Proudfoot et a l ,  1996). A stock solution 
o f 10 mM L-NRME was made up in RPMI and used in these experiments. The D- 
isomer of this compound (D-NRME), which is not biologically active, was used as a 
control. The parasite load at 7 days was determined microscopically, as before (2.2.4).
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3.3. RESULTS
3.3.1. The phenotype of mutants null for Imcpb
3.3.1. L Biochemical analyses
Western blot analysis o f promastigote cell lysates with an antiseium raised to 
purified LmCPb (group C) showed that whereas a major band of around 25 kDa 
(actually consisting o f 2 distinct bands, which are apparent when shorter exposure times 
are used) was present in wild type L. mexicana (Fig 3.1, lane 1), there was no similar 
band in the null mutant, Almcpbn (lane 2). A faint band in this position was observed 
with Almcpbcl (lane 4), whereas a strong signal was detected with Alm cpbgl.8 (lane 3). 
Samples from Almcpbcl and Alm cpbgl.8 also yielded a lower mobility band (38 kDa) 
not found with the wild type L. mexicana. These are likely to be unprocessed precursors. 
The other low mobility bands (>42 kDa) were non-specific as they also appeared in the 
control blot using pre-immune serum (lane 5).
Active LmCPb enzymes were detected in stationary phase promastigotes of wild 
type L. mexicana as several bands of around 24 kDa on gelatin gels (Fig. 3.2, lane 1) as 
reported previously (Robertson and Coombs, 1992). In contrast, Almcpbn had no 
detectable CP activity (lane 2). The lower mobility bands with apparent molecular 
masses o f >60kDa that were present in all the leishmanial samples are due to 
proteinases other than CPs, including the surface-located metalloproteinase gp63 
(Bouvier et al., 1989). The line Alm cpbgl.8 (lane 3) had a single high mobility, high 
activity band, which on shorter exposures clearly had the same mobility as the second 
fastest moving of the multiple bands produced by extracts o f wild type cells. It also 
contained several lower mobility, high activity bands with apparent molecular masses 
between 30 and 46 kDa; these activities are not normally seen with wild-type samples 
(except when much greater amounts o f sample are used), suggesting that processing of 
the initial translation product o f Imcpb is less effecient in this transfectant than in wild 
type cells and that precursor forms can be activated in the gel after electrophoresis. Line 
Almcpbcl showed no CP activity toward gelatin (lane 4). Lmcpb nulls transfected with a 
T. brucei CP gene (Almcpbtb) showed an activity band at around 30 kDa (lane 8), 
similar to the main CP activity found with T. brucei procyclic forms (lane 6).
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Interestingly, it also had a band o f low activity with an apparent molecular mass of 
about 50 kDa, an activity not apparent in the extract o f wild type T. brucei. In summary, 
these results (shown in Figures 3.1 and 3.2) confirmed that the null mutants were indeed 
null for lmcpb and that genes re-expressed in the null mutants were enzymatically 
active.
3.3.1.2. Growth and differentiation o f transfected lines
Transfected lines that had been passaged tlu’ough mice and re-isolated were 
studied for growth and morphological characteristics. All the transfected lines grew 
readily as promastigotes in vitro and the growth rates were similar to that o f wild type L. 
mexicana (see Fig. 3.3). However, it was observed that the small putative metacyclic 
form typically present in stationary phase cultures o f wild type parasites was not evident 
with the transfectants (Fig. 3.4). There is still no good biochemical marker for 
identifying the metacyclic form in L. mexicana, hence wild type and the different 
transfectants were compared with respect to their complement sensitivities, cell lengths 
and surface ultrastructure.
Unfortunately, sensitivity to guinea pig complement proved not to be a good test 
for metacyclogenesis in L. mexicana (Table 3.1), since log. phase promastigotes o f wild 
type parasites containing few putative metacyclics did not appear to be more susceptible 
to GPS than did stationaiy phase promastigotes containing many putative metacyclics. 
There was also a problem with clumping o f cells in the controls containing heat- 
inactivated GPS, which were disrupted by passing through a 26G needle. However, the 
results obtained (Table 3.1) do suggest that the nulls were more susceptible to 
complement than were wild type promastigotes.
Measurement o f the sizes o f stationary phase promastigotes (subpassage 1 ) also 
showed a great difference between the cell lengths o f wild type parasites and Almcpbn 
(Fig. 3.5, A). The median (since data were skewed) lengths were 10 and 17.5 pm for 
wild type and Almcpbn, respectively. Wild type cells were seen to increase slightly in 
length (to median 12.5 pm) as subpassage number increased (Fig. 3.5, B), whereas the 
null mutants stayed much the same (median length 16.3 pm). Transmission electron
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microscopy revealed that the thickening o f the surface coat, thought to be indicative of 
the metacyclic form in L. major (Pimenta et aL, 1989, 1991) and L. mexicana (Bates 
and Tetley, 1993), was clear on a high percentage o f the stationary phase population of 
wild type parasites but could not be seen on any o f the Almcpbn sections examined (Fig. 
3.6).
The transfected lines o f  Almcpbn and Almcpbgl. 8 could transform to axenic 
amastigotes, but grew much more slowly in this form compared to wild type parasites 
(Fig. 3.7). The approximate doubling times were 8.0 ± 1.5 h for wild type parasites and 
38 + 4.0 h for Almcpbn. Axenic amastigotes of AlmcpbBL grew similarly to wild type 
parasites. The axenic amastigotes o f Almcpbn were bigger and more elongated than 
those of the wild type parasite (Fig. 3.8), the mean lengths being 3.8 + 1.4 pm compared 
with 2.4 + 0.5 pm o f the wild type parasite. To provide further information on whether 
these cells were really amastigotes, their nucleases were compared using poly(A) 
substrate gels as described previously (Bates, 1993). The gel pictured in Figure 3.9 
suggests that the axenic amastigotes o f Almcpbn (lane 4) have the 40 kDa nuclease 
specific to promastigotes (lane 1, wild type parasites; lane 2, Almcpbn) as well as the 31 
kDa nuclease specific to amastigotes (lane 3, wild type amastigotes), suggesting that 
they are an intermediate form. Transmission electron microscopy (Fig. 3.10, B) showed 
the null mutant axenic amastigotes to have fewer, less dense membrane bound 
lysosonie-like vesicles, compared with the large dense megasomes typically found in 
wild type L. mexicana amastigotes (Fig. 3.10, A).
3.3.1.3. Infectivity
There was found to be a great difference in infectivity to peritoneal exudate cells 
(PECs) between stationary phase promastigotes of wild type L. mexicana and Almcpbn 
(t) (Table 3.2, A). The null mutants infected some 5 times fewer PECs than did wild 
type parasites. Re-expression o f lm cpbgl.8  in the null mutants restored infectivity 
almost to wild type levels showing complementation o f the phenotype, whereas A 
Imcpbcl (t) and Almcpbtb (t) infected similar numbers o f PECs as did the null mutants 
(Table 3.2, A). These data suggest that the survival o f the null mutants in a small
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percentage o f PECs is due to the chaiucteristics of the PEC subpopulation rather than 
the parasites themselves.
These experiments were repeated several times (Table 3.2, B and C) and 
included Almcpan and AlmcpbBL as additional controls; these lines were found to be as 
infective as wild type parasites to PECs. The phenotype o f the double null Almcpbn/A 
Imcpan was indistinguishable from Almcpbn with respect to growth and differentiation 
in vitro, including infection o f PECs; however re-expression o f g2.8 in the double null 
did not restore infectivity levels (Table 3.2, B). The number o f amastigotes within 
infected PECs was significantly different between wild type and Almcpbn in two out of 
thiee experiments (Table 3.2, A and C).
The null mutant parasites produced subcutaneous lesions in BALB/c mice (see 
section 3.3.2.1); although the lesions resulting from inoculation o f these parasites 
appeared considerably later than those due to the wild type parasites. This was also true 
for other transfected lines including Almcpbgl.8 (t). It was confirmed by Southern 
blotting, gelatin gel analysis and Western blotting that parasites obtained from the 
lesions in mice resulting from inoculation o f Almcpbn (t) indeed lacked the lmcpb gene, 
LmCPb protein (Fig. 3.11, A, lane 3) and the active LmCPb proteinase (Fig. 3.11, B, 
lane 4). Parasites isolated from animals infected with Almcpbgl. 8 (t) possessed all three, 
although LtnCPb activity was at a low level (Fig. 3.11, B, lane 6); levels were restored 
by culturing isolated Alm cpbgl.8 promastigotes in 500 pg/ml neomycin as before (Fig. 
3.11, B, lane 5). Mutant parasites passaged tlrrough mice, reisolated, transformed to 
promastigotes and used to infect PECs in vitro gave the results presented in Table 3.2 (B 
and C) and indeed were the cells used tlrroughout this study unless designated otherwise 
by the letter t (as stated in section 3.2.1).
3.3.2. Host-parasite interactions of wild type parasites and transfected lines 
3.3.2A. Kinetics o f  infectivity to peritoneal exudate cells and BALB/c mice
Having found that the null mutant promastigotes were infective to PECs, time 
course experiments were set up to establish whether the null mutant line simply did not 
get in to the PECs as readily as the wild type line, or did but was subsequently killed.
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Similar percentages o f the PECs were initially infected by wild type and Almcpbn 
stationaiy phase promastigotes (Figs. 3.12 and 3.13), but between 4 and 24 h there was a 
rapid decline in the number of null mutant-infected PECs such that by 24 h the 
percentage infected was similai' to that at 7 days (Fig. 3.12, A). The number of 
amastigotes per infected macrophage was similar with both lines up to about 24 h, 
whereupon wild type parasites appeared to multiply more quickly (Fig. 3.12, B). This 
appeared not to be entirely consistent with the experiment detailed in section 3.3.1.3, 
which showed the number o f amastigotes/infected PEC was similar with the two lines; 
however, perhaps by 7 days Almcpbn had 'caught up' somewhat. This experiment was 
repeated using log phase promastigotes (as this stage o f wild type parasites has veiy low 
CP activity) to see if  there was a difference in infectivity between log phase 
promastigotes o f the two lines (Fig. 3.14). Again both lines initially infected 
macrophages to a similar level, but this percentage was about half that seen with 
stationaiy phase promastigotes (Fig. 3.12); there was then a slight decline with both 
lines, but by 24 h the number o f null mutant-infected PECs was still dropping whereas 
with wild type parasites the number had apparently stabilised.
Another experiment was then carried out to assess the effects o f increasing the 
exposure time o f the PECs to the promastigotes and/or increasing the parasite to PEC 
ratio. The results o f one such experiment are summarised in Figure 3.15. These show 
that increasing the parasite to PEC ratio from 1:1 to 10:1 enabled the null mutants to 
infect substantially more PECs, although still significantly less than wild type. 
Increasing the exposure time from 4 h to 8 h also increased the percentage o f infected 
macrophages.
The infectivity o f stationary phase promastigotes and axenic amastigotes to 
BALB/c mice was investigated. Wild type parasites produced large lesions by 20 to 25 
weeks on each occasion (Fig. 3.16, A-F), with the axenic amastigote form generally 
producing bigger lesions more quickly (B, D and F). The results with Almcpbn (t) 
showed surprisingly that they did infect. Almcphn (t) promastigotes produced lesions 6 
months after the wild type but only in one out o f the 3 experiments undertaken using 
stationaiy phase promastigotes (Graph E). However, the axenic amastigote form o f A
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Imcpbn (t) appeared to be more infectious than the promastigote form, producing lesions 
in 3 out o f 3 experiments (B, D and F); nevertheless these lesions still took between 10 
and 16 weeks longer to appear than the wild type lesions, and grew poorly in 
comparison. Although the promastigotes o f islmcpbg2.8 (t) infected in 1 out o f 2 
experiments, taking 10 weeks longer to produce lesions than wild type, the axenic 
amastigotes o f Almcpbg2.S (t) produced lesions only 3 weeks after wild type on both 
occasions and 7-13 weeks before Almcpbn (t) axenic amastigotes (B and D) - suggesting 
perhaps some complementation o f the phenotype was occurring. However it should be 
noted that the resulting lesions increased in size very slowly, similar to those o f A 
Imcpbn. AlmcpbBL (t) promastigotes produced lesions 12 weeks after wild type 
parasites, more slowly than would have been expected for the single knockout for 
Imcpb, but as axenic amastigotes they produced lesions only 4 weeks after the wild type, 
and 8 weeks before Almcpbn (t) axenic amastigotes. Interestingly, the use o f 10-fold 
fewer parasites o f wild type than the standard dose of 5 x 10  ^ cells (E and F) produced 
faster growing lesions, at least at the early stages of infection. The 'double null' (A 
Imcpbn/lmcpan) did not produce lesions at all when tested (E and F).
It was noted that on excision o f lesions the null mutant amastigotes looked 
morphologically identical to wild type parasites at the light microscope level (Fig. 3.17), 
although TEM showed there to be an ultrastuctural difference, in that the megasomes 
were much less dense (Fig 3.18).
As the null mutants did infect animals, the study was extended by using 
amastigotes isolated from lesions to infect PECs. The results given in Figure 3.19 
indicate the null lesion amastigotes were as infective as wild type amastigotes to PECs, 
and that the multiplication o f  amastigotes within the macrophages was similar with the 
two lines.
Lesion amastigotes o f the nulls and other transfectants were also used to infect 
animals (Fig. 3.20). Again Almcpbn produced lesions in animals much more slowly than 
did the wild type line, the lesions taking 12 weeks longer to appear, indicating that the 
situation in vivo is more complex than that in vilro. Almcpbg2.8 lesion amastigotes 
produced lesions only two weeks after the wild type; however these lesions grew poorly.
79
chapter three results
The lesion amastigotes o f AlmcpbBL produced lesions four* weeks after wild type; these 
lesions did not grow as fast as those o f wild type although they grew to be at least 4 
times as big as those o f the other Imcpb transfectants. Almcpan lesions grew in a manner 
indistinguishable from wild type lesions (as was presented in Chapter 2).
3.3.2.2, Comparison o f  parasitophorous vacuole sizes in wild type parasite-infected 
and null mutant-infected macrophages
In order to establish whether the Imcpb CPs contribute to the large 
parasitophorous vacuole (PV) size normally observed with L. mexicana-mîc^cicà 
macrophages (Pupkis et al., 1986), PECs that had been infected with lesion amastigotes 
o f wild type and Almcpbn and incubated for 72 h were fixed, stained and examined 
under the light microscope, using an eyepiece graticule to measure their PV sizes (Table
3.3). Both large and small PVs were observed housing wild type parasites and those o f 
Almcpbn (Fig. 3.21 and Fig. 3.22), and the PV size generally increased as the number of 
parasites within increased (Fig. 2.22). However, the results in Table 3.3. indicate that 
the mean PV diameter per amastigote is significantly different between wild type 
parasite-infected and null mutant-infected PECs.
3.3.2.3. Analysis o f  enzymes o f  infected macrophages
To test the hypothesis that the Imcpb CPs may be involved in the degradation of 
host cell lysosomal enzymes, an 'Api Zym' enzyme screening kit was used with 
uninfeeted and wild type parasite-infected macrophages, to see if  there were any 
differences in hydrolase activities between them, with a view to extending the 
experiment by comparing hydrolase activities in macrophages infected with null 
mutants. However, as can be seen from the results in Table 3.4, there was found to be 
no difference with any o f the 19 enzymes tested, at least 6 o f which (e.g. esterase, beta- 
galactosidase) are known to be located in macrophage lysosomes.
Wild type parasite-infected and uninfected macrophage lysates were also 
analysed for proteinase activity using gelatin-SDS-PAGE (Fig. 3.23), but again 
macrophage proteinase activity against gelatin was the same regardless o f whether the
8 0
chapter three results
macrophages were infected with parasites (lane 2) or not (lane 1).
3.3.2.4. Susceptibility o f  parasites to components o f  the microbicidal defence 
mechanisms o f  macrophages
In an attempt to understand the mechanism by which wild type promastigotes 
survive in PECs while the null mutants do not, stationary phase cells o f the two lines 
were exposed to varying concentrations o f and NO (both known components of 
the microbicidal activities o f macrophages) and examined under phase contrast at 
various time intervals. The effect o f  H 2 O2  appeared to be dose-dependent, as judged by 
cell motility, but no difference was seen between the susceptibility o f wild type parasites 
and Almcpbn (Table 3.5, A). The effect o f NO appeared also to be dose dependent, but 
differed in that non-motile cells exposed to NO were not necessarily dead; some 
recovery was revealed by subpassaging the exposed cells into fresh medium and looking 
for motility after 24 h (Table 3.5, B). To investigate this further, parasites were washed 
free o f NO after 24 hours exposure and resuspended in fresh medium containing MTT 
overnight to assess the viability o f the cells. The results of such experiments are shown 
in Table 3.6. The results suggest that although there is no difference in susceptibility to 
NO between wild type parasites and Almcpbn stationary phase promastigotes, NO 
affects cell motility without killing and the cytostatic effect o f NO on the cells can be 
reversed, depending on the concentration involved.
Promastigotes were used to infect PECs in the presence o f L-NRME, an 
inhibitor o f nitric oxide synthase (Janies, 1995), to see if this resulted in an increase in 
the number o f  macrophages infected with Almcpbn. However the results in Table 3.7 
indicate that this did not happen, and in fact there may even have been a decrease in the 
number o f cells infected with wild type parasites when this inhibitor was present.
3.3.3. Analyses o f null mutant lines re-expressing different copies of the Imcpb 
array
3.3.3.1. Proteinase activities
In order to compare the CPs encoded by different copies o f Imcpb, lysates o f
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stationaiy phase promastigotes o f null mutants re-expressing genes 1 {gl, the first copy),
2.8 {g2.8, an internal copy) and 18 {gl8, the penultimate copy) of the array were 
analysed on gelatin gels for CP activity and on Western blots for the presence o f LmCPb 
protein (Fig. 3.24). Two main bands o f CP activity aie characteristically detected on 
gelatin gels with wild type L. mexicana stationary phase promastigote extracts (Fig. 
3.24, A, lane 1). These are stage regulated and occur predominantly in this parasite form 
(Robertson and Coombs, 1992; Bates et al., 1994). Lysates of Almcpbgl (t) (lane 2) and 
AlmcpbglS  (t) (lane 4) had a single CP activity which co-migrated with the lower 
mobility band detected in wild type extracts, whereas Almcpbg2.8 (lane 3) had an 
activity whose mobility was between those in the wild type extracts (as shown in section 
3.3.1.1) and similar to the situation with wild type amastigotes (Robertson and Coombs, 
1990, 1992). Almcpbg2.8 (lane 3) and to a lesser extent AlmcpbglS  (t) (lane 4) also had 
significant activities with much lower mobilities (apparently 30-40 kDa; but it should be 
noted that proteins do not migrate strictly according to molecular mass in gelatin SDS- 
PAGE). Equivalent activities to these were not readily detected with wild type or A 
Imcpbgl (t) cell extracts.
Western blotting o f wild type stationaiy phase promastigote extracts with anti- 
LmCPb (group C) antiserum detected two major proteins (25 and 29 kDa, Fig. 3.24, B, 
lane 1). The product o f gene 1 was also 25 kDa (lane 2), whereas the main Imcpb 
products in Almcpbg2.8 and Alm cpbglS  (t) migrated with a molecular weight o f 28 
kDa. These lines also contained larger molecular weight proteins (about 38 kDa) 
detected by the antiserum.
The cell lines were also analysed for their ability to hydrolyse two fluorogenic 
peptide substrates (Fig. 3.25). BzFVR-NHMec had previously been shown to be a good 
substrate for the type C CPs o f the Imcpb array, and SucLY-NHMec a good substrate for 
the type B CPs (Robertson and Coombs, 1990). Both CP activities detected in wild type 
extracts (lane 1) hydrolysed each o f the substrates, although the lower mobility activity 
showed greater activity towards SucLY-NHMec whereas the reverse was true for the 
higher mobility activity. The CP in each o f the three cell lines expressing one Imcpb 
gene, Almcpbgl (t) (lane 2), Almcpbg2.8 (lane 3) and AlmcpbglS  (t) (lane 4) were
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equally proficient at hydrolysing BzFVR-NHMec (Fig. 3.25, A), whereas the CP in A 
Imcpbgl 8 (t) had a significantly higher activity towards SucLY-NHMec than the CP in 
either Almcpbgl (t) or Almcpbg2.8 (Fig. 3.25, B).
Since wild type cells undergo stage regulation o f their CP activity, different 
stages of the re-expressor Almcpbg2.8 were analysed by gelatin-SDS-PAGE (Fig. 3.26). 
The banding pattern differed between log phase (lane 1), stationary phase (lane 2) and 
axenic amastigotes (lane 3), indicating that some stage regulation o f activity occurred.
3.3.3.2. Subcellular localisation o f  CPs using immunogold electron microscopy
Immiinogold labeling o f wild type L. mexicana axenic amastigotes with anti- 
LmCPb antiserum (Fig. 3.27, A) resulted in strong labelling o f the large lysosomes 
(termed megasomes) as previously reported (Pupkis et al., 1986). As expected, no 
labelling was detected in the Imcpb null mutant axenic amastigotes, demonstrating the 
specificity of the antiserum used to detect the LmCPb enzymes (Fig. 3.27, B). The 
megasomes were also labelled in Almcpbg2.8 and Almcpbgl (t) axenic amastigotes, 
indicating that both g2.8 (complete CTE) and g l  (truncated GTE) isoenzymes were 
targeted to megasomes (Fig. 3.27, C and D). With each o f the 3 cell lines expressing 
LmCPb, no significant labelling was detected outside megasomes - indicating that the 
trafficking o f the proteinase was efficient in these parasites and that there was no 
accumulation o f precursors in other compartments o f the cell such as the Golgi.
3.3.3.3. Growth and differentiation
It was found that the re-expressors essentially had the same growth and 
differentiation characteristics as those described for Almcpbn and Almcpbg2.8 in section
3.3.1.2, that is, they did not appear to form metacyclics o f typical morphology and did 
not grow well as axenic amastigotes.
3.3.3.4. Infectivity
One o f the criteria used (section 3.3.1.3) to assess the phenotype o f the Imcpb 
null mutants was their ability to survive in macrophages in vitro. PECs were exposed to
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stationary phase promastigotes and assessed for parasite survival after 7 days in culture 
(Table 3.8). As before (Table 3.2) the null mutant Almcpbn survived in just a fev^ 
macrophages and had a lower number of amastigotes per infected PEC, whereas 
expressing g2.8 in the null mutant restored levels of infectivity back to almost wild type 
levels. In contrast, expression o f g7 or g l8  in the null mutant increased infectivity only 
to a minor extent, although the difference was found to be statistically significant with 
g l8 .
The infectivity of stationaiy phase promastigotes to animals was also 
investigated. Again Almcpbn was much less infective than wild type (Fig. 3.28), the 
lesions taking 7 months longer to appear on this occasion, whereas the control lines A 
Imcpan and AlmcpbBL took, respectively, only one and two weeks longer than wild type 
parasites. In this experiment none o f the re-expressor lines tested {Almcpbgl (t), A 
Imcpbgl 8 (t) and Almcpbg2.8) produced lesions within the maximum time permitted for 
the experiment; however, since the Almcpbn lesions did not appear until near the end of 
the experiment it is not impossible that the re-expressors would have produced lesions 
had the experiment been extended beyond 9 months.
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Figure 3.1. Western blot using anti-LmCPb antibody. Lane 1, wild type parasites; 
lane 2, A/mcphn; lane 3, Almcpbg2.8; lane 4, Almcpbcl. Each lane was loaded with 
lysate from 5x10^ stationary phase promastigotes. AlmcpbTEX gave the same profile as 
Almcpbn. llie bands >42 kD were also produced with the pre-immune serum (lane 5). 
Molecular mass markers are shown in kDa.
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Figure 3.2. Gelatin-SDS-PAGE analysis of cell lines. Lane 1, wild type L  mexicana; 
lane 2, Almcpbn; lane 3, Almcpbg2.8; lane 4, Almcpbcl; lane 5, AlmcpbTEX; lane 6, T. 
hrucei procyclics; lane 7, AlmcpbTEX; lane 8, Almcpbtb. All lanes were loaded with 
lysates containing 10^  stationary phase promastigotes, except lane 6(10? procyclics). 
Molecular mass markers are shown in kDa.
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Figure 3.3. Typical in vitro growth curves of transfected promastigote lines.
Cultures o f wild type parasites (-#-), ^.Imcpbn (-A-) and /^Imcpbg2.8 (-A-) were initiated 
at 5 X 10^  cells/ml in HOMEM medium and incubated at 25°C, with cell counts being 
performed on consecutive days. The results are the means ±  SD from 3 independent 
cultures for each line; some error bars have been omitted for clarity, and some are 
obscured by the data points.
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Figure 3.4. Morphology of stationary phase promastigotes. Light micrographs o f  
stationary phase promastigotes o f wild type parasites (A) and Almcpbn (B). Cells were 
fixed in methanol and stained in 10% Giemsa's stain. Tliere is a clear difference between 
the size o f cells o f the two lines, with the Almcpbn promastigotes (B) being much bigger 
than the majority o f wild type cells (A). lTie scale bar represents 10 pm
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Figure 3.5. The cell lengths of stationary phase promastigotes. Giemsa-stained 
smears o f stationary phase promastigotes (see Fig. 3.4) were used to compare the 
lengths o f promastigotes o f the various lines. Measurements were made with a graticule 
under lOOOx bright field microscopy. At least 100 cells were measured in each case, to 
the nearest graticule unit (1 graticule unit = 1.25 pm). Results (A) indicate a highly 
significant difference between the lengths o f wild type (closed bars) and àîmcphn (open 
bars), at subpassage 1 (z=15.26, greatly exceeding the critical value of 2.58 at P-0.01). 
There was also a significant difference at subpassage 7 (figure B, where z=8.21, 
exceeding the critical value o f 2.58 at P=0.01), although wild type parasites contained 
fewer short promastigotes (putative metacyclics) than at subpassage 1, possibly due to 
adaptation to long term growth in vitro (Bates el aL, 1994).
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cell line % cells intact
log phase wild type 45 ± 7.0
stationary phase wild type 54 + 9.3
stationary phase Almcpbn 19 + 8.4
Table 3.1. Complement-mediated lysis of promastigotes. Cells were incubated in 
30% (v/v) guinea pig serum at 25°C for 30 minutes, as described in section 3.2.3.2; the 
results are the means + SD o f 3 independent experiments. The % lysis was calculated by 
reference to controls containing heat-inactivated serum, in which there was no 
detectable lysis. The % lysis results with both log and stationary phase wild type 
promastigotes were significantly different from those with àlmcphn (P values o f <0.02 
and <0.01 respectively) but not from each other.
B
Figure 3.6. Surface structure of stationary phase promastigotes. Section through the 
plasma membrane (scale bar 0.4 pm). 'Surface coaf material is clearly visible with the 
wild type cells (A) but not on the null mutant line d^lmcphn (B). Micrographs by L. 
Tetley, University o f Glasgow.
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Figure 3.7. Typical in vitro growth curves of transfected lines as axenic 
amastigotes. Cultures were routinely initiated using stationary phase promastigotes at I 
X 10^ ’ cells/ml in complete SDM, pH 5.5, and incubated at 32°. Cell counts revealed a 
clear difference in growth rates and final cell density between the different lines, with A 
Imcpbn (-A-) and l!almcpbg2.8 (-^ ) growing much more slowly than either wild type (-#-) 
or AlmcpbBL (-■-) axenic amastigotes.
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Figure 3.8. Light micrographs of Giemsa-stained axenic amastigotes; (A), wild type 
parasites, (B), Almcpbn. There is a difference between the size o f the cells o f the 2 lines, 
with the Almcpbn axenic amastigotes (B) being larger than the majority o f wild type cells 
(A). Almcpbg2.8 axenic amastigotes were similar in proportions to the null mutants. The 
scale bar represents 10 pm.
89
chapter three fiffure.s
4 6 "-
30 -
Figure 3.9. Analysis of parasite nucleases using poly(A)-SDS-PAGE. Lane 1, wild 
type stationary phase promastigotes; lane 2, Almcpbn stationary phase promastigotes; 
lane 3, wild type axenic amastigotes; lane 4, Almcpbn axenic amastigotes. Each lane was 
loaded with lysate from 10^  cells. Tlie positions o f molecular weight markers are given 
on the left.
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Figure 3.10. Transmission electron micrograph revealing ultrastructure of axenic 
amastigotes. (A), wild type parasites; (B), Almcpbn. Megasomes are seen in the wild 
type axenic amastigotes (A, arrowed); less dense lysosome-like organelles are evident in 
the null mutants (B, arrowed), n, nucleus; mi, mitochondrion. The scale bar represents 
0.5 pm. Micrograph by L. Tetley, University o f Glasgow.
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cell line % infected PECs am astigotes/infected PEC
wild type 46 + 10 3 .8+  0.2
Almcpbti (t) 9.2 ±3 .9 2.6 ±0 .7
Almcpbgl. 8 (t) 40 + 9.0 3.2 ±0 .2
Almcpbcl (t) 12 + 1.2 4.4 ± 2 .2
Almcpbtb (t) 7 .2 +  2.6 3.0 ± 1.2
B
wild type 50 ± 9.4 4.1 ± 1.0
AlmcpbBL 5 4 ±  10 5.3 ± 1.0
Almcpbn 3 .2 ±1 .1 2.7 ±0 .9
Almcpbn/Almcpan (t) 3.3 ±2 .0 2.6 ± 0 .7
Almcpbn/Almcpa2.8 (t) 2.4 ± 1.3 2 .3 +  0.7
wild type 36 ±8 .3 4.6 ± 1.3
Almcpan 3 6 ±  10 4.4 ± 1.2
AlmcpbBL 39 ±6 .8 4.5 ± 1.6
Almcpbn 1.6 ±0 .3 1.6 ±0 .3
Almcpbn/Almcpan (t) 2.8 ±2 .0 2 .2 +  1.8
Table 3.2. Infectivity o f transfectants to macrophages. PECs were obtained from 
peritoneal lavage o f BALB/c mice and infected with stationary phase promastigotes of 
the L  mexicana lines at a ratio o f 1:1. After 7 days incubation at 32°C, ceils were fixed, 
stained with Giemsa's stain, and parasite load determined by counting 200 PECs. The 
values in each of the tables designated A, B and C are means ±  SD from 4 independent 
experiments. Table A: the infection rates with both wild type and Almcpbgl. 8 (t) were 
significantly different from those for Almcpbn (t), Almcpbcl (t) and Almcpbtb (t) 
parasites (P values of <0.01) but not from each other; the mean values for 
amastigotes/infected cell with both Almcpbn (t) and Alm cpbgl.8 (t) were significantly 
different from those with wild type parasites (P values o f <0.02 and <0.01, respectively) 
but not from each other. Table B: the infection rates with both wild type and ImcpbBL 
were significantly different from those with Almcpbn^ Almcpbn!Almcpan (t) and A 
Imcpbn!Almcpal.8 (t) parasites (P values o f <0.01) but not from each other; there were 
no significant differences with reference to the number of amastigotes/infected cell. 
Table C: the infection rates with both wild type, Almcpan and ImcpbBL were 
significantly different from those with Almcpbn and Almcpbn!Almcpan (t) (P values of 
<0.01) but not from each other; the mean values for amastigotes/infected cell with both 
Almcpbn and Imcpbn!Almcpan (t) were significantly different from those for wild type, 
Almcpan and ImcpbBL parasites (P values o f <0,02) but not from each other.
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Figure 3.11. Western blot and gelatin-SDS-PAGE analyses of lesion amastigotes. 
(A) Samples containing lysates (equivalent to 5 x 10^ ’ cells) o f lesion amastigotes and 
lesion-derived stationary phase promastigotes were electroblotted and probed with anti- 
LmCPb (group C) antiserum: wild type amastigotes (lane 1) and promastigotes (lane 2); 
Almcpbn amastigotes (lane 3) and promastigotes (lane 4). Lane 5 was probed with pre- 
immune serum. (B) Samples containing lysates (equivalent to 10^  cells) were analysed by 
gelatin-SDS-PAGE: wild type promastigotes (lane 1) and amastigotes (lane 2); Almcpbn 
promastigotes (lane 3) and amastigotes (lane 4); Almcpbgl.8 promastigotes (lane 5) and 
amastigotes (lane 6); Almcpbtb promastigotes (lane 7) and amastigotes (lane 8). The 
usual positions o f molecular weight markers are indicated.
93
ch opter three figures
60
U)oï  4 0 -  
%
2 0 -C
20 40 800 60
time (hours)
B
t50)c 2 . 0 -
D)4=  1 . 0 -«
E(0 0.0
4020 600 80
time (hours)
Figui'e 3.12. The fate of wild type (-#-) and Almcpbn (-A-) stationary phase 
promastigotes after entry into macrophages in vitro. PECs were obtained fiom 
peritoneal lavage o f  BAI^B/c mice and infected with stationary phase promastigotes of 
the T. mexicana lines at a ratio o f 1:1. After certain incubation times at 32°C, cells were 
fixed, stained with Giemsa's stain, and the parasite load o f 200 PECs determined by 
counting the number o f infected PECs (A) and number o f parasites per infected ceU (B), 
The points are means + SD fiom 3 independent ex|)eiiments.
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Figure 3.13. Light micrographs of Leishmania-infected macrophages. PECs were 
harvested at the 4 h time point (see Fig. 3.12) and stained with Giemsa's stain. 
Intracellular parasites o f both wild type (A) and Almcpbn (B) are clearly visible. 
Parasites are arrowed; n, nucleus. The scale bar represents 10 pm.
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Figure 3.14. The fate of wild type (-•-) and Almcpbn (W ) log phase promastigotes 
after entry into macrophages in vitro. PECs were obtained from peritoneal lavage of 
BALB/c mice and infected with log phase promastigotes o f the L. mexicana lines at a 
ratio o f 1:1. After certain incubation times at 32°C, cells were fixed, stained with 
Giemsa's stain, and the parasite load determined by counting 200 PECs. The points are 
means ± SD from 3 independent experiments.
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Figure 3.15. The effects of varying exposure tim e/ratios of stationary  phase 
prom astigotes to PECs on infection rates. A ratio o f 1:1 was set up with wild ty})e 
parasites (-#-) and Almcpbn (-A-); a ratio o f 10:1 with wild tyi^e parasites (* -)  and A 
Imcpbn ( O )  was also tested. Exposure o f PECs to parasites was either the standard 4 h 
(A) or 8 h  (B). The results o f one ex[)erinient are presented.
96
chapter three figures
prom astigotes
EE
1000-1
800 —0)
3  600 H o  >
01 4 0 0 -200 -
weeks
CDÛ)3
IO1 3<o_c3CD
?3
B axenic amastigotes
2000I
ig  o  >coy
-  500cto0E
1 5 0 0 -
1000 -
f  I + f - f  + t"T-| I I V I  I I I I I r
30 35
weeks
3CD
C O3
CD"<Ao'3<Oc3CD
Figure 3.16. Infectivity of L, mexicana lines to animals. Subcutaneous lesions in the 
rumps o f female BALB/c mice resulting from an inoculum of 5 x 10^ ’ stationary phase 
promastigotes (A, C and E) or axenic amastigotes (B, D and F) were measured weekly 
using a micrometer, and the mean lesion volume + SD per group (5 mice) calculated 
using the equation for the volume o f a hemisphere. Lines used in experiments A and B 
were as follows: wild type; -A-, Almcpbn (t); Alm cpbgl.8 (t); note the 20-fold
(A) and 100-fold (B) differences in the two Y axes for each graph, and that Almcpbn (t) 
did not produce lesions at all in (A). Experiments C and D: note that Almcpbgl.8 and A 
Imcpbn did not produce lesions at all in (C), and the difference in scales of the two Y 
axes in graph F. The majority o f eiTor bars have been omitted for clarity.
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Figure 3.17. Light micrographs of Giemsa-stained lesion amastigotes. (A) wild type 
parasites; (B) Almcpbn. The scale bar represents 10pm.
100
Figure 3.18. Ultrastructure of lesion amastigotes. Transmission electron micrographs 
revealing iiltrastructiiral differences in the lesion amastigotes o f (a) wüd type (scale bar 
0.3 pm) and (b) Almcpbn (scale bar 0.6 pm). Note the difference in densities o f the 
megasomes o f  the two Ihies. Megasomes are arrowed; k, kinetoplast; mi, mitochondrion, 
11, nucleus. Micrographs by L. Tetley, University o f  Glasgow.
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Figure 3.19. Infectivity of lesion amastigotes of wild type (-#-) and Almcpbn  (^ôr) for 
peritoneal m acrophages. (A) percentage of macrophages infected; (B) number of 
parasites per infected cell. The number o f intracellular parasites in at least 200 
macrophages was coimted fiom  each time point. The results are the means ± SD fiom 3 
exjjeriments.
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Figure 3.20. Infectivity of lesion amastigotes to animals. Subcutaneous lesions in the 
rumps o f female BALB/c mice resulting from an inoculum o f 5 x 10  ^ parasites were 
measured at weekly intervals using a micrometer, and the mean lesion volume ± SD per 
group of 5 mice calculated using the formula for a half spheroid. wild type; -A-, A 
Imcpbn; -àr, Almcpbg2.8; AlmcpbBL; ~0~, Almcpan. Note the difference in scales o f 
the Y axes. The majority o f  error bars have been omitted for clarity.
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Figure 3.21. Light micrographs of Leishmania-ïnïecieû peritoneal macrophages.
Infections were initiated using lesion amastigotes of wild type parasites (A) and A 
Imcphn (B) and the cultures then fixed and stained with Giemsa's stain at the 72 h time 
point (see Fig. 3.19). Amastigotes are arrowed; n, nucleus; pv, parasitophorous vacuole. 
The scale bar represents 10 pm.
line amastigotes/vacuole vacuole diameter (pm) diameter/amastigote
(pm)
wild type 4.9+ 2.4 17 + 6.5 3.9 + 1.6
Mmcpbn 6.4+ 3.9 16 + 6.0 3.0 + 1.4
Table 3.3. Parasitophorous vacuole sizes. Macrophages infected with lesion 
amastigotes o f wild type and Almcpbn were stained with Giemsa's stain after 72 h and 
their PVs measured using a graticule. Fifty parasitophorous vacuoles were measured in 
each case, and the number o f parasites per vacuole was also counted. Figures represent 
means + SD, n=50. Results indicate a significant difference between the vacuole 
diameter/amastigote with wild type and Almcpbn (z=3.18, exceeding the critical value of  
2.58 at P=0.01).
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Figure 3.22. Scatter plots of parasitophorous vacuole sizes. PV size (see Table 3.3) 
was plotted against the number o f parasites within, for wild type (A) and Almcpbn (B). 
Fifty cells were measured in each case.
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enzyme m acrophage infected m acrophage
1. control 0 0
2. phosphatase alkaline 1 1
3. esterase* 1 1
4. esterase lipase 3 3
5. lipase* 1 1
6. leucine arylamidase 3 3
7. valine arylamidase 0 0
8. cystine arylamidase 0 0
9. trypsin 0 0
10. chymotrypsin 0 0
11. phosphatase acid* 5 5
12. phosphohydrolase 5 5
13.a galactosidase 0 0
14. p galactosidase* 3 3
15. p glucoronidase* 4 4
16. a  glucosidase* 0 0
17. p glucosidase 1 1
18. N-acetyl-glucosaminidase 3 3
19. a  mannosidase* 1 1
20. a  fucosidase 0 0
Table 3.4. Analysis of enzyme activities of uninfected and infected macrophages 
using the ’Api Zym’ colorimetric screening kit. Colour changes ranging from 0 (no 
colour, no activity) to 5 (intense orange/violet, high activity) were observed. * Denotes 
lysosomal enzyme.
66 " -
46 —
Figure 3.23. Gelatin SDS PAGE analysis of infected and uninfected peritoneal 
macrophages. Lane 1, resident macrophages; lane 2, L  mexicana-mïtciQà macrophages 
(40% infection rate). Extracts from 1x10^ macrophages were loaded in each track.
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CELL MOTILITY
time mM HgOg
(h) 100 50 10 2 0.4 0.2 0.04 0.008 0.0016 0.00016
2 - - - — -  + ++ 4-4-+ + + +
4 — - “ - « + ++ +++ +++
8 - “ + ++ ++
24 — - - - » + + ++
>L24 - - - - — — + + ++
B
CELL MOTILITY
time
(h) 100 50 10 2
mM Na nitrite 
0.4 0.2 0.04 0.008 0.0016 0.00016
2 - « - + ++ ++ +++ + + + +++ + + +
4 ■" + ++ ++ +++ + + + +++ +++
8 " - - + + ++ ++ ++ +++
24 - - ” “ - + + ++ ++
^^24 - + + + + ++ ++ ++
T able 3.5. Effect on cell m otility of hydrogen peroxide (A) and  n itric  oxide (B).
Stationary phase promastigotes o f wild type and Ahncpb were exjiosed to  varions 
concentrations o f  HgOg and sodium nitrite (a source o f nitric oxide at acidic pH) and 
examined for motihty at different time points. Cell motility was designated as follows:
(-) no motihty; (+), if  veiy few cells were obsewed to be moving; (++), if approximately 
half the field o f cells were moving; and (+++), ff the majority o f cells showed movement. 
After the 24 h tkne point cells were subpassaged mto fiesh medium and examined for 
motility after a fiiither 24 h (4'24). Tlie results presented in Tables A and B are fiom one 
experiment and are the data for both wild type parasites and Almcpb, since no differences 
were foimd between then relative susceptibilities.
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cell line
% MTT REDUCTION
10 2
mM sodium  nitrite 
1 0.5 0.25 0
wild type 41 + 18 7 0 + 1 1 75 + 2.7 81 + 5.2 102 + 10 100
motility - “ - - + +++
Atmcpbn 30 + 7.2 56 + 4 .6 87 ± 3 .0 93 + 6.7 109 + 9.6 100
motility " + +++
Table 3.6. Dose dependent effect of exogenous nitric oxide on promastigote 
viability. Parasites were incubated for 24 h in varying concentrations o f sodium nitrite 
(a source o f nitric oxide at acidic pH) and their motilies noted, after which cells were 
resuspended in medium containing MTT for 24 h in order to measure cell viability. 
Results are the means + S.D. o f 3 experiments performed in duplicate, and are expressed 
as a % o f the control.
cell line + inhibitor % infected PECs am astigotes/infected PEC
wild type + L-NRME 24 + 4.3 6 .4 +  0.9
wild type + D-NRME 32 + 4.2 6.4 + 0.6
Almcpbn + L-NRME 1.0 + 1 .2 2.8 + 1 .6
Almcpbn + D-NRME 1 .3+  0.9 2.3 +1 .8
Table 3.7. Effects of a nitric oxide synthase inhibitor on infectivity to PECs. PECs 
were infected using stationary phase promastigotes o f wild type and Almcpbn along with 
the nitric oxide synthase inhibitor N-nitro-L-arginine methyl ester (L-NRME) at 0.4 
mM. Controls included the non-bioactive D-isomer o f the inhibitor. Results give 
parasite load after 7 days and are the means ± S.D. o f 2 experiments performed in 
duplicate.
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Figure 3.24. Analysis of LmCPb isoenzymes expressed in the Imcpb null mutant.
Lysates from 1 x 10^  (A) or 5 x 10^  (B) stationary phase promastigotes were used for 
gelatin-SDS-PAGE (A) and Western blotting using anti-LmCPb antibody (B). Lanes 1, 
wild type L  mexicana\ lanes 2, Alnicphgl (t); lanes 3, Almcpbg2.8\ lanes 4, AlmcpbgIS 
(t). Molecular mass markers are shown in kDa.
B
-21
1
Figure 3.25. Substrate specificity differences between LmCPb isoenzymes. Activity 
o f  LmCPb isoenzymes expressed in the Imcpb null mutant towards two peptidyl 
amidomethylcoumarin fluorogenic substrates, Bzl VR-NHMec (A) and SucLY-NHMec
(B). Lane 1, wild type; lane 2, ImcpbgJ (t); lane 3, lmcphg2.8\ lane 4, ImcpbglS (t). 
Molecular mass markers are shown in kDa.
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Figure 3.26. Gelatin SDS PAGE analysis of different stages of the re-expressor A 
Imcpbg2.8 cultured in vitro. Lane 1, log phase promastigotes; lane 2, stationary phase 
promastigotes; lane 3, axenic amastigotes. Each track was loaded with lysate from 1 x 
10^  cells. The usual positions o f molecular weight markers are indicated.
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Figure 3.27. Localisation of LmCPb to the megasome (large lysosome) by 
immunogold labelling. Ultrathin sections o f L. mexicana axenic amastigotes labelled 
with anti-LmCPb antiserum and goat anti-rabbit/10 nm gold conjugate, (a), wild type 
parasites; (b), Almcpbn, (c), Almcpbg2.8\ (d), Almcpbgl (t). m, megasome; mi, 
mitochondrion; fp, flagellar pocket; n, nucleus; 1, lipid; kp, kinetoplast. Scale bar, 0.5 pm 
Micrographs by L. Tetley, University o f Glasgow.
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cell line % infected PECs am astigotes/infected PEC
wild type 38 ±  9.0 5 .2 +  0.9
Almcpbn 1.5 + 0 .2 1.7 + 0.2
Almcpbg2.8 29 + 9.2 3 .6 +  0.4
Alm cpbgl (t) 3 .5 +  2.8 1 .8+  0.9
A lm cpbgl8 (t) 4.6 + 1.4 2.6 + 0.4
Table 3.8. Infectivity of transfected lines to peritoneal exudate cells. PECs were 
obtained from peritoneal lavage o f BALB/c mice and infected with stationary phase 
promastigotes o f the L. mexicana lines at a ratio o f 1:1. After 7 days incubation at 32°C, 
cells were fixed, stained with Giemsa's stain, and parasite load determined by counting 
200 PECs. The values are the means ± SD from three independent experiments 
performed in duplicate. The infection rates with wild type and Almcpbg2.8 were highly 
significantly different from those o f Almcpbn, Almcpbgl (t) and A lm cpbgl8 (t) (P values 
o f <0.01), but not from each other; furthermore, the infection rate with Almcpbn was 
significantly different from that o f Alm cpbgl8 (t) (P value o f <0.05) but not from that o f 
Almcpbgl (t). The mean values for amastigotes/infected PEC with wild type and A 
lmcpbg2.8 were significantly different from each other (P value o f <0.05) but also from 
those for Almcpbn, Almcpbgl (t) and Alm cpbgl8 (t) (P values o f <0.01); the number of 
amastigotes/infected PEC was also significantly different with Almcpbn and A 
Imcpbg2.8.
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Figure 3.28. Infectivity of stationary phase promastigotes to BALB/C mice. Results 
show the mean lesion volume + SD per group (3 mice). wild type; -A-, Almcpbn\ 
AlmcpbBlL\ O ,  Almcpan. Note that Almcpbg2.8, Almcpbgl (t), Alm cpbgl8 (t) and A 
Imcphn/Almcpan (t) did not produce lesions at all within the 9 month duration o f the 
experiment. The majority o f error bars have been omitted for clarity, while some are so 
small they are obscured by the data points.
:
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3.4. DISCUSSION
Western blot (Fig. 3.1) and gelatin gel (Fig. 3.2) analyses o f Almcpbn confirmed 
that no LmCPb protein was present in this cell line, and confirmed the previous 
suggestion that all of the high mobility CPs activities are encoded by the Imcpb array. 
Furthermore, LmCPb appears to be the only L. mexicana CP detectable using gelatin- 
SDS-PAGE.
Stationary phase promastigotes o f the null mutants for Imcpb appeared not to 
form metacyclics o f typical moiphology as judged by their cell lengths (Fig. 3.4 and 
3.5); this was reminiscent o f the morphology displayed by Almcpan (Chapter 2). 
Although the nulls were more susceptible to complement-mediated lysis than wild type 
(Table 3.1), the finding that log phase promastigotes o f wild type were not more 
susceptible than stationary phase cells questions the validity o f this as a test for 
metacyclics o f L. mexicana - although It had been used previously (Bates and Tetley, 
1993). Increased resistance to complement is a characteristic of L. major metacyclics 
(Mallinson and Coombs, 1989b). However in the same study it was found that there was 
little difference between the susceptibility o f log and stationary phase promastigotes o f 
L. mexicana (and that heat-inactivated serum agglutinated both stages), which is in 
agreement with the results presented in section 3.3.1.2. More reliable, perhaps, are the 
transmission electron micrographs, a method previously used to identify metacyclics in 
L. mexicana (Bates and Tetley, 1993). Similar studies on the null mutant line and wild 
type parasites showed surface coat differences between stationary phase promastigotes 
o f the two lines (Fig. 3.6). Although the transfectants could be cultured under the 
conditions used for axenic amastigotes, they grew very poorly in comparison to wild 
type parasites, were bigger, and did not grow in clumps (Fig. 3.7 and 3.8). Furthermore 
their nuclease profiles suggested that they were not fully transforming to amastigotes 
(Fig. 3.9). Taken together these results point to a role for LmCPb in differentiation to 
both metacyclics and to amastigotes. The finding that re-expression o f an internal copy 
o f Imcpb {g2.8) in the null mutant failed to restore the wild type morphology argues that 
the morphological changes may not have been caused solely by the deletion o f Imcpb, 
but perhaps by the transfection procedure or even the antibiotics used (which is
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applicable also to Almcpan, Chapter 2). It is possible, however, that the full range o f 
LmCPb isoenzymes, rather than just one, must be re-expressed to restore wild type 
phenotype.
Since the null mutants will grow under the conditions used for axenic 
amastigotes, albeit more slowly and with atypical moiphology, then it seems likely that 
the major role o f LmCPb must be in interacting with the host cell. This correlates well 
with the observation that inhibitors o f LmCPb such as peptidyl diazomethanes, which 
enter the parasites and inhibit LmCPb in situ, have little or no effect on the growth o f 
the wild type lines as axenic amastigotes, but will kill Leishmania in macrophages (see 
Chapter 5).
The large reduction in infectivity to PECs resulting from the deletion o f the 
Imcpb array and the reversal of this effect by re-expression o f g2.8 (Table 3.2) suggests 
that LmCPb plays an important part in enabling the parasite to survive against the 
microbicidal activity o f the host cell and so is an important virulence factor. 
Furthermore the complementation o f the phenotype by re-expression of g2.8 confirmed 
that the infectivity differences between the null mutant and wild type parasites are 
indeed due to deletion o f  Imcpb and not simply attenuation resulting from the 
transfection procedure. In addition, Almcpan is a useful control since it is a double 
knockout selected for using the same antibiotic resistance markers as Almcpbn, but is 
still as infective as wild type parasites to PECs. The same was shown to be the case for 
the single knockout for Imcpb, AlmcpbBL (Table 3.2). The lack o f enzyme activity for 
the Imcpb cDNA (Fig. 3.2, lane 4) may account for its inability to restore virulence. 
Unfortunately the number o f Almcpbn amastigotes per infected cell was found to vary 
between experiments, contending my initial conclusion that once the null parasite 
becomes established in the macrophage the infection proceeds normally.
One hypothesis aimed at explaining the successful invasion o f  a small percentage 
o f the PECs by the null mutants is that these PECs were a distinct subpopulation less 
able to kill L. mexicana. It has previously been reported that resident peritoneal 
macrophages can be separated into 2 functional subsets (mature and immature) based on 
a number o f criteria related to the state o f cell maturity, such as surface antigen
114
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expression (Plasman and Vray, 1993). In this study, it was attempted to distinguish 
different (infected and uninfected) macrophage subpopulations with an antibody to the 
F4/80 antigen (a "mature" macrophage marker, Plasman and Vray, 1993) by indirect 
immunofluorescence; this method, however, proved unsuccessful (data not shown).
Time course experiments showed that the null mutants initially infect PECs as 
successfully as wild type, but are then killed within 24 h (Fig. 3.12). This could be due 
to the nulls being less able to transform to amastigotes sufficiently rapidly (see section 
3.3.1.2), or being less able to withstand the microbicidal action o f the macrophage (see 
section 3.3.2.4), or both. This contrasts with findings using other transfectants, where 
dhfr-ts mutants infected PECs but did not replicate and began to be slowly destroyed 
after 48 h (Titus et al., 1995). A similar result to this was found with gp63-deficient L. 
amazonensis variants (McGwire and Chang, 1994) which started to gradually disappear 
from culture 3 - 5  days post-infection; this process was partially delayed by genetic 
complementation o f the variants.
Bates et a l, (1993) found that log phase cells initially infected as many 
macrophages as did stationary phase promastigotes but most o f  the log. phase cells were 
rapidly killed - a situation very similar, in fact, to the kinetics o f infectivity o f Almcpbn 
to PECs. In contrast, I found that log phase cells initially infected a lower percentage o f 
macrophages than did stationaiy phase promastigotes (Fig. 3.4), although stationary 
phase cells were not tested in parallel in the same experiment. The finding that 
increasing the parasite to macrophage ratio and/or exposure time results in more null 
mutant-infected macrophages (Fig, 3.15) may be due to the macrophage simply 
becoming overloaded and hence unable to kill all the parasites.
An 80% reduction in the number of macrophages infected could possibly 
account for the slow appearance o f lesions in mice infected with the null mutants (Fig. 
3.16). The finding that the nulls grew more slowly as axenic amastigotes (Fig. 3.7) than 
wild type, AlmcpbBL and Almcpan (see Chapter 2) may also be relevant, but it is 
difficult to correlate in vitro growth with in vivo. O f interest is the finding that axenic 
amastigotes o f the transfected lines were more infectious than promastigotes, even 
though they differed from wild type with respect to morphology and growth
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characteristics. It seems therefore that the culture o f these cells under the conditions 
used for amastigotes e.g. incubation at 32“C may have preadapted them for survival in a 
mammalian host. Almcpbg2.8 mutants also produced smaller lesions in mice (Fig. 3.16) 
although this line consistently produced lesions several weeks before those o f Almcpbn. 
The absence o f neomycin selection in mice allowed lmcpbg2.8 expression to drop 
substantially during lesion formation (Fig. 3.11, lane 6) which could account for the 
resulting smaller lesions. It may, however, be expected that if  g2.8  was advantageous to 
the parasite then these parasites would be selected for naturally without the need for 
neomycin pressure. A decrease in expression o f pX-gp63 was observed in amastigote 
transfectants from macrophages (McGwire and Chang, 1994), although there was little 
loss o f their plasmids; they suggested that the plasmid genes do not function efficiently 
in this form o f the parasite (as opposed to promastigotes) to produce gp63, which may 
be o f some relevance to the episomal expression o f g2.8  in lesion amastigotes.
LmCPb has been shown to be present at high concentrations in the extracellular 
milieu o f the mouse lesion, prompting speculation that the proteinases may be involved 
in tissue damage associated with lesion formation (Ilg et a l, 1994). The occurrence o f 
apparently normal lesions, albeit only from gross observations, in infections with Imcpb 
null mutants argues against an important role for the enzyme in lesion pathogenesis, 
although histological examination o f lesion tissue may reveal otherwise.
The finding, however, that null lesion amastigotes were as infective as wild type 
to PECs (Fig. 3.19) suggests that the deficiency is not in the resistance o f amastigotes to 
killing, but more likely that the major role o f  the CPs is in differentiation, or in enabling 
the promastigotes themselves to survive. It may be interesting to repeat these 
experiments using null mutant axenic amastigotes, since they produced lesions more 
quickly than promastigotes, and it may give an indication o f how amastigote-like they 
are. However, the discovery that null mutant lesion amastigotes infected mice much 
more slowly than did wild type lesion amastigotes (Fig. 3.20) indicates that more factors 
are involved in survival in mice than in macrophages in vitro and that CPs play an 
important role. One possibility is in MHC II processing, as was recently reported (Leao 
et a l ,  1995). It may be interesting to look at amounts o f MHC II in null mutant-infected
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macrophages, either by Western blotting or immunofluorescence, to confiim this. It has 
also been reported that CPs may modulate cytokine responses in a way that is beneficial 
to the parasite's survival (Finkelman and Urban, 1992). Therefore it could be useful to 
look at cytokine responses in mice infected with different mutants. There is little 
evidence to suggest that the amastigotes secrete their CPs (Coombs, 1982; Pupkis et aL, 
1986); in this study it was attempted to detect circulating LmCPb in serum from infected 
mice by Western blotting, and also use infected mouse serum as an antiserum to detect 
LmCPb in parasite lysates; both experiments, however, proved unsuccessful.
It is possible that the parasite may be able to compensate to an extent for the loss 
o f LmCPb with other factors, most likely other proteinases. LmCPa is the most closely 
related L. mexicana CP to LmCPb and so appeared to be a good candidate for this role. 
The finding that the Imcpa/lmcpb double null mutant had the same infectivity profile to 
macrophages as the Imcpb null (Fig 3.2, B and C) shows that if  another proteinase is 
partially compensating for Imcpb it is not Imcpa. Interestingly the double null did not 
produce lesions in mice within the maximum time permitted for the experiment (Fig. 
3.16; E and F). This implies that both genes are needed for survival in mice. What is 
difficult to explain is that the double null re-expressing g2.S  produced an active enzyme 
but did not restore infectivity to PECs. Could this indicate a synergistic role for Imcpa in 
conjunction with Imcpb?
The L  mexicana complex differs from other Leishmania species in that the 
amastigotes not only contain numerous megasomes but also reside in very large PVs, the 
size increasing as the number o f parasites increases (Pupkis et ah, 1986; Rabonovitcli, et 
ah, 1986; Antoine et ah, 1990). It had been postulated that the amastigote CPs are 
mainly responsible for this increase in vacuole size, either by releasing amines that 
would raise the pH and cause the vacuole to expand due to osmotic stress (Coombs, 
1982), or by degrading PV membrane proteins internalised by the amastigotes (Leao el 
al, 1995). However, the data presented in section 3.3.2.2 clearly indicate that parasites 
lacking the /mcp6-encoded CPs also reside in large PVs, although a significant 
difference in mean PV diameter per amastigote was found with wild type and Almcpbn, 
This finding is consistent with the report that infected macrophages treated with CP
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inhibitors for 20 h have only slightly smaller PVs (Leao et al., 1995) which also 
suggests that indeed the parasite CPs contribute only slightly to the large PV sizes 
observed with L. mexicana infections, although a longer incubation time with the 
inhibitors may reveal a bigger effect.
Infected and uninfected macrophages were compared with respect to their 
enzyme activities using an 'Api Zym' enzyme detection kit (Table 3.4) and substrate- 
SDS-PAGE (Fig. 3.23), but in agreement with previous findings macrophage lysosomal 
enzyme activities were unaffected after infection (Antoine et al, 1987), as were 
proteinase activities (Prina et al, 1990). It seems unlikely therefore that amastigote CPs 
have a role in inactivating host cell lysosomal enzymes.
A major component o f the respiratory burst exhibited by macrophages is 
hydrogen peroxide (Lewis and McGhee, 1992). Previous studies have indicated that 
stationaiy phase promastigotes do trigger a respiratory burst but may be more resistant 
to its consequences (Mallinson and Coombs, 1989). Stationary phase promastigotes o f 
wild type parasites and Almcpbn were found to be equally susceptible/resistant to 
hydrogen peroxide and so it seems unlikely that the respiratory burst is responsible for 
the specific decline in null mutant-infected macrophages over 24 h. It may be expected 
that if  the respiratory burst was responsible then the nulls would have been killed 
instantly or within a couple o f hours (see below). It is possible that dead parasites aie 
taken up by macrophages and it takes time to digest them. However only parasites that 
looked intact i.e. had a distinct nucleus and kinetoplast, were counted (since at early 
stages of infection a definite parasite cell membrane was difficult to see).
Aside from reactive oxygen intermediates, it has recently become apparent that 
nitric oxide (NO) also has an important role in the microbicidal activity o f macrophages. 
NO from activated macrophages has been shown to be cytostatic or cytotoxic for a 
variety o f pathogens including Leishmania (Liew et a l ,  1990) and T. cruzi (Munoz- 
Fernandes et aL, 1992). Moreover, immature macrophages have been found to be highly 
susceptible to T. cruzi infection, a susceptibility which was associated with a low 
production o f both NO and TN F-a (Plasman et aL, 1994).
In a study by Assreuy et al (1994) superoxide production by activated
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macrophages was found to peak 1-2 h post-stimulation and then steadily decline. In 
contrast NO was not produced until 6 h post-stimulation, increasing rapidly until 24 h 
and reaching a plateau by 48 h. The timing o f this seemed to correspond to the decline 
in null mutant-infected macrophages over 24 h and so the relative susceptibilities o f 
wild type and Almcpbn stationary phase promastigotes to NO derived from sodium 
nitrite were compared (Table 3.6). Again there was no significant difference in 
susceptibilities. The nitric oxide synthase inhibitor L-NRME did not increase the 
number o f null mutant-infected macrophages (although it was not confirmed that this 
enzyme was actually being inhibited). These data suggest that the nulls simply caimot 
survive in macrophages rather than are killed by a specific microbicidal activity; or that 
the null mutants' surface coat triggers a different and lethal route o f receptor-mediated 
phagocytosis compared with the wild type parasites (see section 1.6.1).
When the individual Imcpb isoenzymes g l,  g2.8  and g l8  were re-expressed in 
the null mutant, the re-expressed gene products showed activity toward gelatin and 
fluorogenic substrates, but the enzymes differed both in their relative activities toward 
the different substrates and also their physical characteristics as displayed by the 
mobilities on gels. These differences correlated with evidence from biochemical studies 
which showed that the isoenzymes have distinct properties (Robertson and Coombs, 
1990, 1994). CP activity found in Almcpbgl (t) co-migrates on gelatin gels with one o f 
the 2 major activities characteristically present in stationary phase (metacyclic) 
promastigotes o f wild type cells (Fig. 3.24, A). The protein also co-migrates on Western 
blots with a protein in stationaiy phase wild type promastigotes (Fig. 3.24, B). The 
results correlate with Northern blot data (Appendix B: Mottram et aL, 1997) 
demonstrating levels o f  mRNA transcribed from g l  are elevated in stationary phase 
promastigotes relative to multiplicative promastigotes or amastigotes. Taken together 
these results suggest that some o f the proteinase activity in wild type metacyclic 
promastigotes is encoded by g l  o f the Imcpb array. The differences observed between 
the relative activities o f wild type and Almcpbgl (t) toward the two fluorogenic 
substrates (Fig. 3.25, lanes 1 and 2) suggest however that the lower mobility activity in 
wild type cells may comprise more than one gene product. It has been shown previously
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that some activity bands detected using gelatin gels do indeed represent several 
isoenzymes (Robertson and Coombs, 1990). Overall the data indicate that expression o f 
g l  o f the array, which is characterised by the lack o f sequence encoding a full length 
CTE, is stage regulated and occurs primarily in the infective metacyclic promastigote. 
The stage specific expression o f g l  suggests that it plays an important role at this stage 
o f  the life cycle, perhaps involving the interaction o f the metacyclic promastigote with 
its sandfly vector or the process o f differentiation itself. It could also be important for 
the early events associated with invasion o f  a macrophage following inoculation into a 
mammal. The finding that Almcpbgl (t) was less able to survive in macrophages than 
the wild type cells (Table 3.7) shows that g l  is not able to complement the loss o f the 
Imcpb array under these circumstances and in this way differs from g2.8. This lack o f 
complementation is not due to the lack o f a CTE as g l8 , although apparently expressed 
in amastigotes naturally, is also unable to restore wild type-infectivity levels to the null 
mutant, although g l8  did significantly increase infectivity o f Almcpbn. This indicates 
that the individual genes o f the array indeed perform different functions, a suggestion 
supported by the observed differences in substrate specificities. The precise timing of 
expression o f the different isoenzymes may be an important factor for parasite invasion 
and survival in the macrophage.
Almcpbg2.8 and Alm cpbgl8 (t) exhibit a number o f lower mobility bands in 
gelatin gels (30-40 kDa) and also larger molecular weight species in Western blots 
(about 38 kDa) (Fig. 3.24). By contrast, similar larger molecular mass proteins were not 
seen with Almcpbgl (t), which exhibited just the fully processed protein. These lower 
mobility activities may be precursors o f the mature CPs that are activated in situ 
following gel electrophoresis. Non-covalent complexes between lysosomal cathepsin B 
and its pro-peptide that are formed during autolytic maturation o f the precursor have 
been described (Mach et aL, 1994). These inactive complexes are believed to keep the 
proteinase in an inactive state until it is secreted, when it is activated by local 
acidification. It is possible that either the LmCPb pro-region or the CTE (or both) could 
be acting as an inhibitoiy peptide in a similar fashion, and the processing o f the gel 
subsequent to electrophoresis provides conditions in which the inliibitory peptide is
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removed. The finding that g l  /acks a full CTE and does not appear to produce these 
putative precursor forms that are activated in situ provides some evidence that it may be 
this domain that is important with regai'd to any such processing events. Indeed 
processing o f the CTE may be a pre-requisite for correct and efficient processing o f the 
pro-domain. Previous speculations on the function o f the CTE have included a role in 
the targeting o f the protein to lysosomes, a theory strengthened by the finding that a 
trypanosome CP apparently lacks mannose-6-phosphate which therefore cannot play a 
role in the enzymes' trafficking (Cazzulo et aL, 1990). The finding using 
immunoelectron microscopy that the mature LmCPb enzyme in Almcpbgl (t), which has 
a truncated CTE, is located in lysosomes that are typical o f the amastigotes o f L  
mexicana shows that a full length CTE is not essential for successful intracellular 
trafficking. It is clearly also not essential for the activity of these CPs, as g l  is highly 
active toward gelatin (Fig. 3.24, A) and other substrates (Fig. 3.25). This is consistent 
with previous reports which demonstrated that recombinant CPs from T. cruzi and T. 
brucei lacking the CTE can be expressed as active enzymes (Pamer et aL, 1991; Eakin 
et aL, 1993).
When the Imcpb cDNA was expressed in the null mutant cell line it produced a 
protein o f the predicted molecular size (section 3.3.1.1, Fig 3.1), indicating correct 
processing, but it was inactive toward gelatin under the standard condition tested (Fig.
3.2). This contrasts with the results obtained for the genes g l ,  g2.8, and g l8  which are 
expressed in the null mutant to produce active CPs. The product o f the Imcpb cDNA 
expressed in Escherichia coli had previously been shown to be inactive (Wolfram et aL, 
1995), so it is possible that the sequence differences between the products o f g l ,  g2.8, 
and gl8 , and the cDNA, are important in determining enzyme activity and/or substrate 
specificity. Overall it appears that the different genes encode not only different mobility 
proteinases, but proteinases with different substrate specificities, and confirms the 
working hypothesis that the different genes o f the array encode different enzyme 
activities, and that possibly all 18 active isoenzymes perform different roles in the 
parasite. The observed stage regulation o f enzyme activity seen with Almcpbg2.8 (Fig. 
3.26) is difficult to explain, but since the g2.8  copy is being re-expressed on an episome
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then it is possible that different stages o f the parasite vary in their ability to transcribe it 
in its unnatural form, giving rise to the apparent stage regulation.
The results presented in this chapter implicate the Imcpb CPs as non-essential 
virulence factors, involved in both differentiation and intracellular survival within the 
mammalian host. They also imply that individual genes o f the array encode different 
enzyme activities. The very high LmCPb activity in L. mexicana amastigotes in 
comparison with promastigotes was suggestive o f a crucial role for the enzymes in the 
parasite's survival in macrophages and so their suitability as a ding target. Clearly, 
however, being stage regulated and at high activity is not sufficient evidence to confirm 
the suitability o f an enzyme for chemotherapeutic attack. The results o f  this chapter 
show unambiguously that LmCPb is not essential for parasite survival in the BALB/c 
host (although it may be useful to investigate this in other animals) and therefore that 
even veiy specific inhibitors of LmCPb are unlikely to be effective as antileislnnanial 
drugs.
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CHAPTER FOUR
ANALYSIS OF THE CATHEPSIN B-LIKE CYSTEINE PROTEINASE 
{LMCPC) OF LEISHMANIA MEXICANA
4.1. INTRODUCTION
4.1.1. The Imcpc gene products
As detailed in Chapter 3, L. mexicana has a number of stage-regulated CPs 
which in terms o f their structure and activities are largely similar to the mammalian CP 
cathepsin L. Most CPs o f  parasitic protozoa have been found to be o f this type (see 
section 1.2.2.2), although some resembling (in terms o f substrate utilisation) the related 
mammalian CP, cathepsin B, have been reported in Entamoeba (Scholze and Schulte, 
1990; and references therein). The predicted amino acid sequences o f the enzymes 
differed significantly, however, from that o f cathepsin B (Reed et a l, 1993).
In addition to the Imcpa and Imcpb gene products, L. mexicana has a distinct 
group o f CPs designated group D CPs (Robertson and Coombs, 1993). Unlike the Imcpb 
gene products, these enzymes do not hydrolyse gelatin in substrate SDS-PAGE gels and 
are characterised by hydrolysing efficiently peptides with the moiety Phe-Val-Arg. The 
31 and 33 kDa group D CPs were found to be hydrophobic, indicating that they could be 
membrane associated; furthermore the N-terminal amino acid sequence data for the 
group D CPs indicated that they are homologous to mammalian cathepsin B and are 
therefore distinct from the products o f the two L. mexicana cathepsin L-like CP genes 
previously described, Imcpa and Imcpb (Robertson and Coombs, 1993). The group D 
CPs appeared to be products o f a third class o f L  mexicana CP gene. Although their 
molecular weights differ from those o f  cathepsin B, it was proposed that this difference 
may be related to the hydrophobic nature o f the enzymes (Robertson and Coombs, 
1993).
The Imcpc gene was recently cloned and sequenced (Bart et a l, 1995). The 
amino acid sequence derived from the purified group D enzymes was almost identical to 
that predicted from the gene sequence. As Imcpc is a single copy gene, it was suggested 
that it was highly likely that Imcpc encodes the group D CPs. The mature domain of
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LmCPc was found to have a high level o f homology to the cathepsin B class o f  CPs, 
having 53% identity with the Schistosoma mansoni cathepsin B and 52% indentity with 
the human homologue. The predicted size o f the mature LmCPc enzyme, 27 kDa, was 
however, smaller than that determined by SDS-PAGE for the two major group D 
enzymes (31 and 33 kDa). As LmCPc does not have a CTE which could be 
differentially processed in the 31 and 33 kDa enzymes, the authors suggested 
glycosylation as most likely the explanation for both the large molecular masses and the 
presence o f two products o f different electrophoretic mobilities encoded by the single 
copy Imcpc gene (Bart et aï., 1995). Although the Imcpc mRNA was present in all life 
cycle stages it was found to have elevated expression in the multiplicative promastigote 
form.
4.1.2. Aims
In keeping with the rationale o f investigating the roles o f L. mexicana CPs 
thi’ough targeted gene disruption, this part o f my work focussed on analysing the 
biological phenotype of the null mutants for Imcpc, which were created by colleagues in 
the Wellcome Unit o f Molecular Parasitology (WUMP), University o f Glasgow 
(Appendix B: Bart et al., 1997). The proteinases o f these cells were examined, as well 
as their ability to navigate the parasite life cycle in vitro, infect explanted peritoneal 
macrophages, and form lesions in mice. The results give rise to some interesting 
questions regarding the role o f LmCPc in parasite virulence and pathogenicity.
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4.2. MATERIALS AND METHODS
4.2.1. Parasites
4.2.1.1. Transfected cell lines o fL .  mexicana
The lines used in this chapter were created by colleagues in WUMP, and are 
summarised in Table 4.0. Details o f the transfection procedures used can be found in 
Appendix B (Mottram et aL, 1996, Bart et aL, 1997). All lines used in this study were 
parasites derived from a BALB/c mouse lesion subsequent to the transfection procedure, 
unless designated otherwise by the letter (t) following the cell line name.
Table 4.0. Transfected lines of Z. mexicana used
cell line gene deletion(s) antibiotic used for 
selection
Almcpbn
Almcpc
AlmcpcPC
null mutant for Imcpb
null mutant for Imcpc
null mutant for Imcpc re-expressing 
Imcpc
hyg/phleo
sat/puro
neo
Abbreviations: hyg, hygromycin; phleo, phleomycin; sat, nourseothricin hydrosulphate; 
puro, puromycin; neo, neomycin
4.2.1.2. Cell culture
The tlnee major developmental stages o f L. mexicana (MNYC/BZ/62/M379) 
were cultured and harvested as described in Chapter 2, section 2.2.1, with the exception 
that the following antibiotics were added, singly or in combination as appropriate (see 
Table 4.0), for selection o f transfectants: nourseotlnicin hydro sulphate (Hans-Knoll 
Inst., Thuringen, Germany) at 25 pg/ml, puromycin (Sigma) at 10 qg/ml, or neomycin 
(Geneticin, BRL) at 25 pg/ml. Doubling times were calculated as in Chapter 3, section
3.2.1.2, and t-tests were used to determine the statistical significance o f any observed 
differences in doubling times between the different lines.
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4.2.2. Proteinase assays and analyses
Substrate SDS-PAGE and Western blotting were carried out essentially as 
described in Chapter 2, section 2.2.2. The primary antibodies used were 1:500 anti- 
LmCPb group C CP (Chapter 3, section 3.2.2.2) and 1:50 anti-PEP662 antiserum 
(Appendix: B artc/r//., 1997).
4.2.3, Infection o f peritoneal exudate cells and BALB/c mice
The infectivity o f stationary phase promastigotes to PECs and female BALB/c 
mice was determined as described in Chapter 2, sections 2.2.4. and 2.2.5. respectively.
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4.3. RESULTS
4.3.1. The phenotype of mutants null for Imcpc
4.3.1.1. Growth and differentiation
The null mutant lines grew significantly more rapidly than the wild type 
parasites as promastigotes in vitro (Fig. 4.1), where the approximate doubling times o f 
wild type and Almcpan were 11.0 + 2.2 and 6.8 + 1 . 4  h, respectively (P value o f <0.1). 
In contrast to wild type parasites, few small promastigotes (the putative metacyclic 
stage) were found in stationary phase cultures o f Almcpcn (Fig. 4.2). Despite this, A 
Imcpcn successfully transformed to axenic amastigotes which resembled those o f  wild 
type cells in both growth characteristics (Fig. 4.3) and morphology (Fig 4.4).
4.3.1.2. Proteinases
The lack o f LmCPc protein in Almcpcn was confirmed by Western blotting using 
anti-PEP662 antiserum, which recognised a major band (30-33 kDa) in lysates o f 
stationary phase promastigotes o f wild type cells (Fig. 4.5, lane 1). Lower loading 
confirmed that this comprised two bands as expected (Robertson and Coombs, 1993). 
The null mutant Almcpcn (t) lacked these proteins (lane 2), whereas a major band was 
recognised in lysates of the re-expressor AlmcpcPC  (t) (lane 3), which had the same 
mobility as the band detected in wild type cells (lane 1), and was at a similar level o f 
expression.
Analysis o f the null mutant by gelatin-SDS-PAGE showed there to be a 
significant difference between the proteinase activities detected in lysates o f wild type 
parasites and Almcpcn. There was much less high mobility CP activity in Almcpcn 
stationary phase promastigotes (Fig. 4.6, lane 4) compared with wild type promastigotes 
(lane 1), although activities >60 kDa (not CPs) were similar in the two lines.
Western blot analysis with anti-LmCPb (group C) antiserum (Fig. 4.7) revealed, 
in agreement with the gelatin gel analysis, that Almcpcn stationary phase promastigotes 
(lane 3) had comparatively less LmCPb than the same form o f wild type parasites (lane 
1), especially with regards to the higher mobility band o f the doublet (arrowed). In 
contrast Almcpcn axenic amastigotes (lane 4) had a similar amount o f LmCPb to wild
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type axenic amastigotes (lane 2).
4,3,1,3, Infectivity
A major difference in phenotype was detected between Almcpcn and wild type 
cells in that the infectivity o f the null mutant to explanted mouse peritoneal exudate 
cells was greatly reduced (Table 4.1). Re-expression o f Imcpc in the null mutant (A 
ImcpcPC), however, increased infectivity to PECs (Table 4.1). This finding suggested 
that Almcpcn (t) would be much less infective to mice than wild type cells. In the two 
experiments canied out, however, stationary phase promastigotes o f  Almcpcn produced 
lesions one week before (Fig. 4.8, A) and 3 weeks after (Fig. 4.8, B) the wild type 
parasites. Thereafter, however, lesions due to Almcpcn grew more slowly than those due 
to wild type parasites. Analysis o f the parasites isolated from these lesions confirmed 
that the mutants had the same genotype at the Imcpc locus as the inoculated mutants 
(Appendix B: Bart et al., 1997).
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Figure 4.1. Typical in vitro growth curves of L. mexicana promastigotes. Cultures o f  
wild type (-#-) and /almcpcn ( -o )  were initiated at 5 x 10^  cells/ml in complete HOMEM 
medium and incubated at 25°C, with cell counts being performed on consecutive days. 
The results are the means + SD from 3 independent cultures for each line.
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Figure 4.2. Light micrographs of stationary phase promastigotes. Wild type (A) and 
àlmcpcn (B) cells were fixed in methanol and stained in 10% Giemsa's stain. There was a 
clear difference in cell size between the two lines, with the Almcpcn promastigotes (B) 
appearing much bigger then the majority o f wild type cells (A). The scale bar represents 
10 pm.
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Figure 4.3. Typical in vitro growth curves as axenic amastigotes of transfected lines. 
Cultures were routinely initiated using stationary phase promastigotes at 1 x 10^  cells/ml 
in complete SDM, pH 5.5, and incubated at 32° C. Cell counts revealed no difference in 
growth rates and final cell density between wild type (-#-) and /S.lmcpcti ( -o )  axenic 
amastigotes.
B
Figure 4.4. Light micrographs of Giemsa-stained axenic amastigotes; (A), wild type 
parasites, (B), Mmcpcn. There was no difference in cell size between the two lines, with 
the Almcpcn axenic amastigotes (B) appearing morphologically identical to wild type 
cells (A). Tlie scale bar represents 10 pm.
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Figure 4.5. Western blot analysis of Imcpc null mutants. Anti-PEP662 anti se rum was
used to assess the presence o f LmCPc in wild type L. mexicana (lane 1 ), Almcpcn (lane 
2) and the re-expressor AlmcpcPC (lane 3). To check for protein loading (lower panel), 
a duplicate blot was probed with a polyclonal antiserum raised to CRKI (Mottram et al.. 
1993). Sizes were derived from Bio-rad molecular weight markers. (Blot by (i. Bart, 
University o f Glasgow).
3 4
Figure 4.6. Gelatin-SDS-PAGE analysis of eell lines. Lane 1. wild type L. mexicana; 
lane 2, Almcpan; lane 3, Almcphn; lane 4, Almcpcn. Lanes were loaded with lysates 
containing 10^  stationary phase promastigotes. The positions o f molecular weight 
markers are indicated in kDa.
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Figure 4.7. Western blot probed with anti-LmCPb antiserum. Lane 1, wild type 
stationary phase promastigotes; lane 2, wild type axenic amastigotes; lane 3, Almcpcn 
stationary phase promastigotes; lane 4, Almcpcn axenic amastigotes. An equal number 
o f cells (5 X 10^) was loaded in each lane. The high mobility LmCPb band (lane 3, 
arrowed) was less intense in lysates o f Almcpcn than in those o f wild type (lane 1 ).
ceil line % infected PECs amastigotes/infected PEC
wild type 38 + 14 5 .9 +  0.8
Almcpbn 2.0 + 1.3 2.9 + 1.0
Almcpcn 4.7 ±2 .9 4 .0 +  0.6
AlmcpcPC (t) 20 + 11 5.2 + 1.4
Table 4.1, Infectivity of transfectants to macrophages. PECs were obtained from 
peritoneal lavage o f BALB/c mice and infected with stationary phase promastigotes o f 
the various cell lines at a promastigote to PEC ratio o f 1:1. After 7 days incubation at 
32°C, cells were fixed, stained with Giemsa's stain, and parasite load determined by 
counting 200 PECs. The values presented are means ±  SD from 3 independent 
experiments perfoimed in duplicate. The infection rates with Almcpbn and Almcpcn 
were significantly different from those with wild type parasites (P values of <0.02), but 
not from each other. The infection rate with AlmcpcPC  (t) was significantly different 
from that with Almcpcn (P<0.1), but not significantly different from the wild type 
infection rate. Mean values for amastigotes/PEC with Almcpbn and Almcpcn were 
significantly different from those with wild type parasites (P values of <0.02 and <0.05 
respectively), but not from each other.
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Figure 4.8. Infectivity to BALB/c mice. Subcutaneous lesions in the rumps o f female 
BALB/c mice resulting from an inoculum of 5 x 10^ stationary phase promastigotes 
were measured at weekly intervals using a micrometer and the mean lesion volume ± 
SD per group o f 3 mice calculated. The lines inoculated were: A, wild type (-#-) and A 
Imcpcn (t) (-0-); B, wild type (-# ) and Almcpcn { O ) .  The majority o f error bars have 
been omitted for clarity.
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4.4. DISCUSSION
Stationary phase promastigotes o f Almcpcn did not form metacyclics o f typical 
morphology; they were, however, very similar to wild type promastigotes with respect to 
differentiation to and growth as axenic amastigotes (it was attempted to examine how 
amastigote-like the axenic amastigotes o f  the Imcpc nulls were by examining their 
nuclease profiles; however technical difficulties with the nuclease gels meant that 
unfortunately useful data were not obtained). These results are very similar to those 
found with Almcpan (Chapter 2). It has to be considered, therefore, whether the 
formation o f atypical metacyclics with Almcpan and Almcpcn is a result o f the 
transfection procedure itself, rather than a direct result o f the gene deletions. (It should 
be noted that the same morphological differences were apparent whether the lines had 
been passaged through mice or not, and that the reduced activity o f the Imcph 
proteinases in these two lines may be related to the atypical morphology observed).
The results presented in this chapter indicate that LmCPc plays a role in enabling 
L. mexicana to live within macrophages in vitro, and in this respect is similar to LmCPb 
in being a virulence factor (see Chapter 3). However it differs from LmCPb in that it 
appears to be less important in aiding survival o f the parasite in BALB/c mice. Almcpcn 
stationary phase promastigotes were similar to those o f Almcpan (Chapter 2) in that they 
produced lesions after approximately the same nmnber o f weeks post-inoculation as did 
wild type parasites in each experiment. This contrasts greatly with the results obtained 
with Almcpbn stationary phase promastigotes, which took at least 24 weeks longer to 
produce lesions, and in some cases did not produce any (Chapter 3). Clearly though, the 
lesions resulting from inoculation o f Almcpcn stationary phase promastigotes did not 
grow as quickly as those produced by wild type parasites. These results indicate that the 
two CPs have different roles in the parasite and also suggest that the infectivity to PECs 
is not a reliable indicator o f the infectivity o f the mutant lines to animals; perhaps 
because more factors are involved in vivo than in vitro. The findings on the relative 
infectivity o f the Imcpc null mutants (which produced lesions in mice almost as rapidly 
as wild type parasites) and Imcpb null mutants (which produced lesions six months later 
than wild type parasites) are consistent with Imcpb having a role in immune evasion, and
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Imcpc perhaps not being involved in this respect. The lack o f a dramatic difference in 
infectivity to mice between Almcpcn and wild type parasites does not mean that Imcpc 
plays no role in intracellular survival in vivo; BALB/c are highly susceptible to infection 
with L. mexicana and the inoculation dose was much higher than that likely to be 
delivered by a sand fly. It may be worthwhile comparing the infectivity o f Almcpcn to 
less susceptible mouse strains and in lower numbers.
A possible explanation for the observed lack o f necessity in vivo o f Imcpc may 
be compensation by other enzymes. The way in which the parasite is able to overcome 
this loss o f Imcpc, however, is less clear. The decreased activity o f the LmCPb CPs 
detected using gelatin-SDS-PAGE, in stationary phase promastigotes o f the Imcpc null 
mutants obtained by transformation o f the amastigotes isolated from mice (Fig. 4.6) 
indicates that these enzymes are not compensating for the loss o f Imcpc and moreover 
suggests that there could be a role for LmCPc in the maturation o f Imcpb gene products 
to give active enzymes. The absence o f increased activity o f >60 kDa proteinases (Fig. 
4.6) suggests that if  it is these enzymes that are compensating for the lack o f LmCPc 
then the wild type levels are sufficient to fulfil the parasite's requirements. There may, o f 
coui'se, be other proteinases not detected using gelatin-SDS-PAGE that are up-regulated 
in the Imcpc null mutants and compensating for the absence o f LmCPc.
The finding that the Imcpc null mutant infected far fewer macrophages in vitro 
than did wild type parasites confirms that Imcpc plays some part in the mammalian 
infective stages and that it is somehow involved in protecting the parasite from the 
microbicidal activity o f at least some populations o f macrophages, either at the invasion 
stage or in maintaining infection. From the results found with AlmcpcPC  (Table 4.1), it 
would appear that expression o f LmCPc enables the infection o f a greater number o f 
particular sub-populations o f macrophages present in the PEC population; this 
hypothesis warrants further investigation.
The finding that LmCPc o f L. mexicana has some unusual features (Robertson 
and Coombs, 1993), indicating that it may be membrane-associated or released, gave 
hope that this parasite CP could be a good drug target. The findings o f this study, 
however, suggest that specific inhibitors o f LmCPc would not prevent or cure infection
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with L. mexicana. Some cysteine proteinase inhibitors do have aiitileishmanial activity 
in vitro (see Chapter 5), but it is not known if  these inliibitors are acting synergistically 
on several enzymes to produce their effect or whether they are inliibiting an as yet 
unidentified CP (see discussion in Chapter 5). My results, however, demonstrate that 
Imcpc is not essential (under the conditions tested) and would appear to be a poor target 
for chemotherapeutic exploitation.
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CHAPTER FIVE
CYSTEINE PROTEINASES AS EXPLOITABLE DRUG TARGETS
5.1. INTRODUCTION
5.1.1. Anti-leishmanial activity of proteinase inhibitors
As was discussed in section 1.3.3.2., inhibitors o f  CPs can hinder the 
development o f some protozoan parasites, and there is much interest in developing 
proteinase inhibitors as novel chemotherapeutic agents. Inhibition o f the food vacuole 
CPs o f P. falciparum  by administration o f peptidyl-fluoromethanes led to an 
accumulation o f undegraded haemoglobin inside the food vacuoles and inliibited the 
parasite from multiplying, both in vitro and in vivo (Rocket et a l , 1990; Rosenthal et 
a l ,  1991, 1993). Use o f specific, irreversible inhibitors o f the major CP o f T. cruzi have 
shown transformation events of the parasite to be particularly vulnerable, as well as 
inhibiting invasion and multiplication o f the parasites in cultmed mammalian cells 
(Mereilles, et a l ,  1992; Bonaldo, et a l ,  1991; Franke de Cazzulo, et a l, 1994).
With regards to other tiypanosomatid species, much less is known about the 
effects o f CP inhibitors. Antipain, a known inhibitor o f CPs, has been shown to inhibit 
both the growth o f L. mexicana promastigotes by >50% over 7 days, and the in vitro 
transformation o f amastigotes to promastigotes by >78% (Coombs et a l ,  1982). This 
higher susceptibility o f amastigotes correlated with their higher CP content, and 
suggested that some inhibitors o f Leishmania amastigote CPs may have potential as 
antileishmanial agents. This suggestion was given credence by the finding that antipain 
and leupeptin were found to be potent inhibitors o f the growth o f L. mexicana 
amastigotes in explanted mouse peritoneal macrophages (Coombs and Baxter, 1984). 
However, neither o f the inhibitors used in the above studies are known to target CPs 
specifically, e.g. leupeptin can also inhibit some tiypsin-like serine proteinases (North et 
a l,  1990).
L. pifanoi, a member o f the L. mexicana complex, has 2 developmentally 
regulated Type I and Type II CP genes Lpcys2 and Lpcysl (see section 1.4..2). 
Treatment o f axenic amastigotes o f L. pifanoi with selected cysteine (but not aspartic)
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proteinase inhibitors, arrested proteolytic processing o f Lpcys2 in vivo and inhibited 
parasite cell division (Duboise et ah, 1994). Antipain substantially blocked the 
processing o f a 40 kDa intermediate and inhibited parasite growth at levels down to less 
than 5 pM, although this effect was reversed when parasites were transferred to inhibitor 
free medium. The peptidyhfluoromethane inhibitor Z-Phe-Ala-CH^F also showed 
significant inhibition o f Lpcys2 processing and amastigote growth but required a higher 
concentration o f between 100 and 200 pM. The overall conclusion regarding the effects 
o f these inhibitors were that they were cytostatic rather than leishmanicidal (Duboise et 
a l ,  1994).
5.1.2. A m astigote CPs as activators of p ro-drugs
Lysosomotropic amino acid and peptide esters such as leucine methyl ester (Leu- 
OMe) destroy isolated L. amazonenesis amastigotes by a mechanism postulated to 
involve trapping o f the compounds and their breakdown within acidified parasite 
organelles (review: Rabinovitch 1989). Amino acid esters kill intracellular L. 
amazonensis at concentrations that allow the survival o f the host cells (Rabinovitch et 
a l,  1986), a killing that is thought to be dependent on ester hydrolysis by the parasite 
proteinases (Alfieri et a l ,  1988, 1989; Hunter et a l ,  1989) since amastigotes pre­
incubated with the cysteine and and serine -proteinase inhibitors antipain and 
chymostatin are protected from Leu-OMe toxicity. The hypothesis that megasomes 
could be the target o f the esters was supported by the observation that these organelles 
are acidified and thus potentially able to concentrate the compounds (Antoine et a l ,  
1988). Amastigotes o f L. mexicana are also susceptible to Leu-OMe since this 
compound is rapidly hydrolysed by the low molecular weight CPs that occur in 
abundance in the megasomes o f this stage (Himter et a l , 1992).
5.1.3. Aims
Although I have shown that LmCPb is not essential for parasite survival in vitro 
or in vivo (Chapter 3), it remained a possibility that other CPs may be, either singly or 
collectively with Imcpb. The majority o f  this chapter focuses therefore on leishmanial
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proteinases as potentially exploitable drug targets, and involves studies on the effects o f
V
"Ï
new generations o f  irreversible CP inliibitors, that permeate into living parasites, on the 
CPs themselves and the growth, differentiation and infectivity o f L  mexicana.
I also investigated the effects o f Leu-OMe on wild type and transfected lines o f 
L. mexicana in order to elucidate the extent o f the involvement of LmCPb in the 
activation o f the pro-drug, and therefore provide more information on the potential of 
this compound as a pro-drug against leishmaniasis. ^
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5.2. MATERIALS AND METHODS
5.2.1. In vitro culture with cysteine proteinase inhibitors
The three major developmental stages o f wild type L  mexicana 
(MNYC/BZ/62/M379) and the transfected cell lines were cultured and harvested as 
described in Chapters 2 and 3, sections 2.2.1 and 3.2.1. The peptidyl-diazomethanes Z- 
LVG-DMK and Z-FA-DMK were made up as 10 mg/ml stock solutions in DMSO, and 
included in the appropriate promastigote or axenic amastigote culture medium to give a 
final concentration o f 10 pg/ml (-25 pm). Normally 10 pi o f stock inliibitor was 
carefully added to 10 ml o f medium prior to the addition o f the required number o f 
promastigotes, giving a final concentration o f 10 pg/ml inhibitor/0.1% DMSO (v/v). 
Stock solutions o f the inhibitors were stored at -20°C until further required.
5.2.2. Analyses using gelatin-SDS-PAGE
Substrate-SDS-PAGE was carried out essentially as described in Chapter 2, 
section 2.2.2. Where DMK proteinase inhibitors were included, they were added to the 
lysates prior to electrophoresis to give a final concentration o f 10 pg/ml (-25 pm); 
normally 2 pi o f 100 pg/ml DMK dissolved in 1% (v/v) DMSO was added to 18 pi o f 
lysate and incubated for 10 min on ice. Thereafter the lysate was diluted 1:1 with 2x 
sample buffer and loaded into the well o f  a gelatin gel.
5.2.3. Use of a biotinylated inhibitor
A stock solution o f 0.02 M Biotin-F-A-DMK (Biosyn) in dimethylformamide 
(DMF) was stored at -20“C, and diluted to 600 pm with DMF immediately prior to use. 
Preparation o f parasite lysates (omitting the proteinase inhibitors) was carried out as 
described in Chapter 2, section 2.2.2.2. Cell lysates were incubated 5:1 with the affinity 
label (100 pM  final concentration) at 37^C for 30 min, before addition o f an equal 
volume o f 2x sample buffer and boiling for 10 min. Control samples contained lysate 
plus DMF. Electrophoresis and electroblotting were carried out as described in Chapter 
2, section 2.2.2.2. After blocking overnight at 4°C in TBS-Tween (section 2.2.2.2), pH
7.6, containing 3% (w/v) bovine serum albumin (BSA), detection o f cysteine
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proteinases was achieved by incubating with a 1 in 1000 solution o f streptavidin- 
alkaline phosphatase (Biosyn), in TBS-Tween, pH 7.6, for 2 hours at ambient 
temperature. After 3 x 20 min washes in TBS-Tween, pH 9.5, blots were developed 
using the BCIP/NBT development system according to the manufacturers instructions 
(Sigma), and rinsed thoroughly with water.
5.2.4. Infection of peritoneal exudate cells in the presence of cysteine proteinase 
inhibitors
The infection of peritoneal exudate cells was carried out as described earlier 
(Chapter 2, section 2.2.4 and Chapter 3, section 3.2.5) with the following additions. 
Stock solutions (10 mg/ml in DMSO) were made up o f the CP inhibitors Z-LVG-DMK, 
Z-FA-DMK, 'P87' (Mu-Phe-Homophe-vinyl sulfone) and 'K02' (Mu-Phe-Homophe- 
oxycoumarin) and stored at -20°C until required (gifts from Prof. J. McKerrow, 
California, USA). Parasites were resuspended to the required density in complete RPMI 
medium containing 10 pg/ml (-25 pm) inhibitor and 0.1% DMSO (final concentrations) 
and incubated for 15 min at 25°C (promastigotes) or 32‘^ C (amastigotes). Parasites were 
then added to the PECs in chamber slides and incubated as appropriate (sections 2.2.4 
and 3.2.5), washed 3x in complete RPMI medium, and then incubated for either 72 h or 
7 days in complete RPMI medium containing 10 pg/ml inhibitor, after which slides 
were fixed and stained as before (section 2.2.4).
In certain cases the timing o f exposure o f the cells to the inliibitor Z-FA-DMK 
was varied, such that the parasites were either pre-incubated with the inhibitor at 10 
pg/ml (-25 pm) for 15 min before addition to the PECs, and the inhibitor subsequently 
included throughout the incubation (as above), or the inliibitor was added (to give the 
same final concentration) 4 h or 24 h after the PECs were first exposed to the parasites.
5.2.5. Incubation o f axenic parasites with leucine methyl ester
The effect o f Leu-OMe (Sigma) on axenic amastigotes and isolated lesion 
amastigotes of wild type and Almcpbn was measured using the quantatative tétrazolium 
salt assay (see Chapter 3, section 3.2.S.2) as follows. Briefly, parasites were re suspended
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at a density of 1 x 10^ cells/ml in complete HOMEM medium containing Leu-OMe (5 
mM final concentration) and incubated at 32°C for one hour. After washing in complete 
medium, cells were incubated at the above cell density with MTT (450 pg/ml final 
concentration in complete HOMEM) at 32°C for 3 h, after which samples were diluted 1 
in 6 with 0.04 M HCl-isopropanol and the absorbances read at 540nm (as in section
3.2.8.2). T-tests were used to determine the statistical significance o f any observed 
differences in % MTT reduction between the differnt lines after exposure to Leu-OMe.
5.2.6. Inclusion of leucine methyl ester in parasite-infected peritoneal exudate cell 
cultures
The infection o f peritoneal exudate cells by lesion amastigotes was carried out as 
described earlier (Chapter 2, section 2.2.4 and Chapter 3, section 3.2.5). Leu-OMe was 
added to the PECs 24 h after first exposure to the parasites, to give a final concentration 
o f  5 mM. Parasite load was determined after a further 48 h incubation, as described 
previously (section 2.2.4).
142
chapter five  results
5.3. RESULTS
5.3.1. Proteinase inhibitor studies
5.3.1.1. Effects o f  peptidyl-diazomethanes on transformation and growth o f  L. 
mexicana
Wild type promastigotes (Fig. 5.1, A) and axenic amastigotes (Fig. 5.1, B) grew 
well in the presence o f 10 pg/ml Z-LVG-DMK. The results suggested that this 
proteinase inhibitor does not affect the growth, or transformation to metacyclics (as 
judged by morphology), o f  promastigotes, nor the transformation to and multiplication 
o f axenic amastigotes, compared to control cultures containing 0.1% DMSO. The other 
inhibitor tested in the same set o f experiments Z-FA-DMK appeared to slightly inhibit 
amastigote multiplication (Fig. 5.1, B), although it had no discernible effect on 
promastigote growth or transformation to metacyclics or axenic amastigotes as judged 
by morphology (Fig. 5.1, A). These experiments were repeated using the transfected 
lines Almcpbn and Almcpbg2.8 (Figs. 5.2 and 5.3, respectively). Similar results to those 
found with wild type parasites were obtained, except that the multiplication o f A 
lmcpbg2.8 axenic amastigotes (Fig. 5.3, B) was affected a little by both inhibitors (note 
that these transfected lines typically grow poorly as axenic amastigotes, as was shown in 
Chapter 3). It was also apparent that the 0.1% DMSO in the control promastigote 
cultures appeared to produce a lag effect, and no obvious logarithmic phase, when 
compared with the typical growth curves presented in Chapter 3, which was suiprising 
as cultures o f wild type Leishmania cultures are generally considered to be unaffected 
by concentrations o f up to 0.25% (v/v) DMSO.
5.3.1.2. Effects o f  peptidyl-diazomethanes on parasite proteinases
Gelatin-gel analyses o f stationary phase promastigotes o f the wild type parasites 
from the experiment described in section 5.3.1.1. were carried out. Lysates o f cells that 
had been grown in medium with 0.1% DMSO added as a control gave the characteristic 
two main bands o f high mobility CP activity, between 25 and 20 kDa, (Fig. 5.4, lane 1) 
previously confirmed to be encoded by Imcpb (see Chapter 3). Cells grown in the 
presence o f  the inhibitors Z-LVG-DMK and Z-FA-DMK (lanes 2 and 3, respectively)
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had vei7  little o f this high mobility CP activity, whereas the slightly slower moving CP 
activities of apparently 35 to 40 kDa, which normally are at very low activity in 
promastigotes, were at relatively high activity. The slowest moving activities o f 60 kDa 
and greater (due to proteinases other than CPs, such as the metalloproteinase gp63) also 
appeared to be upregulated in eells grown in the presence o f these inhibitors. Control 
lysates incubated with 10 pg/ml Z-LVG-DMK (lane 4) or Z-FA-DMK (not shown) 
lacked both the high (20-25 kDa) and lower mobility (35-40 kDa) CP activities. This 
confirmed that the bands aroimd 40 kDa are inliibitable by these DMKs, although this 
did not apparently occur in the living cell.
Wild type axenic amastigotes grown in the presence o f Z-LVG-DMK (Fig. 5.4, 
lane 6) or Z-FA-DMK (Fig. 5.4, lane 7) lacked the typical high mobility CP activity (as 
seen with control axenic amastigotes. Fig. 5.4, lane 5) but the characteristic lower 
mobility activities o f axenic amastigotes (Bates et a l ,  1992) approximately 35-40 kDa, 
were active. Although these lower mobility activities were not inhibited by Z-LVG- 
DMK or Z-FA-DMK in the living cells, they were inliibited when the cells were lysed 
with culture medium from day 7 o f the above experiment containing Z-FA-DMK (lane 
8). This confirmed that the activities were due to CPs, and indicated that the DMK was 
still intact and fairly concentrated in the medium from which the cells were harvested.
Although the cells were washed well during harvesting, it remained a possibility 
that inliibitor bound to the cell surface may cause inliibition o f  the CPs when the cells 
were lysed, and that the enzymes were not in fact inliibited in the living cells. However, 
analysis on gelatin gels o f  a mixture o f DMK-grown axenic amastigotes plus control 
axenic amastigotes showed the control CP activity to be unaffected, indicating that 
indeed there was no inhibitor bound to the cell surfaces (data not shown). As was found 
with the promastigotes, there was increased activity o f enzymes o f around 60 kDa 
(apparently predominantly metalloproteinases, since they were fully inhibited by 1 mM 
o-phenanthi'oline added during substrate digestion) in these cells compai’ed with control 
axenic amastigotes.
The proteinases o f promastigotes o f the line Almcpbg2.8 grown in the presence 
o f these inliibitors were also examined. Gelatin gel analysis (Fig. 5.5) revealed results
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similar (in relative terms) to those found with wild type parasites, in that the high 
mobility proteinase activity detected in the controls (lane 1) was absent (lanes 2 and 3), 
and the lower mobility activities were enhanced.
5.3.1.3. Detection o f  cathepsin L-like CPs using a biotinylated inhibitor
The possibility that L. mexicana possesses additional CPs that can compensate 
for the lack o f Imcpa and Imcpb was investigated using biotin-F-A-DMK to detect 
active cathepsin L-like CPs in a Western blot (Fig. 5.6). Lysates o f stationary phase 
promastigotes o f wild type cells (lanes 5 and 6), Almcpbn (lanes 3 and 4) and A 
Imcpbn/lmcpan 'double null' (lanes 1 and 2) were incubated with the biotinylated 
inhibitor (lanes 1, 3 and 5) or not (lanes 2, 4 and 6). This sensitive method detected the 
main cathepsin L-like CPs in wild type cells as a broad, dense band at around 24 kDa 
(lane 5, arrowed). The staining around 24 kDa was considerably less in Almcpbn, but 3 
faint bands remained (lane 3). These appeared to be due to Imcpa as they were absent 
from the double null (lane 1). The only bands detected in this line were those o f higher 
molecular mass, some o f which were also present in the control lanes 4 and 2. These 
may have been due to non-specific binding; there is likely to be significantly less 
autohydrolysis in lysates o f the transfected lines, than in those o f wild type parasites 
(lane 6). These experiments indicate that Imcpa and Imcpb may be the only cathepsin L- 
like CPs in L mexicana stationary phase promastigotes. A similar result was found using 
the above method on axenic amastigote lysates (data not shown).
5.3.1.4. Effects o f  inhibitors on parasite infection o f  peritoneal exudate cells
The effects o f CP inhibitors on the infectivity of parasites to macrophages was 
investigated (Table 5.1). The infectivity o f stationary phase promastigotes o f wild type 
parasites in the absence o f inhibitor was found to be 53%. Although it had been shown 
to inhibit the CPs in axenic parasites, Z-LVG-DMK surprisingly did not reduce the 
infectivity o f promastigotes to macrophages, although these results proved rather 
variable (see Discussion, section 5.4). In contrast, Z-FA-DMK reduced infectivity to 
very low levels (7%), in fact to levels similar to those obtained with Almcpbn in the
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absence o f CP inliibitors (Table 5.1 and Chapter 3). There also appeared to be a lower 
number o f amastigotes per infected cell when Z-FA-DMK was present compared with 
both wild type parasites and Almcpbn. Control cultures with 0.1% DMSO included in 
the medium had infectivity levels that were not significantly different from those with 
wild type parasites, although the number o f amastigotes per infected PEC was slightly 
lower (P value <0.1).
Having ascertained that Z-FA-DMK could reduce both parasite infection o f  
PECs and perhaps intracellular multiplication, experiments were set up to investigate at 
which stage in the infection process parasites were most susceptible to this inhibitor 
(Fig. 5.7). Similar results were obtained inespective o f whether the parasites were pre- 
incubated with Z-FA-DMK for 15 min, and the inliibitor subsequently included 
thr oughout the incubation, or it was added 4 h or 24 h after infection o f the macrophages 
with the parasites (Fig. 5.7, A). However, the length o f the incubation was found to be 
important. The inhibitor had greater anti-parasite effect over 7 days, after which the 
number o f parasite-infected cells was found to be less than 10 % o f the control, than 
when the experiment was stopped after 72 h. The mean number o f parasites per infected 
macrophage was not affected greatly by the time o f initial exposure to the DMK (Fig.
5.7, B); but was reduced more by 7 days than by 3 days.
This approach was pursued using other CP inhibitors known to inhibit the 
leishmanial CPs on gelatin gels (Coombs, unpublished) and looking for their effects on 
macrophage infections over 72 h and 7 days (Fig. 5.8). Like Z-FA-DMK, the CP 
inhibitors 'P87' and 'K 02' had some anti-parasite effects after 7 days, although they were 
not as potent as Z-FA-DMK after 3 days (Fig. 5.8, A). Furthermore, 'P87' and 'K 02 ' did 
not reduce the number o f amastigotes per infected PEC to as low a level as occurred 
with Z-FA-DMK after 7 days (Fig. 5.8, B).
The effect o f CP inhibitors on the infectivity o f lesion amastigotes to 
macrophages was examined (Fig. 5.9). After 7 days incubation with the inhibitor Z-FA- 
DMK, the % infected macrophages was again reduced to a very low level compared 
with the control parasites (and, as with promastigotes, this reduction in infectivity was 
not as pronounced after just 72 h); as was the number o f amastigotes per macrophage,
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The CP inhibitor Z-LVG-DMK, however, had a lesser effect.
5.3.2. Susceptibility to the amino acid ester leucine methyl ester 
S. 3.2.1. Toxicity fo r  axenic parasites
Toxicity for isolated parasites was measured by a quantitative tétrazolium salt 
(MTT) assay. After exposure to 5 mM Leu-OMe the reduction o f MTT by wild type 
axenic amastigotes was only 23% of that o f the control (untreated cells). The MTT 
reduction by Almcpbn was 51% of the control (Table 5.2), These results were consistent 
with the hypothesis that the lack o f LmCPb would render the Almcpbn cells less 
susceptible to Leu-OMe. Nevertheless, a substantial proportion o f the Almcpbn axenic 
amastigotes were still affected by the ester. However results using lesion amastigotes o f 
the 2 lines (Table 5.2) showed that MTT reduction after exposure to the ester was 12% 
with wild type parasites and 17% with Almcpbn amastigotes. Although these results are 
significantly different, they clearly indicate that the Imcpb proteinases are not the only 
ones that hydrolyse the ester, although they may play a large part when they are present. 
It is also apparent from these results that axenic amastigotes are not identical to lesion 
amastigotes (as they do not appear to be as susceptible as lesion amastigotes) although 
cultured amastigote-like forms were previously found to be very similar to lesion 
amastigotes (Bates et aL, 1992)
5.3.2.2. Toxicity fo r  infections ofperitoneal exudate cells
PEC cultures infected with either wild type or Almcpbn lesion amastigotes were 
almost cured o f parasites by exposing the cells to Leu-OMe 24 h after infection (Table 
5.4). There were no apparent deleterious effects on the host cells, suggesting that amino 
acid esters may be effective pro-drugs that are activated specifically by parasite 
enzymes.
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Figure 5.1. G row th of wild type L. m exicana  in the presence of peptidyl- 
diazom ethanes. (A) Promastigotes cultured in complete HOM EM containing 10 pg/ml 
o f  the following inhibitors: control (0.1% DMSO); Z-LVG-DMK; -V-, Z-FA-
DMK. (B) Axenic amastigote cultures, initiated using stationary phase promastigotes, in 
complete SDM containing inhibitors as in (A). Results are the means ±  SD from 3 
independent expeiiments.
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Figure 5.2. G row th of M m cpbn L. m exicana  in the presence of peptidyl- 
diazom ethanes. (A) Ihomastigotes cultmed iu complete HOMEM  contaiuiiig 10 pg/ml 
o f the following inhibitors: control (0.1% DMSO); -Q-, Z-LVG-DMK; Z-FA-
DMK. (B) Axenic amastigote cultures, initiated using stationary phase promastigotes, in 
complete SDM containing inhibitors as m (A). Results are the means ± SD fiom  3 
independent ex^reiiments.
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Fig m e  5,3. G row th of AImcpbg2.8 L. m exicana  in the presence of peptidyl- 
diazom ethanes. (A) Promastigotes cultured in complete HOMEM coutaiimig 10 pg/ml 
o f the following inhibitors: control (0.1% DMSO); -0-, Z-LVG-DMK; -V-, Z-FA-
DMK. (B) Axenic amastigote ciiltmes, initiated using stationaiy phase promastigotes, in 
complete SDM containing inhibitors as in (A). Results are the means ±  SD from 3 
independent ex|)eiTments.
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Figure 5.4. Gelatin-gel analysis of wild type parasites grown in the presence of CP 
inhibitors. Wild type cells were harvested on day 7 from the experiment described in 
section 5.3.1.1 (Fig. 5.1) and their lysates subjected to gelatin-SDS-PAGE. Lane 1, 
control stationaiy phase promastigotes; lanes 2 and 3, promastigotes grown with Z 
LVG-DMK and Z-FA-DMK respectively; lane 4, control promastigotes lysed with Z- 
LVG-DMK. Lanes 5-8: as lanes 1-4 except cells were axenic amastigotes. D ie positions 
o f molecular weight markers in kDa are indicated.
66 —
3 0 -
21 -
1 2 3
Figure 5.5. Gelatin-gel analysis of Aimcpbg2.8 grown in the presence of CP 
inhibitors. Almcpbg2.8 promastigotes were harvested on day 7 from the experiment 
described in section 5.3.1.1 and their lysates subjected to gelatin-SDS-PAGE. Lane 1, 
control stationary phase promastigotes; lanes 2 and 3, promastigotes grown with Z- 
LVG-DMK and Z-FA-DMK, respectively. D ie positions o f molecular weight markers 
are arrowed.
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Figure 5.6. Western blot analysis of proteinases of A mexicana using biotinylated 
peptidyl-diazomethane to label enzymes. Lysates o f stationary phase promastigotes of 
wild type (lanes 5 and 6), Ahvcphn (lanes 3 and 4) and Ahiicphn Inicpan (lanes I and 2) 
were incubated with the biotinylated inhibitor (lanes I, 3 and 5) or not (lanes 2, 4 and 6). 
The positions o f molecular weight markers are indicated on the left; the position o f the 
main cathepsin L-like CPs is indicated on the right (large arrowhead).
cell line, inhibitor % infected PECs am astigotes/infected PEC
wild type 53 + 6.1 4 .8 +  0.9
+ DMSO 45 + 11 3 .4 +  0.7
+ Z-LVG-DMK 42 + 24 3.0 + 1.5
+ Z-FA-DMK 7 .0 +  8.7 1.9 + 1.3
Almcpbn 5.3 + 5.5 3 .6 +  4.1
Table 5.1. Effect of proteinase inhibitors on the infectivity of vrild type stationary 
phase promastigotes of A. mexicana to peritoneal exudate cells. Cells were pre- 
incubated with the inhibitors for 15 min and constantly exposed to them over the 7 day 
duration of the experiment After 7 days, the cells were fixed, stained with Giemsa's 
stain, and parasite load determined by counting 200 PECs. The values given are the 
means ± SD from 3 independent experiments. Infection rates for wild type, DMSO and 
Z-LVG-DMK were significantly difterent from both Z-FA-DMK and Aimcphn (P values 
of <0.01, 0.01 and 0.1 respectively) but not from each other; infection rates for Z-FA- 
DMK and Almcpbn were not significantly difterent. Values for amastigotes/infected PEC!' 
with + DMSO, Z-LVG-DMK, Z-FA-DMK and Aimcphn were all significantly different 
from that for wild type (P values o f at least < 0 .1 ) but not from each other
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Figure 5.7. Effect o f the peptidyl-diazomethaiie proteinase inhibitor Z-FA-DMK  
on the infectivity of wild type promastigotes to PECs. The stationary phase 
promastigotes were either pre-incubated for 15 min with 10 pg/ml Z-FA-DMK and 
exposed to the inhibitor throughout ( H  ), or the inhibitor was added 4 h ( C ] ) or 24 h 
( C l )  after the PECs were first exposed to the parasites. Controls ( H ) contained 0.1% 
DMSO. The % infectivity (A) and amastigotes/infected PEC (B) data are the means ± 
SD from 3 independent experiments. Graph A: infection rates after 72 h for pre- and 4 h 
incubations were significantly different from the control (P values o f <0.05 and <0.02, 
respectively) but not from each other; after 7 d infection rates for pre-, 4 h and 24 h 
incubations were all highly significantly different from the control (P values <0.01). 
Graph B: mean values after 72 h for amastigotes/infected PEC with pre-, 4 h and 24 h 
incubations were all significantly different from the control (P values of <0.02, <0.02 and 
<0.05, respectively) but not from each other; after 7 d mean values for 
amastigotes/infected PEC with pre-, 4 h and 24 h incubations were still significantly 
different from the control (P values o f <0.05, <0.05 and <0.1, respectively).
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Figure 5.8. The effect of CP inhibitors on the infectivity of wild type stationary 
phase promastigotes to PECs. The parasites were pre-incubated for 15 min with the 
inhibitors, which were also present in the culture medium for the duration of each 
experiment (72 h or 7 days). The inhibitors used (at 10 pg/ml) were as follows: H ,  Z- 
FA-DMK; □ ,  Z-LVG-DMK; □ ,  P87; HI, K02; ■ ,  control (0.1% DMSO). The % 
infectivity (A) and amastigotes/infected PEC (B) data are the means ±  SD (except for Z- 
LVG-DMK) from 3 independent experiments performed in duplicate. Graph A; the 
infection rate after 72 h was significantly different from the control (P value o f <0.05) 
with Z-FA-DMK, but not with P87 or K 02; after 7 d infection rates with Z-FA-DMK, 
P87 and K 02  were all highly significantly different from the control (P values <0.01), but 
not from each other. Graph B: mean values after 72 h for amastigotes/infected PEC with 
Z-FA-DMK, P87 and K 02  were all significantly different from the control (P values of 
<0.02, <0,05 and <0.05 respectively) but not from each other; after 7 d the mean value 
for amastigotes/infected PEC with Z-FA-DMK was significantly different from the 
control (P value o f <0.05), but was not significantly different with P87 or K02.
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Figure 5.9. Effect of CP inhibitors on the infectivity of wild type Lesion ainastigotes 
to PECs. The parasites were pre-incubated for 15 min with the inhibitors, which were 
also present in the culture medium at 10 pg/ml for the duration of each experiment (72 h 
or 7 days). Key to graphs: H ,  control (no addition); [ ] ,  Z-LVG-DMK; EH, Z-FA- 
DMK; H ,  control (0.1% DMSO). The % infectivity (A) and amastigotes/infected PEC 
(B) data are the means ± SD from 3 independent experiments performed in duplicate. 
Graph A: the infection rates after 72 h with either Z-FA-DMK or Z-LVG-DMK were 
not significantly different from the controls; after 7 d the infection rates with the controls 
and Z-LVG-DMK were highly significantly different from Z-FA-DMK (P values <0.01), 
but not from each other. Graph B: mean values after 72 h for amastigotes/infected PEC 
with Z-FA-DMK and Z-LVG-DMK were significantly different from the controls (P 
values o f <0.02 and <0.01, respectively) but not from each other; after 7 d the mean 
values for amastigotes/infected PEC with Z-FA-DMK and Z-LVG-DMK were still 
significantly different from the controls (P values of <0.05 and <0.1, respectively). 
Control (no addition) and control (0.1% DMSO) results were not significantly different 
in A or B.
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cell line % MTT reduction
wild type lesion amastigotes 12 + 0.1
Almcpbn lesion amastigotes ■ 17 + 1.1
wild type axenic amastigotes 23 + 15
Almcpbn axenic amastigotes 51 +21
Table 5.2. Effect o f leucine methyl ester on lines of Leishm ania  m exicana in  vitro. 
After exposure to 5 mM Leu-OMe for one hour, cells were incubated with 450 pg/ml 
MTT for 3 h in order to assess parasite viability. Values are expressed as a % o f the 
control (100%) and are the means ± S.D. from 7 independent experiments for axenic 
amastigotes, and 3 independent experiments for lesion amastigotes. % MTT reduction by 
wild type axenic amastigotes was significantly different from that o f  àimcp/vi axenic 
amastigotes (P<0.05); % MTT reduction by wild type lesion amastigotes was highly 
significantly different from that o f Almcpbn lesion amastigotes (P<0.01),
cell line % infected am astigotes/infected PEC
wild type + ester 0.5 3
wild type control 24 3.5
Almcpbn + ester 0.5 2
Almcpbn control 16 4
Table 5.3. Effect of the amino acid ester leucine methyl ester on lesion amastigote- 
infected macrophages. The ester was added to the macrophages 24 h after they were 
infected (final concentration 5 mM) and was not removed for the duration o f the 
experiment. Results give parasite load at 72 h.
;
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5.4. DISCUSSION
The peptidyl-diazomethane CP inhibitors Z-FA-DMK and Z-LVG-DMK were 
found to have little effect on parasite growth and differentiation axenically in vitro 
(Figs. 5.1-5.3). This was surprising as much o f the evidence presented in Chapter 3 
pointed toward a major role for the CPs in differentiation, either o f promastigotes to 
metacyclics or metacyclics to amastigotes. Indeed transformation events, particularly 
metacyclogenesis and trypomastigote to amastigote differentiation, have been found to 
be the most susceptible to peptidyl-DMKs in the related trypanosomatid T. cruzi (Franke 
de Cazzulo et a l ,  1994, and references therein). However, Z-FA-DMK was found not to 
inhibit metacyclic to amastigote transformation of L  mexicana in vitro (Bates et al., 
1994), in agreement with the results presented in this chapter. The finding that the 
growth o f axenic amastigotes o f wild type parasites, Almcpbn and Almcpbg2.8 were all 
equally, albeit very slightly, inhibited by Z-FA-DMK suggests that the inhibitor's effect 
was not mediated by Imcpb but perhaps another CP that has a role in this stage. It was 
interesting that Almcpbg2.8 axenic amastigotes were slightly inhibited by both DMKs 
whereas wild type were not affected by Z-LVG-DMK; whether or not this relates to 
over-expression o f lmcpbg2.8 remains to be elucidated.
Gelatin-SDS-PAGE analyses o f wild type cells grown with the DMK inhibitors 
revealed that both stationaiy phase promastigotes and axenic amastigotes were lacking 
in high mobility CPs (encoded by Imcpb), but lower mobility proteinases (including 
possible pro-enzymes for the major high mobility CPs) were up-regulated (Fig. 5.4). 
There are several potential explanations for this. Firstly, that these activities are up- 
regulated to compensate for the enzymes that are inhibited. Secondly, that the DMK 
inhibitors interfere with maturation o f the enzymes in vivo resulting in a build up o f  pro­
enzymes which are then activated post-electrophoresis. If, in fact, the inhibited enzymes 
are being compensated for, then this may explain the lack o f an obvious effect o f the 
inhibitors on parasite growth and transformation. It is also possible that these lower 
mobility proteinases are normally degraded in lysates by the high mobility CPs, giving 
rise to an 'apparent' upregulation o f the low mobility proteinases when the high mobility 
proteinases are inhibited.
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The non-inhibition o f these 35-40 kDa enzymes in vivo is similar to findings o f 
other researchers with other peptidyl-diazomethane inliibitors (Pral et a l ,  1993). They 
suggested that in vivo the enzymes are inactivated by endogenous inhibitors, or 
predominantly exist as larger molecular weight precursors. It is also possible, but 
perhaps less likely, that these lower mobility CPs are in a cell compartment impeiwious 
to the diazomethane CP inhibitors tested.
Since different CPs may compensate for one another, we were interested in 
looking for cathepsin L-like CPs in L  mexicana in addition to LmCPa and LmCPb. To 
investigate this, the use o f biotinylated inhibitors to label active CPs (McGinty et a l ,
1993) was attempted. No novel CPs were detected using the biotinylated inhibitor (Fig. 
5.6) which is thought to detect primarily cathepsin L-like CPs, suggesting that any other 
CPs in L. mexicana must be somewhat different from those already characterised. 
However, this method, although fairly sensitive, will only detect enzymes with suitable 
substrate sensitivities and so a definite conclusion regarding the existence o f other CPs 
in L. mexicana cannot be made soley from these results.
Previous studies had shown amastigote growth in macrophages to be hindered by 
antipain and leupeptin (Coombs and Baxter, 1984), although these inhibitors do not 
specifically tai'get CPs. The results in this chapter clearly indicate that specific peptidyl- 
DMK CP inhibitors are active against L. mexicana growing intracellularly in vitro. At 
the same concentration (10 pg/ml) that had little effect on axenic parasite growth and 
differentiation, but abolished all major CP activities, Z-FA-DMK was found to reduce 
the infectivity o f both wild type promastigotes and lesion amastigotes to PECs by 80% 
by day 7 o f  infection (Table 5.1 and Fig. 5.9). This reduced infectivity to PECs is very 
similar to the infectivity level found with Almcpbn promastigotes (Table 5.1). It should 
be emphasised, however, that although Imcpb is almost certainly inhibited during these 
infection experiments, it is not necessarily this inhibition that reduces infectivity; other 
enzymes not yet detected may be the key tai’gets. On the other hand, Z-FA-DMK may be 
less effective against enzymes other than Imcpb such as Imcpc, which is inactive toward 
gelatin. The fact that Z-FA-DMK may have reduced intracellular parasite multiplication 
more than the deletion o f Imcpb appeared to (Table 5.1) also suggests the involvement
158
chapter five  discussion
o f  a crucial CP other than LmCPb as the target o f the inhibition (although this difference 
was found not to be statistically significant). Z-FA-DMK appears to take up to 7 days to 
exert its full effect on the infectivity o f the parasites to PECs; this is in direct contrast to 
the reduction in infectivity resulting from the deletion o f Imcpb, where the cells were 
killed rapidly such that the % infectivity at 24 h was the same as that after 7 days 
(Chapter 3, section 3.3.2.1). As Z-FA-DMK killed the parasites only slowly over 7 days, 
it seems that Z-FA-DMK targets an enzyme involved in the maintenance o f intracellular 
infection/parasite multiplication, rather than initial establisliment o f 
infection/transformation. Further evidence to support this theory is that when Z-FA- 
DMK was administered up to 24 h after infection had been initiated it still reduced 
infectivity levels at day 7 by more than 80% (Fig. 5.7).
The finding that infections initiated using lesion amastigotes were also affected 
by Z-FA-DMK differed from data presented by other researchers (Leao et al.. 1995); 
however, their infections were only maintained for 24 h (as opposed to 72 h and 7 days 
in this study) and as shown by the data presented in this chapter, an effect would not be 
apparent by this time. The finding with amastigotes was surprising considering the 
finding in Chapter 3 that the Imcpb null lesion amastigotes were fully infective to PECs. 
Again this suggests that Imcpb is not the prime target of this inhibitor. Overall the data 
regarding Z-FA-DMK suggest that an important enzyme is being targeted by this 
inhibitor, but it is not Imcpb.
It may be interesting to incubate the infected PECs in the presence of Z-FA- 
DMK for more than 7 days, as % infectivity may well drop to zero if  the experiment was 
left longer. An observation worth noting is that the PECs often appeared more 'spiky' in 
cultures exposed to this DMK - could it be that the DMK causes a change in the PECs 
themselves, which either induces them to kill the parasites, or perhaps starves the 
parasite o f a particular nutrient?
The other CP inhibitors investigated 'P87' and 'K02' were not as potent towards 
the parasitic infections, especially with regards to reducing the number o f amastigotes 
per infected PEC, but there are possible explanations for this such as inhibitor 
instability. Z-FA-DMK appeared to inhibit the CPs (that hydrolyse gelatin) in living
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parasites more folly than did Z-LVG-DMK (Fig. 5.4), and this may be reflected in the 
ability o f Z-FA-DMK to decrease parasite infectivity to PECs more than Z-LVG-DMK. 
It is also possible that the macrophages were able to metabolise Z-LVG-DMK (but not 
Z-FA-DMK), resulting in the lack o f effect. Results with Z-LVG-DMK were, however, 
found to be variable (note the large SDs, Table 5.1), and in several cases appeared to 
have killed the PECs; it was felt that there may be a eritieal level around 10 pg/ml that 
the PECs could not withstand.
Another approach that has been adopted to target leishmanial CPs is by the use 
o f  amino acid esters as pro-drugs that are activated specifically by the parasite enzymes 
(Rabinovitch, 1989). This causes an accumulation o f amino acids, leading to osmotic 
stress and ultimately parasite rupture. In previous studies low molecular weight CPs, 
now known to be the enzymes encoded by Imcpb, had been implicated as being the 
major enzymes activating Leu-OMe (Rabinovitch et a l ,  1986; Rabinovitch, 1989; 
Flunter et a l ,  1992). Purified proteinases rapidly hydrolysed the ester, and this was 
prevented by the use o f the CP inhibitor E-64 (Hunter et a l , 1992). Results presented in 
this ehapter o f  experiments where parasites were exposed to the amino acid ester and 
then their viability assessed by their ability to reduce the tétrazolium salt MTT are not in 
complete agreement with the conclusions that arose from previous experiments. A t the 
same concentration used by previous investigators (Hunter et a l ,  1989; Alfîeri, et a l ,  
1989), 1 found that amastigotes were consistently more resistant (by about 10-fold) to 
the effects o f 5 mM Leu-OMe. Aside from this, the finding that the Imcpb null 
amastigotes were also very susceptible (Tables 5.2 and 5.3) gives strong evidence that 
the Imcpb enzymes are not soley responsible for the hydrolysis o f the ester, although 
they may have greater activity than other enzymes capable o f the hydrolysis and so be 
the major mediators of the toxicity when they are present.
The results of this part o f my study show that CP inhibitors do have potential as 
drugs, but in the case o f L. mexicana these would need to be inhibitors o f enzymes other 
than Imcpb, that is, enzymes which are essential, or inhibitors o f  several enzymes. It has 
been suggested that specific inhibitors may also inhibit any pathological effects o f 
released amastigote proteinases (llg et a l ,  1994). The antileislimanial activity o f these
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inliibitors in vitro is promising, but whether the compounds will prove as efficacious in 
vivo awaits examination.
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C H A PT E R  SIX 
GENERAL DISCUSSION
This project set out with the principal aims o f learning more about the CPs o f T. 
mexicana and thereby identifying which, if  any, were suitable drug targets. Two main 
approaches were adopted in order to elucidate the roles that the different CPs play 
during the life cycle o f L. mexicana. The first was an investigation o f the phenotypes o f 
mutants deficient in specific CP genes, while the second approach utilised novel CP 
inliibitors.
I have analysed the phenotypes o f mutant lines o f L  mexicana lacking genes 
encoding tliree CPs, and in which CP genes have been re-expressed. It would appear 
that the null mutants for the Imcpa CP gene have a ciyptic phenotype under the 
conditions tested. They differed fi-om wild type parasites in that they did not seem to 
form metacyclics o f typical morphology, but still transformed to and grew as 
amastigotes axenically, and infected both macrophages and mice at a rate comparable 
with wild type. Although an exact function for the Imcpa proteinase has not yet been 
demonstrated, it would appear from the infectivity data that LniCPa is not a suitable 
drug target since the enzyme is non-essential in the mammalian host (Souza et al.,
1994).
The main CP activity o f T. cruzi has highest levels in the epiniastigote (insect 
vector) stage (Campetella et al., 1990) suggesting a biological role for cruzipain in the 
insect host. My finding that the highest levels o f LmCPa were not in amastigotes (as 
was previously thought) suggested LmCPa may similarly be involved in the insect 
stage o f the life-eycle. However, more recent studies have shown that the Imcpa null 
mutants can successfully be passaged through sandflies (Bates, unpublished) which 
argues against a crucial role for LmCPa in the sandfly vector.
Mutant promastigotes lacking the Imcpb gene array did not appear to form 
metacyclics in vitro either; however they did not grow well as axenic amastigotes and 
infected both macrophages and mice poorly in comparison with wild type parasites. 
This was also the case for promastigotes transformed from lesion amastigotes. These
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results suggested that imcpb plays a significant role in differentiation to amastigotes 
and survival within macrophages, and should therefore be classed as a virulence factor. 
The data from experiments studying the infectivity o f  Almcpbn to PECs suggested that 
the null mutant promastigotes possibly infect only a subpopulation o f the cells. 
Previous studies have shown that immature macrophages are much more susceptible 
than mature macrophages to T. cruzi infection (Plasman et ah, 1994) and hence it is 
not impossible that a similar scenario occurs with L. mexicana. The finding that 
increasing the parasite:PEC ratio resulted in a higher percentage o f infected cells 
could, however, mean that even when low parasite ratios are used, some PECs may 
phagocytose several parasites at once and simply be unable to kill all o f them. This 
would result in the observed proliferation o f the null mutants in a small percentage of 
cells, but which is not actually a distinct subpopulation.
Further evidence supporting the importance o f the Imcpb genes in infection was 
demonstrated when expression o f an active Imcpb gene {g2.8) in the null mutants for 
Imcpb increased their infectivity to macrophages almost to the level seen with wild 
type parasites. However, the infectivity was not restored when this gene was re­
expressed in the double null. This suggests that perhaps LmCPa does have a role in 
infection, either working synergistically with the Imcpb gene products or in activating 
Imcpb inactive precursor forms (as indeed Imcpb activity was reduced in Almcpan).
In agreement with the findings of Assreuy et al. (1994) (see Chapter 3 
Discussion), other researchers have found that the attacliment o f Leishmania to 
macrophages initiates an oxidative burst within 15 minutes, but no NO production until 
at least 6 h later (Bhunia et ah, 1996). My observations that Almcpbn promastigotes 
were rapidly killed between 4 and 24 h post-internalisation strongly suggested an 
increased susceptibility o f the null mutants to NO. In this study I found that neither 
hydrogen peroxide nor NO had increased leishmanicidal activity towards the Imcpb null 
mutant promastigotes in comparison with wild type parasites. It is worth noting, 
however, that some workers have suggested that the toxic activities o f NO depend in 
part on cooperation with reactive oxygen intermediates (Lin and Chadee, 1992), a 
combination that was not examined in this study. Interestingly, cystatins have been
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found to upregulate NO release from mouse peritoneal macrophages during infection by 
T. cruzi (Verdott et al., 1996), which may possibly indicate a role for the 
dowmegulation o f NO by parasite CPs (although the cystatin inliibitory site was thought 
not to be involved in the mechanism).
The observations o f other researchers have direct relevance to the timing o f the 
infection kinetics o f Almcpbn stationary phase promastigotes to PECs. For example, it 
was recently found that PECs infected with Leishmania amastigotes presented little 
parasite antigens to CD4+ T cells. This was in contrast to promastigote-infected 
macrophages, which did present parasite molecules, with maximal presentation 
occurring within 24 h o f  infection (Kima et al., 1996). Thus, if  Almcpbn promastigotes 
are diminished in their ability to transform sufficiently quickly to amastigotes (as they 
are in vitro) then it is likely fi'om the above findings that the number degraded after 
phagocytosis will be substantial, resulting in a low percentage o f infected cells. It is also 
possible that the null mutants trigger a more potent anti-microbial mechanism since the 
receptors utilised in entry to macrophages are thought to play a pivotal role in the 
pathogenesis o f the disease (Zwilling and Eisenstein, 1994) and in this study 
ultrastructural differences between the surface coats of wild type and Almcpb stationary 
phase promastigotes were shown.
The finding that the Imcpb null mutant promastigotes did still infect cells and 
produce lesions, albeit at a lower rate, suggested that Imcpb was important but not vital 
for infection. However, the discovery that lesion amastigotes o f the Imcpb null mutants 
infected macrophages in vitro to the same extent as wild type lesion amastigotes 
suggested that the major role o f the enzymes was either in catalysing the differentiation 
to amastigotes (at which stage intracellular parasites may be particularly vulnerable) or 
alternatively in the formation o f the metacyclic form, which may result in reduced 
macrophage activation upon phagocytosis or enhanced transformation to amastigotes. 
These findings rather contradicted the accepted opinion that, since the enzyme activity 
is highest in amastigotes, then the enzymes' major role must be in that stage o f the 
parasite, but was supported by evidence that the Imcpb null mutants did not transform 
to and grow as axenic amastigotes efficiently in vitro.
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Results o f the infectivity o f Almcpbn lesion amastigotes to animals were crucial 
to resolving in which stage o f the parasite the Imcpb CPs were most important. If they 
produced lesions as quickly as wild type then it could be concluded that differentiation 
was the most important role; if  not then more likely their role was in circumventing the 
host immune system e.g. in degradation o f MHC class 11 molecules (as reported by 
Leao et al., 1995) or other immune-effector molecules such as cytokines (Finkelman 
and Urban, 1992) which would not be of consequence in in vitro macrophage 
infections.
CPs o f  organisms are reported to degrade host proteins such as immunoglobulins 
(Bontempi and Cazzullo, 1990) and complement factors (Reed et al., 1989). They can 
modulate cytokine activity either directly (Kapur et ah, 1993) or through interaction 
with the plasma proteinase inliibitor a2-macroglobulin (Lamarre et al., 1991). In several 
cases they are suspected to interfere with antigen presentation and processing (Arholdt 
and Seharfstein, 1991, Leao et al., 1995). The discovery that lesion amastigotes o f A 
Imcpbn took some three months longer to produce lesions than this stage of wild type 
parasites indicates that the Imcpb CPs may also be involved in immune evasion, and 
play an important but non-essential role in enabling L. mexicana to survive in the 
mammalian host tested. It is also possible that the Almcpbn lesion amastigotes do invade 
macrophages to the same extent in vivo as they do in vitro, but are reduced in their 
capacity to invade other cell types o f low phagocytic potential such as Langerhan's cells 
and fibroblasts (Blank et al., 1993, and references therein) which could contribute to the 
reduced lesion sizes observed.
It is possible during animal infections that there is selection for Imcpb null 
mutants which have an alternative means o f degradating MHC class II molecules; it may 
be interesting therefore to test whether lesion amastigotes o f Almcpbn can perform this 
degradation, and identify which, if  any, enzymes are upregulated in this form o f the 
parasite. It is also worth considering how important this strategy o f immune evasion is 
to the parasite, since Almcpbn does eventually produce lesions, albeit more slowly. 
Moreover, Leishmania amastigotes are fundamentally resistant to the degradative 
conditions o f the phagolysosome and do not secrete their antigens, which would surely
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result in a basic lack o f parasite antigens for complexing with MHC II and presentation 
at the host eell surface in natural infections. However it is known that many intracellular 
lesion amastigotes lyse, especially in late infections (llg et aL, 1994), which would 
presumably lead to Leishmania antigens being available for inunmie recognition, and 
hence it could be at this stage that MHC II degradation by amastigotes is most 
important.
It has been postulated (McKerrow, 1991) that the CTE o f the Type 1 CPs may be 
involved in the folding o f the nascent proteinase, may function to inhibit the proteinase 
(until the CTE is removed) or, given the reported absence o f mannose-6-phosphate 
targeting signals in T. cruzi and promastigotes o f Leishmania (Cazzulo et aL, 1990), to 
be responsible for intracellulai' targeting o f the enzymes. Our results using immunogold 
labelling o f an enzyme with a truncated CTE (g l)  were in agreement with other studies, 
which revealed that Lpcysl o f L. pifanoi, like Lpcys2, is localised to the flagellar pocket 
and megasomes, suggesting enzyme sorting to the megasome does not require a CTE 
(Duboise et aL, 1994). Further studies on Almcpbn re-expressing different genes o f the 
Imcpb array confirmed that not only do the genes encode isoenzymes with different 
activities, but also that they have different functions. This was clearly demonstrated by 
the failuie o f both g l  and g l8  to restore infectivity to PECs, in direct contrast with 
results obtained using g2.8.
The observation that Almcpbn amastigotes also reside in large PVs typical o f the 
L. mexicana complex strongly argued against the theory that the Type I CPs contribute 
to this phenomenon. Furthermore, a more recent study has shown that polyanionic 
proteophosphoglycan, which is secreted into the PV by intraeellular L. mexicana, is 
highly effective in inducing macrophage vaeuolisation and is therefore implicated in 
causing the expansion o f amastigote-containing PVs (Peters et aL, 1997).
Studies on the cathepsin-B like CP o f L. mexicana using Imcpc null mutants 
revealed that although this CP appeared to play a role in the infection of PECs, it did not 
seem to have as an important role in the infectivity to animals, and in these respects 
differs from the roles o f both the Type 1 and Type II CPs that have been implicated in 
this study. Similarities between Almcpan and Almcpcn, such as a reduction in the Type I
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CP activities and unusual morphology o f stationary phase promastigotes o f both lines, 
indicate that the transfection process may be the cause o f these features, and that 
phenotypic judgements on some criteria should be made with great caution. Cruz et aL, 
(1993) reported the loss o f virulence in some, but not all, transfected clones o f L  major, 
and postulated that this was due to long term culture in vitro. However, other 
researchers have found cell morphology to be unaffected after transfection e.g. HEXBP 
deletion mutants o f L. major were identical to wild type at the light microscope level 
(Webb and McMaster, 1994).
In previous studies, peptidyl-diazomethane inhibitors such as Z-Phe-Ala-DMK 
have been shown to selectively inactivate L. amazonensis amastigote CPs (Alfieri et aL, 
1989, 1991) and metacyclic specific CPs o f L. mexicana (Bates et aL, 1994). In this 
investigation it was found that Z-Phe-Ala-DMK inhibited the Imcpb CPs but did not 
prevent the growth or transformation o f  L. mexicana in vitro. However, mutants lacking 
the Imcpb array were severely impeded in these proeesses. Results from experiments 
using radioiodinated DMK inliibitors suggested rapid de novo synthesis or processing o f 
inactive enzyme precursors in L. amazonenesis (Alfieri et aL, 1991), which may account 
for the lack o f effect on differentiation with inliibitor tr eated parasites. Also the lack o f 
upregulation o f the lowest mobility proteinases (>60 kDa) in Almcpbn in comparison to 
inhibitor-treated wild type parasites may also have a bearing on the differentiation 
process.
Especially promising results were obtained in vitro using Z-Phe-Ala-DMK. This 
inhibitor reduced the infection rates o f wild type parasites to PECs, although the specific 
enzyme(s) targeted was not established. Evidence exists that CPs in B cells and 
macrophages complete the removal o f N terminal li (invariant chain) fragments from 
nascent class 11 molecules, a process which enables antigenic peptide binding within 
MHC compartments before subsequent delivery to the cell surface (Morton et aL, 1995). 
Therefore, in the search for new chemotherapeutic agents, it is important that inhibitors 
are specific for parasite proteinases and do not interfere with mammalian enzymes, 
which could in fact exacerbate infections by interfering with host cell antigen 
presentation.
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In summaiy, studies on the null mutants for the thi'ee CP genes so far detected in 
L. mexicana have revealed that each enzyme type probably has a distinct biological 
function, albeit non-essential. O f the three CP genes, Imcpb would appear to play the 
biggest role in virulence under the conditions tested, a finding which is not surprising 
considering the multicopy existence and high activity o f these CPs. Studies on multiple 
CP null mutants (e.g. AXmcpc/lmcpbn or Almcpa/lmcpb/lmcpcn) may reveal whether or 
not the CPs o f L. mexicana have an essential synergistic role. It is also clear from this 
investigation that aside from their utilisation in drug target validation, mutants lacking 
certain CP genes may have potential as attenuated live vaccines.
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appendix
wild type measurements (pm) dimcpan measurements (pm)
7 . 5 1 0 1 2 . 5 1 0 1 6 . 2 5 1 8 . 7 5
7 . 5 1 0 1 2 . 5 1 0 1 6 . 2 5 1 8 . 7 5
7 . 5 1 0 1 2 . 5 1 0 1 6 . 2 5 1 8 . 7 5
7 . 5 1 0 1 2 . 5 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
7 . 5 1 0 1 2 . 5 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
7 . 5 1 0 1 2 . 5 1 1 . 2 5 1 6 . 2 5 2 0
7 . 5 1 0 1 2 . 5 1 2 . 5 1 6 . 2 5 2 0
8 . 7 5 1 0 1 2 . 5 1 2 . 5 1 6 . 2 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 2 . 5 1 6 . 2 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 2 . 5 1 6 . 2 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 2 . 5 1 6 . 2 5 2 0
8 . 7 5 1 0 1 3 - 7 5 1 2 . 5 1 6 . 2 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 0
8 . 7 5 1 0 1 5 1 3 . 7 5 1 7 . 5 2 0
8 . 7 5 1 0 1 5 1 3 . 7 5 1 7 . 5 2 0
8 . 7 5 1 1 . 2 5 1 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 3 . 7 5 1 7 . 5 ■ 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 7 . 5 2 2 . 5
8 . 7 5 1 1 . 2 5 1 6 . 2 5 1 5 1 7 . 5 2 2 . 5
8 . 7 5 1 1 . 2 5 1 7 . 5 1 5 1 7 . 5 2 2 . 5
8 . 7 5 1 1 . 2 5 1 7 . 5 1 5 1 7 . 5 2 2 . 5
1 0 1 1 . 2 5 1 8 . 7 5 1 5 1 8 , 7 5 2 2 . 5
1 0 1 1 . 2 5 1 8 . 7 5 1 5 1 8 . 7 5 2 3 . 7 5
1 0 1 1 . 2 5 1 8 . 7 5 1 5 1 8 . 7 5 2 3 . 7 5
1 0 1 1 . 2 5 1 5 1 8 . 7 5
1 0 1 1 . 2 5 1 5 1 8 . 7 5
1 0 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
1 0 1 2 . 5 1 6 . 2 5 1 8 . 7 5
1 0 1 2 . 5 1 6 . 2 5 1 8 . 7 5
length ( p m ) wild type dimcpan
7 . 5 7 0
8 . 7 5 2 0 0
1 0 2 4 3
1 1 . 2 5 1 7 3
1 2 . 5 1 0 6
1 3 . 7 5 7 1 0
1 5 9 1 0
1 6 . 2 5 1 1 5
1 7 . 5 2 1 5
1 8 . 7 5 3 1 3
2 0 0 1 2
2 1 . 2 5 0 6
2 2 . 5 0 5
2 3 . 7 5 0 2
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Fig. 2.2. (cont)
wild type length dimcpan length
M e a n 1 1 . 2 1 2 5  M e a n 1 7 . 0 3 7 5
S t a n d a r d  E 0 . 2 6 9 7 1 2  S t a n d a r d  E 0 . 3 2 1 6
M e d i a n 1 0  M e d i a n 1 7 . 5
M o d e 1 0  M o d e 1 6 . 2 5
S t a n d a r d  C 2 . 6 9 7 1 2 1  S t a n d a r d  C 3 . 2 1 5 9 9 8
V a r i a n c e 7 . 2 7 4 4 6 3  V a r i a n c e 1 0 . 3 4 2 6 5
K u r t o s i s 0 . 5 0 5 1 3 5  K u r t o s i s - 0 . 4 7 9 3 1
S k e w n e s s 0 . 9 6 2 9 2 9  S k e w n e s s - 0 . 1 2 0 1 6
R a n g e 1 1 . 2 5  R a n g e 1 3 . 7 5
M i n i m u m 7 . 5  M i n i m u m 1 0
M a x i m u m 1 8 , 7 5  M a x i m u m 2 3 . 7 5
S u m 1 1 2 1 . 2 5  S u m 1 7 0 3 . 7 5
C o u n t 1 0 0  C o u n t 1 0 0
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
wild type dimcpan
M e a n 1 1 . 2 1 2 5 1 7 . 0 3 7 5
V a r i a n c e 7 . 2 7 4 4 6 3 1 0 . 3 4 2 6 5
O b s e r v a t i o 1 0 0 1 0 0
d f 9 9 9 9
F 1 . 4 2 1 7 7 4
P ( F < = f )  o n 0 . 0 4 0 7 6 9
F  C r i t i c a l  o 1 . 2 9 5 1 3
z - T e s t ;  T w o - S a m o i e  f o r  M e a n s
wild type dimcpan
M e a n 1 1 . 2 1 2 5 1 7 . 0 3 7 5
K n o w n  V a r 7 . 3 1 0 . 3
O b s e r v a t i o 1 0 0 1 0 0
H y p o t h e s i z 0
z 1 3 . 8 8 4 8 S i n c e  z >  t h e  c r i t i c a l  v a l u e  o f
P ( Z < = z )  o r 0 2 . 5 8  a t  P = 0 . 0 1  t h e  d i f f e r e n c e
z  C r i t i c a l  01 2 . 5 7 5 8 3 5 i s  h i g h l y  s i g n i f i c a n t .
P ( Z < = z )  t w 0
z  C r i t i c a l  t v 2 . 3 2 6 3 4 2
z  C r i t i c a l  t v 1 . 6 4 4 8 5 3
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wild type measurements (pm) SP1 dlmcpbn measurements (pm) SP1
7 . 5 1 0 1 2 . 5 1 0 1 6 . 2 5 2 0
7 . 5 1 0 1 2 . 5 1 0 1 6 . 2 5 2 0
7 . 5 1 0 1 2 . 5 1 0 1 6 . 2 5 2 0
7 . 5 1 0 1 2 . 5 1 1 . 2 5 1 6 . 2 5 2 0
7 . 5 1 0 1 2 . 5 1 1 . 2 5 1 7 . 5 2 0
7 . 5 1 0 1 2 . 5 1 2 . 5 1 7 . 5 2 0
7 . 5 1 0 1 2 . 5 1 2 . 5 1 7 . 5 2 0
8 . 7 5 1 0 1 2 . 5 1 2 . 5 1 7 . 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 2 . 5 1 7 . 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 0
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 , 5 2 1 . 2 5
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 0 1 3 . 7 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 0 1 5 1 3 . 7 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 0 1 5 1 3 . 7 5 1 7 . 5 2 1 , 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 7 . 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 8 . 7 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 8 . 7 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 8 . 7 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 8 . 7 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 5 1 5 1 8 . 7 5 2 1 . 2 5
8 . 7 5 1 1 . 2 5 1 6 . 2 5 1 5 1 8 . 7 5 2 2 . 5
8 . 7 5 1 1 . 2 5 1 7 . 5 1 6 . 2 5 1 8 . 7 5 2 2 . 5
8 . 7 5 1 1 . 2 5 1 7 . 5 1 6 . 2 5 1 8 . 7 5 2 2 . 5
1 0 1 1 . 2 5 1 8 . 7 5 1 6 . 2 5 1 8 . 7 5 2 3 . 7 5
1 0 1 1 . 2 5 1 8 . 7 5 1 6 . 2 5 1 8 . 7 5 2 3 . 7 5
1 0 1 1 . 2 5 1 8 . 7 5 1 6 . 2 5 1 8 . 7 5 2 3 . 7 5
1 0 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
1 0 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
1 0 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
1 0 1 2 . 5 1 6 . 2 5 2 0
1 0 1 2 . 5 1 6 . 2 5 2 0
l e n g t h  ( p m ) w i l d  t y p e dlmcpbn
7 . 5 7 0
8 . 7 5 2 0 0
1 0 2 4 3
1 1 . 2 5 1 7 2
1 2 . 5 1 0 4
1 3 . 7 5 7 8
1 5 9 8
1 6 . 2 5 1 1 4
1 7 . 5 2 1 5
1 8 . 7 5 3 1 4
2 0 0 1 2
2 1 . 2 5 0 1 4
2 2 . 5 0 3
2 3 . 7 5 0 3
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Fig. 3.5. A (cont)
wild type length dlmcpbn length
M e a n 1 1 . 2 1 2 5  M e a n 1 7 . 6 1 2 5
S t a n d a r d  E 0 . 2 6 9 7 1 2  S t a n d a r d  E 0 . 3 2 0 3 4 1
M e d i a n 1 0  M e d i a n 1 7 . 5
M o d e 1 0  M o d e 1 7 . 5
S t a n d a r d  C 2 . 6 9 7 1 2 1  S t a n d a r d  C 3 . 2 0 3 4 1
V a r i a n c e 7 . 2 7 4 4 6 3  V a r i a n c e 1 0 . 2 6 1 8 4
K u r t o s i s 0 . 5 0 5 1 3 5  K u r t o s i s - 0 . 3 2 9 2 3
S k e w n e s s 0 . 9 6 2 9 2 9  S k e w n e s s - 0 . 3 4 8 2 2
R a n g e 1 1 . 2 5  R a n g e 1 3 . 7 5
M i n i m u m 7 . 5  M i n i m u m 1 0
M a x i m u m 1 8 . 7 5  M a x i m u m 2 3 . 7 5
S u m 1 1 2 1 . 2 5  S u m 1 7 6 1 . 2 5
C o u n t 1 0 0  C o u n t 1 0 0
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
wild type dlmcpbn
M e a n 1 1 . 2 1 2 5 1 7 . 6 1 2 5
V a r i a n c e 7 . 2 7 4 4 6 3 1 0 . 2 6 1 8 4
O b s e r v a t i o 1 0 0 1 0 0
d f 9 9 9 9
F 1 . 4 1 0 6 6 6
P ( F < = f )  o n 0 . 0 4 4 2 6 6
F  C r i t i c a l  o 1 . 2 9 5 1 3
z - T e s t :  T w o - S a m o l e  f o r  M e a n s
wild type dlmcpbn
M e a n 1 1 . 2 1 2 5 1 7 . 6 1 2 5
K n o w n  V a r 7 . 3 1 0 . 3
O b s e r v a t i o 1 0 0 1 0 0
H y p o t h e s i z 0
z 1 5 . 2 5 5 4 S i n c e  z  g r e a t l y  e x c e e d s  t h e
P ( Z < = z )  o r 0 c r i t i c a l  v a l u e  o f  2 . 5 8  a t  P - 0 . 0 1
z  C r i t i c a l  o t 2 . 5 7 5 8 3 5 t h e  d i f f e r e n c e  i s  h i g h l y  s i g n i f i c a n t .
P ( Z < “ z )  t w 0
z  C r i t i c a l  t v 2 . 3 2 6 3 4 2
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wild type measurements (pm) SP7 dlmcpbn measurements (pm) SP7
7 . 5 1 1 . 2 5 1 3 . 7 5 8 . 7 5 1 5 1 7 . 5
7 . 5 1 1 . 2 5 1 3 . 7 5 1 0 1 5 1 7 , 5
7 . 5 1 1 . 2 5 1 3 . 7 5 1 0 1 5 1 7 . 5
7 . 5 1 1 . 2 5 1 3 . 7 5 1 0 1 5 1 7 . 5
7 . 5 1 1 . 2 5 1 3 . 7 5 1 0 1 5 1 8 . 7 5
7 . 5 1 1 . 2 5 1 3 . 7 5 1 1 . 2 5 1 5 1 8 . 7 5
7 . 5 1 1 . 2 5 1 3 . 7 5 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 1 . 2 5 1 5 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 1 . 2 5 1 5 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 1 . 2 5 1 5 1 1 . 2 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 1 . 2 5 1 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 2 . 5 1 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 2 . 5 1 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 2 , 5 1 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 2 . 5 1 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
8 . 7 5 1 2 . 5 1 6 . 2 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
1 0 1 2 . 5 1 6 . 2 5 1 2 . 5 1 6 . 2 5 1 8 . 7 5
1 0 1 2 . 5 1 6 . 2 5 1 3 . 7 5 1 6 . 2 5 1 8 . 7 5
1 0 1 2 . 5 1 6 . 2 5 1 3 . 7 5 1 6 . 2 5 2 0
1 0 1 2 . 5 1 7 . 5 1 3 . 7 5 1 6 . 2 5 2 0
1 0 1 2 . 5 1 7 . 5 1 3 . 7 5 1 6 . 2 5 2 0
1 0 1 2 . 5 1 7 . 5 1 3 . 7 5 1 6 . 2 5 2 0
1 0 1 2 . 5 1 8 . 7 5 1 3 . 7 5 1 6 . 2 5 2 0
1 0 1 2 . 5 1 8 . 7 5 1 3 . 7 5 1 7 . 5 2 0
1 0 1 2 . 5 1 8 . 7 5 1 3 . 7 5 1 7 . 5 2 0
1 0 1 2 . 5 1 8 . 7 5 1 3 . 7 5 1 7 . 5 2 0
1 0 1 2 . 5 1 8 , 7 5 1 5 1 7 . 5 2 0
1 0 1 2 . 5 2 0 1 5 1 7 . 5 2 0
1 0 1 2 . 5 2 1 . 2 5 1 5 1 7 . 5 2 1 . 2 5
1 0 1 2 . 5 2 3 . 7 5 1 5 1 7 . 5 2 1 . 2 5
1 0 1 2 . 5 1 5 1 7 . 5
1 0 1 2 . 5 1 5 1 7 . 5
1 0 1 3 . 7 5 1 5 1 7 . 5
1 1 . 2 5 1 3 . 7 5 1 5 1 7 . 5
1 1 . 2 5 1 3 . 7 5 1 5 1 7 . 5
length (pm) wild type dlmcpbn
7 . 5 7 0
8 . 7 5 9 1
1 0 1 7 4
1 1 . 2 5 1 3 5
1 2 . 5 2 1 7
1 3 . 7 5 1 0 9
1 5 8 1 5
1 6 . 2 5 4 1 7
1 7 . 5 3 1 6
1 8 . 7 5 5 1 4
2 0 1 1 0
2 1 . 2 5 1 2
2 2 . 5 0 0
2 3 . 7 5 1 0
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Fig. 3.5. B (cont)
wild type length dlmcpbn length
M e a n 1 2 . 4 3 7 5  M e a n 1 6 . 0 2 5
S t a n d a r d  E 0 . 3 3 0 1 8 2  S t a n d a r d  E 0 . 2 8 6 6 8 9
M e d i a n 1 2 . 5  M e d i a n 1 6 . 2 5
M o d e 1 2 . 5  M o d e 1 6 . 2 5
S t a n d a r d  C 3 . 3 0 1 8 1 6  S t a n d a r d  C 2 . 8 6 6 8 9 1
V a r i a n c e 1 0 . 9 0 1 9 9  V a r i a n c e 8 . 2 1 9 0 6 6
K u r t o s i s 0 . 8 1 3 0 6 4  K u r t o s i s - 0 . 4 1 6 9 6
S k e w n e s s 0 . 8 6 7 1 9 5  S k e w n e s s - 0 . 4 3 0 7 7
R a n g e 1 6 . 2 5  R a n g e 1 2 . 5
M i n i m u m 7 , 5  M i n i m u m 8 . 7 5
M a x i m u m 2 3 . 7 5  M a x i m u m 2 1 . 2 5
S u m 1 2 4 3 . 7 5  S u m 1 6 0 2 . 5
C o u n t 1 0 0  C o u n t 1 0 0
F - T e s t :  T w o - S a m o l e  f o r  V a r i a n c e s
M e a n
V a r i a n c e
O b s e r v a t i o
d f
F
P ( F < = f )  o n  
F  C r i t i c a l  o
wild type
1 2 . 4 3 7 5
1 0 . 9 0 1 9 9
100
9 9
1 . 3 2 6 4 2 7
0 . 0 8 0 8 3 1
1 . 3 9 4 0 6 2
dlmcpbn
1 6 . 0 2 5
8 . 2 1 9 0 6 6
100
9 9
Z - T e s t :  T w o - S a m p l e  f o r  M e a n s  
wild type dlmcpbn
M e a n 1 2 . 4 3 7 5 1 6 . 0 2 5
K n o w n  V a r 1 0 . 9 8 . 2
O b s e r v a t i o 1 0 0 1 0 0
H y p o t h e s i z 0
z 8 . 2 0 8 7 1 6 S i n c e  z  e x c e e d s  t h e
P ( Z < = z )  o r 5 . 5 5 E - 1 7 c r i t i c a l  v a l u e  o f  2 . 5 8  a t  P = 0 . 0 1
z  C r i t i c a l  01 2 . 5 7 5 8 3 5 t h e  d i f f e r e n c e  i s  h i g h l y  s i g n i f i c a n t .
P ( Z < = z )  t w 1 . 1 1 E - 1 6
z  C r i t i c a l  t v 2 . 3 2 6 3 4 2
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Table 3.2. A
% infected
w i l d  t v o e dImcDbn 1fmcDba2.8
3 3 1 4 2 9
4 4 5 3 8
5 8 1 0 4 2
4 7 7 . 5 5 1
4 6  ±  1 0 9 . 2  ±  1 0 4 0  ±  9 . 0
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
w i l d  t y p e dlmcpbn w i l d  t y p e  dlmcpbn
M e a n 4 5 . 5 9 . 1 2 5 M e a n 4 5 . 5  9 . 1 2 5
V a r i a n c e 1 0 5 , 6 6 6 7 1 4 . 7 2 9 1 7 V a r i a n c e 1 0 5 . 6 6 6 7  1 4 . 7 2 9 1 7
O b s e r v a t i c 4 4 O b s e r v a t i c 4  4
d f 3 3 P o o l e d  V a i 6 0 . 1 9 7 9 2
F 7 . 1 7 3 9 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 6 9 9 1 6 d f 6
F  C r i t i c a l  0 9 . 2 7 6 6 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
6 . 6 3 0 2 1  s i n c e  t > 3 . 7 0 7  t h e r e  i s  a  h i g h l y  
0 . 0 0 0 2 8 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1  
1 . 9 4 3 1 8 1  
0 , 0 0 0 5 6 8  
2 . 4 4 6 9 1 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
w i l d  t y p e  tmcpbg2.8
t - T  e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
w i l d  t y p e  Imcpbg2.8
M e a n 4 5 . 5 4 0 M e a n 4 5 . 5  4 0
V a r i a n c e 1 0 5 . 6 6 6 7 8 3 . 3 3 3 3 3 V a r i a n c e 1 0 5 . 6 6 6 7  8 3 . 3 3 3 3 3
O b s e r v a t i c 4 4 O b s e r v a t i c 4  4
d f 3 3 P o o l e d  V a i 9 4 . 5
F 1 . 2 6 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 2 4 9 4 9 d f 6
F  C r i t i c a l  o 9 . 2 7 6 6 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
0 . 8 0 0 1 3 2  n o  s i g n i f i c a n t  d i f f e r e n c e  
0 . 2 2 7 0 7  
1 . 9 4 3 1 8 1  
0 . 4 5 4 1 3 9  
2 . 4 4 6 9 1 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
d l m c p b n  Imcpbg2.8
t - T  e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
d l m c p b n  Imcpbg2.8
M e a n 9 . 1 2 5 4 0 M e a n 9 . 1 2 5  4 0
V a r i a n c e 1 4 . 7 2 9 1 7 8 3 . 3 3 3 3 3 V a r i a n c e 1 4 . 7 2 9 1 7  8 3 . 3 3 3 3 3
O b s e r v a t i c 4 4 O b s e r v a t i c 4  4
d f 3 3 P o o l e d  V a i 4 9 . 0 3 1 2 5
F 5 . 6 5 7 7 0 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 9 4 2 4 4 d f 6
F  C r i t i c a l  o 5 . 3 9 0 7 7 4 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
6 . 2 3 5 7 0 4  s i n c e  t > 3 . 7 0 7  t h e r e  i s  a  h i g h l y
0 , 0 0 0 3 9 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
1 . 9 4 3 1 8 1
0 . 0 0 0 7 8 7
2 . 4 4 6 9 1 4
2 1 0
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Table 3.2. A (cont)
amastigotes/PEC
w i l d  t y p e  
4
3 . 9
3 . 7
3 . 6
dlmcpbn dlmcDba2.8
2 . 4  
1.8
3 . 4  
2.8
3 . 4
3 . 1
3 . 3
3
3 . 8  ± 0 . 2  2 . 6  ±  0 . 7  3 . 2  ±  0 . 2
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
w i l d  t y p e dlmcpbn w i l d  t y p e  dlmcpbn
M e a n 3 . 8 2 . 6 M e a n 3 . 8  2 . 6
V a r i a n c e 0 . 0 3 3 3 3 3 0 . 4 5 3 3 3 3 V a r i a n c e 0 . 0 3 3 3 3 3  0 . 4 5 3 3 3 3
O b s e r v a t i c 4 4 O b s e r v a t i c 4  4
d f 3 3 P o o l e d  V a i 0 . 2 4 3 3 3 3
F 1 3 . 6 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 2 9 7 9 8 d f 6
F  C r i t i c a l  o 5 . 3 9 0 7 7 4 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
3 . 4 4 0 2 9 3  s i n c e  t > 3 . 1 4  t h e r e  i s  a
0 . 0 0 6 8 9 8  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 2
1 . 9 4 3 1 8 1
0 . 0 1 3 7 9 6
2 . 4 4 6 9 1 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
w i l d  t y p e  tmcpbg2.8
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
w i l d  t y p e  Imcpbg2.8
M e a n 3 . 8 3 . 2 M e a n 3 . 8  3 . 2
V a r i a n c e 0 . 0 3 3 3 3 3 0 . 0 3 3 3 3 3 V a r i a n c e 0 . 0 3 3 3 3 3  0 . 0 3 3 3 3 3
O b s e r v a t i c 4 4 O b s e r v a t i c 4  4
d f 3 3 P o o l e d  V a t 0 . 0 3 3 3 3 3
F 1 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 5 d f 6
F  C r i t i c a l  o 9 . 2 7 6 6 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
4 . 6 4 7 5 8  s i n c e  t > 3 . 7 0 7  t h e r e  i s  a  h i g h l y  
0 . 0 0 1 7 5 6  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1  
1 . 9 4 3 1 8 1  
0 . 0 0 3 5 1 3  
2 . 4 4 6 9 1 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
d l m c p b n  Imcpbg2.8 d l m c p b n  Imcpbg2.8
M e a n 2 . 6 3 . 2 M e a n 2 . 6  3 . 2
V a r i a n c e 0 . 4 5 3 3 3 3 0 . 0 3 3 3 3 3 V a r i a n c e 0 . 4 5 3 3 3 3  0 . 0 3 3 3 3 3
O b s e r v a t i c 4 4 O b s e r v a t i c 4  4
d f 3 3 P o o l e d  V a i 0 . 2 4 3 3 3 3
F 1 3 . 6 H y p o t h e s i z 0
P { F < = f )  o n 0 . 0 2 9 7 9 8 d f 6
F  C r i t i c a l  o 9 . 2 7 6 6 1 9 t
P { T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
1 . 7 2 0 1 4 7  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 0 6 8 0 9 8
1 . 9 4 3 1 8 1
0 . 1 3 6 1 9 7
2 . 4 4 6 9 1 4
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Table 3.2. B % infected
dlmcpbn
wild tvoe dimcDbBL dlmcpbn /dimcpan dlmcDbn/dlmcpaa2.,
59.6 46 4.5 5.6 3.3
41 42 2.4 1.8 3.1
47.4 66
62
2.8 2.5 0.9
50 ± 9.4 54 ± 10 3.2 ± 1.1 3.3 ±2 2.4 ±1.3
F-Test: Two-Sampie for Variances t-Test: Two-Sample Assuming Equal Variances 
wild type dImcpbBL
Mean 49.33333 54 Mean 49.33333 54
Variance 89.29333 138.6667 Variance 89,29333 138.6667
Observatic 3 4 Observatic 3 4
df 2 3 Pooled Va 118.9173
F 1.552934 Hypothesis 0
P(F<=f)on 0.414783 df 5
F Critical c 9.161795 t 0.560307 no significant difference
P{T<=t) on 0.299723
t Critical 01 2.015049
P(T<=t) tw 0.599445
t Critical tv 2.570578
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
wild type dlmcpbn wild type dlmcpbn
Mean 49.33333 3.233333 Mean 49.33333 3.233333
Variance 89.29333 1.243333 Variance 89.29333 1.243333
Observatic 3 3 Observatic 3 3
df 2 2 Pooled Va 45.26833
F 71.81769 Hypothesiz 0
P(F<=f)on 0.013733 df 4
F Critical c 19.00003 t 8.391687 since t>4.604 there is a highly
P(T<=t) on 0.000552 significant difference at P=0.01
t Critical oi 2.131846
P{T<=t) tw 0.001103
t Critical tv 2.776451
F-Test; Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dlmcpbn dimcpbn/dlmcpan dlmcpbn dimcpbn/dlmcpan
Mean 3.233333 3.3 Mean 3.233333 3,3
Variance 1.243333 4.09 Variance 1.243333 4,09
Observatic 3 3 Observatic 3 3
df 2 2 Pooled Va 2.666667
F 3.289544 Hypothesiz 0
P(F<=f) on 0.233125 df 4
F Critical c 9.000019 t 0.05 no significant difference
P(T<=t) on 0.48126
t Critical 01 2.131846
P(T<=t) tw 0.96252
t Critical tv 2.776451
F-Test: Two-Sample for Variances t-Test; Two-Sample Assuming Equal Variances
dimcpbn/dlmcpan dlmcpbn/dlmcpag2.8 dimcpbn/dlmcpan dlmcpbn/dlmcpag2.8
Mean 3.3 2.433333
Variance 4.09 1.773333
Obsen/atic 3 3
df 2 2
F 2.306391
P{F<=f)on 0.302445 
F Critical c 19.00003
Mean 
Variance 
Observatic 
Pooled Va 
Hypothesis 
df 
t
P(T<=t)cn 0.284438 
t Critical 01 2.131846 
P(T<=t) tw 0.568876 
t Critical tv 2.776451
3.3 2.433333 
4.09 1.773333
3 3 
2.931667
0
4
0.619927 no significant difference
2 1 2
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Table 3.2. B (cont) amastigotes/PEC
dlmcpbn
wild tvoe dlmcobBL dlmcobn /dlmcoan dlmcobn/dlmcpaa2.8
3.5 4,6 1.6 2.75 2.1
3.6 5 3 3.2 1.7
5.3 5.2 3.5 1.8 3
5.8
4.1 ±1 5,3 ±1 2.7 ±0.9 2.6 ± 0.7 2.3 ± 0.7
F-Test; Two-Sample for Variances t-Test: Two-Sampie Assuming Equal Variances
wild type dImcpbBL wild type dImcpbBL
Mean 4.133333 5.15 Mean 4.133333 5.15
Variance 1.023333 0.25 Variance 1.023333 0.25
Observatic 3 4 Observatic 3 4
df 2 3 Pooled Va 0.559333
F 4.093333 Hypothesiz 0
P(F<=f)on 0.138877 df 5
F Critical c 9.552082 t 1.779856 no significant difference
P(T<=t) on 0,06761
t Critical 01 2.015049
P{T<=t) tw 0,13522
t Critical tv 2,570578
F-Test; Two-Sample for Variances t-Test: Two-Sampie Assuming Equal Variances
wild type dlmcpbn wild type dlmcpbn
Mean 4.133333 2.7 Mean 4.133333 2.7
Variance 1.023333 0,97 Variance 1.023333 0.97
Observatic 3 3 Observatic 3 3
df 2 2 Pooled Va 0.996667
F 1.054983 Hypothesiz 0
P(F<=f) on 0.486622 df 4
F Critical c 19.00003 t 1,758401 no significant difference
P(T<=t) on 0,076752
t Critical oi 2.131846
P(T<=t) tw 0.153503
t Critical tv 2.776451
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dlmcpbn dimcpbn/dlmcpan dlmcpbn dimcpbn/dlmcpan
Mean 2.7 2.583333 Mean 2.7 2.583333
Variance 0.97 0.510833 Variance 0.97 0.510833
Observatic 3 3 Observatic 3 3
df 2 2 Pooled Va 0.740417
F 1.898858 Hypothesiz 0
P(F<=f)on 0.344963 df 4
F Critical c 19.00003 t 0.166056 no significant difference
P(T<=t) on 0.438084
t Critical or 2.131846
P(T<=t) tw 0.876168
t Critical tv 2.776451
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dimcpbn/dlmcpan dlmcpbn/dlmcpag2.8 dimcpbn/dlmcpan dlmcpbn/dlmcpag2.8
Mean 2.583333 2.266667 Mean 2.583333 2.266667
Variance 0.510833 0.443333 Variance 0.510833 0.443333
Observatic 3 3 Observatic 3 3
df 2 2 Pooled Va 0.477083
F 1.152256 Hypothesiz 0
P(F<=f)on 0.464629 df 4
F Critical c 19.00003 t 0.561501 no significant difference
P(T<=t) on 0.302212
t Critical oi 2.131846
P(T<-t) tw 0.604424
t Critical tv 2.776451
2 1 3
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Table 3.2. C % infected
wild tvoe dlmcoan dlmcobBL dlmcobn dimcob/dl
28 27 46 1.6 0,4
39 30 42 1.6 4.2
30 40 39 1.9 4.8
46 50 30 1.2 1.9
36 ± 8.3 36 ± 10 39 ±6.8 1.6 ±0.3 2.8 ± 2
F-Test; Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances 
wild type dimcpan
Mean 38.33333 36.75 Mean 35.75 36.75
Variance 64.33333 108.9167 Variance 69.58333 108.9167
Observatic 3 4 Observatic 4 4
df 2 3 Pooled Va 89.25
F 1.693005 Hypothesiz 0
P(F<=f) on 0.392271 df 6
F Critical c 9.161795 t 0.149696 no significant difference
P(T<=t) on 0.442955
t Critical or 1.943181
P(T<=t) tw 0.885909
t Critical tv 2.446914
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dimcpan dImcpbBL dimcpan dImcpbBL
Mean 36.75 39.25 Mean 36.75 39.25
Variance 108.9167 46.25 Variance 108.9167 46.25
Observatic 4 4 Observatic 4 4
df 3 3 Pooled Va 77.58333
F 2.354955 Hypothesiz 0
P(F<=f) on 0.250062 df 6
F Critical c 9.276619 t 0,401394 no significant difference
P(T<=t) on 0.351018
t Critical or 1.943181
P(T<=t) tw 0,702035
t Critical tv 2.446914
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dImcpbBL dlmcpbn dImcpbBL dlmcpbn
Mean 39.25 1.575 Mean 39.25 1.575
Variance 46.25 0.0825 Variance 46.25 0.0825
Observatic 4 4 Observatic 4 4
df 3 3 Pooled Va 23.16625
F 560.6061 Hypothesiz 0
P(F<=f) on 0.000127 df 6
F Critical c 9.276619 t 11.06982 since t>3.707 there is a highly
P(T<=t) on 1.62E-05 significant difference at P=0,01
t Critical or 1.943181
P{T<=t) tw 3.24E-05
t Critical tv 2.446914
F-Test; Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dlmcpbn dimcpbn/dlmcpan dlmcpbn dimcpbn/dlmcpan
Mean 
Variance 
Observatic 4
df 3
F 50.61616
P(F<=f)on 0.004551 
F Critical c 5.390774
1,575 2.825 
0.0825 4.175833
Mean 
Variance 
Observatic 
Pooled Va 
Hypothesiz 
df 
t
P(T<=t)on 0.135626 
t Critical oi 
P(T<=t) tw 
t Critical tv
1.575 2.825 
0.0825 4.175833 
44
2.129167
0
6
1.211491 no significant difference
1.943181
0.271251
2.446914
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Table 3.2, C (cont) amastigotes/PEC
wild ty p e
5.1 
6
3.1
4.3
dimcpan
5.6
5.1
3
4
dlmcobBL
6.3 
5.1
3
3.4
dlmcobn
2
1.7
1.3
1.5
dlmcob/dlmcoan
0
2
2.6
4.4
4.6 ±1.3 4.4 ±1.2  4.5 ±1.6 1.6 ±0.3 2.2 ±1.8
F-Test: Two-Sample for Variances 
wild type dimcpan
t-Test: Two-Sample Assuming Equal Variances 
________ wild type dimcpan
Mean 4.625 4.425 Mean 4.625 4.425
Variance 1.515833 1.349167 Variance 1.515833 1.349167
Observatic 4 4 Observatic 4 4
df 3 3 Pooled Va 1.4325
F 1.123533 Hypothesiz 0
P(F<=f)on 0.462987 df 6
F Critical c 9.276619 t 0.236318 no significant difference
P(T<=t) on 0.410523
t Critical ot 1.943181
P(T<-t) tw 0.821046
t Critical tv 2.446914
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dimcpan dImcpbBL dimcpan dImcpbBL
Mean 4.425 4.45 Mean 4.425 4.45
Variance 1.349167 2.35 Variance 1.349167 2.35
Observatic 4 4 Observatic 4 4
df 3 3 Pooled Va 1.849583
F 1.741816 Hypothesiz 0
P(F<=f) on 0.329883 df 6
F Critical c 5.390774 t 0.025997 no significant difference
P{T<=t) on 0.490052
t Critical oi 1.943181
P(T<=t) tw 0.980103
t Critical tv 2.446914
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dImcpbBL dlmcpbn dImcpbBL dlmcpbn
Mean 4.45 1.625 Mean 4.45 1.625
Variance 2.35 0.089167 Variance 2.35 0.089167
Observatic 4 4 Observatic 4 4
df 3 3 Pooled Va 1.219583
F 26.35514 Hypothesiz 0
P{F<=f)on 0.011735 df 6
F Critical c 9.276619 t 3.61766 since t>3.14 there is a
P(T<=t) on 0.005564 significant difference at P=0,02
t Critical ot 1.943181
P ( T < = t )  t w 0.011128
t Critical tv 2.446914
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dimcpbn/dlmcpan dlmcpbn dimcpbn/dlmcpan dlmcpbn
Mean 2.25 1.625 Mean 2.25 1.625
Variance 3,29 0.089167 Variance 3.29 0,089167
Observatic 4 4 Observatic 4 4
df 3 3 Pooled Va 1.689583
F 36.8972 Hypothesiz 0
P(F<=f)on 0.007219 df 6
F Critical c 9.276619 t 0.679994 no significant difference
P(T<=t) on 0.260933
t Critical or 1.943181
P(T<=t) tw 0.521866
t Critical tv 2.446914
2 1 5
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Table 3.3. 
wild type
gotes/ vacuole vacuole size/zuole size (pm) amastigote (pm)
1 5 5
2 7 . 5 3 . 7 5
2 1 0 5
2 1 0 5
2 1 1 . 2 5 5 , 6 2 5
2 1 2 . 5 6 . 2 5
2 1 2 . 5 6 . 2 5
2 1 3 . 7 5 no. amastlgotes 6 . 8 7 5
2 1 3 . 7 5 6 . 8 7 5
2 1 7 . 5 Mean 4 . 9 8 . 7 5
3 1 1 . 2 5 S t a n d a r d  E 0 . 3 4 0 7 6 7 3 . 7 5
3 1 5 M e d i a n 4 5
3 2 6 . 2 5 M o d e 4 8 . 7 5
4 1 0 Standard C 2 . 4 0 9 5 9 2 . 5
4 1 1 . 2 5 V a r i a n c e 5 . 8 0 6 1 2 2 2 . 8 1 2 5
4 1 1 . 2 5 K u r t o s i s 0 . 3 2 3 3 3 3 2 . 8 1 2 5
4 1 3 . 7 5 S k e w n e s s 0 . 7 2 3 8 9 4 3 . 4 3 7 5
4 1 3 . 7 5 R a n g e 1 1 3 . 4 3 7 5 vac. size/amastigote
4 1 5 M i n i m u m 1 3 . 7 5
4 1 6 . 2 5 M a x i m u m 1 2 4 . 0 6 2 5 M e a n 3 . 9 4 0 8 8 3
4 1 6 . 2 5 S u m 2 4 5 4 . 0 6 2 5 S t a n d a r d  E 0 . 2 3 0 6 7 4
4 1 6 . 2 5 C o u n t 5 0 4 . 0 6 2 5 M e d i a n 3 . 7 5
4 1 6 . 2 5 4 . 0 6 2 5 M o d e 5
4 1 7 . 5 vacuole size 4 . 3 7 5 Standard C 1 . 6 3 1 1 1
4 1 8 . 7 5 4 . 6 8 7 5 V a r i a n c e 2 . 6 6 0 5 1 9
4 1 8 . 7 5 Mean 1 6 . 8 5 4 . 6 8 7 5 K u r t o s i s 1 . 4 5 6 6 0 3
4 2 0 S t a n d a r d  E 0 . 9 1 2 1 0 7 5 S k e w n e s s 1 . 1 4 9 2 2 7
5 1 2 . 5 M e d i a n 1 6 . 2 5 2 . 5 R a n g e 7 . 2 9 1 6 6 7
5 1 3 . 7 5 M o d e 1 6 . 2 5 2 . 7 5 M i n i m u m 1 . 4 5 8 3 3 3
5 1 6 . 2 5 Standard C 6 . 4 4 9 5 6 9 3 . 2 5 M a x i m u m 8 . 7 5
5 1 8 . 7 5 V a r i a n c e 4 1 . 5 9 6 9 4 3 . 7 5 S u m 1 9 7 , 0 4 4 1
6 8 . 7 5 K u r t o s i s 1 . 3 0 1 4 4 3 1 . 4 5 8 3 3 3 C o u n t 5 0
6 1 1 . 2 5 S k e w n e s s 1 . 0 1 3 0 9 1 . 8 7 5
6 1 2 . 5 R a n g e 3 2 . 5 2 . 0 8 3 3 3 3
6 1 5 M i n i m u m 5 2 . 5
6 1 6 . 2 5 M a x i m u m 3 7 . 5 2 . 7 0 8 3 3 3
6 1 7 . 5 S u m 8 4 2 . 5 2 . 9 1 6 6 6 7
6 2 5 C o u n t 5 0 4 . 1 6 6 6 6 7
6 2 7 . 5 4 . 5 8 3 3 3 3
7 1 8 . 7 5 2 . 6 7 8 5 7 1
7 2 1 . 2 5 3 . 0 3 5 7 1 4
7 2 6 . 2 5 3 . 7 5
8 1 5 1 , 8 7 5
8 2 0 2 . 5
8 2 6 . 2 5 3 . 2 8 1 2 5
8 3 7 . 5 4 . 6 8 7 5
9 1 8 . 7 5 2 . 0 8 3 3 3 3
9 2 5 2 . 7 7 7 7 7 8
1 0 2 5 2 . 5
1 2 3 2 . 5 2 . 7 0 8 3 3 3
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Table 3.3. dlmcpbn
amastlgotes/ vacuole 
vacuole size (pm)
vacuole size/ amastigote (pm)
2 8 . 7 5 4 . 3 7 5
2 1 0 5
2 1 0 5
2 1 3 . 7 5 6 . 8 7 5
2 1 5 7 . 5
3 6 . 2 5 2 . 0 8 3 3 3 3
3 6 . 2 5 2 . 0 8 3 3 3 3
4 5 no. amastlgotes 1 . 2 5
4 8 . 7 5 2 . 1 8 7 5
4 1 1 . 2 5 Mean 6 . 3 6 2 . 8 1 2 5
4 1 1 . 2 5 S t a n d a r d  E 0 . 5 5 1 6 2 8 2 . 8 1 2 5
4 1 1 . 2 5 M e d i a n 6 2 . 8 1 2 5
4 1 2 . 5 M o d e 4 3 . 1 2 5
4 1 2 . 5 Standard C 3 . 9 0 0 6 0 2 3 . 1 2 5
4 1 2 . 5 V a r i a n c e 1 5 . 2 1 4 6 9 3 . 1 2 5
4 1 3 . 7 5 K u r t o s i s 2 . 4 6 5 8 9 8 3 . 4 3 7 5
4 1 3 . 7 5 S k e w n e s s 1 . 5 5 2 6 6 4 3 . 4 3 7 5
4 1 3 . 7 5 R a n g e 1 8 3 . 4 3 7 5 vac. size/amastigote
4 1 5 M i n i m u m 2 3 . 7 5
4 1 5 M a x i m u m 2 0 3 . 7 5 Mean 2 . 9 6 7 5 4 5
4 1 6 . 2 5 S u m 3 1 8 4 . 0 6 2 5 S t a n d a r d  E 0 . 2 0 0 9 2 2
4 2 0 C o u n t 5 0 5 M e d i a n 2 . 7 2 9 1 6 7
4 2 1 . 2 5 5 . 3 1 2 5 M o d e 2 . 5
5 1 3 . 7 5 vacuole size 2 . 7 5 S t a n d a r d  C 1 . 4 2 0 7 3 6
6 7 . 5 1 . 2 5 V a r i a n c e 2 . 0 1 8 4 9 1
6 1 2 . 5 M^an 1 5 . 5 7 5 2 . 0 8 3 3 3 3 K u r t o s i s 1 . 6 1 8 4 8 3
6 1 3 . 7 5 S t a n d a r d  E 0 . 8 4 9 8 2 7 2 . 2 9 1 6 6 7 S k e w n e s s 1 . 1 6 9 9 8 5
6 1 5 M e d i a n 1 5 2 . 5 R a n g e 6 . 3 7 5
6 1 5 M o d e 1 5 2 . 5 M i n i m u m 1 . 1 2 5
6 1 5 Standard C 6 . 0 0 9 1 8 7 2 . 5 M a x i m u m 7 . 5
6 1 6 . 2 5 V a r i a n c e 3 6 . 1 1 0 3 3 2 . 7 0 8 3 3 3 S u m 1 4 8 . 3 7 7 2
6 1 7 . 5 K u r t o s i s 1 . 3 8 0 8 1 2 . 9 1 6 6 6 7 C o u n t 5 0
6 1 8 . 7 5 S k e w n e s s 0 . 9 7 5 3 5 7 3 . 1 2 5
6 2 3 . 7 5 R a n g e 2 7 . 5 3 . 9 5 8 3 3 3
6 3 1 . 2 5 M i n i m u m 5 5 . 2 0 8 3 3 3
7 1 8 . 7 5 M a x i m u m 3 2 . 5 2 . 6 7 8 5 7 1
7 2 2 . 5 S u m 7 7 8 . 7 5 3 . 2 1 4 2 8 6
8 1 2 . 5 C o u n t 5 0 1 . 5 6 2 5
8 1 5 1 . 8 7 5
8 2 0 2 . 5
9 1 1 . 2 5 1 . 2 5
1 0 1 6 . 2 5 1 . 6 2 5
1 0 1 6 . 2 5 1 . 6 2 5
1 2 1 6 . 2 5 1 . 3 5 4 1 6 7
1 2 2 3 . 7 5 1 . 9 7 9 1 6 7
1 2 3 1 . 2 5 2 . 6 0 4 1 6 7
1 3 3 2 . 5 2 . 5
1 5 1 7 . 5 1 . 1 6 6 6 6 7
1 6 1 8 . 7 5 1 . 1 7 1 8 7 5
2 0 2 2 . 5 1 . 1 2 5
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Table 3.3. (cont)
z - T e s t :  T w o - S a m p l e  f o r  M e a n s
vacuole sizes (pm)
w i l d  t v o e  dlmcpbn
M e a n 3 . 9 4 0 8 8 3 2 . 9 6 7 5 4 5
K n o w n  V a r 2 . 6 6 1 2 . 0 1 8
O b s e r v a t i o 5 0 5 0
H y p o t h e s i z 0
z 3 . 1 8 1 7 9 6
P ( Z < = 2) o r 0 . 0 0 0 3 6 6
z  C r i t i c a l  01 2 . 5 7 5 8 3 6
P ( Z < = z )  t w 0 . 0 0 0 7 3 2
z  C r i t i c a l  t v 2 . 3 2 6 3 4 2
S i n c e  z  e x c e e d s  t h e  c r i t i c a l  v a l u e  
o f  2 . 5 8  t h e r e  i s  a  h i g h l y  s i g n i f i c a n t  
d i f f e r e n c e  a t  P = 0 . 0 1 .
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Table 3.8.
% infected
wild t v o e dlmcobn mcoba2.8 ilmcobal ilmcobal 8
2 8 1 . 6 1 9 0 . 6 5 . 5
4 6 1 . 6 3 7 6 2 . 9
3 9 1 . 2 3 1 3 . 8 5 . 4  j
3 8  ±  9 . 0 1 . 5  ±  0 . 2 2 9  ±  9 . 2 3 . 5  ±  2 . 8 4 . 6  ± 1 . 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
wild type dlmcpbn
M e a n
V a r i a n c e
O b s e r v a t i c
d f
F
P ( F < = f )  o n  
F  C r i t i c a l  o
3 7 . 6 6 6 6 7
8 2 . 3 3 3 3 3
3
2
1 5 4 3 . 7 5
0 . 0 0 0 6 4 7
1 9 . 0 0 0 0 3
1 . 4 6 6 6 6 7
0 . 0 5 3 3 3 3
3
2
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
wild type Hmcpbg2.8
M e a n
V a r i a n c e
O b s e r v a t i c
d f
F
P ( F < - f )  o n  
F  C r i t i c a l  o
3 7 . 6 6 6 6 7
8 2 . 3 3 3 3 3
3
2
1 . 0 2 0 2 4 3
0 . 4 9 4 9 9
9 . 0 0 0 0 1 9
2 9
8 4
3
2
t - T e s t :  T w o - S a m p i e  A s s u m i n g  E q u a l  V a r i a n c e s  
wild type dlmcpbn
M e a n  3 7 . 6 6 6 6 7  
V a r i a n c e  8 2 . 3 3 3 3 3  
O b s e r v a t i c  3
P o o l e d  V a i  4 1 . 1 9 3 3 3  
0 
4
1 . 4 6 6 6 6 7
0 . 0 5 3 3 3 3
3
H y p o t h e s i s  
d f
t  6 , 9 0 7 8 1 6  S i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y
P { T < = t )  o n  0 . 0 0 1 1 5 2  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 0 0 2 3 0 4  
t  C r i t i c a l  t v  2 . 7 7 6 4 5 1
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
wild type Hmcpbg2.8
M e a n  3 7 . 6 6 6 6 7  2 9
V a r i a n c e  8 2 . 3 3 3 3 3  8 4
O b s e r v a t i c  3  3
P o o l e d  V a i  8 3 . 1 6 6 6 7
H y p o t h e s i s  0
d f  4
t  1 . 1 6 3 9 2  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t ) o n  0 . 1 5 4 5 7 4  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 3 0 9 1 4 8  
t  C r i t i c a l  t v  2 . 7 7 6 4 5 1
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Table 3.8. (cont)
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s  
dlmcpbn dimcpbgl
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a i  V a r i a n c e s  
dlmcpbn dimcpbgl
M e a n  1 . 4 6 6 6 6 7 3 . 4 6 6 6 6 7 M e a n 1 . 4 6 6 6 6 7  3 . 4 6 6 6 6 7
V a r i a n c e  0 . 0 5 3 3 3 3 7 . 3 7 3 3 3 3 V a r i a n c e 0 . 0 5 3 3 3 3  7 . 3 7 3 3 3 3
O b s e r v a t i c  3 3 O b s e r v a t i c 3  3
d f  2 2 P o o l e d  V a i 3 . 7 1 3 3 3 3
F  1 3 8 . 2 5 H y p o t h e s i s 0
P ( F < = f ) o n  0 . 0 0 7 1 8 1 d f 4
F  C r i t i c a l  0 9 . 0 0 0 0 1 9 t 1 . 2 7 1 1 4 1  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 3 6 2 8 5
t  C r i t i c a i  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 2 7 2 5 6 9
t  C r i t i c a l  t v 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
dlmcpbn ilmcpbg18 dlmcpbn ilmcpbg18
M e a n  1 . 4 6 6 6 6 7 4 . 6 M e a n 1 . 4 6 6 6 6 7  4 . 6
V a r i a n c e  0 . 0 5 3 3 3 3 2 . 1 7 V a r i a n c e 0 . 0 5 3 3 3 3  2 . 1 7
O b s e r v a t i c  3 3 O b s e r v a t i c 3  3
d f  2 2 P o o l e d  V a i 1 . 1 1 1 6 6 7
F  4 0 . 6 8 7 5 H y p o t h e s i s 0
P ( F < = f ) o n  0 . 0 2 3 9 8 8 d f 4
F  C r i t i c a l  0 9 . 0 0 0 0 1 9 t 3 . 6 3 9 6 9 5  S i n c e  t > 3 . 7 4 7  t h e r e  i s  a  h i g h l y
P ( T < = t )  o n 0 . 0 1 0 9 8 5  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 2 1 9 7 1
t  C r i t i c a l  t v 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a i  V a r i a n c e s
dimcpbgl ilmcpbg18 dimcpbgl ilmcpbg18
M e a n  3 . 4 6 6 6 6 7 4 . 6 M e a n 3 . 4 6 6 6 6 7  4 . 6
V a r i a n c e  7 . 3 7 3 3 3 3 2 . 1 7 V a r i a n c e 7 . 3 7 3 3 3 3  2 . 1 7
O b s e r v a t i c  3 3 O b s e r v a t i c 3  3
d f  2 2 P o o l e d  V a i 4 . 7 7 1 6 6 7
F  3 . 3 9 7 8 4 9 H y p o t h e s i s 0
P ( F < = f )  o n  0 . 2 2 7 3 8 4 d f 4
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t 0 . 6 3 5 4 3 1  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 7 9 8 4 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 5 5 9 6 8 2
t Critical tv  2.776451
2 2 0
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Table 3.8. (cont) amastigotes/PEC
w i l d  t v o e dlmcobn mcoba2.8 ilmcobal ilmcobal 8
5 . 1 2 3 . 1 0 . 9 2 . 5
4 . 4 1 . 7 3 . 7 2 2 . 4
6 1 . 5 3 . 8 2 . 6 2 . 8
5 . 2  ± 0 . 9 1 . 7  ± 0 . 2 3 . 6  ±  0 . 4 1 . 8  ±  0 . 7 2 . 6  ±  0 . 2
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
w i l d  t y p e  dlmcpbn
M e a n  1 . 7 3 3 3 3 3  3 . 5 3 3 3 3 3  
V a r i a n c e  0 . 0 6 3 3 3 3  0 . 1 4 3 3 3 3  
O b s e r v a t i c  3  3
d f  2  2
F  2 . 2 6 3 1 5 8
P ( F < = f ) o n  0 . 3 0 6 4 5 2  
F  C r i t i c a l  o  9 . 0 0 0 0 1 9
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
w i l d  t y p e  dlmcpbn
M e a n 5 . 1 6 6 6 6 7 1 . 7 3 3 3 3 3 M e a n 5 . 1 6 6 6 6 7  1 . 7 3 3 3 3 3
V a r i a n c e 0 . 6 4 3 3 3 3 0 . 0 6 3 3 3 3 V a r i a n c e 0 . 6 4 3 3 3 3  0 . 0 6 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 3 5 3 3 3 3
F 1 0 . 1 5 7 8 9 H y p o t h e s i s 0
P ( F < = f )  o n 0 . 0 8 9 6 2 3 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
7 . 0 7 4 0 6 9  S i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y
0 . 0 0 1 0 5 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
2 . 1 3 1 8 4 6
0 . 0 0 2 1 0 7
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
w i l d  t y p e  Ilmcpbg2.8
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
w i l d  t y p e  1lmcpbg2.8
M e a n 5 . 1 6 6 6 6 7 3 . 5 3 3 3 3 3 M e a n 5 . 1 6 6 6 6 7  3 . 5 3 3 3 3 3
V a r i a n c e 0 . 6 4 3 3 3 3 0 . 1 4 3 3 3 3 V a r i a n c e 0 . 6 4 3 3 3 3  0 . 1 4 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 3 9 3 3 3 3
F 4 . 4 8 8 3 7 2 H y p o t h e s i s 0
P ( F < = f )  o n 0 . 1 8 2 2 0 3 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  t v
3 . 1 8 9 6 2 8  S i n c e  t > 2 . 7 7 6  t h e r e  i s  a  h i g h l y
0 . 0 1 6 6 1 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 5
2 . 1 3 1 8 4 6
0 . 0 3 3 2 2 8
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
dlmcpbn 1lmcpbg2.8
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
dlmcpbn IlmcpbgZS
M e a n  
V a r i a n c e  
O b s e r v a t i c  
P o o l e d  V a i  
H y p o t h e s i s  
d f  
t
P ( T < = t )  o n  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 0 0 2 3 6 7  
t  C r i t i c a l  t v  2 . 7 7 6 4 5 1
1 . 7 3 3 3 3 3  3 . 5 3 3 3 3 3  
0 . 0 6 3 3 3 3  0 . 1 4 3 3 3 3
3  3  
0 . 1 0 3 3 3 3
0
4
6 . 8 5 8 0 0 7  S i n c e  t > 4 , 6 0 4  t h e r e  i s  a  h i g h l y  
0 . 0 0 1 1 8 3  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
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Table 3.8. (cont)
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s  
dlmcpbn dimcpbgl
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
dlmcpbn dimcpbgl
M e a n 1 . 7 3 3 3 3 3 1 . 8 3 3 3 3 3 M e a n 1 , 7 3 3 3 3 3  1 . 8 3 3 3 3 3
V a r i a n c e 0 . 0 6 3 3 3 3 0 . 7 4 3 3 3 3 V a r i a n c e 0 . 0 6 3 3 3 3  0 . 7 4 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 4 0 3 3 3 3
F 1 1 . 7 3 6 8 4 H y p o t h e s i s 0
P ( F < = f )  o n 0 . 0 7 8 5 1 2 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 1 9 2 8 4 7  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 4 2 8 2 3 7
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 8 5 6 4 7 4
t  C r i t i c a l  t v 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
dlmcpbn ilmcpbgl 8 dlmcpbn ilmcpbgl8
M e a n 1 . 7 3 3 3 3 3 2 . 5 6 6 6 6 7 M e a n 1 . 7 3 3 3 3 3  2 . 5 6 6 6 6 7
V a r i a n c e 0 . 0 6 3 3 3 3 0 . 0 4 3 3 3 3 V a r i a n c e 0 . 0 6 3 3 3 3  0 . 0 4 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 0 5 3 3 3 3
F 1 . 4 6 1 5 3 8 H y p o t h e s i s 0
P ( F < “ f )  o n 0 . 4 0 6 2 5 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 4 . 4 1 9 4 1 7  S i n c e  t > 3 . 7 4 7  t h e r e  I s  a
P ( T < = t )  o n 0 . 0 0 5 7 5 8  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 1 1 5 1 6
t  C r i t i c a l  t v 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
dimcpbgl ilmcpbgl 8 dimcpbgl ilmcpbgl8
M e a n 1 . 8 3 3 3 3 3 2 . 5 6 6 6 6 7 M e a n 1 . 8 3 3 3 3 3  2 . 5 6 6 6 6 7
V a r i a n c e 0 . 7 4 3 3 3 3 0 . 0 4 3 3 3 3 V a r i a n c e 0 . 7 4 3 3 3 3  0 . 0 4 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 3 9 3 3 3 3
F 1 7 . 1 5 3 8 5 H y p o t h e s i s 0
P ( F < = f )  o n 0 . 0 5 5 0 8 5 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 1 . 4 3 2 0 7 8  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 1 2 6 9 4
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 2 2 5 3 8 8
t  C r i t i c a l  t v  2 . 7 7 6 4 5 1
1 1 1
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Fig. 4.1.
cell line 
wild type dlmcpcn
doubling time (h) 8 . 3  5 . 3
1 1  7 . 1
1 2 . 7  8 . 1
1 1  ± 2 . 0  6 . 8  ±  1 . 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
wild type dlmcpcn 
M e a n  1 0 . 6 6 6 6 6 6 7  6 . 8 3 3 3 3 3 3 3
V a r i a n c e  4 . 9 2 3 3 3 3 3 3  2 . 0 1 3 3 3 3 3 3  
O b s e r v a t i o n s  3  3
d f  2  2
F  2 . 4 4 5 3 6 4 2 4
P ( F < = f )  o n e -  0 . 2 9 0 2 4 5 0 7  
F  C r i t i c a l  o n e  1 9 . 0 0 0 0 2 6 4
t - T e s t ;  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
wild type dlmcpcn 
M e a n  1 0 . 6 6 6 6 6 6 7  6 . 8 3 3 3 3 3 3 3
V a r i a n c e  4 . 9 2 3 3 3 3 3 3  2 . 0 1 3 3 3 3 3 3  
O b s e r v a t i o n s  3  3
P o o l e d  V a r i a  3 . 4 6 8 3 3 3 3 3  
H y p o t h e s i z e c  0  
d f  4
t  2 . 5 2 0 9 3 5 8 8  s i n c e  t > 2 . 1 3 1  t h e r e  i s  a
P ( T < = t )  o n e -  0 . 0 3 2 6 4 5 8 2  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 1 
t  C r i t i c a l  o n e - 2 . 1 3 1 8 4 6 4 9  
P ( T < = t ) t W O - t  0 . 0 6 5 2 9 1 6 4  
t  C r i t i c a l  t w o -  2 . 7 7 6 4 5 0 8 6
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T a b l e  4 , 1 . % infected
wild tvoe dlm cobn dlm cpcn dImcpcPC
54 3.5 1.4 32
29 1.4 6.9 18
30 1.2 5.9 9.8
38 ±14  2.0 ±1 ,3 4.7 ±2.9 20 ± 11
F-Test; Two-Sampie for Variances t-Test: Two-Sample Assuming Equai Variances
wild type dlmcpbn wild type dlmcpbn
Mean 37.66667 2.033333 Mean 37.66667 2.033333
Variance 200.3333 1.623333 Variance 200.3333 1.623333
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 100.9783
F 123.4086 Hypothesiz 0 :
P{F<=f)on 0.008038 df 4
F Criticai 0 19.00003 t 4.342982 Since t>3.747 there is a highly i
P(T<=t) on 0.006112 significant difference at P=0.02
significant difference at P=0.01 t Criticai or 2.131846
P(T<=t) tw< 0.012224
t Criticai tw 2.776451
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dlmcpbn dlmcpcn dlmcpbn dlmcpcn
Mean 2.033333 4.733333 Mean 2.033333 4.733333
Variance 1.623333 8.583333 Variance 1.623333 8.583333
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 5.103333
F 5.287474 Hypothesiz 0
P(F<=f)on 0.159046 df 4
F Critical o 9.000019 t 1.463802 no significant difference
P(T<=t) on 0.108546
t Criticai or 2.131846
P(T<=t) twi 0.217092
t Critical tw 2.776451
F-Test: Two-Sampie for Variances t-Test; Two-Sampie Assuming Equal Variances
dlmcpcn dImcpcPC dlmcpcn dImcpcPC
Mean 4.733333 19.93333 Mean 4.733333 19.93333
Variance 8.583333 126.0133 Variance 8.583333 126.0133
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 67.29833
F 14.68117 Hypothesiz 0
P(F<=f) on 0.063771 df 4
F Critical 0 9.000019 t 2.269275 Since t>2.131 there is a
P(T<=t) on 0.042898 significant difference at P=0,1
t Criticai or 2.131846
P(T<-t) tw« 0.085796
t Critical tw 2.776451
F-Test: Two-Sampie for Variances t-Test: Two-Sample Assuming Equal Variances
wild type dImcpcPC wild type dImcpcPC
Mean 37.66667 19,93333 Mean 37,66667 19.93333
Variance 200.3333 126.0133 Variance 200.3333 126.0133
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 163.1733
F 1.589779 Hypothesiz 0
P(F<=f)on 0.386133 df 4
F Criticai 0 19.00003 t 1.700245 no significant difference
P(T<=t) on 0.082154
t Critical or 2.131846
P(T<=t) twi 0.164308
t Critical tw 2.776451
2 2 4
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T a b l e  4 . 1 .  (cont) amastigotes/PEC
wild tvoe dlm cpbn dlmcpcn  idImcpcPC
5 3.7 3.3 3.6
6.2 3.2 4 5.6
6,4 1.8 4.6 6.4
5.9 ±0.8 2.9 ±1.0 4.0 ±0.6 5.2 ± 1.4
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
wild type dlmcpbn wild type dlmcpbn
Mean 5.866667 2.9 Mean 5.866667 2.9
Variance 0.573333 0.97 Variance 0.573333 0.97
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Var 0.771667
F 1.69186 Hypothesiz 0
p(F<=f) on 0.37149 df 4
F Critical o 9.000019 t 4.136181 since t>3.747 there is a
P(T<=t) on 0.007211 significant difference at P=i
t Critical or 2.131846
P(T<=t) twi 0.014421
t Critical tw 2.776451
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dlmcpbn dlmcpcn dlmcpbn dlmcpcn
Mean 2.9 3.966667 Mean 2.9 3.966667
Variance 0.97 0.423333 Variance 0.97 0.423333
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 0.696667
F 2.291339 Hypothesiz 0
P(F<=0 on 0.303828 df 4
F Critical 0 19.00003 t 1.565171 no significant difference
P(T<=t) on 0.096298
t Critical or 2.131846
P(T<=t) twi 0.192596
t Critical tw 2.776451
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
dlmcpcn dImcpcPC dlmcpcn dImcpcPC
Mean 3.966667 5.2 Mean 3.966667 5,2
Variance 0.423333 2.08 Variance 0.423333 2.08
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 1.251667
F 4.913386 Hypothesiz 0
P(F<=f) on 0.169108 df 4
F Critical o 9.000019 t 1.350149 no significant difference
P(T<=t) on 0.124154
t Critical or 2.131846
P(T<=t) twi 0.248307
t Critical tw 2.776451
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
wild type dImcpcPC wild type dImcpcPC
Mean 5.866667 5,2 Mean 5,866667 5.2
Variance 0.573333 2.08 Variance 0.573333 2.08
Observatio 3 3 Observatio 3 3
df 2 2 Pooled Vai 1.326667
F 3.627907 Hypothesiz 0
P(F<=f) on 0.21608 df 4
F Critical o 9.000019 t 0.708881 no significant difference
P(T<=t) on 0.258764
t Critical or 2.131846
P(T<=t) twi 0.517528
t Critical tw 2.776451
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Fig 5.7. A % Infected (z-fa)
72h Horn 3) 24h 4) controlpromastigote 1 2 2 0 1 4 3 4
2 1 2 2 1 6 2 9
2 4 1 9 3 6 4 2
1 9  ± 6 . 2 2 0  ±  1 . 5 2 2  ±  1 2 3 5  ±  6 . 6
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 2 ) 4 h 1 )  p r e 2 ) 4 h
M e a n 1 8 . 8 6 6 6 7 2 0 . 3 3 3 3 3 M e a n 1 8 . 8 6 6 6 7 2 0 . 3 3 3 3 3
V a r i a n c e 3 8 . 2 5 3 3 3 2 . 3 3 3 3 3 3 V a r i a n c e 3 8 . 2 5 3 3 3 2 . 3 3 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 2 0 . 2 9 3 3 3
F 1 6 . 3 9 4 2 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 5 7 4 9 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 0 . 3 9 8 7 5 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 3 5 5 2 2 4
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw< 0 . 7 1 0 4 4 8
t  C r i t i c a i  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 ) p r e 3 )  2 4 h 1 )  p r e 3 )  2 4 h
M e a n 1 8 . 8 6 6 6 7 2 2 M e a n 1 8 . 8 6 6 6 7 2 2
V a r i a n c e 3 8 . 2 5 3 3 3 1 4 8 V a r i a n c e 3 8 . 2 5 3 3 3 1 4 8
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 9 3 . 1 2 6 6 7
F 3 . 8 6 8 9 4 4 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 2 0 5 3 8 3 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 3 9 7 6 6 3  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 3 5 5 5 9 4
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < ~ t )  t w ( 0 . 7 1 1 1 8 7
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 4 )  c o n t r o l 1 )  p r e 4 )  c o n t r o l
M e a n 1 8 . 8 6 6 6 7 3 5 M e a n 1 8 . 8 6 6 6 7 3 5
V a r i a n c e 3 8 . 2 5 3 3 3 4 3 V a r i a n c e 3 8 . 2 5 3 3 3 4 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f .2 2 P o o l e d  V a r 4 0 . 6 2 6 6 7
F 1 . 1 2 4 0 8 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 7 0 7 9 1 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 3 . 1 0 0 0 1 7 S i n c e  t > 2 . 7 7 6  a t  P = 0 . 0 5
P ( T < = t )  o n 0 . 0 1 6 1 1 t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e .  s
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P(T<=t) tw< 0.03622
t Critical tw 2.776451
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Fig 5.7. A (cont)
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s  
2 )  4 h  4 )  c o n t r o l
t - T e s t :  T w o - S a m p i e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  4 h  4 )  c o n t r o l
M e a n 2 0 . 3 3 3 3 3 3 5 M e a n 2 0 . 3 3 3 3 3 3 5
V a r i a n c e 2 . 3 3 3 3 3 3 4 3 V a r i a n c e 2 . 3 3 3 3 3 3 4 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 2 2 . 6 6 6 6 7
F 1 8 . 4 2 8 6 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 5 1 4 7 1 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 3 . 7 7 2 9 6 9  S i n c e  t > 3 . 7 4  a t  P = 0 . 0 2
P ( T < = t )  o n 0 . 0 0 9 7 7 7  t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w ( 0 . 0 1 9 5 5 4
t  C r i t i c a i  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
3 )  2 4 h  4 )  c o n t r o l 3 )  2 4 h 4 )  c o n t r o l
M e a n 2 2 3 5 M e a n 2 2 3 5
V a r i a n c e 1 4 8 4 3 V a r i a n c e 1 4 8 4 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 9 5 . 5
F 3 . 4 4 1 8 6 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 2 2 5 1 3 1 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 1 . 6 2 9 2 4 8 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 0 8 9 2 9 6
v a r i a n c e s  s i m i l a r t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw< 0 . 1 7 8 5 9 3
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
2 )  4 h 3 ) 2 4 h 2 ) 4 h 3 )  2 4 h
M e a n 2 0 . 3 3 3 3 3 2 2 M e a n 2 0 . 3 3 3 3 3 2 2
V a r i a n c e 2 . 3 3 3 3 3 3 1 4 8 V a r i a n c e 2 . 3 3 3 3 3 3 1 4 8
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 7 5 . 1 6 6 6 7
F 6 3 . 4 2 8 5 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 1 5 5 2 1 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 2 3 5 4 4 1 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 4 1 2 7 1 5
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w ( 0 . 8 2 5 4 2 9
t  C r i t i c a l  t w  2 . 7 7 6 4 5 1
227
appendix
Fîg 5.7. A %  infected (z-fa)
7d ore 2)4h 3)24h 4) controlpromastigote 0 0 . 5 2 . 4 2 6
2 2 . 4 3 . 3 3 3
0 0 0 2 8
0 . 6 6  ±  1 . 1 5  0 . 9 7  ± 1 . 3 1 . 9  ±  1 . 7 1 9 ±  3 . 6
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 2 )  4 h 1 )  p r e 2 )  4 h
M e a n 0 . 6 6 6 6 6 7 0 . 9 6 6 6 6 7 M e a n 0 . 6 6 6 6 6 7 0 . 9 6 6 6 6 7
V a r i a n c e 1 . 3 3 3 3 3 3 1 . 6 0 3 3 3 3 V a r i a n c e 1 . 3 3 3 3 3 3 1 . 6 0 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 1 . 4 6 8 3 3 3
F 1 . 2 0 2 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 5 4 0 3 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 3 0 3 2 1 8 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 , 3 8 8 4 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w ( 0 . 7 7 6 8 4
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t ;  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 3 )  2 4 h 1 )  p r e 3 )  2 4 h
M e a n 0 . 6 6 6 6 6 7 1 , 9 M e a n 0 . 6 6 6 6 6 7 1 . 9
V a r i a n c e 1 . 3 3 3 3 3 3 2 . 9 1 V a r i a n c e 1 . 3 3 3 3 3 3 2 . 9 1
O b s e r v a t i o 3 3 O b s e r v a t i o 3 3
d f 2 2 P o o l e d  V a r 2 . 1 2 1 6 6 7
F 2 . 1 8 2 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 1 4 2 1 8 d f 4
F  C r i t i c a l  o 9 , 0 0 0 0 1 9 t 1 . 0 3 7 0 2 1 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 7 9 1 5
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w ( 0 . 3 5 8 3
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t ;  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e  4 )  c o n t r o l 1 )  p r e 4 )  c o n t r o l
M e a n 0 . 6 6 6 6 6 7 2 9 M e a n 0 . 6 6 6 6 6 7 2 9
V a r i a n c e 1 . 3 3 3 3 3 3 1 3 V a r i a n c e 1 . 3 3 3 3 3 3 1 3
O b s e r v a t i o 3 3 O b s e n / a t i o 3 3
d f 2 2 P o o l e d  V a r 7 . 1 6 6 6 6 7
F 9 . 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 9 3 0 2 3 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 2 . 9 6 2 3 8 S i n c e  t > 4 . 6 0 4  a t  P = 0 . 0 1
P ( T < = t )  o n 0 . 0 0 0 1 0 2 t h e r e  i s  a  h i g h l y
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6 s i g n i f i c a n t  d i f f e r e n c e .
P ( T < = t )  tw < 0 . 0 0 0 2 0 4
t Critical tw 2.776451
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F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2) 4h 3) 24h
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2) 4h 3) 24h
M e a n 0 . 9 6 6 6 6 7 1 . 9 M e a n 0 . 9 6 6 6 6 7  1 . 9
V a r i a n c e 1 . 6 0 3 3 3 3 2 . 9 1 V a r i a n c e 1 . 6 0 3 3 3 3  2 . 9 1
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 2 . 2 5 6 6 6 7
F 1 . 8 1 4 9 6 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 5 5 2 4 4 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 7 6 0 9 3 7  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 4 4 5 4 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w ( 0 , 4 8 9 0 8 3
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
2 )  4 h 4 )  c o n t r o l 2 )  4 h  4 )  c o n t r o l
M e a n 0 . 9 6 6 6 6 7 2 9 M e a n 0 . 9 6 6 6 6 7  2 9
V a r i a n c e 1 . 6 0 3 3 3 3 1 3 V a r i a n c e 1 . 6 0 3 3 3 3  1 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 7 . 3 0 1 6 6 7
F 8 . 1 0 8 1 0 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 0 9 7 9 2 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 2 . 7 0 6 0 2  S i n c e  t > 4 . 6 0 4  a t  P = 0 . 0 1
P ( T < = t )  o n 0 . 0 0 0 1 1  t h e r e  i s  a  h i g h l y
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6  s i g n i f i c a n t  d i f f e r e n c e .
P ( T  < = t )  t w ( 0 . 0 0 0 2 2 1
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
3 ) 2 4 h 4 )  c o n t r o l 3 )  2 4 h  4 )  c o n t r o l
M e a n 1 . 9 2 9 M e a n 1 . 9  2 9
V a r i a n c e 2 . 9 1 1 3 V a r i a n c e 2 . 9 1  1 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 7 . 9 5 5
F 4 . 4 6 7 3 5 4 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 8 2 9 0 4 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 1 . 7 6 7 7 9  S i n c e  t > 4 . 6 0 4  a t  P = 0 . 0 1
P ( T < = t )  o n 0 . 0 0 0 1 4 9  t h e r e  i s  a  h i g h l y
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6  s i g n i f i c a n t  d i f f e r e n c e .
P ( T < - t )  t w ( 0 . 0 0 0 2 9 8
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
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Fig 6.7. B amastigotes/PEC (z-fa)
72h 1) pre 2) 4h 3) 24h .4) controlpromastigote 1 . 3 1 . 6 1 . 5 2 . 4
1 . 7 1 . 7 - 1 . 8 3 . 2
1 . 8 1 . 8 2 . 2 2 . 7
1 . 6  ± 0 . 3  1 . 7 ± 0 . 1 1 . 8  ±  0 . 4 2 . 8  ±  0 . 4
F - T e s t ;  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 2 )  4 h 1 )  p r e  2 ) 4 h
M e a n  1 . 6 1 , 7 M e a n 1 . 6  1 . 7
V a r i a n c e  0 . 0 7 0 . 0 1 V a r i a n c e 0 . 0 7  0 . 0 1
O b s e r v a t i o  3 3 O b s e r v a t i o 3  3
d f  2 2 P o o l e d  V a r 0 . 0 4
F  7 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 1 2 5 d f 4
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t 0 . 6 1 2 3 7 2  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 8 6 6 9 6
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw ( 0 . 5 7 3 3 9 2
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 3 )  2 4 h 1 )  p r e  3 ) 2 4 h
M e a n  1 . 6 1 . 8 3 3 3 3 3 M e a n 1 . 6  1 . 8 3 3 3 3 3
V a r i a n c e  0 . 0 7 0 . 1 2 3 3 3 3 V a r i a n c e 0 . 0 7  0 . 1 2 3 3 3 3
O b s e r v a t i o  3 3 O b s e r v a t i o 3  3
d f  2 2 P o o l e d  V a r 0 . 0 9 6 6 6 7
F  1 . 7 6 1 9 0 5 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 3 6 2 0 6 9 d f 4
F  C r i t i c a l  o  9 . 0 0 0 0 1 9 t 0.919146 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 0 5 0 1 6
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw ( 0 . 4 1 0 0 3 1
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 4 )  c o n t r o l 1 )  p r e  4 )  c o n t r o l
M e a n  1 . 6 2 . 7 6 6 6 6 7 M e a n 1 . 6  2 . 7 6 6 6 6 7
V a r i a n c e  0 . 0 7 0 . 1 6 3 3 3 3 V a r i a n c e 0 . 0 7  0 . 1 6 3 3 3 3
O b s e r v a t i o  3 3 O b s e r v a t i o 3  3
d f  2 2 P o o l e d  V a r 0 . 1 1 6 6 6 7
F  2 . 3 3 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 3 d f 4
F  C r i t i c a l  o  9 . 0 0 0 0 1 9 t 4 . 1 8 3 3  S i n c e  t > 3 . 7 4 7  a t  P = 0 . 0 2
P ( T < = t )  o n 0 . 0 0 6 9 4 1  t h e r e  i s  a  h i g h l y
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6  s i g n i f i c a n t  d i f f e r e n c e .
P ( T < = t )  tw c 0.013881
t Critical tw 2.776451
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F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  4 h 3 ) 2 4 h  ■ 2 )  4 h  3 )  2 4 h
M e a n 1 . 7 1 . 8 3 3 3 3 3 M e a n 1 . 7  1 . 8 3 3 3 3 3
V a r i a n c e 0 . 0 1 0 . 1 2 3 3 3 3 V a r i a n c e 0 . 0 1  0 . 1 2 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 0 6 6 6 6 7
F 1 2 . 3 3 3 3 3 H y p o t h e s i z 0
P { F < = f )  o n 0 . 0 7 5 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 6 3 2 4 5 6  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 8 0 7 1 9
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw < 0 . 5 6 1 4 3 8
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
2 )  4 h 4 )  c o n t r o l 2 )  4 h  4 )  c o n t r o l
M e a n 1 . 7 2 . 7 6 6 6 6 7 M e a n 1 . 7  2 . 7 6 6 6 6 7
V a r i a n c e 0 . 0 1 0 . 1 6 3 3 3 3 V a r i a n c e 0 . 0 1  0 . 1 6 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 0 8 6 6 6 7
F 1 6 . 3 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 6 7 6 9 2 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 4 . 4 3 7 6 0 2  S i n c e  t > 3 . 7 4 7  a t  P = 0 . 0 2
P ( T < = t )  o n 0 . 0 0 5 6 7 7  t h e r e  i s  a  h i g h l y
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6  s i g n i f i c a n t  d i f f e r e n c e .
P ( T < = t )  t w ( 0 . 0 1 1 3 5 5
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
3 )  2 4 h 4 )  c o n t r o l 3 )  2 4 h  4 )  c o n t r o l
M e a n 1 . 8 3 3 3 3 3 2 . 7 6 6 6 6 7 M e a n 1 . 8 3 3 3 3 3  2 . 7 6 6 6 6 7
V a r i a n c e 0 . 1 2 3 3 3 3 0 . 1 6 3 3 3 3 V a r i a n c e 0 . 1 2 3 3 3 3  0 . 1 6 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 1 4 3 3 3 3
F 1 . 3 2 4 3 2 4 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 3 0 2 3 3 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 3 . 0 1 9 3 1 8  S i n c e  t > 2 . 7 7 6  a t  P = 0 . 0 5
P ( T < = t )  o n 0 . 0 1 9 5 9 5  t h e r e  i s  a  s i g n i f i c a n t  d i f f e n
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw ( 0 . 0 3 9 1 9
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Fig 5.7. B amastigotes/PEC (z-fa)
7 day U  pre 2) 4h 3) 24h 41 control
promastigote 0 1 1 . 6 2 . 8
■ 1 . 5 1 . 4 1 . 7 2 . 4
0 0 0 2 . 2
0 . 5  ± 0 . 9  0 . 8  ± 0 . 7 1 .1  ± 0 . 9  2 . 5  ± 0 . 3
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 2 ) 4 h 1 )  p r e  2 )  4 h
M e a n 0 . 5 0 . 8 M e a n 0 . 5  0 . 8
V a r i a n c e 0 . 7 5 0 . 5 2 V a r i a n c e 0 . 7 5  0 . 5 2
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 6 3 5
F 1 . 4 4 2 3 0 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 0 9 4 4 9 d f 4  1
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 0 . 4 6 1 0 8 4  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 3 3 4 3 4 7
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw< 0 . 6 6 8 6 9 5
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1  '
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 3 )  2 4 h 1 )  p r e  3 )  2 4 h
M e a n 0 . 5 1 . 1 M e a n 0 . 5  1 .1
V a r i a n c e 0 . 7 5 0 . 9 1 V a r i a n c e 0 . 7 5  0 . 9 1
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 8 3
F 1 . 2 1 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 5 1 8 0 7 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 8 0 6 5 9 9  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 3 2 5 6 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw ( 0 . 4 6 5 1 2 2
t  C r i t i c a l  t w 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  p r e 4 )  c o n t r o l 1 ) p r e  4 )  c o n t r o l
M e a n 0 . 5 2 . 4 6 6 6 6 7 M e a n 0 . 5  2 . 4 6 6 6 6 7
V a r i a n c e 0 . 7 5 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 7 5  0 . 0 9 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 4 2 1 6 6 7
F 8 . 0 3 5 7 1 4 H y p o t h e s i z 0
P { F < = f )  o n 0 . 1 1 0 6 7 2 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 3 . 7 0 9 2 9 8  S i n c e  t > 2 . 7 7 6  a t  P = 0 . 0 5
P ( T < - t )  o n 0 . 0 1 0 3 3 3  t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e .
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  tw ( 0 . 0 2 0 6 6 7
t Critical tw 2.776451
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Fifl. 5.7. B (cont)
F-Test; Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  4 h 3 ) 2 4 h 2 )  4 h  3 )  2 4 h
M e a n 0 . 8 1 . 1 M e a n 0 . 8  1 .1
V a r i a n c e 0 . 5 2 0 . 9 1 V a r i a n c e 0 . 5 2  0 . 9 1
O b s e n / a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 7 1 5
F 1 . 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 6 3 6 3 6 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  tw < 
t  C r i t i c a l  t w
0 . 4 3 4 5 2 4  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 3 4 3 1 6 1
2 . 1 3 1 8 4 6
0 . 6 8 6 3 2 1
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  4 h  4 )  c o n t r o l
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  4 h  4 )  c o n t r o l
M e a n 0 . 8 2 . 4 6 6 6 6 7 M e a n 0 . 8  2 . 4 6 6 6 6 7
V a r i a n c e 0 . 5 2 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 5 2  0 . 0 9 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 3 0 6 6 6 7
F 5 . 5 7 1 4 2 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 5 2 1 7 4 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  tw (  
t  C r i t i c a l  t w
3 . 6 8 6 0 4 9  S i n c e  t > 2 . 7 7 6  a t  P = 0 . 0 5
0 . 0 1 0 5 4 6  t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e .
2 . 1 3 1 8 4 6
0 . 0 2 1 0 9 2
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
3 )  2 4 h  4 )  c o n t r o l
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
3 )  2 4 h  4 )  c o n t r o l
M e a n 1 .1 2 . 4 6 6 6 6 7 M e a n 1 . 1  2 . 4 6 6 6 6 7
V a r i a n c e 0 . 9 1 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 9 1  0 . 0 9 3 3 3 3
O b s e r v a t i o 3 3 O b s e r v a t i o 3  3
d f 2 2 P o o l e d  V a r 0 . 5 0 1 6 6 7
F 9 . 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 9 3 0 2 3 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w (
2 . 3 6 3 2 0 1  S i n c e  t > 2 . 1 3 2  a t  P = 0 . 1  
0 . 0 3 8 6 9 6  t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e .  
2 . 1 3 1 8 4 6  
0 . 0 7 7 3 9 2
t  C r i t i c a l  t w  2 . 7 7 6 4 5 1
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Fig 5.8. A %  infected
72h 1) zfa 2) P87 31 K02 41 control
promastigote 1 2 2 8 3 8 3 4
2 0 . 6 3 8 4 . 5 2 9
2 4 3 6 1 7 4 2
1 9  ± 6 . 0  3 4  ± 5 . 3 2 0 ±  1 2 3 5  ±  6 . 6
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  4
1 )  z f a 2 )  P 8 7 1 )  z f a  2 ) P 8 7
M e a n 1 8 . 8 6 6 6 7 3 4 M e a n 1 8 . 8 6 6 6 7  3 4
V a r i a n c e 3 8 . 2 5 3 3 3 2 8 V a r i a n c e 3 8 . 2 5 3 3 3  2 8
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3  Î
d f 2 2 P o o l e d  V a i 3 3 . 1 2 6 6 7
F 1 . 3 6 6 1 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 2 2 6 2 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 3 . 2 2 0 2 6 3  s i n c e  t > 2 . 7 7 6  a t  P = 0 . 0 5
P ( T < = t )  o n 0 . 0 1 6 1 3 6  t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e .
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 3 2 2 7 2
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 ) z f a 3 )  K 0 2 1 ) z f a  3 ) K 0 2
M e a n 1 8 . 8 6 6 6 7 1 9 . 8 3 3 3 3 M e a n 1 8 . 8 6 6 6 7  1 9 . 8 3 3 3 3
V a r i a n c e 3 8 . 2 5 3 3 3 2 8 6 . 5 8 3 3 V a r i a n c e 3 8 . 2 5 3 3 3  2 8 6 . 5 8 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 1 6 2 . 4 1 8 3
F 7 . 4 9 1 7 2 2 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 1 7 7 6 2 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 0 9 2 8 9 8  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 4 6 5 2 2 6  '
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 9 3 0 4 5 2
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1  Î
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  z f a 4 )  c o n t r o l 1 ) z f a  4 )  c o n t r o l
M e a n 1 8 . 8 6 6 6 7 3 5 M e a n 1 8 . 8 6 6 6 7  3 5
V a r i a n c e 3 8 . 2 5 3 3 3 4 3 V a r i a n c e 3 8 . 2 5 3 3 3  4 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 4 0 . 6 2 6 6 7
F 1 . 1 2 4 0 8 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 7 0 7 9 1 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 3 . 1 0 0 0 1 7  s i n c e  t > 2 . 7 7 6  a t  P = 0 . 0 5
P ( T < = t )  o n 0 . 0 1 8 1 1  t h e r e  i s  a  s i g n i f i c a n t  d i f f e r e n c e .
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 3 6 2 2
t Critical tw 2.776451
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Fig. 5.8. A (cont)
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  P 8 7 3 )  K 0 2 2 )  P 8 7  3 )  K 0 2
M e a n 3 4 1 9 . 8 3 3 3 3 M e a n 3 4  1 9 . 8 3 3 3 3
V a r i a n c e 2 8 2 8 6 . 5 8 3 3 V a r i a n c e 2 8  2 8 6 . 5 8 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 1 5 7 . 2 9 1 7
F 1 0 . 2 3 5 1 2 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 8 9 0 0 7 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
1 . 3 8 3 4 4  n o  s i g n i f i c a n t  d i f f e r e n c e  
0 . 1 1 9 3 6 4  
2 . 1 3 1 8 4 6  
0 . 2 3 8 7 2 8  
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  P 8 7  4 )  c o n t r o l
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  P 8 7  4 )  c o n t r o l
M e a n 3 4 3 5 M e a n 3 4  3 5
V a r i a n c e 2 8 4 3 V a r i a n c e 2 8  4 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 3 5 . 5
F 1 . 5 3 5 7 1 4 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 9 4 3 6 6 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
0 , 2 0 5 5 5 7  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 4 2 3 5 8 7
2 . 1 3 1 8 4 6
0 . 8 4 7 1 7 5
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
3 )  K 0 2  4 )  c o n t r o l
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
3 )  K 0 2  4 )  c o n t r o l
M e a n 1 9 . 8 3 3 3 3 3 5 M e a n 1 9 . 8 3 3 3 3  3 5
V a r i a n c e 2 8 6 . 5 8 3 3 4 3 V a r i a n c e 2 8 6 . 5 8 3 3  4 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 1 6 4 . 7 9 1 7
F 6 . 6 6 4 7 2 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 3 0 4 6 8 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w
1 . 4 4 6 9 9 9  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 1 1 0 7 2 4
2 . 1 3 1 8 4 6
0 . 2 2 1 4 4 7
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Fig 5.8. A % infected
7d 11 zfa 21P87 31 K02 41 control
promastigote 0  1 . 4 5 2 6  ;
2  8 . 9 1 3 3 3
0  1 . 2 2 . 9 2 8  -
0 . 7  ±  1 . 1  3 . 8  ± 4 . 4 7  ±  5 . 3 3 0  ± 2 . 5
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  z f a 2 )  P 8 7 1 ) z f a  2 ) P 8 7
M e a n 0 . 6 6 6 6 6 7 3 . 8 3 3 3 3 3 M e a n 0 . 6 6 6 6 6 7  3 . 8 3 3 3 3 3
V a r i a n c e 1 . 3 3 3 3 3 3 1 9 . 2 6 3 3 3 V a r i a n c e 1 . 3 3 3 3 3 3  1 9 . 2 6 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3  :i
d f 2 2 P o o l e d  V a i 1 0 . 2 9 8 3 3
F 1 4 . 4 4 7 5 H y p o t h e s i z 0  ::
P { F < = f )  o n 0 . 0 6 4 7 3 5 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 . 2 0 8 5 5  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 4 6 6 9 6
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 2 9 3 3 9 3
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  z f a 3 )  K 0 2 1 ) z f a  3 ) K 0 2
M e a n 0 . 6 6 6 6 6 7 6 . 9 6 6 6 6 7 M e a n 0 . 6 6 6 6 6 7  6 . 9 6 6 6 6 7
V a r i a n c e 1 . 3 3 3 3 3 3 2 8 . 4 0 3 3 3 V a r i a n c e 1 . 3 3 3 3 3 3  2 8 . 4 0 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a t 1 4 . 8 6 8 3 3
F 2 1 . 3 0 2 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 4 4 8 3 8 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 2 . 0 0 1 0 3 7  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 0 5 7 9 9
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < - t )  t w 0 . 1 1 5 9 7 9
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  z f a 4 )  c o n t r o l 1 )  z f a  4 )  c o n t r o l
M e a n 0 . 6 6 6 6 6 7 2 9 M e a n 0 . 6 6 6 6 6 7  2 9  J
V a r i a n c e 1 . 3 3 3 3 3 3 1 3 V a r i a n c e 1 . 3 3 3 3 3 3  1 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 7 . 1 6 6 6 6 7
F 9 . 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 9 3 0 2 3 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 2 . 9 6 2 3 8  s i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y
P ( T < = t )  o n 0 . 0 0 0 1 0 2  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P{T<=t) tw 0 . 0 0 0 2 0 4
t Critical tw 2.776451
236
appendix
Fig. 5.8. A (cont)
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  P 8 7 3 )  K 0 2 2 )  P 8 7 3 )  K 0 2
M e a n 3 . 8 3 3 3 3 3 6 . 9 6 6 6 6 7 M e a n 3 . 8 3 3 3 3 3 6 . 9 6 6 6 6 7
V a r i a n c e 1 9 . 2 6 3 3 3 2 8 . 4 0 3 3 3 V a r i a n c e 1 9 . 2 6 3 3 3 2 8 . 4 0 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3 3
d f 2 2 P o o l e d  V a i 2 3 . 8 3 3 3 3
F 1 . 4 7 4 4 7 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 0 4 1 2 6 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 7 8 6 0 6 7 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 3 7 8 9
t C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 4 7 5 7 8 1
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
2 )  P 6 7 4 )  c o n t r o l 2 )  P 8 7 4 )  c o n t r o l
M e a n 3 . 8 3 3 3 3 3 2 9 M e a n 3 . 8 3 3 3 3 3 2 9
V a r i a n c e 1 9 . 2 6 3 3 3 1 3 V a r i a n c e 1 9 . 2 6 3 3 3 1 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3 3
d f 2 2 P o o l e d  V a i 1 6 . 1 3 1 6 7
F 1 . 4 8 1 7 9 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 0 2 9 3 4 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 7 , 6 7 4 1 7 5 s i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y
P ( T < = t )  o n 0 . 0 0 0 7 7 5 s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 0 1 5 5
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
3 )  K 0 2 4 )  c o n t r o l 3 ) K 0 2 4 )  c o n t r o l
M e a n 6 . 9 6 6 6 6 7 2 9 M e a n 6 . 9 6 6 6 6 7 2 9
V a r i a n c e 2 8 . 4 0 3 3 3 1 3 V a r i a n c e 2 8 . 4 0 3 3 3 1 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3 3
d f 2 2 P o o l e d  V a i 2 0 . 7 0 1 6 7
F 2 . 1 8 4 8 7 2 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 1 3 9 8 4 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 5 . 9 3 0 9 3 5 s i n c e  t > 4 . 6 0 4  t h e r e  I s  a  h i g h l y
P ( T < = t )  o n 0 . 0 0 2 0 2 5 s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 0 4 0 5 1
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Fig 5.8. B amastigotes/PEC
72h Dzfa 2)P87 3) K02 41 control
promastigote 1 . 3  2 2 . 2 2 . 4
1 . 7  2 . 1 1 . 6 3 . 2
1 . 8  1 . 9 2 2 . 7
1 . 6  ± 0 . 3  2 . 0  ± 0 . 1 1 . 9  ±  0 . 3 2 . 8  ±  0 . 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  z f a 2 )  P 8 7 1 ) z f a  2 )  P 8 7
M e a n 1 . 6 2 M e a n 1 . 6  2
V a r i a n c e 0 . 0 7 0 . 0 1 V a r i a n c e 0 . 0 7  0 . 0 1
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 0 4
F 7 H y p o t h e s i z 0
P { F < ~ f )  o n 0 . 1 2 5 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 2 . 4 4 9 4 9  s i n c e  t > 2 . 1 3 2  t h e r e  i s  a
P ( T < = t )  o n 0 . 0 3 5 2 4 2  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 1
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6  1
P ( T < = t )  t w 0 . 0 7 0 4 8 4
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  :
1 )  z f a 3 )  K 0 2 1 ) z f a  3 ) K 0 2
M e a n 1 . 6 1 . 9 3 3 3 3 3 M e a n 1 . 6  1 . 9 3 3 3 3 3
V a r i a n c e 0 . 0 7 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 0 7  0 . 0 9 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 0 8 1 6 6 7
F 1 . 3 3 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 2 8 5 7 1 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 . 4 2 8 5 7 1  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 1 3 1 6 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 2 2 6 3 2 5
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  Z f a 4 )  c o n t r o l 1 )  z f a  4 )  c o n t r o l
M e a n 1 . 6 2 . 7 6 6 6 6 7 M e a n 1 . 6  2 . 7 6 6 6 6 7
V a r i a n c e 0 . 0 7 0 . 1 6 3 3 3 3 V a r i a n c e 0 . 0 7  0 . 1 6 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 1 1 6 6 6 7
F 2 . 3 3 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 4 . 1 8 3 3  s i n c e  t > 3 . 7 4 7  t h e r e  i s  a
P ( T < = t )  o n 0 . 0 0 6 9 4 1  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P { T < = t )  t w 0 . 0 1 3 8 8 1
t Critical tw 2.776451
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Fig. 5.8. B (cont)
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  P 8 7 3 )  K 0 2 2 )  P 8 7  3 )  K 0 2
M e a n 2 1 . 9 3 3 3 3 3 M e a n 2  1 . 9 3 3 3 3 3
V a r i a n c e 0 . 0 1 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 0 1  0 . 0 9 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 0 5 1 6 6 7
F 9 . 3 3 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 9 6 7 7 4 d f 4
F  C r i t i c a l  0 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
0 . 3 5 9 2 1 1  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 3 6 8 7 9 9
2 . 1 3 1 8 4 6
0 . 7 3 7 5 9 7
2 , 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  P 8 7  4 )  c o n t r o l
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  P 8 7  4 )  c o n t r o l
M e a n 2 2 . 7 6 6 6 6 7 M e a n 2  2 . 7 6 6 6 6 7
V a r i a n c e 0 . 0 1 0 . 1 6 3 3 3 3 V a r i a n c e 0 . 0 1  0 . 1 6 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 0 8 6 6 6 7
F 1 6 . 3 3 3 3 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 5 7 6 9 2 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
3 . 1 8 9 5 2 6  s i n c e  t > 2 . 7 7 6  t h e r e  i s  a
0 . 0 1 6 6 1 6  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 5
2 . 1 3 1 8 4 6
0 . 0 3 3 2 3 1
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
3 )  K 0 2  4 )  c o n t r o l
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
3 )  K 0 2  4 )  c o n t r o l
M e a n 1 . 9 3 3 3 3 3 2 . 7 6 6 6 6 7 M e a n 1 . 9 3 3 3 3 3  2 . 7 6 6 6 6 7
V a r i a n c e 0 . 0 9 3 3 3 3 0 . 1 6 3 3 3 3 V a r i a n c e 0 . 0 9 3 3 3 3  0 . 1 6 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 1 2 8 3 3 3
F 1 . 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 6 3 6 3 6 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < ” t )  t w
2 . 8 4 9 0 1 4  s i n c e  t > 2 . 7 7 6  t h e r e  i s  a  
0 . 0 2 3 2 2 1  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 5  
2 . 1 3 1 8 4 6  
0 . 0 4 6 4 4 2
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Fig 5.8. B amastigotes/PEC
7 day 1 1  z f a 2 )  P 8 7 3 1  K 0 2  4 1  c o n t r o l
promastigote 0 2 . 7 2 . 6 2 . 8
1 . 5 2 1 . 9 2 . 4
0 1 1 2 . 2
0 . 5  ± 0 . 9  1 . 9  ± 0 . 9 1 . 8  ± 0 . 8 2 . 6  ± 0 . 5
1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s 4
1 )  z f a 2 )  P 8 7 D z f a  2 )  P 8 7
M e a n  0 . 5 1 . 9 M e a n 0 . 5  1 . 9
V a r i a n c e  0 . 7 5 0 . 7 3 V a r i a n c e 0 . 7 5  0 . 7 3 [
O b s e r v a t i c  3 3 O b s e r v a t i c 3  3
d f  2 2 P o o l e d  V a i 0 . 7 4
F  1 . 0 2 7 3 9 7 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 4 9 3 2 4 3 d f 4
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t 1 , 9 9 3 2 3 2  n o  s i g n i f i c a n t  d i f f e r e n c e 'S'P ( T < = t )  o n 0 . 0 5 8 5 0 9
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 1 1 7 0 1 8
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  z f a 3 )  K 0 2 D z f a  3 ) K 0 2
M e a n  0 . 5 1 . 8 3 3 3 3 3 M e a n 0 . 5  1 . 8 3 3 3 3 3
V a r i a n c e  0 . 7 5 0 . 6 4 3 3 3 3 V a r i a n c e 0 . 7 5  0 . 6 4 3 3 3 3
O b s e r v a t i c  3 3 O b s e r v a t i c 3  3
d f  2 2 P o o l e d  V a i 0 . 6 9 6 6 6 7
F  1 . 1 6 5 8 0 3 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 4 6 1 7 2 2 d f 4 ;
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t 1 . 9 5 6 4 6 4  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 0 6 1 0 2 4
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6 j
P ( T < = t )  t w 0 . 1 2 2 0 4 9 i
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1 S
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s 11 )  z f a 4 )  c o n t r o l 1 )  z f a  4 )  c o n t r o l I
M e a n  0 . 5 2 . 4 6 6 6 6 7 M e a n 0 . 5  2 . 4 6 6 6 6 7
V a r i a n c e  0 . 7 5 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 7 5  0 , 0 9 3 3 3 3 Ï
O b s e r v a t i c  3 3 O b s e r v a t i c 3  3 ,i.
d f  2 2 P o o l e d  V a i 0 . 4 2 1 6 6 7 •Î
F  8 . 0 3 5 7 1 4 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 1 1 0 6 7 2 d f 4
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t 3 . 7 0 9 2 9 8  s i n c e  t > 2 . 7 7 6  t h e r e  i s  a Ï1,
P ( T < = t )  o n 0 . 0 1 0 3 3 3  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 5
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 , 0 2 0 6 6 7
t Critical tw 2.776451
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Fig 5.8. B (cont)
F-Test Two-Sampie for Variances t-Test; Two-Sample Assuming Equal Variances
2 )  P 8 7 3 )  K 0 2 2 )  P 8 7  3 )  K 0 2
M e a n 1 . 9 1 . 8 3 3 3 3 3 M e a n 1 . 9  1 . 8 3 3 3 3 3
V a r i a n c e 0 . 7 3 0 . 6 4 3 3 3 3 V a r i a n c e 0 . 7 3  0 . 6 4 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 6 8 6 6 6 7
F 1 . 1 3 4 7 1 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 6 8 4 4 7 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 0 . 0 9 8 5 3 3  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 4 6 3 1 2 5
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 9 2 6 2 4 9
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
2 )  P 8 7 4 )  c o n t r o l 2 )  P 8 7  4 )  c o n t r o l
M e a n 1 . 9 2 . 4 6 6 6 6 7 M e a n 1 . 9  2 . 4 6 6 6 6 7
V a r i a n c e 0 . 7 3 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 7 3  0 . 0 9 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 4 1 1 6 6 7
F 7 . 8 2 1 4 2 9 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 1 3 3 6 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 1 . 0 8 1 6 8 4  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 7 0 1 2 4
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 3 4 0 2 4 7
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
3 )  K 0 2 4 )  c o n t r o l 3 )  K 0 2  4 )  c o n t r o l
M e a n 1 . 8 3 3 3 3 3 2 . 4 6 6 6 6 7 M e a n 1 . 8 3 3 3 3 3  2 . 4 6 6 6 6 7
V a r i a n c e 0 . 6 4 3 3 3 3 0 . 0 9 3 3 3 3 V a r i a n c e 0 . 6 4 3 3 3 3  0 . 0 9 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 3 6 8 3 3 3
F 6 . 8 9 2 8 5 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 2 6 6 9 7 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t 1 . 2 7 8 0 7 8  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < “ t )  o n 0 . 1 3 5 1 7 5
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 2 7 0 3 5
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Fig 5.9. A %  Infected
11 ams 21 ziyg 31 zfa 41 control fdmsol
72h 3 0 2 0 3 . 3 2 2
lesion amastlgotes 3 5 2 8 2 9
5 1 4 5 2 3 4 2
4 0  ±  1 4 3 3  ±  1 2 1 8  ±  1 3 3 1  ±  1 0
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 2 )  z l v g 1 ) a m s  2 )  z l v g
M e a n  4 0 . 5 3 3 . 3 3 3 3 3 M e a n 4 0 . 5  3 3 . 3 3 3 3 3
V a r i a n c e  2 2 0 . 5 1 5 8 . 3 3 3 3 V a r i a n c e 2 2 0 . 5  158.3333
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 1 7 9 . 0 5 5 6
F  1 . 3 9 2 6 3 2 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 3 5 9 3 0 7 d f 3
F  C r i t i c a l  0 1 8 . 5 1 2 7 6 t 0 . 6 8 6 6 9 7  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 9 9 3 1 7
1 C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0 . 5 9 8 6 3 4
t  C r i t i c a l  tw 3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 3 )  z f a 1 ) a m s  3 )  z f a
M e a n  4 0 . 5 1 8 . 1 M e a n 4 0 . 5  1 8 . 1
V a r i a n c e  2 2 0 . 5 1 7 0 . 5 3 V a r i a n c e 2 2 0 . 5  1 7 0 . 5 3
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 1 8 7 . 1 8 6 7
F  1 . 2 9 3 0 2 8 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 3 7 3 3 7 7 d f 3
F  C r i t i c a l  0 1 8 . 5 1 2 7 6 t 1 . 7 9 3 4 9 9  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 0 8 5 3 9 4
t  C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0 . 1 7 0 7 8 9
t  C r i t i c a l  tw 3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s  r o l  ( d m s o ) 1 )  a m s  r o l  ( d m s o )
M e a n  4 0 . 5 3 1 M e a n 4 0 . 5  3 1
V a r i a n c e  2 2 0 . 5 1 0 3 V a r i a n c e 2 2 0 . 5  1 0 3
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a t 1 4 2 . 1 6 6 7
F  2 . 1 4 0 7 7 7 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 2 8 0 9 7 4 d f 3
F  C r i t i c a l  0 1 8 . 5 1 2 7 6 t 0 . 8 7 2 8 0 1  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 2 3 5 0 4
t  C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0 . 4 4 7 0 0 7
t  C r i t i c a l  tw 3 . 1 8 2 4 4 9
2 4 2 1
Lippcndix
% m A  (cont)
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  z l v g 3 )  z f a 2 )  z l v g  3 )  z f a
M e a n 3 3 . 3 3 3 3 3 1 8 . 1 M e a n  3 3 . 3 3 3 3 3  1 8 . 1
V a r i a n c e 1 5 8 . 3 3 3 3 1 7 0 . 5 3 V a r i a n c e  1 5 8 . 3 3 3 3  1 7 0 . 5 3
O b s e r v a t i c 3 3 O b s e r v a t i c  3  3
d f 2 2 P o o l e d  V a i  1 6 4 , 4 3 1 7
F 1 . 0 7 7 0 3 2 H y p o t h e s i z  0
P ( F < = f )  o n 0 . 4 8 1 4 5 6 d f  4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t  1 , 4 6 4 9 4 9  n o  s i g n i f i c a n t  d i f f e r e n c e  
P ( T < “ t ) o n  0 . 1 0 9 6 8 8  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 2 1 9 3 7 6  
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
2 )  z l v g  r o l  ( d m s o ) 2 )  z l v g  r o l  ( d m s o )
M e a n 3 3 . 3 3 3 3 3 3 1 M e a n  3 3 . 3 3 3 3 3  3 1
V a r i a n c e 1 5 8 . 3 3 3 3 1 0 3 V a r i a n c e  1 5 8 . 3 3 3 3  1 0 3
O b s e r v a t i c 3 3 O b s e r v a t i c  3  3
d f 2 2 P o o l e d  V a i  1 3 0 . 6 6 6 7
F 1 . 5 3 7 2 1 7 H y p o t h e s i z  0
P ( F < = f )  o n 0 . 3 9 4 1 3 3 d f  4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t  0 . 2 5  n o  s i g n i f i c a n t  d i f f e r e n c e  
P ( T < = t )  o n  0 . 4 0 7 4 5 1  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 8 1 4 9 0 2  
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
3 )  z f a  r o l  ( d m s o ) 3 )  z f a  r o l  ( d m s o )
M e a n 1 8 . 1 3 1 M e a n  1 8 . 1  3 1
V a r i a n c e 1 7 0 . 5 3 1 0 3 V a r i a n c e  1 7 0 . 5 3  1 0 3
O b s e r v a t i c 3 3 O b s e r v a t i c  3  3
d f 2 2 P o o l e d  V a i  1 3 6 . 7 6 5
F 1 . 6 5 5 6 3 1 H y p o t h e s i z  0
P ( F < = f )  o n 0 . 3 7 6 5 5 8 d f  4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t  1 . 3 5 0 9 7 7  n o  s i g n i f i c a n t  d i f f e r e n c e  
P ( T < = t )  o n  0 . 1 2 4 0 3 2  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 2 4 8 0 6 5
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Fig S.9. A
1) ams
%  infected 
21 zlvq 31 zfa ontrol (dmsol
7d 4 0 0 . 5 3 9
lesion amastigotes 3 5 0 . 2 3 6
4 2 2 3 0 . 5 3 5
4 1  ±  1 . 4 2 9  ± 8 , 5 0 . 4  ±  0 . 2 3 7  ± 2 . 0
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 2 )  z l v g 1 )  a m s  2 )  z l v g
M e a n 4 1 2 9 M e a n 4 1  2 9
V a r i a n c e 2 7 2 V a r i a n c e 2  7 2
O b s e r v a t i c 2 2 O b s e r v a t i c 2  2
d f 1 1 P o o l e d  V a i 3 7
F 3 6 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 0 5 1 3 7 d f 2
F  C r i t i c a l  o 3 9 . 8 6 3 6 1 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
1 . 9 7 2 7 8 8  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 0 9 3 6 2 9
2 . 9 1 9 9 8 7
0 . 1 8 7 2 5 7
4 . 3 0 2 6 5 6
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
1 ) a m s  3 )  z f a
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
1 )  a m s  3 )  z f a
M e a n 4 1 0 . 4 M e a n 4 1  0 . 4
V a r i a n c e 2 0 . 0 3 V a r i a n c e 2  0 . 0 3
O b s e n / a t i c 2 3 O b s e r v a t i c 2  3
d f 1 2 P o o l e d  V a i 0 . 6 8 6 6 6 7
F 6 6 . 6 6 6 6 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 1 4 6 7 1 d f 3
F  C r i t i c a l  o 1 8 . 5 1 2 7 6 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
5 3 . 6 7 1 4 9  s i n c e  t > 5 . 8  t h e r e  I s  a  h i g h l y
7 . 1 2 E - 0 6  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
2 . 3 5 3 3 6 3
1 . 4 2 E - 0 5
3 , 1 8 2 4 4 9
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s  
1 )  a m s  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
1 )  a m s  r o l  ( d m s o )
M e a n 4 1 3 6 . 6 6 6 6 7 M e a n 4 1  3 6 . 6 6 6 6 7
V a r i a n c e 2 4 . 3 3 3 3 3 3 V a r i a n c e 2  4 . 3 3 3 3 3 3
O b s e r v a t i c 2 3 O b s e r v a t i c 2  3
d f 1 2 P o o l e d  V a i 3 . 5 5 5 5 5 6
F 2 . 1 6 6 6 6 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 3 3 0 1 3 d f 3
F  C r i t i c a l  o 4 9 . 5 0 0 1 6 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w
2 . 5 1 7 4 3 9  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 0 4 3 1 8 5
2 . 3 5 3 3 6 3
0 . 0 8 6 3 7 1
t Critical tw 3.182449
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Fig. 5.9. A (cont)
F-Test: Two-Sampie for Variances t-Test: Two-Sampie Assuming Equal Variances
2 )  z l v g 3 )  z f a 2 )  z l v g  3 )  z f a
M e a n 2 9 0 . 4 M e a n 2 9  0 . 4
V a r i a n c e 7 2 0 . 0 3 V a r i a n c e 7 2  0 . 0 3  !
O b s e r v a t i c 2 3 O b s e r v a t i c 2  3
d f 1 2 P o o l e d  V a i 2 4 . 0 2
F 2 4 0 0 H y p o t h e s i z 0
P ( F < = f )  o n 0 , 0 0 0 4 1 6 d f 3
F  C r i t i c a l  o 1 8 , 5 1 2 7 6 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
6 . 3 9 2 4 9 1  s i n c e  t > 5 . 8  t h e r e  i s  a  h i g h l y
0 . 0 0 3 8 7 6  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1  1
2 . 3 5 3 3 6 3
0 . 0 0 7 7 5 3
3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  z l v g  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  z l v g  r o l  ( d m s o )
M e a n 2 9 3 6 . 6 6 6 6 7 M e a n 2 9  3 6 . 6 6 6 6 7
V a r i a n c e 7 2 4 . 3 3 3 3 3 3 V a r i a n c e 7 2  4 . 3 3 3 3 3 3
O b s e r v a t i c 2 3 O b s e r v a t i c 2  3
d f 1 2 P o o l e d  V a i 2 6 . 8 8 8 8 9
F 1 6 . 6 1 5 3 8 H y p o t h e s i z 0  4
P ( F < = f )  o n 0 . 0 5 5 2 4 5 d f 3
F  C r i t i c a l  o 1 8 . 5 1 2 7 6 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
1 . 6 1 9 6 1 1  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 1 0 1 8 7 7  i
2 . 3 5 3 3 6 3
0 . 2 0 3 7 5 5
3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
3 )  z f a  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
3 )  z f a  r o l  ( d m s o )
M e a n 0 . 4 3 6 . 6 6 6 6 7 M e a n 0 . 4  3 6 . 6 6 6 6 7
V a r i a n c e 0 . 0 3 4 . 3 3 3 3 3 3 V a r i a n c e 0 , 0 3  4 . 3 3 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3  n
d f 2 2 P o o l e d  V a i 2 . 1 8 1 6 6 7
F 1 4 4 . 4 4 4 4 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 0 6 8 7 5 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
3 0 . 0 7 1 7 8  s i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y  ;
3 . 6 4 E - 0 6  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
2 . 1 3 1 8 4 6
7 . 2 8 E - 0 6
2 . 7 7 6 4 5 1
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m .  5,9.6 amastigotes/PEC
72h Dams 2) zlvq 31 zfa ontrol (dmsol
lesion amastigotes 4 . 4 2 . 6 3 3 . 5
2 . 6 2.4 4 . 1
4 . 2 2 . 5 2 . 9 4 . 4
4 . 3  ± 0 . 1  2 . 6  ± 0 . 1 2 . 8  ±  0 . 3 4 . 0  ±  0 . 4
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 2 )  z l v g 1 )  a m s  2 )  z l v g
M e a n  4 . 3 2 . 5 6 6 6 6 7 M e a n 4 . 3  2 . 5 6 6 6 6 7
V a r i a n c e  0 . 0 2 0 . 0 0 3 3 3 3 V a r i a n c e 0 . 0 2  0 . 0 0 3 3 3 3
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 0 . 0 0 8 8 8 9
F  6 H y p o t h e s i z 0
P ( F < = f ) o n  0 , 1 3 3 9 7 5 d f 3
F  C r i t i c a l  0 1 8 . 5 1 2 7 6 t 2 0 . 1 3 9 5 1  s i n c e  t > 5 . 8  t h e r e  i s  a  h i g h l y
P ( T < " t )  o n 0 . 0 0 0 1 3 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
t  C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0.000268
t  C r i t i c a l  tw 3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 3 )  z f a 1 ) a m s  3 )  z f a
M e a n  4 . 3 2 . 7 6 6 6 6 7 M e a n 4 . 3  2 . 7 6 6 6 6 7
V a r i a n c e  0 . 0 2 0 . 1 0 3 3 3 3 V a r i a n c e 0 . 0 2  0 . 1 0 3 3 3 3
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 0 . 0 7 5 5 5 6
F  5 . 1 6 6 6 6 7 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 2 9 7 0 4 4 d f 3
F  C r i t i c a l  0 4 9 . 5 0 0 1 6 t 6 . 1 1 0 7 4 3  s i n c e  t > 5 , 8  t h e r e  i s  a  h i g h l y
P ( T < = t )  o n 0 . 0 0 4 4 0 3  s i g n i f i c a n t  d i f f e r e n c e  a t  P - 0 . 0 1
t  C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0 . 0 0 8 8 0 7
t  C r i t i c a l  tw 3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s  r o l  ( d m s o ) 1 )  a m s  r o l  ( d m s o )
M e a n  4 . 3 4 M e a n 4 . 3  4
V a r i a n c e  0 . 0 2 0 . 2 1 V a r i a n c e 0 . 0 2  0 . 2 1
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 0 . 1 4 6 6 6 7
F  1 0 . 5 H y p o t h e s i z 0
P ( F < = f ) o n  0 . 2 1 3 2 0 1 d f 3
F  C r i t i c a l  0 4 9 . 5 0 0 1 6 t 0 . 8 5 8 1 1 6  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 2 2 6 9 6
t  C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0 . 4 5 3 9 1 9
t Critical tw 3.182449
246
appendix
Fig, 6.9. B (cont)
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  z l v g 3 )  z f a 2 )  z l v g  3 )  z f a
M e a n 2 . 5 6 6 6 6 7 2 . 7 6 6 6 6 7 M e a n 2 . 5 6 6 6 6 7  2 . 7 6 6 6 6 7
V a r i a n c e 0 . 0 0 3 3 3 3 0 . 1 0 3 3 3 3 V a r i a n c e 0 . 0 0 3 3 3 3  0 , 1 0 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 0 5 3 3 3 3
F 3 1 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 3 1 2 5 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
1 . 0 6 0 6 6  n o  s i g n i f i c a n t  d i f f e r e n c e  
0 . 1 7 4 3 2 1  
2 . 1 3 1 8 4 6  
0 . 3 4 8 6 4 1  
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  z l v g  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  z l v g  r o l  ( d m s o )
M e a n 2 . 5 6 6 6 6 7 4 M e a n 2 . 5 6 6 6 6 7  4
V a r i a n c e 0 . 0 0 3 3 3 3 0 . 2 1 V a r i a n c e 0 . 0 0 3 3 3 3  0 . 2 1
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 1 0 6 6 6 7
F 6 3 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 0 1 5 6 2 5 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  tW ' 
t  C r i t i c a l  tw
5 . 3 7 5  s i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y  
0 . 0 0 2 8 9 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1  
2 . 1 3 1 8 4 6  
0 . 0 0 5 7 8 8  
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
3 )  z f a  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
3 )  z f a  r o l  ( d m s o )
M e a n 2 . 7 6 6 6 6 7 4 M e a n 2 . 7 6 6 6 6 7  4
V a r i a n c e 0 . 1 0 3 3 3 3 0 . 2 1 V a r i a n c e 0 . 1 0 3 3 3 3  0 . 2 1
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 0 . 1 5 6 6 6 7
F 2 . 0 3 2 2 5 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 2 9 7 8 7 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w
3 . 8 1 6 2 5 9  s i n c e  t > 3 . 7 4 7  t h e r e  i s  a  h i g h l y  
0 . 0 0 9 4 1 9  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 2  
2 . 1 3 1 8 4 6  
0 . 0 1 8 8 3 9
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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amastigotes/PEC
7d 11 ams 21 zlvq 31 zfa ontrol Idmsol
lesion amastigotes 7 . 7 1 5 . 8
2 . 8 3 4
5 . 7  2 . 4 3 3 . 1
6 . 7  ± 1 , 4  2 . 6  ± 0 . 3 2 . 3  ±  1 . 2 4 . 3  ±  1 . 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 2 )  z l v g 1 ) a m s  2 )  z l v g
M e a n  6 . 7 2.6 M e a n 6 . 7  2 . 6
V a r i a n c e  2 0 . 0 8 V a r i a n c e 2  0 . 0 8
O b s e r v a t i c  2 2 O b s e r v a t i c 2  2
d f  1 1 P o o l e d  V a i 1 . 0 4
F  2 5 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 1 2 5 6 6 6 d f 2
F  C r i t i c a l  0 1 6 1 . 4 4 6 2 t 4 . 0 2 0 3 8 1  s i n c e  t > 2 . 9 1  t h e r e  i s  a
P ( T < = t )  o n 0 . 0 2 8 3 3  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 1
t  C r i t i c a l  o r 2 . 9 1 9 9 8 7
P(T<=t) tw 0 . 0 5 6 6 6 1
t  C r i t i c a l  tw 4 . 3 0 2 6 5 6
F - T e s t :  T w o - S a m p l e f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 )  a m s 3 )  z f a 1 ) a m s  3 )  z f a
M e a n  6 . 7 2 . 3 3 3 3 3 3 M e a n 6 . 7  2 . 3 3 3 3 3 3
V a r i a n c e  2 1 . 3 3 3 3 3 3 V a r i a n c e 2  1 . 3 3 3 3 3 3
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 1 . 5 5 5 5 5 6
F  1 . 5 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 3 4 5 3 4 6 d f 3
F  C r i t i c a l  0 1 8 . 5 1 2 7 6 t 3 . 8 3 5 2 8 7  s i n c e  t > 3 . 1 8  t h e r e  i s  a
P ( T < = t )  o n 0 . 0 1 5 6 2 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . Q 5
t  C r i t i c a l  o r 2 , 3 5 3 3 6 3
P(T<=t) tw 0 . 0 3 1 2 4 9
t  C r i t i c a l  tw 3 , 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
1 ) a m s  r o l  ( d m s o ) 1 ) a m s  r o l  ( d m s o )
M e a n  6 . 7 4 . 3 M e a n 6 . 7  4 . 3
V a r i a n c e  2 1 . 8 9 V a r i a n c e 2  1 . 8 9
O b s e r v a t i c  2 3 O b s e r v a t i c 2  3
d f  1 2 P o o l e d  V a i 1 . 9 2 6 6 6 7
F  1 . 0 5 8 2 0 1 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 4 1 1 7 6 5 d f 3
F  C r i t i c a l  0 1 8 . 5 1 2 7 6 t 1 . 8 9 4 0 8 1  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 0 7 7 2 6 5
t  C r i t i c a l  o r 2 . 3 5 3 3 6 3
P ( T < = t )  t w 0 . 1 5 4 5 3 1
t Critical tw 3.182449
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F |g.5 .9 .B  (cont)
F-Test: Two-Sample for Variances t-Test: Two-Sample Assuming Equal Variances
2 )  z l v g 3 )  z f a 2 )  z l v g  3 )  z f a
M e a n 2 . 6 2 . 3 3 3 3 3 3 M e a n 2 . 6  2 . 3 3 3 3 3 3
V a r i a n c e 0 . 0 8 1 . 3 3 3 3 3 3 V a r i a n c e 0 . 0 8  1 . 3 3 3 3 3 3
O b s e r v a t i c 2 3 O b s e r v a t i c 2  3
d f 1 2 P o o l e d  V a i 0 . 9 1 5 5 5 6
F 1 6 . 6 6 6 6 7 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 7 0 6 6 4 d f 3
F  C r i t i c a l  o 4 9 . 5 0 0 1 6 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
0 . 3 0 5 2 9 3  n o  s i g n i f i c a n t  d i f f e r e n c e  
0 . 3 9 0 0 5  
2 . 3 5 3 3 6 3  
0 . 7 3 0 0 9 9  
3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  z l v g  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  z l v g  r o l  ( d m s o )
M e a n 2 . 6 4 . 3 M e a n 2 . 6  4 . 3
V a r i a n c e 0 . 0 8 1 . 8 9 V a r i a n c e 0 . 0 8  1 . 8 9
O b s e r v a t i c 2 3 O b s e r v a t i c 2  3
d f 1 2 P o o l e d  V a i 1 . 2 8 6 6 6 7
F 2 3 . 6 2 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 4 3 9 6 3 d f 3
F  C r i t i c a l  o 4 9 . 5 0 0 1 6 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
1 . 6 4 1 7 4 8  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 0 9 9 5 9 1
2 . 3 5 3 3 6 3
0 . 1 9 9 1 8 1
3 . 1 8 2 4 4 9
F - T e s t :  T w o - S a m p i e  f o r  V a r i a n c e s  
3 )  z f a  r o l  ( d m s o )
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
3 )  z f a  r o l  ( d m s o )
M e a n 2 . 3 3 3 3 3 3 4 . 3 M e a n 2 . 3 3 3 3 3 3  4 . 3
V a r i a n c e 1 . 3 3 3 3 3 3 1 . 8 9 V a r i a n c e 1 . 3 3 3 3 3 3  1 . 8 9
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 1 . 6 1 1 6 6 7
F 1 . 4 1 7 5 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 1 3 6 5 d f 4
F  C r i t i c a l  0 9 . 0 0 0 0 1 9 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w
1 . 8 9 7 3 1 2  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 0 6 5 3 2 2
2 . 1 3 1 8 4 6
0 . 1 3 0 6 4 3
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Table 5.1. cell line, inhibitor
wild tvoe + dmso + z-lva + z-fa dimcpbn
% 6 0  5 7 7 0 1 7 1 1
infected 4 7  4 2 3 2 2 4 , 9
5 2  3 7 2 5 2 0  r
5 3  ± 6 . 1  4 5  ± 1 1 4 2  ± 2 4 7 , 0  ±  8 . 7 5 . 3  ±  5 . 5
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
wild type + dmso wild type + dmso
M e a n 5 3 4 5 . 3 3 3 3 3 M e a n 5 3 4 5 . 3 3 3 3 3
V a r i a n c e 4 3 1 0 8 . 3 3 3 3 V a r i a n c e 4 3 1 0 8 . 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3 3
d f 2 2 P o o l e d  V a i 7 5 . 6 6 6 6 7
F 2 . 5 1 9 3 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 2 8 4 1 4 1 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 1 . 0 7 9 4 4 3 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 7 0 5 6 7
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 3 4 1 1 3 3
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
+ dmso + z-lvg + dmso + z-lvg
M e a n 4 5 . 3 3 3 3 3 4 2 . 3 3 3 3 3 M e a n 4 5 . 3 3 3 3 3 4 2 . 3 3 3 3 3
V a r i a n c e 1 0 8 . 3 3 3 3 5 8 6 . 3 3 3 3 V a r i a n c e 1 0 8 . 3 3 3 3 5 8 6 . 3 3 3 3
O b s e r v a t i c 3 3 O b s e r v a t i c 3 3
d f 2 2 P o o l e d  V a i 3 4 7 . 3 3 3 3
F 5 . 4 1 2 3 0 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 5 5 9 5 d f 4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t 0 . 1 9 7 1 4 9 n o  s i g n i f i c a n t  d i f f e r e n c e
P { T < = t )  o n 0 . 4 2 6 6 6 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P { T < = t )  t w 0 . 8 5 3 3 2 4
î  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Table 5.1. ( c o n t )
F - T e s t ;  T w o - S a m p l e  f o r  V a r i a n c e s  
+ z-lvg + z-fa
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
+ z-lvg + z-fa
M e a n 4 2 . 3 3 3 3 3 7 M e a n 4 2 . 3 3 3 3 3  7
V a r i a n c e 5 8 6 . 3 3 3 3 7 5 V a r i a n c e 5 8 6 . 3 3 3 3  7 5
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 3 3 0 . 6 6 6 7
F 7 . 8 1 7 7 7 8 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 1 1 3 4 0 7 d f 4
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w  
t  C r i t i c a l  tw
2 . 3 7 9 7 7  s i n c e  t > 2 . 1 3 1  t h e r e  i s  a  
0 . 0 3 8 0 0 4  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 1 
2 . 1 3 1 8 4 6  
0 . 0 7 6 0 0 8  
2 . 7 7 6 4 5 1
F - T e s t ;  T w o - S a m p l e  f o r  V a r i a n c e s  
+ dmso + z-fa
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
+ dmso + z-fa
M e a n 4 5 . 3 3 3 3 3 7 M e a n 4 5 . 3 3 3 3 3  7
V a r i a n c e 1 0 8 . 3 3 3 3 7 5 V a r i a n c e 1 0 8 . 3 3 3 3  7 5
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a t 9 1 . 6 6 6 6 7
F 1 . 4 4 4 4 4 4 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 4 0 9 0 9 1 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P { T < = t )  t w  
t  C r i t i c a l  tw
4 . 9 0 3 6 1 6  s i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y
0 . 0 0 4 0 1 2  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 1
2 . 1 3 1 8 4 6
0 . 0 0 8 0 2 3
2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
+ z-fa dimcpbn
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
+ z-fa dimcpbn
M e a n 7 5 . 3 M e a n 7  5 . 3
V a r i a n c e 7 5 3 0 . 3 7 V a r i a n c e 7 5  3 0 . 3 7
O b s e r v a t i c 3 3 O b s e r v a t i c 3  3
d f 2 2 P o o l e d  V a i 5 2 . 6 8 5
F 2 . 4 6 9 5 4 2 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 2 8 8 2 2 2 d f 4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t
P ( T < = t )  o n  
t  C r i t i c a l  o r  
P ( T < = t )  t w
0 . 2 8 6 8 4 7  n o  s i g n i f i c a n t  d i f f e r e n c e
0 . 3 9 4 2 3 7
2 . 1 3 1 8 4 6
0 . 7 8 8 4 7 4
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Table 5.1. cell line, inhibitor
wild tvoe + dmso + z-lva + z-fa dimcpbn
5 . 2  3 . 7 4 . 7 3 . 3 8
amastigotes/PEC 5 . 4  3 . 9 2 . 4 0 . 7 2 . 8
3 . 8  2 . 6 1 . 8 1 . 7 0
4 . 8  ± 0 . 9  3 . 4  ± 0 . 7 3 ±  1 . 5 1 . 9  ±  1 . 3 3 . 6  ± 4 . 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p i e  A s s u m i n g  E q u a l  V a r i a n c e s
wild type + dmso wild type + dmso
M e a n  4 . 8 3 . 4 M e a n 4 . 8 3 . 4
V a r i a n c e  0 . 7 6 0 . 4 9 V a r i a n c e 0 . 7 6 0 . 4 9
O b s e r v a t i c  3 3 O b s e r v a t i c 3 3
d f  2 2 P o o l e d  V a i 0 . 6 2 5
F  1 . 5 5 1 0 2 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 3 9 2 d f 4
F  C r i t i c a l  0 1 9 . 0 0 0 0 3 t 2 . 1 6 8 8 7 1 s i n c e  t > 2 . 1 3 1  t h e r e  i s  a
P ( T < = t )  o n 0 . 0 4 7 9 6 6 s i g n i f i c a n t  d i f f e r e n c e  a t  P = i
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 0 9 5 9 3 1
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p i e  A s s u m i n g  E q u a l  V a r i a n c e s
+ dmso + z-lvg + dmso + z-lvg
M e a n  3 . 4 2 . 9 6 6 6 6 7 M e a n 3 . 4 2 . 9 6 6 6 6 7
V a r i a n c e  0 . 4 9 2 . 3 4 3 3 3 3 V a r i a n c e 0 . 4 9 2 . 3 4 3 3 3 3
O b s e r v a t i c  3 3 O b s e r v a t i c 3 3
d f  2 2 P o o l e d  V a i 1 . 4 1 6 6 6 7
F  4 . 7 8 2 3 1 3 H y p o t h e s i z 0
P ( F < = f )  o n  0 . 1 7 2 9 4 1 d f 4
F  C r i t i c a l  0 9 . 0 0 0 0 1 9 t 0 . 4 4 5 8 9 6 n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 3 3 9 3 7 2
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 6 7 8 7 4 4
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Table 5.1. (cont)
F-Test: Two-Sample for Variances t-Test; Two-Sample Assuming Equal Variances
+ z-lvg + z-fa + z-lvg + z-fa
M e a n 2 . 9 6 6 6 6 7 1 . 9 M e a n  2 . 9 6 6 6 6 7  1 . 9
V a r i a n c e 2 . 3 4 3 3 3 3 1 . 7 2 V a r i a n c e  2 . 3 4 3 3 3 3  1 . 7 2
O b s e r v a t i c 3 3 O b s e r v a t i c  3  3
d f 2 2 P o o l e d  V a i  2 . 0 3 1 6 6 7  :
F 1 . 3 6 2 4 0 3 H y p o t h e s i z  0
P ( F < = f )  o n 0 . 4 2 3 2 9 8 d f  4
F  C r i t i c a l  o 1 9 . 0 0 0 0 3 t  0 . 9 1 6 5 3 3  n o  s i g n i f i c a n t  d i f f e r e n c e   ^
P ( T < = t ) o n  0 . 2 0 5 6 2 3  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 4 1 1 2 4 6  
t  C r i t i c a l  t\A 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
+ dmso + z-fa + dmso + z-fa
M e a n 3 . 4 1 . 9 M e a n  3 . 4  1 . 9
V a r i a n c e 0 . 4 9 1 . 7 2 V a r i a n c e  0 . 4 9  1 . 7 2
O b s e r v a t i c 3 3 O b s e r v a t i c  3  3
d f 2 2 P o o l e d  V a i  1 . 1 0 5
F 3 . 5 1 0 2 0 4 H y p o t h e s i z  0
P ( F < = f )  o n 0 . 2 2 1 7 1 9 d f  4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t  1 . 7 4 7 6 5 5  n o  s i g n i f i c a n t  d i f f e r e n c e  
P ( T < = t ) o n  0 . 0 7 7 7 2 1  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P { T < = t ) t w  0 . 1 5 5 4 4 1  
t  C r i t i c a l  tv \ 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
+ z-fa dimcpbn + z-fa dimcpbn
M e a n 1 . 9 3 . 6 M e a n  1 . 9  3 . 6
V a r i a n c e 1 . 7 2 1 6 . 4 8 V a r i a n c e  1 . 7 2  1 6 . 4 8
O b s e r v a t i c 3 3 O b s e r v a t i c  3  3
d f 2 2 P o o l e d  V a i  9 . 1
F 9 . 5 8 1 3 9 5 H y p o t h e s i z  0
P ( F < = f )  o n 0 . 0 9 4 5 0 5 d f  4
F  C r i t i c a l  o 9 . 0 0 0 0 1 9 t  0 , 6 9 0 1 9 8  n o  s i g n i f i c a n t  d i f f e r e n c e  
P ( T < = t )  o n  0 . 2 6 4 0 1 4  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t )  t w  0 . 5 2 8 0 2 8  
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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Table 5.2. wt lesion null lesion wt axam null axam
12 18 26 44 51 93
% MTT 12.1 16.4 31 33 52 57
reduction 12 16 2 14 44 30
11 28
12 ±0.1 17 ± 1.1 23 ± 15 51 ± 21
F-Test: Two-Sample for Variances 
w t lesion null lesion
Mean
Variance
Observatic
df
F
12.03333
0.003333
3
2
336
P(F<=f)on 0.002967 
F Critical 0 9.000019
16.8
1.12
3
2
t-Test: Two-Sample Assuming Equal Variances 
__________w t lesion null lesion
12.03333 16.8
0.003333 1.12
3 3 
0.561667
0
4
7.789706 since t>4.604 there is a highly 
P(T<=t) on 0.000732 significant at P = 0.01 
t Critical or 2.131846 
0.001465 
2.776451
Mean
Variance
Observatic
Pooled Va
Hypothesiz
df
t
P(T<=t) tw 
t Critical tv^
F-Test: Two-Sample for Variances 
w t axam null axam
Mean
Variance
Observatic
df
F
23
213.3333
7
6
2.202679
50.71429
469.9048
7
6
P(F<=f)on 0.179644 
F Critical 0 3.054552
F-Test: Two-Sample for Variances 
w t lesion w t axam
Mean
Variance
Observatic
df
F
P(F<=f) on
12.03333
0.003333
3
2
64000
1.56E-05
23
213.3333
7
6
F Critical 0 9.325504
t-Test: Two-Sample Assuming Equal Variances
 w taxam  null axam
Mean 23 50.71429
Variance 213.3333 469.9048 
Observatic 7 7
Pooled Va 341.619 
Hypothesiz 0
df 12
t 2,805218 since t>2.68 there is a highly
P(T<=t)on 0.007945 significant difference at P=0.02 
t Critical or 1.782287 
P(T<=t) tw 0.01589 
t Critical tw 2.178813
t-Test: Two-Sample Assuming Equal Variances 
w t lesion w t axam
Mean 
Variance 
Observatic 
Pooled Va 
Hypothesiz 
df 
t
P(T<=t)on 0.122211 
t Critical or 1.859548 
P(T<=t)tw 0.244421 
t Critical tw 2.306006
12.03333 23
0.003333 213.3333 
3 7
160.0008 
0 
8
1.256386 no significant difference
F-Test: Two-Sample for Variances 
null lesion null axam
Mean
Variance
Observatic
df
F
P(F<=f) on
16.8
1.12
3
2
419.5578
0.00238
50.71429
469.9048
7
6
F Critical o 9.325504
t-Test: Two-Sample Assuming Equal Variances 
null lesion null axam
Mean
Variance
Observatic
Pooled Va
Hypothesiz
df
t
P(T<=t) on 
t Critical or 
P ( T < = t )  tw
16.8 50.71429 
1.12 469.9048 
3 7
352.7086 
0 
8
2.616883 since t>2.306 there is a 
0.0154 significant difference at P=0.05 
1.859548 
0.030799
Critical tw 2.306006
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Tabla 3.1.
%
cells
intact
cell line
log wt 21 stat wt 31 stat null
4 3
3 9
5 3
4 5
5 4
6 3
10
20
2 7
4 5  ± 7 . 0  5 4  ± 9 . 3  1 9  ± 8 . 4
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
1 ) t o g  w t  2 )  s t a t  w t
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
1 ) l o g  w t  2 )  s t a t  w t
M e a n 4 5 5 4 M e a n 4 5 5 4
V a r i a n c e 5 2 8 1 V a r i a n c e 5 2 8 1
O b s e r v a t i c 3 3 O b s e r v a t i c 3 3
d f 2 2 P o o l e d  V a i 6 6 . 5
F 1 . 5 5 7 6 9 2 H y p o t h e s i z 0
P ( F < = f )  o n 0 . 3 9 0 9 7 7 d f 4
F  C r i t i c a l  o 9 , 0 0 0 0 1 9 t 1 . 3 5 1 6 9 1  n o  s i g n i f i c a n t  d i f f e r e n c e
P ( T < = t )  o n 0 . 1 2 3 9 2 8
t  C r i t i c a l  o r 2 . 1 3 1 8 4 6
P ( T < = t )  t w 0 . 2 4 7 8 5 5
t  C r i t i c a l  tw 2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s  
2 )  s t a t  w t  3 )  s t a t  n u l l
M e a n 5 4 1 9
V a r i a n c e 8 1 7 3
O b s e r v a t i c 3 3
d f 2 2
F 1 . 1 0 9 5 8 9
P ( F < = f )  o n 0 . 4 7 4 0 2 6
F  C r i t i c a l  o 1 9 . 0 0 0 0 3
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s  
2 )  s t a t  w t  3 )  s t a t  n u l l  
M e a n  5 4  1 9
V a r i a n c e  8 1  7 3
O b s e r v a t i c  3  3
P o o l e d  V a i  7 7
H y p o t h e s i z  0
d f  4
t  4 . 8 8 5 0 4 2  s i n c e  t > 4 . 6 0 4  t h e r e  i s  a  h i g h l y
P ( T < = t )  o n  0 . 0 0 4 0 6 6  s i g n i f i c a n t  d i f f e r e n c e  a t  P - 0 , 0 1  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 0 0 8 1 3 1  
t C r i t i c a l l y  2 . 7 7 6 4 5 1
F - T e s t :  T w o - S a m p l e  f o r  V a r i a n c e s
1 ) l o g  w t  3 )  s t a t  n u l l
M e a n 4 5 1 9
V a r i a n c e 5 2 7 3
O b s e r v a t i c 3 3
d f 2 2
F 1 . 4 0 3 8 4 6
P ( F < = f )  o n 0 . 4 1 6
F  C r i t i c a l  o 9 . 0 0 0 0 1 9
t - T e s t :  T w o - S a m p l e  A s s u m i n g  E q u a l  V a r i a n c e s
_ _ _ _ _ _ _ _ _ _ _ _ 1 )  l o g  w t  3 )  s t a t  n u l l
M e a n  4 5  1 9
V a r i a n c e  5 2  7 3
O b s e r v a t i c  3  3
P o o l e d  V a i  6 2 . 5
H y p o t h e s i z  0
d f  4
t  4 . 0 2 7 9 0 3  s i n c e  t > 3 . 7 4 7  t h e r e  i s  a
P ( T < = t )  o n  0 . 0 0 7 8 8  s i g n i f i c a n t  d i f f e r e n c e  a t  P = 0 . 0 2  
t  C r i t i c a l  o r  2 . 1 3 1 8 4 6  
P ( T < = t ) t w  0 . 0 1 5 7 6 1  
t  C r i t i c a l  tw  2 . 7 7 6 4 5 1
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